GadX (PTE*) - *
, * - *
however * - *
, * - *
activates * - *
only * - *
gadA (DNA*) - (A0*)
and * - *
gadBC (DNA*) - *
expression * express (V*)
. * - *

Under * - * *
anaerobic * - (A3* *
conditions * - *) *
, * - * *
FNR (PTE*) - (A1*) (A1*)
binds * bind (V*) *
to * - * *
a (DNA* - (A0* *
site *) - *) *
centred * - * *
at * - * *
position * - * *
-41 * - * *
. * - * *
5 * - * *
at * - * *
pnrfA * - * *
and * - * *
activates * activate * (V*)
transcription (PRC*) - * (A0*)
. * - * *

These * - * *
results * - * *
suggest * - * *
that * - * *
14-3-3eta * - * (A1*)
functions * - * *
as * - * *
a * - * *
positive * - * *
regulator * - * *
in * - * *
the * - * *
glucocorticoid * - * *
signal * - * *
pathway * - * *
by * - * *
blocking * - * *
the * - * *
degradation * - * *
of * - * *
GR (PTE*) - (A0*) *
and * - * *
inducing * - * *
an * - * *
elevation * elevate (V*) *
of * - * *
GR * - * *
, * - * *
thus * - * *
enhancing * enhance * (V*)
the * - * (A0*
transcriptional * - * *
activity * - * *
of * - * *
GR * - * *)
. * - * *

The (DNA* - (A0* (A0*
promoter *) - *) *)
does * - * *
not * - * *
contain * contain (V*) *
TCF-1/TCF-1 (DNA* - (A4* *
alpha * - * *
binding * - * *
sites *) - *) *
and * - * *
is * - * *
therefore * - * *
not * - * *
autoregulated * autoregulate * (V*)
. * - * *

Structure * - * *
and * - * *
regulation * regulation (V*) *
of * - * *
the (DNA* - (A0* (A1*
glpFK * - * *
operon *) - *) *)
encoding * encode * (V*)
glycerol (PTE* - * (A0*
diffusion * - * *
facilitator *) - * *)
and * - * *
glycerol (PTE* - * *
kinase *) - * *
of * - * *
Escherichia * - * *
coli * - * *
K-12 * - * *
. * - * *

The (DNA* - (A1*
second *) - *)
contains * contain (V*)
a (DNA* - (A0*
binding * - *
site *) - *)
at * - (A2*
+20 * - *
bp * - *)
for * - *
both * - *
PU * - *
. * - *
1 * - *
itself * - *
and * - *
the * - *
related * - *
ets * - *
family * - *
member * - *
Spi-B * - *
. * - *

Dominant (PRC* - (A1* *
negative * - * *
mutations *) - *) *
that * - * *
derepress * derepress (V*) *
lysU (DNA*) - (A0* (A0*)
expression * express *) (V*)
were * - * *
isolated * - * *
in * - * *
this * - * *
study * - * *
. * - * *

When * - * *
studied * - * *
with * - * *
operon * - * *
fusions * - * *
to * - * *
lacZ * - * *
, * - * *
the (DNA* - (A0* (A0*
PA * - * *
and * - * *
PF * - * *
promoters *) - *) *)
were * - * *
activated * activate (V*) *
by * - * *
D-xylose (EXP*) - (A1*) *
and * - * *
repressed * repress * (V*)
by * - * *
glucose (EXP*) - * (A1*)
. * - * *

Expression * express (V*) *
from * - * *
this (DNA* - (A6* *
promoter *) - *) *
is * - * *
totally * - * *
dependent * - * *
on * - * *
the * - * *
transcription * - * *
factor * - * *
, * - * *
FNR (PTE*) - * (A1*)
, * - * *
which * - * *
binds * bind * (V*)
between * - * (A7*
positions * - * *
-52 * - * *
and * - * *
-30 * - * *)
upstream * - * *
of * - * *
the * - * *
transcription * - * *
startsite * - * *
. (DNA*) - * *

In * - (A2*
a (None* - *
gntR * - *
deletion * - *
mutant *) - *)
, * - *
the * - *
expression * express (V*)
of * - *
a (DNA* - (A0*
chromosomal * - *
gntT * - *
: * - *
: * - *
lacZ * - *
fusion *) - *)
is * - *
both * - *
high * - *
and * - *
constitutive * - *
, * - *
confirming * - *
that * - *
GntR * - *
is * - *
the * - *
negative * - *
regulator * - *
of * - *
gntT * - *
. * - *

Regulation * - * *
of * - * *
pfl (DNA*) - (A0*) *
expression * express (V*) *
by * - * *
nitrate (EXP*) - * *
was * - * *
dependent * - * *
on * - * *
the (PTE* - * *
NarL * - * *
, * - * *
NarP * - * *
, * - * *
NarQ * - * *
, * - * *
and * - * *
NarX * - * *
proteins *) - * *
but * - * *
independent * - * *
of * - * *
FNR * - * *
, * - * *
ArcA * - * *
, * - * *
and * - * *
integration * - * *
host * - * *
factor * - * *
, * - * *
which * - * *
are * - * *
additional * - * *
regulators * - * *
of * - * *
pfl (DNA*) - * (A0*)
expression * express * (V*)
. * - * *

In * - *
contrast * - *
to * - *
sigma * - *
s * - *
, * - *
which * - *
is * - *
induced * - *
in * - *
response * - *
to * - *
many * - *
different * - *
stresses * - *
, * - *
csiD (DNA*) - (A0*)
, * - *
whose * - *
expression * - *
is * - *
driven * - *
from * - *
a * - *
single * - *
promoter * - *
, * - *
is * - *
induced * induce (V*)
by * - *
carbon * - (A1*
starvation * - *)
only * - *
. * - *

Binding * bind (V*)
of * - *
the (PTE* - (A1*
glp * - *
repressor *) - *)
protected * - *
the (DNA* - *
region * - *
-32 * - *
to * - *
-51 *) - *
( * - *
OT * - *
) * - *
in * - *
the (DNA* - *
glpTQ * - *
promoter *) - *
, * - *
which * - *
was * - *
also * - *
the * - *
binding * - *
site * - *
for * - *
cAMP * - *
. * - *
CRP * - *
. * - *

Moreover * - *
, * - *
we * - *
have * - *
identified * - *
sequences (DNA*) - (A1*)
within * - (A2*
tal * - *)
that * - *
potentially * - *
encode * encode (V*)
an (PTE* - (A0*
amphipathic * - *
helix-loop-helix * - *
motif *) - *)
, * - *
a * - *
DNA-binding * - *
domain * - *
found * - *
in * - *
a * - *
variety * - *
of * - *
proteins * - *
that * - *
control * - *
cell * - *
growth * - *
and * - *
differentiation * - *
. (DNA*) - *

Hybrid (DNA* - (A1*
plasmids *) - *)
carrying * carry (V*)
glpD''lacZ (DNA* - (A0*
and * - *
glpR''lacZ * - *
fusions *) - *)
were * - *
constructed * - *
. * - *

Pseudo-HPr (PTE*) - (A0*) * * *
suppressor * - (A5*) * * *
mutations * mutations (V*) * * *
( * - * * * *
fruR * - * * * *
) * - * * * *
and * - * * * *
a (PRC* - * (A0* * *
deletion *) - * *) * *
extending * extend * (V*) * *
clockwise * - * (A5*) * *
from * - * * * *
leu (DNA*) - * (A6*) * *
resulted * - * * * *
in * - * * * *
the * - * * * *
constitutive * - * * (A5*) *
expression * express * * (V*) *
of * - * * * *
the (DNA* - * * (A0* (A0*
fru * - * * * *
operon *) - * * *) *)
containing * contain * * * (V*)
the * - * * * *
genes * - * * * *
for * - * * * *
IIFru * - * * * *
( * - * * * *
fruA (DNA*) - * * * (A4*)
) * - * * * *
, * - * * * *
IIIFru * - * * * *
( * - * * * *
fruB (DNA*) - * * * *
) * - * * * *
, * - * * * *
fructose * - * * * *
1-phosphate * - * * * *
kinase * - * * * *
( * - * * * *
fruK (DNA*) - * * * *
) * - * * * *
and * - * * * *
pseudo-HPr * - * * * *
( * - * * * *
fruF (DNA*) - * * * *
) * - * * * *
. * - * * * *

Restriction * - *
endonuclease * - *
cleavage * - *
analysis * - *
of * - *
these * - *
two * - *
plasmids * - *
demonstrated * - *
that * - *
glpD (DNA*) - (A0*)
and * - *
glpR (DNA*) - (A0*)
are * - *
divergently * - (A5*)
transcribed * transcribe (V*)
. * - *

Integration * - *
host * - *
factor * - *
is * - *
a * - *
negative * - *
effector * - *
of * - *
in * - (A5*
vivo * - *)
and * - *
in * - *
vitro * - *
expression * express (V*)
of * - *
ompC (PTE*) - (A0*)
in * - (A2*
Escherichia (ORG* - *
coli *) - *)
. * - *

GadE (PTE*) - (A0*)
( * - *
YhiE * - *
) * - *
: * - *
a * - *
novel * - *
activator * - *
involved * involve (V*)
in * - (A4*
the * - *
response * - *)
to * - *
acid * - *
environment * - *
in * - *
Escherichia * - *
coli * - *
. * - *

A (DNA* - (A1* (A0* *
transducing * - * * *
lambda * - * * *
phage *) - *) *) *
carrying * carry (V*) * *
glpD''lacZ (DNA*) - (A0*) * *
, * - * * *
glpR (DNA*) - * * *
, * - * * *
and * - * * *
malT (DNA*) - * * *
was * - * * *
isolated * isolate * (V*) *
from * - * * *
a (None* - * (A6* (A0*
strain *) - * *) *)
harboring * harbor * * (V*)
a (DNA* - * * (A4*
glpD''lacZ * - * * *
fusion *) - * * *)
. * - * * *

Interleukin * - * *
enhancer * - * *
binding * - * *
factor * - * *
( * - * *
ILF (PTE*) - (A1*) *
) * - * *
binds * bind (V*) *
to * - * *
the * - * *
interleukin-2 * - * *
( * - (A7* *
IL-2 * - * *
) * - * *
promoter * - *) *
and * - * *
regulates * - * *
IL-2 (DNA* - * (A0*
gene *) - * *)
expression * express * (V*)
. * - * *

In * - (A5*
vitro * - *)
interactions * interact (V*)
of * - *
integration (PTE* - (A1*
host * - *
factor *) - *)
with * - *
the (DNA* - (A1*
ompF * - *
promoter-regulatory * - *
region *) - *)
of * - *
Escherichia * - *
coli * - *
. * - *

Aerobic * - *
sn-glycerol * - *
3-phosphate * - *
dehydrogenase * - *
is * - *
a (PTE* - (A0*
cytoplasmic * - *
membrane-associated * - *
respiratory * - *
enzyme *) - *)
encoded * encode (V*)
by * - *
the (DNA* - (A1*
glpD * - *
gene *) - *)
of * - *
Escherichia * - *
coli * - *
. * - *

In * - *
previous * - *
work * - *
, * - *
we * - *
found * - *
that * - *
alanine (PTE*) - *
or * - *
leucine (PTE*) - *
acted * - *
as * - *
inducers * - *
to * - *
antagonize * - *
Lrp (PTE*) - (A1*)
repression * repress (V*)
of * - *
the (DNA* - (A0*
three * - *
major * - *
promoters *) - *)
directly * - *
. * - *

Significant * - (A0* *
levels * - * *
of * - * *
luciferase * - * *
activity * - *) *
were * - * *
detected * detect (V*) *
when * - * *
this (DNA* - (A12* *
construct *) - * *
was * - * *
transfected * - * *
into * - * *
two (ORG* - * *
kidney-derived * - * *
cell * - * *
lines *) - * *
, * - * *
293 * - * *
and * - * *
COS-7 * - * *
cells * - *) *
, * - * *
whereas * - * *
only * - * *
background (DNA* - * (A0*
reporter * - * *
gene *) - * *)
expression * express * (V*)
was * - * *
observed * - * *
in * - * *
a (ORG* - * *
cell * - * *
line *) - * *
of * - * *
nonkidney * - * *
origin * - * *
. * - * *

These * - *
results * - *
indicate * - *
that * - *
transcription * transcription (V*)
of * - *
the (DNA* - (A0*
E * - *
. * - *
coli * - *
group * - *
1 * - *
capsule * - *
cluster *) - *)
itself * - *
is * - *
not * - *
regulated * - *
by * - *
the * - *
Rcs * - *
system * - *
and * - *
may * - *
, * - *
in * - *
fact * - *
, * - *
be * - *
constitutive * - *
. * - *

These * - *
results * - *
suggest * - *
involvement * - *
of * - *
glpACB * - *
operator * - *
( * - *
s * - *
) * - *
in * - *
control * - *
of * - *
glpTQ (DNA*) - (A0*)
expression * express (V*)
perhaps * - *
via * - *
formation * - *
of * - *
a * - *
repression * - *
loop * - *
. * - *

In * - * *
agreement * - * *
with * - * *
this * - * *
observation * - * *
, * - * *
the * - * *
introduction * introduce (V*) *
of * - * *
mutations (PRC*) - (A0*) *
into * - (A2* *
the (DNA* - * *
putative * - * *
binding * - * *
element *) - *) *
for * - * *
the * - * *
cAMP-CRP * - * *
complex * - * *
enhanced * - * *
the * - * *
expression * express * (V*)
of * - * *
gcd (DNA*) - * (A0*)
. * - * *

Gel * - *
retardation * - *
experiments * - *
and * - *
DNase * - *
I * - *
footprinting * - *
studies * - *
revealed * - *
that * - *
IHF (PTE*) - (A1*)
binds * bind (V*)
to * - *
three (DNA* - (A7*
sites *) - *)
in * - *
the * - *
ompB * - *
promoter * - *
region * - *
. * - *

Moreover * - *
, * - *
a * - *
fruR * - (A5*
null * - *)
mutation * mutation (V*)
altered * - *
the * - *
rates * - *
of * - *
utilization * - *
of * - *
at * - *
least * - *
36 * - *
carbon * - *
sources * - *
. * - *

The * - (A1*
[ * - *
4Fe-4S * - *
] * - *
( * - *
2+ * - *
) * - *
cluster * - *)
of * - *
FNR * - *
is * - *
oxygen * - *
labile * - *
and * - *
controls * control (V*)
protein * - (A0*
dimerization * - *)
and * - *
site-specific * - *
DNA * - *
binding * - *
. * - *

Dissociation * - *
of * - *
the * - *
expression * express (V*)
of * - *
the (DNA* - (A0*
ftsZ * - *
gene *) - *)
, * - *
located * - *
after * - *
ftsQ * - *
and * - *
A * - *
near * - *
the * - *
3' * - *
end * - *
of * - *
the * - *
cluster * - *
, * - *
from * - *
its * - *
natural * - *
regulatory * - *
signals * - *
leads * - *
to * - *
an * - *
alteration * - *
in * - *
the * - *
physiology * - *
of * - *
cell * - *
division * - *
. * - *

The * - (A0* *
metabolic * - * *
pathways * - *) *
specified * specify (V*) *
by * - * *
the (DNA* - (A1* *
glc * - * *
and * - * *
ace * - * *
operons *) - *) *
in * - * *
Escherichia * - * *
coli * - * *
yield * - * *
glyoxylate * - * *
as * - * *
a * - * *
common * - * *
intermediate * - * *
, * - * *
which * - * *
is * - * *
acted * - * *
on * - * *
by * - * *
two * - * *
malate (PTE* - * (A0*
synthase * - * *
isoenzymes *) - * *)
: * - * *
one * - * *
encoded * encode * (V*)
by * - * *
glcB (DNA*) - * (A1*)
and * - * *
the * - * *
other * - * *
by * - * *
aceB (DNA*) - * *
. * - * *

However * - * *
, * - * *
sigma * - * *
s-dependent * - * *
transcription * transcription (V*) *
of * - * *
aidB (DNA*) - (A0*) *
is * - * *
inhibited * - * *
both * - * *
in * - * *
vitro * - * *
and * - * *
in * - * *
vivo * - * *
by * - * *
binding * bind * (V*)
of * - * *
the * - * *
transcriptional * - * *
regulator * - * *
Lrp * - * *
( * - * *
leucine (PTE* - * (A0*
responsive * - * *
protein *) - * *)
) * - * *
to * - * *
the * - * *
aidB * - * *
promoter * - * *
region * - * *
( * - * *
PaidB (DNA*) - * (A7*)
) * - * *
. * - * *

The * - *
expression * express (V*)
of * - *
MRL3 (PTE*) - (A0*)
is * - *
higher * - (A9*)
in * - (A2*
colon (ORG* - *
carcinoma *) - *)
and * - *
lymphoma (ORG* - *
cell * - *
lines *) - *
than * - *
in * - *
normal * - *
liver * - *
, * - *
placenta * - *
and * - *
diploid * - *
fibroblasts * - *
, * - *
and * - *
is * - *
also * - *
higher * - *
in * - *
fetal * - *
than * - *
in * - *
adult * - *
liver * - *
. * - *

The (DNA* - (A1*
agaZVWEFASYBCDI * - *
gene * - *
cluster *) - *)
encodes * encode (V*)
the (PTE* - (A0*
phosphotransferase * - *
systems * - *
and * - *
enzymes *) - *)
responsible * - *
for * - *
the * - *
uptake * - *
and * - *
metabolism * - *
of * - *
N-acetylgalactosamine * - *
and * - *
galactosamine * - *
in * - *
Escherichia * - *
coli * - *
. * - *

FNR (PTE* - (A0* (A1*
samples *) - *) *)
inactivated * inactivate (V*) *
by * - * *
either * - * *
O (EXP* - (A1* *
( * - * *
2 * - * *
) *) - *) *
or * - * *
NO (EXP*) - * *
bind * bind * (V*)
specifically * - * (A5*)
to * - * *
P (DNA* - * (A7*
( * - * *
hmp * - * *
) * - * *
, *) - * *)
but * - * *
with * - * *
lower * - * *
affinity * - * *
. * - * *

Translation * translate (V*)
of * - *
the (DNA* - (A0*
mRNA *) - *
starting * - *
at * - *
-292 * - *)
, * - *
but * - *
not * - *
the * - *
one * - *
starting * - *
at * - *
-188 * - *
, * - *
requires * - *
RNase (PTE* - (A3*
III *) - *)
. * - *

ISGF3 (PTE* - (A1*
gamma *) - *)
translated * - *
in * - *
vitro * - *
from * - *
recombinant * - *
clones * - *
bound * bound (V*)
DNA (DNA*) - (A7*)
with * - *
a * - *
specificity * - *
indistinguishable * - *
from * - *
that * - *
of * - *
ISGF3 * - *
gamma * - *
purified * - *
from * - *
HeLa * - *
cells * - *
. * - *

Using * - *
the * - *
luciferase * - *
reporter-gene * - *
assay * - *
, * - *
we * - *
found * - *
that * - *
they * - (A1*)
repress * repress (V*)
the * - (A0*
gene (PRC* - *
transcription *) - *
activity * - *)
independent * - *
of * - *
the * - *
differences * - *
of * - *
enhancers * - *
and * - *
promoters * - *
used * - *
, * - *
although * - *
the * - *
repressive * - *
activity * - *
of * - *
RFP * - *
was * - *
much * - *
stronger * - *
than * - *
that * - *
of * - *
EPC * - *
. * - *

We * - * *
propose * - * *
that * - * *
FIS (PTE* - (A1* *
and * - * *
IHF *) - *) *
each * - * *
function * - * *
directly * - * *
as * - * *
anti-activators * - * *
of * - * *
CRP * - * *
, * - * *
each * - * *
working * work (V*) *
independently * - (A5*) *
at * - (A12* *
different * - * *
times * - * *
during * - * *
growth * - *) *
to * - (A11* *
set * - * *
the * - * *
levels * - *) *
of * - * *
CRP-dependent * - * (A5*)
acs (DNA*) - * (A0*)
transcription * transcription * (V*)
. * - * *

DNA * - * *
loop * - * *
formation * - * *
between * - * *
Nag (PTE* - (A1* *
repressor * - * *
molecules *) - *) *
bound * bound (V*) *
to * - * *
its (DNA* - (A7* *
two * - * *
operator * - * *
sites *) - *) *
is * - * *
necessary * - * *
for * - * *
repression * repress * (V*)
of * - * *
the (DNA* - * (A0*
nag * - * *
regulon *) - * *)
of * - * *
Escherichia * - * *
coli * - * *
in * - * (A5*
vivo * - * *)
. * - * *

The * - *
region * - *
of * - *
the * - *
deletion * - *
corresponds * - *
to * - *
the (DNA* - (A1*
second * - *
HMG-box *) - *)
, * - *
which * - *
may * - *
interact * interact (V*)
directly * - *
with * - *
DNA (DNA*) - (A1*)
. * - *

The (DNA* - (A3* (A3*
nucleotides *) - *) *)
extending * - * *
from * - * *
position * - * *
-91 * - * *
to * - * *
-79 * - * *
are * - * *
essential * - * *
not * - * *
only * - * *
for * - * *
sequence-specific * - (A5*) *
recognition * recognize (V*) *
of * - * *
the (DNA* - (A0* (A0*
ompF * - * *
promoter *) - *) *)
by * - * *
the * - (A1* *
OmpR * - * *
protein * - *) *
, * - * *
but * - * *
also * - * *
for * - * *
OmpR-dependent * - * (A5*)
activation * activate * (V*)
of * - * *
the * - * *
ompF * - * *
promoter * - * *
. * - * *

We * - *
report * - *
the * - *
characterization * - *
of * - *
the * - *
in * - (A5*
vitro * - *)
interactions * interact (V*)
of * - *
CRP (PTE*) - (A1*)
with * - *
its (DNA* - (A1*
four * - *
adjacent * - *
binding * - *
sites *) - *)
and * - *
the * - *
analysis * - *
of * - *
their * - *
function * - *
in * - *
vivo * - *
. * - *

Expression * express (V*)
of * - *
fimA (DNA*) - (A0*)
, * - *
the * - *
structural * - *
gene * - *
for * - *
type * - *
1 * - *
fimbriae * - *
of * - *
Escherichia * - *
coli * - *
, * - *
is * - *
phase * - *
variable * - *
. * - *

Positive * - (A5*)
autoregulation * autoregulate (V*)
of * - *
the (DNA* - (A0*
PU * - *
. * - *
1 * - *
promoter *) - *)
may * - *
play * - *
an * - *
important * - *
role * - *
in * - *
the * - *
function * - *
of * - *
PU * - *
. * - *
1 * - *
in * - *
myeloid * - *
cells * - *
. * - *

The (PTE* - *
Stat1 * - *
protein *) - *
is * - *
required * - *
for * - *
all * - *
transcriptional * - (A5*)
responses * respond (V*)
to * - *
IFN (EXP*) - (A0*)
( * - *
both * - *
type * - *
I * - *
and * - *
type * - *
II * - *
) * - *
. * - *

The * - *
interaction * - *
of * - *
Nrf1 (PTE*) - *
with * - *
c (PTE* - *
-jun *) - *
, * - *
junD (PTE*) - *
, * - *
fosB (PTE*) - *
and * - *
ATF2 (PTE*) - *
in * - *
mast (ORG* - *
cells *) - *
is * - *
in * - *
contrast * - *
to * - *
the * - *
recently * - *
reported * - *
binding * bind (V*)
of * - *
Nrf1 * - (A1*)
alone * - (A5*)
at * - *
the (DNA* - (A7*
kappa3/AP1 * - *
( * - *
- * - *
) * - *
site *) - *)
in * - (A2*
dendritic (ORG* - *
cells *) - *)
. * - *

The * - *
complexities * - *
observed * - *
in * - *
the * - *
regulation * - *
of * - *
gene (DNA*) - (A0*)
expression * express (V*)
in * - (A2*
the * - *
cluster * - *)
may * - *
then * - *
have * - *
an * - *
important * - *
biological * - *
role * - *
. * - *

Here * - *
we * - *
report * - *
the * - *
characterization * - *
of * - *
the (DNA* - (A1*
human * - *
gene *) - *)
encoding * encode (V*)
this (PTE* - (A0*
factor *) - *)
. * - *

In * - *
total * - *
, * - *
we * - *
identified * - *
299 (DNA* - (A1*
cDNAs *) - *)
that * - *
activate * activate (V*)
the * - (A0*
NF-kappaB * - *
pathway * - *)
, * - *
and * - *
we * - *
classified * - *
them * - *
into * - *
83 * - *
genes * - *
, * - *
including * - *
30 * - *
characterized * - *
activator * - *
genes * - *
of * - *
the * - *
NF-kappaB * - *
pathway * - *
, * - *
28 * - *
genes * - *
whose * - *
involvement * - *
in * - *
the * - *
NF-kappaB * - *
pathways * - *
have * - *
not * - *
been * - *
characterized * - *
and * - *
25 * - *
novel * - *
genes * - *
. * - *

We * - *
show * - *
here * - *
that * - *
CRP (PTE*) - *
stimulated * - *
the * - *
transcription * transcription (V*)
of * - *
both (DNA* - (A0*
genes *) - *)
. * - *

When * - *
expressed * express (V*)
in * - (A12*
a (EXP* - *
transient * - *
transfection * - *
assay *) - *)
with * - *
a * - *
suitable * - *
reporter * - *
plasmid * - *
, * - *
E4BP4 (PTE*) - (A0*)
strongly * - *
repressed * - *
transcription (PRC*) - *
in * - *
a * - *
DNA-binding-site-dependent * - *
manner * - *
. * - *

Recombinant * - * *
NFAT1 * - * *
( * - * *
NFATp (PTE*) - (A0*) *
) * - * *
is * - * *
regulated * regulate (V*) *
by * - * *
calcineurin (PTE*) - (A1*) *
in * - (A2* *
T (ORG* - * *
cells *) - *) *
and * - * *
mediates * - * *
transcription * transcription * (V*)
of * - * *
several (DNA* - * (A0*
cytokine * - * *
genes *) - * *)
. * - * *

The * - *
role * - *
of * - *
the (PTE* - (A1*
trehalose * - *
system *) - *)
in * - *
regulating * regulate (V*)
the (DNA* - (A0*
maltose * - *
regulon *) - *)
of * - *
Escherichia * - *
coli * - *
. * - *

These * - (A1*
two * - *
regulations * - *)
compete * compete (V*)
to * - *
some * - *
extent * - *
but * - *
they * - *
are * - *
not * - *
mutually * - *
exclusive * - *
. * - *

Regulation * - * * * *
of * - * * * *
expression * express (V*) * * *
of * - * * * *
the (DNA* - (A0* (A1* * (A0*
adhE * - * * * *
gene *) - *) *) * *)
, * - * * * *
encoding * encode * (V*) * *
ethanol (PTE* - * (A0* * *
oxidoreductase *) - * *) * *
in * - * (A2* * *
Escherichia (ORG* - * * * *
coli *) - * *) * *
: * - * * * *
transcription * transcription * * (V*) *
from * - * * * *
a (DNA* - * * (A6* *
downstream * - * * * *
promoter *) - * * *) *
and * - * * * *
regulation * regulation * * * (V*)
by * - * * * *
fnr (PTE*) - * * * (A1*)
and * - * * * *
RpoS (PTE*) - * * * *
. * - * * * *

Binding * bind (V*)
of * - *
IHF (PTE*) - (A1*)
within * - (A2*
the (DNA* - *
region *) - *)
between * - *
the * - *
hyp * - *
and * - *
the * - *
hyc * - *
operon * - *
could * - *
be * - *
shown * - *
. * - *

The * - *
increase * increase (V*)
in * - *
expression (PRC*) - (A0*)
is * - *
due * - *
in * - *
part * - *
to * - *
a * - *
complete * - *
loss * - *
of * - *
autoregulation * - *
and * - *
in * - *
part * - *
to * - *
a * - *
GcvA-independent * - *
mechanism * - *
. * - *

Transcriptional * - (A5*)
repression * repress (V*)
by * - *
a (PTE* - (A1*
novel * - *
member * - *
of * - *
the * - *
bZIP * - *
family *) - *)
of * - *
transcription * - *
factors * - *
. * - *

It * - * *
does * - * *
this * - * *
primarily * - * *
by * - * *
repressing * - * *
production * produce (V*) *
of * - * *
sigma (PTE* - (A0* *
S *) - *) *
, * - * *
the * - * *
sigma * - * *
factor * - * *
responsible * - * *
for * - * *
gadX (DNA*) - * (A0*)
expression * express * (V*)
. * - * *

Regulation * - (A0*)
is * - *
exerted * exert (V*)
at * - *
the * - (A5*
transcriptional * - *
and * - *
post-transcriptional * - *
levels * - *)
. * - *

Examination * - * *
of * - * *
expression * express (V*) *
of * - * *
transcriptional (DNA* - (A0* *
fusions *) - *) *
allowed * - * *
us * - * *
to * - * *
demonstrate * - * *
autoregulation * autoregulate * (V*)
of * - * *
both (DNA* - * (A0*
genes *) - * *)
by * - * *
IHF (PTE*) - * (A1*)
. * - * *

We * - *
demonstrate * - *
here * - *
that * - *
oxLDL (EXP*) - (A1*)
activates * activate (V*)
PPARgamma-dependent (PRC* - (A0*
transcription *) - *)
through * - *
a * - (A5*
novel * - *
signaling * - *
pathway * - *)
involving * - *
scavenger * - *
receptor-mediated * - *
particle * - *
uptake * - *
. * - *

Thus * - * *
, * - * *
a (PTE* - * (A0*
member * - * *
of * - * *
the * - * *
SWI/SNF * - * *
family *) - * *)
acts * - * *
directly * - * *
in * - * *
transcriptional * - (A5*) *
activation * activate (V*) *
and * - * *
may * - * *
regulate * - * *
subsets (DNA* - * *
of * - * *
genes *) - * *
by * - * *
selectively * - * (A5*)
interacting * interact * (V*)
with * - * *
specific (PTE* - * (A0*
DNA-binding * - * *
proteins *) - * *)
. * - * *

Mobility * - *
shift * - *
assays * - *
showed * - *
that * - *
the (PTE* - (A1*
FlhD/FlhC * - *
complex *) - *)
had * - *
a * - *
DNA-binding * - *
activity * - *
and * - *
bound * bound (V*)
to * - *
the (DNA* - (A7*
upstream * - *
regions *) - *)
of * - *
fliA * - *
, * - *
flhB * - *
, * - *
and * - *
fliL * - *
operons * - *
( * - *
class * - *
II * - *
) * - *
, * - *
which * - *
are * - *
under * - *
direct * - *
control * - *
of * - *
the * - *
flhD * - *
operon * - *
. * - *

In * - (A5*
vitro * - *)
transcription * transcription (V*)
from * - *
an (DNA* - (A6*
unmethylated * - *
template *) - *)
was * - *
repressed * - *
by * - *
OxyR (PTE* - *
( * - *
C199S * - *
) *) - *
, * - *
which * - *
resembles * - *
the * - *
reduced * - *
form * - *
of * - *
OxyR * - *
. * - *

The (PTE* - (A1* (A1* (A1*
global * - * * *
regulator * - * * *
CsrA *) - *) *) *)
( * - * * *
carbon * - * * *
storage * - * * *
regulator * - * * *
) * - * * *
is * - * * *
an * - * * *
RNA * - * * *
binding * - * * *
protein * - * * *
that * - * * *
coordinates * coordinate (V*) * *
central * - (A0* * *
carbon * - * * *
metabolism * - *) * *
, * - * * *
activates * activate * (V*) *
flagellum * - * (A0* *
biosynthesis * - * * *
and * - * * *
motility * - * *) *
, * - * * *
and * - * * *
represses * repress * * (V*)
biofilm * - * * (A0*
formation * - * * *)
in * - (A2* (A2* (A2*
Escherichia (ORG* - * * *
coli *) - *) *) *)
. * - * * *

Based * - *
on * - *
the * - *
results * - *
, * - *
the * - *
structure * - *
and * - *
function * - *
of * - *
the * - *
upstream * - *
sequence * - *
of * - *
the (DNA* - (A0*
ompF * - *
promoter *) - *)
are * - *
discussed * - *
in * - *
relation * - *
to * - *
activation * activate (V*)
of * - *
the * - *
ompF * - *
promoter * - *
by * - *
the (PTE* - (A1*
OmpR * - *
protein *) - *)
. * - *

A (PRC* - *
6-bp * - *
insertion *) - *
located * - *
within * - *
OA2 * - *
or * - *
between * - *
OT * - *
and * - *
OA1 * - *
eliminated * - *
repression * repress (V*)
of * - *
the (DNA* - (A0*
glpTQ * - *
promoter *) - *)
, * - *
whereas * - *
significant * - *
repression * - *
was * - *
maintained * - *
in * - *
the * - *
case * - *
of * - *
a * - *
10-bp * - *
insertion * - *
within * - *
OA2 * - *
. * - *

Insertions (PRC*) - (A1*)
which * - *
abolish * abolish (V*)
Alp * - (A0*
activity * - *)
interrupt * - *
this * - *
open * - *
reading * - *
frame * - *
. * - *

The (PTE* - (A1*
argR * - *
protein *) - *)
binds * bind (V*)
to * - *
cer (DNA* - (A7*
DNA *) - *)
both * - *
in * - (A3*
vivo * - *)
and * - *
in * - *
vitro * - *
in * - *
the * - *
presence * - *
of * - *
arginine (EXP*) - *
. * - *

Transcriptional * - (A8*
control * - *)
of * - *
rpoS * - *
involves * involve (V*)
guanosine * - *
3' * - *
, * - *
5'-bispyrophosphate * - *
( * - *
ppGpp * - (A1*)
) * - *
and * - *
polyphosphate * - *
as * - *
positive * - *
regulators * - *
and * - *
the * - *
cAMP * - *
receptor * - *
protein-cAMP * - *
complex * - *
( * - *
CRP-cAMP * - *
) * - *
as * - *
a * - *
negative * - *
regulator * - *
. * - *

However * - * *
, * - * *
the (DNA* - (A1* (A1*
sodB * - * *
gene *) - *) *)
, * - * *
encoding * encode (V*) *
superoxide (PTE* - (A0* *
dismutase *) - *) *
, * - * *
and * - * *
the (DNA* - * *
aceBAK * - * *
operon *) - * *
, * - * *
encoding * encode * (V*)
the (PTE* - * (A0*
glyoxalate * - * *
shunt * - * *
enzymes *) - * *)
, * - * *
show * - * *
the * - * *
opposite * - * *
responses * - * *
, * - * *
being * - * *
activated * - * *
by * - * *
the * - * *
loss * - * *
of * - * *
Crp (PTE*) - * *
and * - * *
repressed * - * *
by * - * *
the * - * *
loss * - * *
of * - * *
Fur (PTE*) - * *
. * - * *

In * - *
addition * - *
, * - *
the * - *
effects * - *
of * - *
H-NS (PTE*) - *
and * - *
RcsB (PTE*) - *
on * - *
the * - *
expression * express (V*)
of * - *
rcsA (DNA*) - (A0*)
are * - *
independent * - *
of * - *
each * - *
other * - *
. * - *

PhoB * - *
is * - *
known * - *
to * - *
be * - *
a * - *
transcriptional * - *
activator * - *
of * - *
the * - (A0*
Pho * - *
regulon * - *)
, * - *
expression * express (V*)
of * - *
which * - *
is * - *
activated * - *
during * - *
phosphate (EXP* - *
starvation *) - *
. * - *

Phosphorylation * phosphorylate (V*) *
of * - * *
OmpR (PTE*) - (A0*) *
by * - * *
the * - * *
osmosensor * - * *
EnvZ * - * *
modulates * - * *
expression * express * (V*)
of * - * *
the (DNA* - * (A0*
ompF * - * *
and * - * *
ompC * - * *
genes *) - * *)
in * - * (A2*
Escherichia (ORG* - * *
coli *) - * *)
. * - * *

The * - *
results * - *
presented * - *
here * - *
also * - *
suggest * - *
interactions * interact (V*)
between * - *
the (PTE* - (A1*
FNR *) - *)
and * - *
the * - *
leucine-responsive * - *
regulatory * - *
protein * - *
( * - *
Lrp (PTE*) - (A1*)
) * - *
regulatory * - *
networks * - *
. * - *

Transcriptional * - * *
organization * organize (V*) *
and * - * *
regulation * regulation * (V*)
of * - * *
the (DNA* - * *
Escherichia * - * *
coli * - * *
K30 * - * *
group * - * *
1 * - * *
capsule * - * *
biosynthesis *) - * *
( * - (A0* (A0*
cps * - * *
) * - * *
gene * - * *
cluster * - *) *)
. * - * *

Gel * - *
retardation * - *
assays * - *
were * - *
used * - *
to * - *
investigate * - *
the * - *
pairwise * - (A5*)
binding * bind (V*)
of * - *
FNR (PTE* - (A1*
, * - *
NarL * - *
, * - *
Fis * - *
and * - *
IHF * - *
proteins *) - *)
to * - *
the (DNA* - (A7*
nrfA-acs * - *
intergenic * - *
region *) - *)
. * - *

ptsG (DNA*) - (A0*)
transcription * transcription (V*)
is * - *
repressed * - *
by * - *
Mlc (PTE*) - *
, * - *
a * - *
glucose-inducible * - *
regulator * - *
of * - *
carbohydrate * - *
metabolism * - *
. * - *

Mutation * mutate (V*) * *
of * - * * *
the (DNA* - (A0* * *
CHOP-binding * - * * *
site *) - *) * *
in * - (A2* * (A2*
the (DNA* - * * *
human * - * * *)
promoter *) - *) * *
abolishes * - * * *
CHOP * - * * *
binding * - * * *
and * - * * *
significantly * - * * *
reduces * - * * *
ethoxyquin * - * (A1*) *
induction * induce * (V*) *
, * - * * *
suggesting * - * * *
that * - * * *
CHOP (PTE*) - * * (A1*)
mediates * mediate * * (V*)
stimulated * - * * *
expression (PRC*) - * * (A0*)
in * - * * *
response * - * * *
to * - * * *
antioxidants (EXP*) - * * (A3*)
in * - * * *
the * - * * *
human * - * * *
. * - * * *

Northern-blot * - *
analysis * - *
demonstrated * - *
ubiquitous * - (A5*)
expression * express (V*)
of * - *
5 (DNA* - (A0*
. * - *
1-kb * - *
and * - *
4 * - *
. * - *
1-kb * - *
transcripts *) - *)
of * - *
the * - *
hSNF2H * - *
gene * - *
. * - *

This * - * *
CysB (PTE*) - (A1*) *
binding * bind (V*) *
, * - * *
apparently * - * *
responsible * - * *
for * - * *
repression * - * *
, * - * *
is * - * *
enhanced * - * *
in * - * *
the * - * *
presence * - * *
of * - * *
the * - * *
ligand * - * *
N-acetylserine * - * *
( * - * *
NAS * - * *
) * - * *
, * - * *
hitherto * - * *
considered * - * *
to * - * *
be * - * *
a * - * *
positive * - * *
cofactor * - * *
in * - * *
CysB-mediated * - * (A5*)
gene (DNA*) - * (A0*)
regulations * regulations * (V*)
. * - * *

These * - * *
data * - * *
strongly * - * *
suggest * - * *
that * - * *
the (PTE* - * *
hRPC32-hRPC39-hRPC62 * - * *
subcomplex *) - * *
directs * - * *
RNA (PTE* - (A1* *
Pol * - * *
III *) - *) *
binding * bind (V*) *
to * - * *
the (PTE* - (A7* *
TFIIIB-DNA * - * *
complex *) - *) *
via * - * *
the * - * *
interactions * interact * (V*)
between * - * *
TFIIIB (PTE*) - * (A1*)
and * - * *
hRPC39 (PTE*) - * (A1*)
. * - * *

Experiments * - * * *
in * - * * *
which * - * * *
deletions (PRC* - (A0* * *
and * - * * *
point * - * * *
mutations *) - *) * *
were * - * * *
introduced * introduce (V*) * *
into * - * * *
the * - * * *
upstream (DNA*) - * (A7*) *
region * - * * *
of * - * * *
pnrfA (DNA*) - (A7*) * *
demonstrated * - * * *
that * - * * *
an * - * (A1* (A1*
additional * - * * *
factor * - * *) *)
must * - * * *
bind * bind * (V*) *
upstream * - * * *
to * - * * *
inhibit * inhibit * * (V*)
FNR-dependent (PRC* - * * (A0*
transcription *) - * * *)
. * - * * *

DNA * - * *
footprint * - * *
analysis * - * *
using * - * *
non-methylated * - * *
pap * - * *
DNAs * - * *
indicates * - * *
that * - * *
Lrp (PTE*) - (A1*) *
binds * bind (V*) *
to * - * *
a (DNA* - (A7* *
region *) - *) *
surrounding * - * *
the * - * *
GATC1130 * - * *
site * - * *
, * - * *
whereas * - * *
PapI (PTE*) - * (A1*)
does * - * *
not * - * *
appear * - * *
to * - * *
bind * bind * (V*)
to * - * *
pap * - * *
regulatory (DNA* - * (A7*
DNA *) - * *)
. * - * *

The * - * *
mutations * mutations (V*) *
in * - (A2* *
these (None* - * *
strains *) - *) *
were * - * *
shown * - * *
to * - * *
lie * - * *
within * - * *
a * - * *
previously * - * *
identified * - * *
gene * - * *
( * - * *
lrp (DNA*) - * (A1*)
) * - * *
that * - * *
encodes * encode * (V*)
Lrp (PTE*) - * (A0*)
( * - * *
leucine-responsive * - * *
regulatory * - * *
protein * - * *
) * - * *
. * - * *

The (PTE* - (A1* *
CpxR * - * *
regulator *) - *) *
was * - * *
shown * - * *
to * - * *
negatively * - * *
affect * - * *
curli (DNA* - * *
gene *) - * *
expression * - * *
when * - * *
binding * bind (V*) *
to * - * *
its * - (A0* (A1*
recognition * - * *
site * - *) *)
that * - * *
overlaps * overlap * (V*)
the (DNA* - * (A0*
csgD * - * *
OmpR-binding * - * *
site *) - * *)
. * - * *

Both * - *
cyclin (PTE* - (A0*
T1 *) - *
and * - *
T2 * - *)
are * - *
ubiquitously * - (A5*)
expressed * express (V*)
. * - *

It * - (A0*) * *
is * - * * *
an * - * * *
inversely * - * * *
growth-dependent * - * * *
mechanism * - * * *
driven * drive (V*) * *
by * - * * *
RNA (PTE* - (A1* (A0* *
polymerase *) - *) *) *
containing * contain * (V*) *
sigma (PTE* - * (A4* *
s *) - * *) *
, * - * * *
the * - * * *
factor * - * * *
involved * - * * *
in * - * * *
the * - * * *
expression * express * * (V*)
of * - * * *
stationary (DNA* - * * (A0*
phase-specific * - * * *
genes *) - * * *)
. * - * * *

The * - *
results * - *
establish * - *
that * - *
Fnr (PTE*) - (A1*)
, * - *
ArcA (PTE*) - *
, * - *
and * - *
Cra (PTE*) - *
exert * exert (V*)
their * - (A0*
effects * - *)
in * - *
an * - (A5*
interdependent * - *
fashion * - *)
. * - *

Transcription (PRC*) - (A0*)
regulation * regulation (V*)
coupling * - *
of * - *
the * - *
divergent * - *
argG * - *
and * - *
metY * - *
promoters * - *
in * - (A2*
Escherichia (ORG* - *
coli * - *
K-12 *) - *)
. * - *

Using * - *
in * - *
vitro * - *
transcription * - *
assays * - *
, * - *
we * - *
demonstrated * - *
that * - *
FIS (PTE* - *
and * - *
IHF *) - *
independently * - *
reduce * - *
CRP-dependent * - (A5*)
acs (DNA*) - (A0*)
transcription * transcription (V*)
. * - *

It * - * *
is * - * *
rather * - * *
unexpected * - * *
that * - * *
such * - * *
divergent * - (A5*) *
transcriptional * - * *
regulation * regulation (V*) *
controls * - * *
the (DNA* - * (A1*
two * - * *
genes *) - * *)
encoding * encode * (V*)
a (PTE* - * (A5*
dimeric * - * *
protein *) - * *)
. * - * *

Fnr (PTE*) - (A1*)
binds * bind (V*)
in * - (A5*
vitro * - *)
at * - *
two (DNA* - (A7*
sites *) - *
within * - *
the (DNA* - *
cydAB * - *
promoter * - *
element *) - *)
. * - *

We * - *
examined * - *
the * - *
structure * - *
of * - *
the (DNA* - (A1*
genomic * - *
gene *) - *)
encoding * encode (V*)
the (PTE* - (A0*
human * - *
mtTF1 *) - *)
to * - *
determine * - *
the * - *
mechanism * - *
of * - *
the * - *
deletion * - *
. * - *

Transfection * - * *
of * - * *
HOX3D (DNA* - (A0* *
upstream * - * *
genomic * - * *
sequences *) - *) *
linked * link (V*) *
to * - * *
a (DNA* - (A0* *
reporter * - * *
gene *) - *) *
allowed * - * *
the * - * *
functional * - * *
definition * - * *
of * - * *
its (DNA* - * (A0*
promoter *) - * *)
, * - * *
containing * contain * (V*)
a (DNA* - * (A4*
canonical * - * *
TATA * - * *
element *) - * *)
. * - * *

No * - *
inducer * - *
molecule * - *
of * - *
the (DNA* - (A0*
yiaK-S * - *
operon *) - *)
has * - *
been * - *
identified * - *
among * - *
over * - *
80 * - *
carbohydrate * - *
or * - *
derivative * - *
compounds * - *
tested * - *
, * - *
the * - *
system * - *
being * - *
expressed * express (V*)
only * - *
in * - (A2*
a (None* - *
mutant * - *
strain *) - *)
lacking * - *
the (PTE* - (A3*
YiaJ * - *
repressor *) - *)
. * - *

A * - * *
regulatory * - * *
role * - * *
for * - * *
IHF * - * *
was * - * *
demonstrated * - * *
by * - * *
showing * - * *
that * - * *
repression (PRC*) repress (V*) *
of * - * *
glpT (DNA*) - (A0*) *
mediated * - * *
by * - * *
GlpR (PTE*) - * *
was * - * *
decreased * - * *
about * - * *
twofold * - * *
in * - * *
strains * - * *
deficient * - * *
in * - * *
IHF * - * *
and * - * *
that * - * *
mutations * mutations * (V*)
in * - * *
IHF1 (PTE*) - * (A6*)
and/or * - * *
IHF2 (PTE*) - * *
decreased * - * *
repression * - * *
about * - * *
two- * - * *
to * - * *
threefold * - * *
. * - * *

Mutational * - (A1* *
or * - * *
physiological * - * *
lowering * - *) *
of * - * *
cAMP * - * *
levels * - * *
increases * increase (V*) *
the * - (A0* *
level * - *) *
of * - * *
RpoS * - * *
and * - * *
thereby * - * *
increases * - * *
the * - * *
production * produce * (V*)
of * - * *
GadX (DNA*) - * (A0*)
. * - * *

FREAC-2 (PTE*) - (A0*)
was * - *
shown * - *
to * - *
interact * interact (V*)
in * - (A3*
vitro * - *)
with * - *
TBP (PTE* - (A0*
and * - *
TFIIB *) - *)
. * - *

By * - *
analogy * - *
with * - *
FNR * - *
and * - *
FLP * - *
( * - *
the * - *
FNR-like * - *
protein * - *
of * - *
Lactobacillus * - *
casei * - *
) * - *
it * - *
was * - *
suggested * - *
that * - *
the * - (A0*
transcription-regulatory * - *
activity * - *
of * - *
YeiL * - *)
might * - *
be * - *
modulated * modulate (V*)
by * - *
a (DNA* - (A1*
sensory * - *
iron-sulphur * - *
cluster *) - *)
and/or * - *
by * - *
reversible (DNA* - *
disulphide * - *
bond * - *
formation *) - *
. (PTE*) - *

Specific * - (A0*
binding * - *)
was * - *
demonstrated * demonstrate (V*)
by * - *
in * - (A10*
vitro * - *
assays * - *)
including * - *
filter * - *
binding * - *
as * - *
well * - *
as * - *
mobility * - *
shift * - *
in * - *
a * - *
polyacrylamide * - *
gel * - *
of * - *
the * - *
DnaA-DNA * - *
complex * - *
. * - *

The * - * *
activity * - * *
of * - * *
sigma * - * *
s * - * *
may * - * *
also * - * *
be * - * *
modulated * - * *
by * - * *
trehalose (EXP* - (A1* (A1*
and * - * *
glutamate *) - *) *)
, * - * *
which * - * *
activate * activate (V*) *
holoenzyme * - (A0* *
formation * - *) *
and * - * *
promote * promote * (V*)
holoenzyme * - * (A0*
binding * - * *)
to * - * *
certain (DNA* - * (A7*
promoters *) - * *)
. * - * *

In * - *
vivo * - *
analysis * - *
and * - *
DNase * - *
I * - *
footprinting * - *
indicated * - *
that * - *
the (DNA* - (A0*
promoter *) - *)
specific * - *
for * - *
agaZ * - *
also * - *
requires * - *
activation * activate (V*)
by * - *
cAMP-CRP (PTE*) - (A1*)
. * - *

The (PTE* - * *
cAMP-CAP * - * *
complex *) - * *
activates * - * *
argG (DNA*) - (A0*) *
transcription * transcription (V*) *
and * - * *
inhibits * - * *
metY (DNA*) - * (A0*)
transcription * transcription * (V*)
from * - * *
the (DNA* - (A6* (A6*
same * - * *
DNA * - * *
position *) - *) *)
. * - * *

CRP (PTE*) - *
also * - *
represses * - *
gadX (DNA*) - (A0*)
expression * express (V*)
. * - *

We * - * * *
show * - * * *
here * - * * *
that * - * * *
RcsA (PTE*) - (A1*) * *
functions * - * * *
to * - * * *
activate * activate (V*) * *
its * - (A0* * *
own * - * * *
expression * - *) * *
, * - * * *
as * - * * *
seen * - * * *
by * - * * *
the * - * * *
100-fold-increased * - * * *
expression * express * (V*) *
of * - * * *
a (DNA* - * (A0* *
rcsA * - * * *
: * - * * *
: * - * * *
lacZ * - * * *
transcriptional * - * * *
fusion *) - * *) *
in * - * (A2* *
strains * - * * *
with * - * * *
high * - * * *
levels * - * * *
of * - * * *
RcsA * - * * *
protein * - * *) *
, * - * * *
either * - * * *
due * - * * *
to * - * * *
a * - * * *
mutation * - * * *
in * - * * *
lon * - * * *
or * - * * *
due * - * * *
to * - * * *
overexpression * overexpression * * (V*)
of * - * * *
RcsA (PTE*) - * * (A0*)
from * - * * *
a (DNA* - * * (A6*
multicopy * - * * *
plasmid *) - * * *)
. (ORG*) - * * *

The (DNA* - (A1*
ndh * - *
gene *) - *)
of * - *
Escherichia * - *
coli * - *
encodes * encode (V*)
the (PTE* - (A0*
non-proton-translocating * - *
NADH * - *
dehydrogenase * - *
II *) - *)
. * - *

The * - * *
cloned * - * *
cDNA * - * *
for * - * *
one (DNA* - (A1* *
such * - * *
gene *) - *) *
encodes * encode (V*) *
a (PTE* - (A0* *
protein *) - *) *
similar * - * *
to * - * *
the (DNA* - * *
E * - * *
. * - * *
coli * - * *
L-3 * - * *
ribosomal * - * *
protein *) - * *
which * - * *
is * - * *
thought * - * *
to * - * *
play * - * *
a * - * *
role * - * *
in * - * *
mRNA (DNA*) - * (A1*)
binding * bind * (V*)
to * - * *
the (DNA* - * (A7*
ribosome *) - * *)
. * - * *

In * - * *
stationary * - (A12* *
phase * - *) *
, * - * *
these (DNA* - (A0* *
genes *) - *) *
are * - * *
transcribed * transcribe (V*) *
by * - * *
the * - * *
sigma * - * *
( * - * *
S (PTE*) - (A1*) *
) * - * *
factor * - * *
, * - * *
and * - * *
expression * express * (V*)
of * - * *
the (DNA* - * (A0*
operon *) - * *)
is * - * *
enhanced * - * *
by * - * *
the (PTE* - * *
small * - * *
protein * - * *
Crl *) - * *
. * - * *

Transcriptional * - (A5*)
responses * respond (V*)
to * - *
interferon * - *
( * - *
IFN (PTE*) - (A0*)
) * - *
are * - *
mediated * - *
by * - *
tyrosine * - *
phosphorylation * - *
and * - *
nuclear * - *
translocation * - *
of * - *
transcription * - *
factors * - *
of * - *
the * - *
signal * - *
transducer * - *
and * - *
activator * - *
of * - *
transcription * - *
( * - *
Stat * - *
) * - *
family * - *
. * - *

ompB (DNA*) - (A0*)
expression * express (V*)
in * - (A2*
an (ORG* - *
ompB-lacZ * - *
chromosomal * - *
fusion * - *
strain *) - *)
was * - *
increased * - *
two- * - *
to * - *
fivefold * - *
when * - *
cells * - *
were * - *
grown * - *
in * - *
medium (EXP* - *
containing * - *
poor * - *
carbon * - *
sources * - *
or * - *
with * - *
added * - *
cyclic * - *
AMP *) - *
. (ORG*) - *

The * - *
results * - *
of * - *
gel * - *
retardation * - *
and * - *
DNase * - *
I * - *
protection * - *
experiments * - *
indicated * - *
that * - *
OmpR (PTE*) - (A1*)
, * - *
after * - *
incubation * - *
with * - *
the * - *
protein * - *
kinase * - *
EnvZ * - *
, * - *
specifically * - *
binds * bind (V*)
to * - *
at (DNA* - (A7*
least * - *
four * - *
sites *) - *)
around * - *
the * - *
fadL * - *
promoter * - *
, * - *
two * - *
upstream * - *
and * - *
two * - *
downstream * - *
from * - *
the * - *
transcriptional * - *
start * - *
site * - *
. * - *

The * - *
Alp * - *
protease * - *
activity * - *
is * - *
detected * - *
in * - *
cells * - *
after * - *
introduction * - *
of * - *
plasmids * - *
carrying * - *
the (DNA* - (A1*
alpA * - *
gene *) - *)
, * - *
which * - *
encodes * encode (V*)
an (DNA* - (A0*
open * - *
reading * - *
frame *) - *)
of * - *
70 * - *
amino * - *
acids * - *
. * - *

In * - * *
order * - * *
to * - * *
investigate * - * *
the * - * *
in * - * *
vivo * - * *
function * - * *
of * - * *
this * - * *
protein * - * *
, * - * *
expression * express (V*) *
of * - * *
the (DNA* - (A0* *
iciA * - * *
gene *) - *) *
was * - * *
studied * - * *
by * - * *
monitoring * - * *
the (PTE* - * (A4*
beta-galactosidase * - * *
activity *) - * *)
specified * specify * (V*)
by * - * *
an (DNA* - * (A0*
iciA * - * *
promoter-lacZ * - * *
fusion *) - * *)
inserted * - * *
into * - * *
the * - * *
chromosome * - * *
. * - * *

Changing * change (V*) * *
the (DNA* - (A0* * *
binding * - * * *
sites *) - *) * *
toward * - * * *
the * - * * *
consensus * - * * *
MetR * - * * *
binding * - * * *
sequence * - * * *
caused * - * * *
an * - * * *
increase * increase * (V*) *
in * - * * *
glyA-lacZ (DNA*) - * (A0* (A0*)
expression * express * *) (V*)
. * - * * *

Overproduction * overproduce (V*) *
of * - * *
the (PTE* - (A0* *
exuR * - * *
repressor *) - *) *
also * - * *
caused * - * *
a * - * *
decrease * decrease * (V*)
of * - * *
the * - * (A0*
beta-galactosidase * - * *
level * - * *)
. * - * *

The * - *
binding * bind (V*)
of * - *
NarL (PTE* - (A1*
and * - *
IHF *) - *)
is * - *
mutually * - *
exclusive * - *
, * - *
whereas * - *
all * - *
other * - *
combinations * - *
can * - *
bind * - *
simultaneously * - *
. * - *

In * - *
this * - *
study * - *
, * - *
we * - *
found * - *
that * - *
transcription * - *
from * - *
the * - *
prpBCDE * - *
and * - *
prpR * - *
promoters * - *
was * - *
down-regulated * - *
by * - *
the * - *
addition * - *
of * - *
glucose * - *
or * - *
glycerol * - *
, * - *
indicating * - *
that * - *
these (DNA* - (A0*
genes *) - *)
may * - *
be * - *
regulated * regulate (V*)
by * - *
the * - (A1*
cyclic * - *
AMP * - *
( * - *
cAMP * - *
) * - *
-cAMP * - *
receptor * - *
protein * - *
( * - *
CRP * - *
) * - *
complex * - *)
. (PTE*) - *

Expression * express (V*)
was * - *
dependent * - *
on * - *
the * - *
presence * - *
of * - *
sigma (PTE* - (A3*
54 *) - *)
, * - *
of * - *
the * - *
upstream * - *
activatory * - *
sequence * - *
( * - *
UAS (DNA*) - *
) * - *
, * - *
and * - *
of * - *
formate * - *
. * - *

Paraquat (EXP*) - *
, * - *
an * - *
inducer * - *
of * - *
the * - *
soxRS * - *
system * - *
, * - *
elevated * - *
inaA (DNA*) - (A0*)
expression * express (V*)
by * - *
6- * - *
to * - *
9-fold * - *
. * - *

Overproduction * - *
of * - *
TorR * - *
in * - *
a * - *
torT * - *
strain * - *
resulted * - *
in * - *
partial * - *
constitutive * - *
expression * express (V*)
of * - *
the (DNA* - (A0*
torA'-'lacZ * - *
fusion *) - *)
, * - *
suggesting * - *
that * - *
TorR * - *
acts * - *
downstream * - *
from * - *
TorT * - *
. * - *

Binding * - *
and * - *
transcriptional * - *
activation * activate (V*)
of * - *
non-flagellar * - (A0*
genes * - *)
by * - *
the * - (A1*
Escherichia * - *
coli * - *
flagellar * - *
master * - *
regulator * - *
FlhD2C2 * - *)
. * - *

Comparison * - *
of * - *
these * - *
, * - *
and * - *
sequence * - *
elements * - *
at * - *
other (DNA* - (A0*
promoters *) - *)
regulated * regulate (V*)
by * - *
NarL (PTE*) - (A1*)
, * - *
suggests * - *
a * - *
consensus * - *
NarL-binding * - *
sequence * - *
. * - *

We * - *
also * - *
show * - *
that * - *
ArgR (PTE*) - *
, * - *
the * - *
specific * - *
repressor * - *
of * - *
the * - *
arginine * - *
biosynthetic * - *
pathway * - *
, * - *
together * - *
with * - *
its * - *
arginine * - *
cofactor * - *
, * - *
acts * - *
on * - *
the * - *
regulation * regulation (V*)
of * - *
metY (DNA*) - (A0*)
mediated * - *
by * - *
CAP (PTE*) - *
. * - *

We * - *
also * - *
provide * - *
evidence * - *
that * - *
OmpR (PTE*) - (A1*)
binding * bind (V*)
at * - *
the (DNA* - (A7*
-360 * - *
to * - *
-380 * - *
region *) - *)
requires * - *
previous * - *
binding * - *
at * - *
downstream (DNA* - *
sequences *) - *
, * - *
which * - *
is * - *
indicative * - *
of * - *
long * - *
range * - *
interactions * - *
between * - *
OmpR * - *
molecules * - *
. * - *

The * - *
DNA-binding * - *
high * - *
mobility * - *
group * - *
( (DNA* - (A0*
HMG * - *
) * - *
box *) - *)
of * - *
TCF-1 * - *
is * - *
encoded * encode (V*)
by * - *
the * - *
closely * - *
spaced * - *
exons * - *
VI (DNA* - (A1*
and * - *
VII *) - *)
. * - *

Two * - * *
genes * - * *
, * - * *
designated * - * *
rcsA (DNA*) - * *
( * - * *
regulation * regulation (V*) *
of * - * *
capsule * - (A0* *
synthesis * - *) *
) * - * *
and * - * *
rcsB (DNA*) - * *
, * - * *
that * - * *
had * - * *
been * - * *
cloned * - * *
from * - * *
the * - * *
chromosome * - * *
of * - * *
Klebsiella * - * *
aerogenes * - * *
( * - * *
K * - * *
. * - * *
pneumoniae * - * *
) * - * *
capsular * - * *
serotype * - * *
K21 * - * *
were * - * *
capable * - * *
of * - * *
activating * - * *
expression * express * (V*)
of * - * *
colanic * - * (A0*
acid * - * *
capsular * - * *
polysaccharide * - * *)
in * - * (A2*
Escherichia (ORG* - * *
coli * - * *
K12 *) - * *
. * - * *)

The * - *
cyclic * - *
AMP * - *
( (PTE* - (A1*
cAMP * - *
) * - *
-cAMP * - *
receptor * - *
protein * - *
complex *) - *)
functions * function (V*)
both (PTE* - (A8*
as * - *
an * - *
activator * - *
and * - *
as * - *
a * - *
corepressor *) - *)
at * - (A2*
the (DNA* - *
tsx-p2 * - *
promoter *) - *)
of * - *
Escherichia * - *
coli * - *
K-12 * - *
. * - *

We * - *
have * - *
studied * - *
in * - *
Salmonella * - *
typhimurium * - *
and * - *
Escherichia * - *
coli * - *
the * - *
properties * - *
of * - *
pseudo-HPr (PTE*) - (A0*)
suppressor * - (A5*)
mutations * mutations (V*)
. * - *

P * - *
( * - *
cer * - *
) * - *
is * - *
unusual * - *
in * - *
that * - *
the * - *
-35 * - *
and * - *
-10 * - *
hexamers * - *
are * - *
separated * - *
by * - *
only * - (A0*
15 * - *
bp * - *)
and * - *
this * - *
study * - *
has * - *
demonstrated * - *
that * - *
increasing * increase (V*)
this * - *
to * - *
a * - *
more * - *
conventional * - *
spacing * - *
results * - *
in * - *
elevated (PRC* - *
activity *) - *
. * - *

We * - *
have * - *
isolated * - *
a (DNA* - (A1*
novel * - *
human * - *
cDNA *) - *)
encoding * encode (V*)
a * - (A0*
homolog * - *
to * - *
Saccharomyces (DNA* - *
cerevisiae * - *
Ire1p *) - *)
, * - *
a * - *
proximal * - *
sensor * - *
for * - *
this * - *
signal * - *
transduction * - *
pathway * - *
in * - *
yeast * - *
. * - *

Alanine (PTE*) - (A1*) *
is * - * *
thought * - * *
to * - * *
act * - * *
as * - * *
an * - * *
inducer * - * *
to * - * *
block * block (V*) *
the * - (A0* *
action * act *) (V*)
of * - * *
a (PTE* - * (A1*
postulated * - * *
repressor *) - * *)
. * - * *

Through * - *
single * - *
base-pair * - *
mutations * - *
, * - *
the * - *
importance * - *
of * - *
three * - *
of * - *
these * - *
five * - *
basepairs * - *
in * - *
the * - *
autoregulation * - *
of * - *
gcvA (DNA*) - (A0*)
expression * express (V*)
is * - *
shown * - *
. * - *

The (PTE* - (A1*
MalT * - *
protein *) - *)
requires * - *
maltotriose * - *
and * - *
ATP * - *
as * - *
ligands * - *
for * - *
binding * bind (V*)
to * - *
a (DNA* - (A7*
dodecanucleotide * - *
MalT * - *
box *) - *)
that * - *
appears * - *
in * - *
multiple * - *
copies * - *
upstream * - (A2*
of * - *
all (DNA* - *
mal * - *
promoters *) - *)
. * - *

These * - *
results * - *
suggest * - *
that * - *
PPARgamma * - *
may * - *
be * - *
a * - *
key * - *
regulator * - *
of * - *
foam * - (A0*
cell * - *
gene * - *)
expression * express (V*)
. * - *

Independent * - *
regulation * regulation (V*)
of * - *
the (DNA* - (A0*
divergent * - *
Escherichia * - *
coli * - *
nrfA * - *
and * - *
acsP1 * - *
promoters *) - *)
by * - *
a (PTE* - (A1*
nucleoprotein * - *
assembly *) - *)
at * - *
a * - *
shared * - *
regulatory * - *
region * - *
. * - *

Since * - *
PU (DNA* - (A0*
. * - *
1 *) - *)
expression * express (V*)
appears * - *
to * - *
play * - *
a * - *
role * - *
in * - *
hematopoietic * - *
development * - *
, * - *
we * - *
characterized * - *
the * - *
PU * - *
. * - *
1 * - *
promoter * - *
. * - *

The (None* - * *
cpxA * - * *
mutant *) - * *
exhibited * - * *
increased * - * *
transcription * transcription (V*) *
of * - * *
ompC (DNA*) - (A0*) *
and * - * *
a * - * (A5*
very * - * *
strong * - * *
decrease * - * *)
in * - * *
transcription * transcription * (V*)
of * - * *
ompF (DNA*) - * (A0*)
under * - * *
conditions * - * *
in * - * *
which * - * *
acetyl (PTE* - * (A3*
phosphate * - * *
levels *) - * *
were * - * *
high * - * *)
. * - * *

Expression * express (V*)
of * - *
Ire1p (DNA* - (A0*
mRNA *) - *)
was * - *
autoregulated * - *
through * - *
a * - *
process * - *
that * - *
required * - *
a * - *
functional * - *
hIre1p * - *
kinase * - *
activity * - *
. * - *

The * - *
formation * form (V*)
of * - *
these (DNA* - (A0*
transcripts *) - *)
was * - *
differentially * - *
regulated * - *
by * - *
cyclic (PTE* - *
AMP-cyclic * - *
AMP * - *
receptor * - *
protein * - *
complex *) - *
, * - *
and * - *
each * - *
was * - *
strongly * - *
repressed * - *
by * - *
Lrp (PTE*) - *
. * - *

marA (DNA* - *
locus *) - *
causes * - *
decreased * - (A5*)
expression * express (V*)
of * - *
OmpF (PTE* - (A0*
porin *) - *)
in * - *
multiple-antibiotic-resistant (None* - *
( * - *
Mar * - *
) * - *
mutants *) - *
of * - *
Escherichia * - *
coli * - *
. * - *

Transcription * transcribe (V*)
of * - *
uvrA (DNA*) - (A0*)
increased * - *
in * - *
DeltaarcA (None* - *
and * - *
DeltaarcB * - *
strains *) - *
more * - *
than * - *
in * - *
the (ORG* - *
wild-type * - *
strain *) - *
, * - *
whose * - *
trend * - *
was * - *
remarkable * - *
under * - *
the * - *
anaerobic * - *
condition * - *
. * - *

Mutant * - *
analysis * - *
indicated * - *
that * - *
cross-induction * crossinduct (V*)
of * - *
the * - (A0*
glc * - *
operon * - *)
by * - *
acetate (EXP*) - (A1*)
is * - *
mediated * - *
by * - *
the (PTE* - *
GlcC * - *
protein *) - *
that * - *
recognizes * - *
the * - *
compound * - *
as * - *
an * - *
alternative * - *
effector * - *
. * - *

Variegated * - *
expression * - *
of * - *
the * - *
lacZ * - *
gene * - *
was * - *
not * - *
confined * - *
to * - *
cultured * - *
cells * - *
since * - *
several (ORG* - (A1*
transgenic * - *
lines *) - *)
also * - *
did * - *
not * - *
express * express (V*)
the (DNA* - (A0*
lacZ * - *
transgene *) - *)
. * - *

The (DNA* - (A1*
gene * - *
BCL6 *) - *)
encodes * encode (V*)
a (PTE* - (A0*
zinc * - *
finger * - *
protein *) - *)
with * - *
similarities * - *
to * - *
transcription * - *
factors * - *
. * - *

DNase * - * * * *
I * - * * * *
footprinting * - * * * *
experiments * - * * * *
revealed * - * * * *
that * - * * * *
ArcA-P (PTE*) - (A1*) * * *
binds * bind (V*) * * *
to * - * * * *
three (DNA* - (A0* * * *
sites *) - *) * * *
upstream * - * * * *
of * - * * * *
the * - * * * *
ptsG (DNA* - * * * (A0*
P1 *) - * * * *)
promoter * - * * * *
, * - * * * *
two * - * * * *
of * - * * * *
which * - * * * *
overlap * - * * * *
the * - * * * *
CRP-binding * - * * * *
sites * - * * * *
, * - * * * *
and * - * * * *
the * - * * * *
ArcA-P (PTE*) - * (A1*) * *
binding * bind * (V*) * *
decreases * - * * * *
the * - * * * *
CRP (PTE*) - * * (A1*) *
binding * bind * * (V*) *
that * - * * * *
is * - * * * *
essential * - * * * *
for * - * * * *
the * - * * * *
ptsG * - * * * *
P1 * - * * * *
transcription * transcription * * * (V*)
. * - * * * *

The (DNA* - (A1*
glpF * - *
gene *) - *)
encodes * encode (V*)
a (PTE* - (A0*
cytoplasmic * - *
membrane * - *
protein *) - *)
which * - *
facilitates * - *
the * - *
diffusion * - *
of * - *
glycerol * - *
into * - *
the * - *
cell * - *
. * - *

The * - *
middle * - *
region * - *
of * - *
the * - *
antisense * - *
p120 * - *
RNA * - *
was * - *
found * - *
to * - *
be * - *
almost * - *
as * - *
inhibitory * - *
as * - *
the * - *
full * - *
length * - *
antisense * - *
construct * - *
but * - *
the (DNA* - (A1*
5' * - *
and * - *
3' * - *
antisense * - *
portions *) - *)
did * - *
not * - *
affect * affect (V*)
NIH * - (A0*
3T3 * - *
cell * - *
proliferation * - *)
. * - *

The * - * *
alpha * - * *
[ * - * *
L262A (DNA*) - * *
] * - * *
, * - * *
alpha * - * *
[ * - * *
R265A (DNA*) - * *
] * - * *
and * - * *
alpha * - * *
[ * - * *
N268A (DNA*) - * *
] * - * *
substitutions * - * *
, * - * *
which * - * *
caused * - * *
the * - * *
most * - * *
drastic * - * *
reduction * - * *
in * - * *
the * - (A5* *
FruR-mediated * - *) *
activation * activate (V*) *
of * - * *
the (DNA* - (A0* *
ppsA * - * *
promoter *) - *) *
, * - * *
had * - * *
previously * - * *
been * - * *
shown * - * *
to * - * *
inhibit * - * *
the * - * (A5*
upstream * - * *
element-mediated * - * *)
activation * activate * (V*)
at * - * *
the (DNA* - * (A0*
rrnBP1 * - * *
promoter *) - * *)
. * - * *

E2F-6 (PTE*) - (A0*)
, * - *
a * - *
member * - *
of * - *
the * - *
E2F * - *
family * - *
that * - *
can * - *
behave * behave (V*)
as * - *
a (PTE* - (A4*
transcriptional * - *
repressor *) - *)
. * - *

Although * - * *
these * - * *
observations * - * *
were * - * *
consistent * - * *
with * - * *
the * - * *
idea * - * *
that * - * *
mioC (PRC* - (A0* *
transcription *) - *) *
might * - * *
have * - * *
to * - * *
be * - * *
terminated * terminate (V*) *
prior * - * *
to * - * *
initiation * - * *
, * - * *
it * - * *
was * - * *
found * - * *
that * - * *
the * - * *
interval * - * *
between * - * *
initiations * - * *
at * - * *
permissive * - * *
temperature * - * *
, * - * *
i * - * *
. * - * *
e * - * *
. * - * *
, * - * *
the * - * *
eclipse * - * *
period * - * *
, * - * *
was * - * *
not * - * *
influenced * - * *
by * - * *
the * - * *
time * - * *
required * - * *
to * - * *
shut * - * *
down * - * *
mioC * - * (A0*)
transcription * - * *
, * - * *
since * - * *
the * - * *
eclipse * - * *
was * - * *
the * - * *
same * - * *
for * - * *
chromosomes (DNA*) - * *
and * - * *
minichromosomes (DNA*) - * *
which * - * *
lacked * - * *
mioC * - * *
transcription * transcription * (V*)
. * - * *

Novel * - *
MetJ * - *
binding * - *
sites * - *
are * - *
found * - *
upstream * - *
of * - *
the * - *
metK * - *
gene * - *
, * - *
as * - *
well * - *
as * - *
upstream * - *
of * - *
a * - *
gene * - *
, * - *
abc (DNA*) - (A1*)
, * - *
a * - *
gene * - *
that * - *
encodes * encode (V*)
for * - *
a (PTE* - (A0*
component *) - *
of * - *
a * - *
multifunction * - *
transporter * - *)
which * - *
may * - *
transport * - *
amino * - *
acids * - *
across * - *
the * - *
membrane * - *
. * - *

Transcription * transcribe (V*)
of * - *
the (DNA* - (A0*
divergently * - *
transcribed * - *
glpTQ * - *
and * - *
glpACB * - *
operons *) - *)
is * - *
initiated * - *
at * - *
sites * - *
separated * - *
by * - *
132 * - *
base * - *
pairs * - *
( * - *
bp * - *
) * - *
of * - *
DNA * - *
. (DNA*) - *

Expansion * - (A0*
of * - *
trophoblast * - *
precursors * - *)
is * - *
restored * restore (V*)
, * - *
however * - *
, * - *
by * - *
an * - *
Oct4 * - *
target * - *
gene * - *
product * - *
, * - *
fibroblast (PTE* - (A1*
growth * - *
factor-4 *) - *)
. * - *

The (DNA* - (A1* *
Klebsiella * - * *
rcsA * - * *
gene *) - *) *
encoded * encode (V*) *
a (PTE* - (A0* *
polypeptide *) - *) *
of * - * *
23 * - * *
kDa * - * *
that * - * *
was * - * *
required * - * *
for * - * *
the * - * *
induction * induce * (V*)
of * - * *
a (DNA* - * (A0*
mucoid * - * *
phenotype *) - * *)
at * - * *
less * - * *
than * - * *
or * - * *
equal * - * *
to * - * *
30 * - * *
degrees * - * *
C * - * *
but * - * *
not * - * *
at * - * *
greater * - * *
than * - * *
or * - * *
equal * - * *
to * - * *
37 * - * *
C * - * *
. * - * *

However * - *
, * - *
in * - *
the * - *
presence * - *
of * - *
melibiose (EXP*) - (A3*)
, * - *
MelR (PTE*) - (A1*)
also * - *
binds * bind (V*)
to * - *
a (DNA* - (A7*
fifth * - *
site *) - *)
( * - *
Site * - *
2' * - *
, * - *
centred * - *
at * - *
position * - *
-42 * - *
. * - *
5 * - *
) * - *
located * - *
immediately * - *
downstream * - *
of * - *
Site * - *
2 * - *
, * - *
and * - *
overlapping * - *
the * - *
-35 * - *
region * - *
of * - *
the * - *
melAB * - *
promoter * - *
. * - *

The * - (A0*
high * - *
activity * - *)
of * - *
the * - *
rrnB * - *
P1 * - *
promoter * - *
in * - *
Escherichia * - *
coli * - *
results * result (V*)
from * - *
a (DNA* - (A1*
cis-acting * - *
DNA * - *
sequence *) - *)
, * - *
the (DNA* - *
UP * - *
element *) - *
, * - *
and * - *
a * - *
trans-acting * - *
transcription * - *
factor * - *
, * - *
FIS (PTE*) - *
. * - *

The * - *
levels * - *
of * - *
beta-galactosidase * - *
indicate * - *
that * - *
ompC (DNA*) - (A0*)
expression * express (V*)
in * - (A3*
vivo * - *)
is * - *
dependent * - *
on * - *
the * - *
function * - *
of * - *
at * - *
least * - *
one * - *
of * - *
the * - *
upstream * - *
promoters * - *
. * - *

Therefore * - *
, * - *
OmpF (DNA* - *
reduction *) - *
required * - *
a * - *
mutation * mutation (V*)
in * - *
the (DNA* - (A0*
marA * - *
region *) - *)
. * - *

The * - *
arginine * - *
repressor * - *
is * - *
essential * - *
for * - *
plasmid-stabilizing * - (A5*
site-specific * - *)
recombination * recombine (V*)
at * - (A2*
the (DNA* - *
ColE1 * - *
cer * - *
locus *) - *)
. * - *

Here * - *
we * - *
describe * - *
the * - *
isolation * - *
and * - *
characterization * - *
of * - *
one * - *
such * - *
gene * - *
( * - *
xerA * - *
) * - *
and * - *
show * - *
it * - *
to * - *
be * - *
identical * - *
to * - *
the (DNA* - (A1*
gene *) - *)
encoding * encode (V*)
the * - *
repressor * - *
of * - *
the * - *
arginine * - *
biosynthetic * - *
genes * - *
( (PTE* - (A0*
argR * - *
) *) - *)
. * - *

We * - *
have * - *
previously * - *
found * - *
that * - *
NFKB2 (PTE*) - (A1*)
( * - *
p49/p52 * - *
) * - *
acts * - *
in * - *
concert * - *
with * - *
RelA (PTE*) - *
( * - *
p65 * - *
) * - *
to * - *
stimulate * stimulate (V*)
the (DNA* - (A0*
HIV * - *
enhancer *) - *)
in * - *
Jurkat * - *
T-leukemia * - *
cells * - *
. * - *

GcvA (PTE*) - (A1*) *
binds * bind (V*) *
to * - * *
three (DNA* - (A7* *
sites *) - *) *
in * - (A2* *
the (DNA* - * *
gcv * - * *
control * - * *
region *) - *) *
and * - * *
to * - * *
one (DNA* - * *
site *) - * *
in * - * *
the * - * *
gcvA * - * *
control * - * *
region * - * *
; * - * *
each * - * *
of * - * *
these (DNA* - * (A0*
binding * - * *
sites *) - * *)
contains * contain * (V*)
the * - * *
conserved * - * *
5 * - * *
bp * - * *
DNA * - * *
sequence * - * *
5'-CTAAT-3' * - * *
. (DNA*) - * (A4*)

Further (PRC* - (A0* *
activation *) - *) *
, * - * *
induced * induce (V*) *
by * - * *
the * - * *
presence * - * *
of * - * *
nitrite (EXP*) - (A3*) *
, * - * *
results * - * *
from * - * *
the * - * *
binding * bind * (V*)
of * - * *
NarL (PTE* - * (A1*
and * - * *
NarP *) - * *)
to * - * *
a (DNA* - * (A7*
site *) - * *)
centred * - * *
at * - * *
position * - * *
-74 * - * *
. * - * *
5 * - * *
. * - * *

We * - * *
propose * - * *
that * - * *
expression * express (V*) *
from * - * *
the (DNA* - (A6* *
melAB * - * *
promoter *) - *) *
has * - * *
an * - * *
absolute * - * *
requirement * - * *
for * - * *
MelR (PTE*) - * (A1*)
binding * bind * (V*)
to * - * *
Site * - * (A7*
2' * - * *)
. (DNA*) - * *

Insertion * insert (V*) *
within * - (A2* *
the (DNA* - * *
torT * - * *
gene *) - *) *
dramatically * - * *
reduced * - * *
the * - * *
expression * express * (V*)
of * - * *
a (DNA* - * (A0*
torA'-'lacZ * - * *
fusion *) - * *)
, * - * *
while * - * *
presence * - * *
of * - * *
the * - * *
gene * - * *
in * - * *
trans * - * *
restored * - * *
the * - * *
wild-type * - * *
phenotype * - * *
. * - * *

Low-affinity (DNA* - (A1*
sites *) - *)
for * - *
the * - *
activator * - *
NRI-P * - *
( * - *
NtrC-P * - *
) * - *
that * - *
map * - *
between * - *
the * - *
enhancer * - *
and * - *
the * - *
glnAp2 * - *
promoter * - *
were * - *
responsible * - *
for * - *
limiting * limit (V*)
promoter (PRC* - (A0*
activity *) - *)
at * - *
high * - *
concentrations * - *
of * - *
NRI (PTE*) - (A3*)
approximately * - *
P * - *
in * - (A2*
intact (ORG* - *
cells *) - *)
and * - *
in * - *
an * - *
in * - *
vitro * - *
transcription * - *
system * - *
consisting * - *
of * - *
purified * - *
bacterial * - *
components * - *
. * - *

From * - * * * *
the * - * * * *
examples * - * * * *
presented * - * * * *
in * - * * * *
this * - * * * *
article * - * * * *
, * - * * * *
it * - * * * *
appears * - * * * *
that * - * * * *
the * - * * * *
formation * form (V*) * * *
of * - * * * *
certain (PTE* - (A0* (A0* * (A0*
nucleoprotein * - * * * *
complexes *) - *) *) * *)
implicated * implicate * (V*) * *
in * - * * * *
transcription (PRC*) - * (A4*) (A0*) *
initiation * initiate * * (V*) *
might * - * * * *
involve * involve * * * (V*)
heterologous * - * * * (A4*
rather * - * * * *
than * - * * * *
isologous * - * * * *
interactions * - * * * *)
, * - * * * *
allowing * - * * * *
differentiation * - * * * *
between * - * * * *
two * - * * * *
classes * - * * * *
of * - * * * *
transcription * - * * * *
activators * - * * * *
. * - * * * *

This * - (A0*
receptor-mediated * - *
event * - *)
occurs * occur (V*)
in * - (A2*
the (ORG* - *
cytoplasm *) - *)
, * - *
with * - *
subsequent * - *
translocation * - *
of * - *
the * - *
activated * - *
factor * - *
to * - *
the * - *
nucleus * - *
. * - *

A (DNA* - (A1*
region * - *
of * - *
antisense * - *
RNA *) - *)
from * - *
human * - *
p120 * - *
cDNA * - *
with * - *
high * - *
homology * - *
to * - *
mouse * - *
p120 * - *
cDNA * - *
inhibits * inhibit (V*)
NIH * - (A0*
3T3 * - *
proliferation * - *)
. * - *

Despite * - *
this * - *
wealth * - *
of * - *
knowledge * - *
, * - *
there * - *
are * - *
still * - *
basic * - *
issues * - *
that * - *
require * - *
clarification * - *
concerning * - *
the * - *
mechanism * - *
of * - *
MalT-mediated * - (A1*)
activation * activate (V*)
, * - *
repression * - *
by * - *
the * - *
transporter * - *
, * - *
biosynthesis * - *
and * - *
assembly * - *
of * - *
the * - *
outer * - *
membrane * - *
and * - *
inner * - *
membrane * - *
transporter * - *
proteins * - *
, * - *
and * - *
interrelationships * - *
between * - *
the * - *
mal * - *
enzymes * - *
and * - *
those * - *
of * - *
glucose * - *
and * - *
glycogen * - *
metabolism * - *
. * - *

Most (PTE* - (A1*
regulators * - *
belonging * - *
to * - *
the * - *
AraC/XylS * - *
family *) - *)
recognize * recognize (V*)
multiple (DNA* - (A0*
binding * - *
sites *) - *)
in * - *
the * - *
regulated * - *
promoters * - *
. * - *

These (DNA* - (A0* *
operons *) - *) *
are * - * *
negatively * - (A5*) *
controlled * control (V*) *
by * - * *
glp (PTE* - (A1* (A1*
repressor *) - *) *)
binding * bind * (V*)
to * - * *
operators (DNA*) - * (A7*)
that * - * *
overlap * - * *
the * - * *
glpA * - * *
promoter * - * *
elements * - * *
. * - * *

CRP (PTE*) - (A1*)
activates * - *
acs (PRC* - *
transcription *) - *
by * - *
binding * bind (V*)
tandem (DNA* - (A7*
DNA * - *
sites *) - *)
located * - *
upstream * - *
of * - *
the * - *
major * - *
promoter * - *
, * - *
acsP2 * - *
. * - *

Anaerobic * - (A5*)
induction * induce (V*)
of * - *
the (DNA* - (A0*
hyb * - *
operon *) - *)
was * - *
only * - *
partially * - *
dependent * - *
on * - *
the (PTE* - (A1*
FNR * - *
protein *) - *)
and * - *
, * - *
surprisingly * - *
, * - *
was * - *
enhanced * - *
by * - *
an (PRC* - *
arcA * - *
mutation *) - *
. * - *

Overexpression * overexpress (V*) * *
of * - * * *
the (PTE* - (A0* * *
human * - * * *
p120 * - * * *
protein *) - *) * *
caused * - * * *
the * - * * *
transformation * transform * (V*) *
of * - * * *
NIH (ORG* - * (A0* *
3T3 * - * * *
cells *) - * *) *
and * - * * *
expression * express * * (V*)
of * - * * *
an (DNA* - * * (A0*
antisense * - * * *
p120 * - * * *
construct *) - * * *)
inhibited * - * * *
the * - * * *
growth * - * * *
of * - * * *
NIH * - * * *
3T3 * - * * *
cells * - * * *
( * - * * *
Perlaky * - * * *
et * - * * *
al * - * * *
. * - * * *
, * - * * *
Cancer * - * * *
Res * - * * *
. * - * * *
, * - * * *
52 * - * * *
: * - * * *
428-436 * - * * *
, * - * * *
1992 * - * * *
) * - * * *
. * - * * *

Under * - *
nitrogen-deficient * - (A3*
growth * - *
conditions * - *)
, * - *
glnAp1 (DNA*) - (A0*)
is * - *
repressed * repress (V*)
by * - *
NtrC-phosphate (PTE*) - (A1*)
. * - *

The (None* - (A10* *
fusion * - * *
strains *) - *) *
were * - * *
used * - * *
to * - * *
study * study (V*) *
the * - (A0* *
regulation * regulation * (V*)
of * - * *
the (DNA* - * (A0*
cysB * - * *
gene *) - *) *)
by * - * *
assaying * - * *
the * - * *
fused * - * *
lacZ * - * *
gene * - * *
product * - * *
. * - * *

All * - *
of * - *
these * - *
properties * - *
were * - *
explained * - *
by * - *
the * - *
ability * - *
of * - *
the (PTE* - *
sdiA * - *
gene * - *
product *) - *
specifically * - *
to * - *
increase * - *
transcription * transcription (V*)
of * - *
the (DNA* - (A0*
ftsQAZ * - *
gene * - *
cluster *) - *)
, * - *
resulting * - *
in * - *
an * - *
increase * - *
in * - *
cellular * - *
concentration * - *
of * - *
the * - *
FtsZ * - *
protein * - *
. * - *

Cognate (DNA* - (A1*
cDNAs *) - *)
were * - *
isolated * - *
and * - *
shown * - *
to * - *
encode * encode (V*)
three (PTE* - (A0*
subunits *) - *)
that * - *
are * - *
specific * - *
to * - *
RNA * - *
Pol * - *
III * - *
and * - *
homologous * - *
to * - *
three * - *
yeast * - *
subunits * - *
. * - *

The * - *
regulation * - *
of * - *
ptsG (DNA* - (A0*
P1 *) - *)
transcription * transcription (V*)
is * - *
also * - *
under * - *
positive * - *
control * - *
by * - *
cyclic * - *
AMP * - *
receptor * - *
protein * - *
and * - *
cyclic * - *
AMP * - *
complex * - *
( * - *
CRP * - *
. * - *
cAMP * - *
) * - *
as * - *
observed * - *
in * - *
other * - *
Mlc * - *
regulon * - *
. * - *

Transfection (EXP*) - (A1*)
of * - *
the * - *
human * - *
promoter * - *
into * - *
ethoxyquin-treated * - *
mouse * - *
3T3 * - *
cells * - *
induces * induce (V*)
a * - (A9*
3 * - *
. * - *
5-fold * - *
increase * - *)
in * - *
promoter * - (A0*
activity * - *)
and * - *
a * - *
CHOP-C/EBP * - *
band * - *
appears * - *
on * - *
gel * - *
shifts * - *
performed * - *
with * - *
the * - *
5' * - *
probe * - *
from * - *
the * - *
human * - *
aldehyde * - *
reductase * - *
promoter * - *
. * - *

To * - *
assess * - *
the * - *
extent * - *
to * - *
which * - *
FlhD (PTE* - (A1*
( * - *
2 * - *
) * - *
C * - *
( * - *
2 * - *
) *) - *)
directly * - *
activates * activate (V*)
promoters (DNA*) - (A0*)
of * - *
a * - *
wider * - *
regulon * - *
, * - *
a * - *
computational * - *
screen * - *
of * - *
the * - *
E * - *
. * - *
coli * - *
genome * - *
was * - *
used * - *
to * - *
search * - *
for * - *
gene-proximal * - *
DNA * - *
sequences * - *
similar * - *
to * - *
the * - *
42-44 * - *
bp * - *
inverted * - *
repeat * - *
FlhD * - *
( * - *
2 * - *
) * - *
C * - *
( * - *
2 * - *
) * - *
binding * - *
consensus * - *
. * - *

This (PRC* - (A1* *
regulation *) - *) *
occurs * occur (V*) *
via * - * *
the (PTE* - (A8* *
NanR * - * *
and * - * *
NagC * - * *
regulators *) - *) *
, * - * *
which * - * *
also * - * *
control * - * *
fimB (DNA*) - * (A0*)
expression * express * (V*)
. * - * *

GalS * - *
has * - *
even * - *
less * - *
affinity * - *
for * - *
the * - *
external * - *
operator * - *
of * - *
galP (DNA*) - (A1*)
, * - *
which * - *
codes * code (V*)
for * - *
galactose (PTE* - (A0*
permease *) - *)
, * - *
the * - *
major * - *
low-affinity * - *
galactose * - *
transporter * - *
in * - *
the * - *
cell * - *
. * - *

The (DNA* - (A1*
PAX7 * - *
gene *) - *)
encodes * encode (V*)
a (PTE* - (A0*
transcription * - *
factor *) - *)
that * - *
is * - *
a * - *
member * - *
of * - *
the * - *
PAX * - *
family * - *
of * - *
developmental * - *
control * - *
genes * - *
. * - *

The (DNA* - (A0* *
maltose * - * *
regulon *) - *) *
consists * consist (V*) *
of * - * *
10 (DNA* - (A4* (A1*
genes *) - *) *)
encoding * encode * (V*)
an (PTE* - * (A0*
ABC * - * *
transporter *) - * *)
for * - * *
maltose * - * *
and * - * *
maltodextrins * - * *
as * - * *
well * - * *
as * - * *
enzymes * - * *
necessary * - * *
for * - * *
their * - * *
degradation * - * *
. * - * *

The * - *
lacZ * - *
transcriptional * - *
fusions * - *
in * - *
the * - *
genetic * - *
background * - *
of * - *
the * - *
mutant * - *
strain * - *
revealed * - *
that * - *
yiaK-S (DNA*) - (A0*)
is * - *
modulated * modulate (V*)
by * - *
the (PTE* - (A1*
integration * - *
host * - *
factor *) - *)
and * - *
by * - *
the * - *
cyclic * - *
AMP * - *
( * - *
cAMP (EXP*) - *
) * - *
-cAMP * - *
receptor * - *
protein * - *
( * - *
Crp (PTE*) - *
) * - *
activator * - *
complex * - *
. * - *

A * - * *
putative * - * *
stem-loop * - * *
structure * - * *
located * - * *
within * - * *
the * - * *
K30 * - * *
cps * - * *
cluster * - * *
separates * - * *
conserved * - * *
genes * - * *
with * - * *
products (PTE*) - * *
that * - * *
are * - * *
required * - * *
for * - * *
surface * - * *
expression * express (V*) *
of * - * *
capsule * - (A0*) *
from * - * *
serotype-specific (DNA* - (A6* (A1*
genes *) - *) *)
encoding * encode * (V*)
enzymes (PTE*) - * (A0*)
for * - * *
polymer * - * *
repeat-unit * - * *
synthesis * - * *
and * - * *
polymerization * - * *
. * - * *

In * - *
this * - *
case * - *
, * - *
the * - *
relative * - *
sensitivity * - *
of * - *
the * - *
glp * - *
operons * - *
to * - *
catabolite (EXP*) - (A0*)
repression * repress (V*)
was * - *
glpTQ * - *
greater * - *
than * - *
glpFK * - *
greater * - *
than * - *
glpACB * - *
greater * - *
than * - *
glpD * - *
. * - *

From * - *
this * - *
comparison * - *
, * - *
it * - *
is * - *
found * - *
that * - *
similar (PTE* - *
regulatory * - *
proteins *) - *
rarely * - *
regulate * - *
the * - *
transcription * transcription (V*)
of * - *
similar (DNA* - (A0*
protein * - *
genes *) - *)
. * - *

Although * - *
the * - *
dcw * - *
cluster * - *
is * - *
conserved * - *
to * - *
a * - *
different * - *
extent * - *
in * - *
a * - *
variety * - *
of * - *
bacteria * - *
, * - *
the * - *
regulation * - *
of * - *
gene (DNA*) - (A0*)
expression * express (V*)
, * - *
the * - *
presence * - *
or * - *
absence * - *
of * - *
individual (DNA* - *
genes *) - *
, * - *
and * - *
even * - *
the * - *
essentiality * - *
of * - *
some * - *
of * - *
them * - *
, * - *
show * - *
variations * - *
in * - *
the * - *
phylogenetic * - *
scale * - *
which * - *
may * - *
reflect * - *
adaptation * - *
to * - *
specific * - *
life * - *
cycles * - *
. * - *

A (EXP* - (A1*
novel * - *
genetic * - *
system *) - *)
to * - *
isolate * isolate (V*)
a (PTE* - (A0*
dominant * - *
negative * - *
effector *) - *)
on * - *
DNA-binding * - *
activity * - *
of * - *
Oct-2 * - *
. * - *

Characterization * characterize (V*)
of * - *
the (DNA* - (A0*
galS * - *
gene *) - *)
and * - *
its (DNA* - *
product *) - *
has * - *
revealed * - *
an (PTE* - *
isorepressor *) - *
of * - *
the * - *
gal * - *
regulon * - *
. * - *

The (DNA* - * *
conserved * - * *
stretch *) - * *
contains * - * *
all * - (A0* *
the * - * *
elements * - *) *
required * - * *
to * - * *
bind * bind (V*) *
DNA * - (A7* *
target * - * *
sequences * - *) *
and * - * *
to * - * *
activate * - * *
transcription * transcription * (V*)
from * - * *
cognate (DNA* - * (A6*
promoters *) - * *)
. * - * *

RLF (DNA*) - (A0*)
is * - *
widely * - *
expressed * express (V*)
in * - (A2*
fetal (ORG* - *
and * - *
adult * - *
tissues *) - *)
, * - *
suggesting * - *
that * - *
it * - *
has * - *
a * - *
general * - *
role * - *
in * - *
transcriptional * - *
regulation * - *
. * - *

MITF-A (DNA* - (A0* (A0*
mRNA *) - *) *)
is * - * *
widely * - (A5*) *
expressed * express (V*) *
and * - * *
represents * represent * (V*)
a * - * *
predominant (PTE* - * (A4*
MITF * - * *
isoform *) - * *)
in * - * (A2*
cultured * - * *
RPE * - * *
cells * - * *)
, * - * *
whereas * - * *
MITF-M (DNA* - * *
mRNA *) - * *
is * - * *
exclusively * - * *
expressed * - * *
in * - * *
melanocytes * - * *
and * - * *
melanoma * - * *
cells * - * *
. (ORG*) - * *

Analysis * - *
of * - *
a * - *
purR-lacZ * - *
transcriptional * - *
fusion * - *
indicated * - *
that * - *
purR (DNA*) - (A0*)
expression * express (V*)
is * - *
autoregulated * - *
. * - *

Results * - *
presented * - *
here * - *
indicate * - *
that * - *
the * - *
increase * - *
of * - *
sdh (DNA*) - (A0*)
and * - *
lct (DNA*) - *
expression * express (V*)
by * - *
nitrate * - *
depended * - *
on * - *
its * - *
chemical * - *
reduction * - *
, * - *
which * - *
in * - *
turn * - *
diminished * - *
the * - *
ArcA-P * - *
pool * - *
. * - *

Escherichia * - *
coli * - *
leucine-responsive * - *
regulatory * - *
protein * - *
( * - *
Lrp (PTE*) - *
) * - *
controls * - *
lysyl-tRNA (PTE* - (A0*
synthetase *) - *)
expression * express (V*)
. * - *

Differential * - (A5*)
regulation * regulation (V*)
by * - *
the * - *
homologous * - *
response * - *
regulators * - *
NarL (PTE*) - (A1*)
and * - *
NarP (PTE*) - *
of * - *
Escherichia * - *
coli * - *
K-12 * - *
depends * - *
on * - *
DNA * - *
binding * - *
site * - *
arrangement * - *
. * - *

Regulation * regulate (V*) *
of * - * *
lrp (DNA* - (A0* (A0*
gene *) - * *)
expression * express *) (V*)
by * - * *
H-NS (PTE* - (A1* *
and * - * *
Lrp * - * *
proteins *) - *) *
in * - (A2* *
Escherichia (ORG* - * *
coli *) - *) *
: * - * *
dominant * - * *
negative * - * *
mutations * - * *
in * - * *
lrp * - * *
. * - * *

We * - * *
show * - * *
here * - * *
that * - * *
Crl (PTE*) - (A1*) *
interacts * interact (V*) *
directly * - (A5*) *
with * - * *
sigma * - * *
( * - * *
S (PTE*) - (A1*) *
) * - * *
and * - * *
that * - * *
this * - * *
interaction * - * *
promotes * - * *
binding * bind * (V*)
of * - * *
the * - * *
sigma * - * *
( * - * *
S * - * *
) * - * *
holoenzyme * - * *
( * - * *
Esigma (PTE* - * (A1*
( * - * *
S * - * *
) *) - * *)
) * - * *
to * - * *
the (DNA* - * (A7*
csgBA * - * *
promoter *) - * *)
. * - * *

Forkhead-related * - * *
activator * - * *
2 * - * *
( * - * *
FREAC-2 (PTE*) - (A0*) (A1*)
) * - * *
is * - * *
a * - * *
human * - * *
transcription * - * *
factor * - * *
expressed * express (V*) *
in * - (A2* *
lung (ORG* - * *
and * - * *
placenta *) - *) *
that * - * *
binds * bind * (V*)
to * - * *
cis-elements (DNA*) - * (A7*)
in * - * *
several * - * *
lung-specific * - * *
genes * - * *
. * - * *

Here * - *
we * - *
show * - *
that * - *
OmpR (PTE*) - *
, * - *
under * - *
certain * - *
conditions * - *
, * - *
could * - *
activate * - *
porin * - (A0*)
expression * express (V*)
in * - (A3*
the * - *
complete * - *
absence * - *
of * - *
EnvZ * - *)
. (PTE*) - *

Mutation (None* - *
hns *) - *
( * - *
- * - *
) * - *
resulted * - *
in * - *
an * - *
increase * - *
in * - *
P * - *
( * - *
mcc * - *
) * - *
-lac (DNA*) - (A0*)
expression * express (V*)
in * - *
crp * - *
, * - *
rpoS * - *
and * - *
lrp * - *
mutant * - *
cells * - *
, * - *
as * - *
in * - *
wild-type * - *
cells * - *
. (None*) - *

The (DNA* - (A1*
torT * - *
gene *) - *)
codes * code (V*)
for * - *
a (PTE* - (A0*
35 * - *
. * - *
7-kDa * - *
periplasmic * - *
protein *) - *)
which * - *
presents * - *
some * - *
homology * - *
with * - *
the * - *
periplasmic * - *
ribose-binding * - *
protein * - *
of * - *
E * - *
. * - *
coli * - *
. * - *

We * - *
show * - *
that * - *
a * - *
dominant-negative * - *
mutant * - *
SMN * - *
( * - *
SMNdeltaN27 (PRC*) - (A1*)
) * - *
causes * cause (V*)
a * - (A0*
dramatic * - *
reorganization * - *
of * - *
snRNPs * - *)
in * - (A2*
the (ORG* - *
nucleus *) - *)
. (PTE*) - *

To * - *
analyze * - *
the * - *
mechanism * - *
of * - *
basal * - *
regulation * - *
of * - *
aldehyde * - (A0*
reductase * - *)
expression * express (V*)
, * - *
we * - *
cloned * - *
the * - *
murine * - *
gene * - *
and * - *
adjacent * - *
regulatory * - *
region * - *
and * - *
compared * - *
it * - *
to * - *
the * - *
human * - *
gene * - *
. * - *

Gel-shift * - * *
assays * - * *
and * - * *
chromatin * - * *
immunoprecipitation * - * *
as * - * *
well * - * *
as * - * *
deletion/mutation * - * *
analysis * - * *
reveal * - * *
that * - * *
selenocysteine * - * *
tRNA * - * *
transcription * - * *
activating * - * *
factor * - * *
( * - * *
STAF (PTE*) - (A1*) *
) * - * *
binds * bind (V*) *
to * - * *
the (DNA* - (A7* *
5' * - * *
element *) - *) *
and * - * *
drives * - * *
constitutive * - * *
expression * express * (V*)
of * - * *
both * - * *
mouse (PTE* - * (A0*
and * - * *
human * - * *
aldehyde * - * *
reductase *) - * *)
. * - * *

( * - *
ii * - *
) * - *
FruR (PTE*) - (A1*)
binds * bind (V*)
to * - *
a (DNA* - (A7*
target * - *
DNA * - *
region *) - *)
centered * - *
around * - *
position (DNA* - (A2*
-45 * - *
. * - *
5 *) - *)
upstream * - *
of * - *
the * - *
ppsA * - *
gene * - *
. * - *

This * - * *
implies * - * *
that * - * *
the * - * (A0*
cysB (DNA* - (A0* *
gene *) - *) *
expression * express (V*) *)
is * - * *
autoregulated * autoregulate * (V*)
by * - * *
its * - * (A1*
own * - * *
product * - * *)
. * - * *

Regulation * - *
of * - *
expression * express (V*)
of * - *
the (DNA* - (A0*
yiaKLMNOPQRS * - *
operon *) - *)
for * - *
carbohydrate * - *
utilization * - *
in * - (A2*
Escherichia (ORG* - *
coli *) - *)
: * - *
involvement * - *
of * - *
the * - *
main * - *
transcriptional * - *
factors * - *
. * - *

In * - *
this * - *
study * - *
, * - *
DNase * - *
I * - *
footprinting * - *
experiments * - *
with * - *
the * - *
fdnG * - *
, * - *
nirB * - *
and * - *
nrfA * - *
control * - *
regions * - *
revealed * - *
that * - *
NarP (PTE*) - (A1*)
only * - (A5*)
binds * bind (V*)
to * - *
heptamer (DNA* - (A7*
sequences *) - *)
organized * - *
as * - *
an * - *
inverted * - *
repeat * - *
with * - *
a * - *
2 * - *
bp * - *
spacing * - *
( * - *
7-2-7 * - *
sites * - *
) * - *
. * - *

One (DNA* - (A1*
cDNA *) - *)
identified * - *
encodes * encode (V*)
a * - *
new * - *
member * - *
of * - *
the * - *
bHLH-Zip * - *
protein * - *
family * - *
, * - *
Mad (PTE*) - (A0*)
. * - *

This (DNA* - (A0* *
gene *) - *) *
, * - * *
designated * - * *
SMARCA5 * - * *
, * - * *
contained * contain (V*) *
an (DNA* - (A4* (A1*
open * - * *
reading * - * *
frame *) - *) *)
of * - * *
3 * - * *
, * - * *
156 * - * *
nucleotides * - * *
encoding * encode * (V*)
a * - * *
1 * - * *
, * - * *
052 * - * *
amino-acid * - * *
peptide * - * *
( * - * *
hSNF2H (PTE*) - * (A0*)
) * - * *
. * - * *

These * - *
are * - *
fumarate (PTE* - (A1*
reductase *) - *)
( * - *
encoded * encode (V*)
by * - *
the (DNA* - (A0*
frdABCD * - *
operon *) - *)
) * - *
, * - *
fumarase * - *
B * - *
, * - *
which * - *
generates * - *
fumarate * - *
from * - *
malate * - *
, * - *
and * - *
the * - *
DcuB * - *
permease * - *
for * - *
fumarate * - *
, * - *
malate * - *
, * - *
and * - *
aspartate * - *
. * - *

SMN (PTE*) - (A0*)
interacts * interact (V*)
with * - *
spliceosomal (PTE* - (A0*
snRNP * - *
proteins *) - *)
and * - *
is * - *
critical * - *
for * - *
snRNP * - *
assembly * - *
in * - *
the * - *
cytoplasm * - *
. * - *

Mutation * mutate (V*) * * *
of * - * * * *
two (PTE* - (A0* * * *
of * - * * * *
the * - * * * *
potential * - * * * *
Zn2+ * - * * * *
coordinating * - * * * *
cysteines *) - *) * * *
to * - * * * *
serines * - * * * *
in * - (A2* * * *
the * - * * * *
RING * - * * * *
finger * - *) * * *
completely * - * * * *
abolished * - * * * *
the * - * * * *
ability * - * * * *
of * - * * * *
SNURF (PTE*) - * (A1*) (A1*) *
to * - * * * *
enhance * enhance * (V*) * *
basal (PRC* - * (A0* * *
transcription *) - * *) * *
, * - * * * *
whereas * - * * * *
its * - * * * *
ability * - * * * *
to * - * * * *
activate * activate * * (V*) *
steroid (PRC* - * * (A0* *
receptor-dependent * - * * * *
transcription *) - * * *) *
was * - * * * *
maintained * - * * * *
, * - * * * *
suggesting * - * * * *
that * - * * * *
there * - * * * *
are * - * * * *
separate (PTE* - * * * (A1*
domains *) - * * * *
in * - * * * *
SNURF * - * * * *)
that * - * * * *
mediate * mediate * * * (V*)
interactions * - * * * (A0*)
with * - * * * *
different * - * * * *
regulatory * - * * * *
factors * - * * * *
. (PTE*) - * * * *

Footprinting * - * *
assays * - * *
have * - * *
suggested * - * *
that * - * *
these (PTE* - (A1* *
regulators *) - *) *
protect * protect (V*) *
a * - (A0* *
stretch * - * *
of * - * *
up * - * *
to * - * *
20 * - * *
bp * - *) *
in * - (A2* *
the (DNA* - * *
target * - * *
promoters *) - *) *
, * - * *
and * - * *
multiple * - * *
alignments * - * *
of * - * *
binding * - * *
sites * - * *
for * - * *
a * - * *
number * - * *
of * - * *
regulators * - * *
have * - * *
shown * - * *
that * - * *
the (PTE* - * (A1*
proteins *) - * *)
recognize * recognize * (V*)
short (DNA* - * (A0*
motifs *) - * *)
within * - * (A2*
the * - * *
protected * - * *
region * - * *)
. * - * *

An * - *
analysis * - *
with * - *
random * - *
transposon * - *
insertions * - *
revealed * - *
that * - *
the * - *
xyl * - *
genes * - *
are * - *
organized * - *
into * - *
two * - *
major * - *
transcriptional * - *
units * - *
, * - *
xylAB (DNA*) - (A0*)
and * - *
xylFGHR (DNA*) - *
, * - *
governed * govern (V*)
by * - *
the * - *
promoters * - *
PA (DNA*) - (A1*)
and * - *
PF (DNA*) - *
, * - *
respectively * - *
. * - *

In * - *
contrast * - *
, * - *
BNIP3 (DNA*) - (A0*)
is * - *
expressed * express (V*)
well * - (A5*)
in * - (A2*
several (ORG* - *
human * - *
tissues *) - *)
and * - *
less * - *
abundantly * - *
in * - *
certain * - *
tissues * - *
such * - *
as * - *
placenta (ORG* - *
and * - *
lung *) - *
. * - *

Consistent * - * * *
with * - * * *
the * - * * *
fact * - * * *
that * - * * *
GalR * - * * *
is * - * * *
the * - * * *
exclusive * - * * *
regulator * - * * *
of * - * * *
the * - * * *
low-affinity * - * * *
galactose * - * * *
transporter * - * * *
, * - * * *
galactose * - * * *
permease * - * * *
, * - * * *
and * - * * *
that * - * * *
the * - * * *
major * - * * *
role * - * * *
of * - * * *
GalS (PTE*) - * * *
is * - * * *
in * - * * *
regulating * - * * *
expression * express (V*) * *
of * - * * *
the (PTE* - (A0* (A0* *
high-affinity * - * * *
galactose * - * * *
transporter *) - *) *) *
encoded * encode * (V*) *
by * - * * *
the (DNA* - * (A1* *
mgl * - * * *
operon *) - * *) *
, * - * * *
we * - * * *
found * - * * *
that * - * * *
the * - * * *
DNA (DNA*) - * * (A7*)
binding * bind * * (V*)
of * - * * *
GalS (PTE*) - * * (A1*)
is * - * * *
15-fold * - * * *
more * - * * *
sensitive * - * * *
than * - * * *
that * - * * *
of * - * * *
GalR * - * * *
to * - * * *
galactose * - * * *
. * - * * *

Interestingly * - * *
, * - * *
when * - * *
gntR * - * *
deletion * - * *
strains * - * *
are * - * *
grown * - * *
in * - * *
the * - * *
presence * - * *
of * - * *
gluconate * - * *
, * - * *
there * - * *
is * - * *
a * - * *
twofold * - * *
decrease * - * *
in * - * *
gntT (DNA*) - (A0*) *
expression * express (V*) *
which * - * *
is * - * *
independent * - * *
of * - * *
catabolite * - * *
repression * - * *
and * - * *
binding * bind * (V*)
of * - * *
GntR (PTE*) - * (A1*)
to * - * *
the (DNA* - * (A7*
operator * - * *
sites *) - * *)
. * - * *

The * - *
interactions * interact (V*)
of * - *
the (DNA* - (A1*
ppsA * - *
promoter *) - *)
with * - *
either * - *
RNA (PTE* - (A1*
polymerase *) - *)
or * - *
FruR (PTE* - (A1*
factor *) - *)
were * - *
analysed * - *
by * - *
the * - *
base * - *
removal * - *
method * - *
. * - *

The * - *
results * - *
suggest * - *
that * - *
glpD (DNA*) - (A0*)
is * - *
controlled * control (V*)
by * - *
formation * - (A1*)
of * - *
a * - *
repression * - *
loop * - *
between * - *
the (DNA* - *
tandem * - *
and * - *
internal * - *
operators *) - *
. * - *

Contributions * - *
of * - *
UP * - *
elements * - *
and * - *
the * - *
transcription * - *
factor * - *
FIS * - *
to * - *
expression * express (V*)
from * - *
the (DNA* - (A6*
seven * - *
rrn * - *
P1 * - *
promoters *) - *)
in * - (A2*
Escherichia (ORG* - *
coli *) - *)
. * - *

Expression * express (V*)
of * - *
a (DNA* - (A0*
similar * - *
gene * - *
fusion *) - *)
of * - *
the * - *
galR * - *
promoter * - *
to * - *
lacZ * - *
was * - *
unregulated * - *
. * - *

NarL (PTE*) - (A1*) *
can * - * *
also * - * *
recognize * recognize (V*) *
other (DNA* - (A0* *
binding * - * *
site * - * *
arrangements *) - *) *
, * - * *
an * - * (A0*
ability * - * *)
that * - * *
appears * - * *
to * - * *
be * - * *
lacking * lack * (V*)
in * - * *
NarP (PTE*) - * (A1*)
. * - * *

Leucine (PTE*) - (A1*) *
counteracts * counteract (V*) *
Lrp * - (A0* *
binding * - *) *
to * - * *
P * - * *
aidB * - * *
, * - * *
as * - * *
does * - * *
binding * - * *
to * - * *
P * - * *
aidB * - * *
of * - * *
me * - * *
Ada * - * *
, * - * *
which * - * *
causes * - * *
Lrp * - * (A1*)
to * - * *
dissociate * dissociate * (V*)
from * - * *
the * - * (A6*
promoter * - * *)
. * - * *

Among * - *
RFX * - *
transcription * - *
factor * - *
family * - *
members * - *
, * - *
RFX1 (PTE* - (A1*
and * - *
3 *) - *)
mainly * - *
interact * interact (V*)
with * - *
repressive (PTE* - (A8*
elements *) - *)
in * - (A10*
vitro * - *)
. * - *

Selective * - *
regulation * - *
of * - *
ptsG (DNA*) - (A0*)
expression * express (V*)
by * - *
Fis (PTE*) - *
. * - *

Human (PTE* - *
TAF * - *
( * - *
II * - *
) * - *
135 *) - *
potentiates * - *
transcriptional * - (A5*)
activation * activate (V*)
by * - *
the (PTE* - (A1*
AF-2s *) - *)
of * - *
the * - *
retinoic * - *
acid * - *
, * - *
vitamin * - *
D3 * - *
, * - *
and * - *
thyroid * - *
hormone * - *
receptors * - *
in * - (A2*
mammalian (ORG* - *
cells *) - *)
. * - *

Constitutive * - (A5*) * *
CsgD (PTE*) - (A0*) * *
expression * express (V*) * *
promotes * - * * *
biofilm * - * * *
formation * - * * *
by * - * * *
PHL565 * - * * *
and * - * * *
activates * - * * *
transcription * transcription * (V*) *
from * - * * *
the (DNA* - * (A6* *
csgBAC * - * * *
promoter *) - * *) *
; * - * * *
however * - * * *
, * - * * *
csgBAC (DNA*) - * * (A0*)
expression * express * * (V*)
remains * - * * *
dependent * - * * *
on * - * * *
temperature * - * * *
and * - * * *
the * - * * *
growth * - * * *
medium * - * * *
. * - * * *

The (DNA* - (A0*
tdh * - *
promoter *) - *)
of * - *
Escherichia * - *
coli * - *
is * - *
induced * induce (V*)
seven- * - (A9*
to * - *
eightfold * - *)
when * - *
cells (ORG*) - (A12*
are * - *
grown * - *
in * - *
the * - *
presence * - *
of * - *
exogenous (EXP* - *
leucine *) - *)
. * - *

Biochemical * - *
and * - *
genetic * - *
evidence * - *
shows * - *
that * - *
these (DNA* - (A1*
two * - *
genes *) - *)
encode * encode (V*)
two (PTE* - *
phosphoprotein * - *
phosphatases *) - *
, * - *
designated * - *
PrpA (PTE*) - (A0*)
and * - *
PrpB (PTE*) - *
. * - *

Lrp (PTE*) - *
acts * - *
as * - *
a (PTE* - *
specific * - *
repressor *) - *
for * - *
sigma * - *
s-dependent * - *
transcription * transcription (V*)
of * - *
aidB (DNA*) - (A0*)
. * - *

In * - *
Escherichia * - *
coli * - *
K-12 * - *
, * - *
the (DNA* - (A1*
shiA * - *
gene *) - *)
is * - *
involved * involve (V*)
in * - *
the * - (A8*
uptake * - *)
of * - *
shikimate * - *
. * - *

hLSIRF (DNA* - (A0*
mRNA *) - *)
was * - *
rapidly * - *
induced * induce (V*)
in * - (A2*
peripheral (ORG* - *
T * - *
cells *) - *)
after * - *
crosslinking * - (A3*
the (PTE* - *
T-cell * - *
receptor *) - *)
. * - *

Expression * express (V*)
of * - *
Crl (PTE*) - (A0*)
is * - *
increased * - *
during * - *
the * - *
transition * - *
from * - *
growing * - *
to * - *
stationary * - *
phase * - *
. * - *

Expression * express (V*)
of * - *
both * - (A0*)
was * - *
induced * - *
by * - *
anaerobiosis * - *
and * - *
repressed * - *
by * - *
nitrate (EXP*) - *
, * - *
which * - *
is * - *
in * - *
complete * - *
accord * - *
with * - *
earlier * - *
biochemical * - *
studies * - *
. * - *

Site-directed * - (A5*) * *
mutagenesis * mutate (V*) * *
of * - * * *
an * - * * *
Lrp (PTE*) - * (A1*) *
binding * - * * *
site * - * * *
strongly * - * * *
reduced * - * * *
Lrp (PTE*) - * * *
binding * bind * (V*) *
and * - * * *
prevented * - * * *
Lrp * - * * *
repression * - * * *
of * - * * *
dad (DNA*) - * * (A0*)
transcription * transcription * * (V*)
in * - * * *
vivo * - * * *
and * - * * *
in * - * * *
vitro * - * * *
. * - * * *

Since * - *
NERF (PTE*) - *
and * - *
ELF-1 (PTE*) - *
are * - *
coexpressed * - *
in * - *
B * - *
and * - *
T * - *
cells * - *
, * - *
both * - *
might * - *
be * - *
involved * - *
in * - *
the * - *
regulation * regulation (V*)
of * - *
the (DNA* - (A0*
same * - *
genes *) - *)
. * - *

PU * - *
. * - *
1 * - *
( * - *
Spi-1 (PTE*) - (A1*)
) * - *
autoregulates * autoregulate (V*)
its (PRC* - (A0*
expression *) - *)
in * - (A2*
myeloid (ORG* - *
cells *) - *)
. * - *

DNase * - *
I * - *
footprinting * - *
experiments * - *
revealed * - *
that * - *
ArcA-P * - (A1*)
binds * bind (V*)
to * - *
the * - *
left * - *
region * - *
of * - *
the * - *
chromosomal * - *
origin * - *
, * - *
oriC * - (A7*)
. * - *

The * - * *
expression * express (V*) *
of * - * *
an (DNA* - (A0* *
ompF'-lacZ+ * - * *
gene *) - * *
( * - * *
translational * - * *
) * - * *
fusion * - *) *
is * - * *
increased * - * *
3 * - * *
. * - * *
7-fold * - * *
in * - * *
an (ORG* - * *
lrp+ * - * *
background *) - * *
compared * - * *
with * - * *
an * - * *
lrp * - * *
background * - * *
, * - * *
but * - * *
expression * express * (V*)
of * - * *
an (DNA* - * (A0*
ompF-lacZ+ * - * *
operon * - * *
fusion *) - * *)
is * - * *
not * - * *
. * - * *

Periplasmic (PTE* - (A0*
nitrate * - *
reductase *) - *)
, * - *
encoded * encode (V*)
by * - *
the (DNA* - (A1*
napFDAGHBC * - *
operon *) - *)
, * - *
functions * - *
with * - *
concentrations * - *
of * - *
nitrate * - *
that * - *
are * - *
too * - *
low * - *
to * - *
support * - *
respiration * - *
by * - *
membrane-bound * - *
nitrate * - *
reductase * - *
. * - *

Transcription * transcribe (V*)
of * - *
yiaK-S (DNA*) - (A0*)
as * - *
a * - *
single * - *
message * - *
from * - *
the (DNA* - (A6*
unique * - *
promoter *) - *)
found * - *
upstream * - *
of * - *
yiaK * - *
is * - *
proven * - *
in * - *
this * - *
study * - *
. * - *

The (DNA* - (A1* (A0* *
hpt * - * * *
gene *) - *) *) *
, * - * * *
which * - * * *
encodes * encode (V*) * *
hypoxanthine (PTE* - (A0* * *
phosphoribosyltransferase *) - *) * *
, * - * * *
is * - * * *
located * - * * *
next * - * * *
to * - * * *
, * - * * *
but * - * * *
transcribed * transcribe * (V*) *
in * - * * *
the * - * (A5* *
opposite * - * * *
direction * - * *) *
to * - * * *
, * - * * *
the (DNA* - * * (A1*
gcd * - * * *
gene *) - * * *)
, * - * * *
which * - * * *
codes * code * * (V*)
for * - * * *
a (PTE* - * * (A0*
membrane-bound * - * * *
glucose * - * * *
dehydrogenase *) - * * *)
, * - * * *
at * - * * *
3 * - * * *
. * - * * *
1 * - * * *
min * - * * *
on * - * * *
the * - * * *
Escherichia * - * * *
coli * - * * *
genome * - * * *
. * - * * *

In * - * *
addition * - * *
, * - * *
circular * - * *
permutation * - * *
analysis * - * *
showed * - * *
that * - * *
, * - * *
upon * - * *
binding * - * *
to * - * *
its * - * *
site * - * *
, * - * *
FruR (PTE*) - (A1*) *
induces * induce (V*) *
a * - (A0* *
sharp * - * *
bend * - *) *
of * - * *
120 * - * *
degrees * - * *
in * - * *
the * - * *
DNA * - * *
helix * - * *
, * - * *
which * - * *
suggests * - * *
a * - * *
crucial * - * *
involvement * - * *
of * - * *
FruR-induced * - * *
bending * - * *
in * - * *
ppsA (DNA* - * (A0*
promoter *) - * *)
activation * activate * (V*)
. * - * *

The * - * *
expression * express (V*) *
of * - * *
the (DNA* - (A0* (A1*
Escherichia * - * *
coli * - * *
torCAD * - * *
operon *) - *) *)
, * - * *
which * - * *
encodes * encode * (V*)
the * - * *
anaerobically * - * *
expressed * - * *
trimethylamine * - * *
N-oxide * - * *
( * - * *
TMAO (PTE* - * (A0*
) * - * *
reductase * - * *
respiratory * - * *
system *) - * *)
, * - * *
requires * - * *
the * - * *
presence * - * *
of * - * *
TMAO (EXP*) - * *
in * - * *
the * - * *
medium * - * *
. * - * *

Nucleolar (PTE* - (A0*
transcription * - *
factor * - *
hUBF *) - *)
contains * contain (V*)
a (PTE* - (A4*
DNA-binding * - *
motif *) - *)
with * - *
homology * - *
to * - *
HMG * - *
proteins * - *
. * - *

Mutations * mutate (V*)
in * - (A2*
arcB (DNA* - *
or * - *
arcA *) - *)
were * - *
epistatic * - *
over * - *
that * - *
of * - *
fnr * - *
. * - *

Evidence * - *
that * - *
dynamin-2 (PTE*) - (A0*)
functions * function (V*)
as * - *
a (PTE* - (A4*
signal-transducing * - *
GTPase *) - *)
. * - *

All * - * *
of * - * *
the * - * *
results * - * *
are * - * *
consistent * - * *
with * - * *
a * - * *
model * - * *
of * - * *
repression (PRC*) - * *
involving * - * *
GlpR (PTE*) - (A1*) *
binding * bind (V*) *
simultaneously * - (A5*) *
to * - * *
the (DNA* - (A0* *
glpA * - * *
and * - * *
remote * - * *
glpT * - * *
operators *) - *) *
, * - * *
with * - * *
intervening * - * *
DNA (DNA*) - * (A1*)
forming * form * (V*)
a * - * (A0*
loop * - * *)
. * - * *

A * - *
regulatory * - *
role * - *
for * - *
HU (PTE*) - *
was * - *
suggested * - *
when * - *
it * - *
was * - *
found * - *
that * - *
repressor-mediated * - *
control * - *
of * - *
glpD (DNA*) - (A0*)
transcription * transcription (V*)
was * - *
increased * - *
fourfold * - *
in * - *
strains * - *
containing * - *
HU * - *
compared * - *
with * - *
that * - *
of * - *
strains (ORG*) - *
deficient * - *
in * - *
HU * - *
. * - *

By * - *
in * - *
vitro * - *
analysis * - *
the * - *
possibility * - *
was * - *
investigated * - *
that * - *
IHF (PTE*) - (A1*)
interacts * interact (V*)
directly * - (A5*)
with * - *
the (DNA* - (A1*
ompF * - *
promoter * - *
region *) - *)
. * - *

We * - *
isolated * - *
a * - *
cDNA * - *
clone * - *
with * - *
an (DNA* - (A1*
open * - *
reading * - *
frame *) - *)
encoding * encode (V*)
a (PTE* - (A0*
putative * - *
protein *) - *)
of * - *
384 * - *
amino * - *
acids * - *
, * - *
which * - *
shared * - *
83% * - *
identity * - *
to * - *
the * - *
mouse * - *
Sox18 * - *
protein * - *
. * - *

These * - *
sequence * - *
similarities * - *
suggest * - *
that * - *
ISGF3 (PTE* - (A1*
gamma *) - *)
and * - *
IRF (PTE* - *
proteins *) - *
and * - *
the (PTE* - *
c-myb * - *
oncoprotein *) - *
use * use (V*)
a (PTE* - (A10*
common * - *
structural * - *
motif *) - *)
for * - *
DNA * - (A11*
recognition * - *)
. * - *

Transactivation * transactivate (V*) * *
by * - * * *
recombinant (PTE* - (A1* * *
NFAT1 *) - *) * *
in * - (A2* * *
Jurkat (ORG* - * * *
T * - * * *
cells *) - *) * *
requires * - * * *
dual * - * (A5*) *
stimulation * stimulate * (V*) *
with * - * * *
ionomycin (EXP*) - * (A1*) *
and * - * * *
phorbol (EXP* - * * *
12-myristate * - * * *
13-acetate *) - * * *
; * - * * *
this * - * * *
activity * - * * *
is * - * * *
potentiated * - * * *
by * - * * *
coexpression * coexpress * * (V*)
of * - * * *
constitutively (PTE* - * * (A0*
active * - * * *
calcineurin *) - * * *)
and * - * * *
is * - * * *
inhibited * - * * *
by * - * * *
CsA * - * * *
. * - * * *

The * - * * *
LysR-type * - * * *
transcriptional * - * * *
regulator * - * * *
( * - * * *
LTTR * - * * *
) * - * * *
CysB (PTE*) - (A1*) (A1*) (A0*)
is * - * * *
a * - * * *
transcription * - * * *
factor * - * * *
in * - * * *
Escherichia * - * * *
coli * - * * *
cells * - * * *
, * - * * *
where * - * * *
as * - * * *
a * - * * *
homotetramer * - * * *
it * - * * *
binds * bind (V*) * *
the (DNA* - (A7* * *
target * - * * *
promoter * - * * *
regions *) - *) * *
and * - * * *
activates * activate * (V*) *
the (DNA* - * (A0* *
genes *) - * *) *
involved * - * * *
in * - * * *
sulphur * - * * *
utilization * - * * *
and * - * * *
sulphonate-sulphur * - * * *
metabolism * - * * *
, * - * * *
while * - * * *
negatively * - * * *
autoregulating * - * * *
its * - * * *
own * - * * *
transcription * transcription * * (V*)
. * - * * *

Interestingly * - *
, * - *
at * - *
high * - (A3*
concentrations * - *)
human (PTE* - (A1*
jun-D *) - *)
displays * display (V*)
decreased * - (A8*
activity * - *)
which * - *
cannot * - *
be * - *
explained * - *
by * - *
a * - *
simple * - *
self * - *
squelching * - *
model * - *
. * - *

We * - * *
propose * - * *
a * - * *
model * - * *
in * - * *
which * - * *
multiple * - * *
binding * - * *
sites * - * *
( * - * *
i * - * *
. * - * *
e * - * *
. * - * *
the * - * *
tor * - * *
boxes * - * *
) * - * *
contribute * - * *
to * - * *
the * - * *
formation * form (V*) *
of * - * *
a (PTE* - (A0* *
nucleoprotein * - * *
complex *) - *) *
, * - * *
but * - * *
only (DNA* - * *
one * - * *
particular * - * *
proximal * - * *
site *) - * *
positions * - * *
TorR (PTE*) - * (A1*)
properly * - * *
so * - * *
that * - * *
it * - * *
interacts * interact * (V*)
with * - * *
RNA (PTE* - * (A1*
polymerase *) - * *)
. * - * *

osmY (DNA*) - (A1*) * *
( * - * * *
csi-5 * - * * *
) * - * * *
is * - * * *
a * - * * *
representative * - * * *
of * - * * *
a * - * * *
large * - * * *
group * - * * *
of * - * * *
sigma * - * * *
s-dependent * - * * *
genes * - * * *
in * - * * *
Escherichia * - * * *
coli * - * * *
that * - * * *
exhibit * exhibit (V*) * *
both * - * * *
stationary-phase * - (A8* (A5*) *
induction * induce *) (V*) *
and * - * * *
osmotic * - * * (A5*)
regulation * regulation * * (V*)
. * - * * *

In * - (A2*
quiescent (ORG* - *
HepG2 * - *
cells *) - *)
, * - *
BD73 (DNA* - (A0*
messenger * - *
RNA * - *
levels *) - *)
are * - *
strongly * - (A5*)
induced * induce (V*)
by * - *
planar * - (A1*
aromatic * - *
antioxidants * - *)
. * - *

Similarly * - * *
, * - * *
FIS (PTE*) - (A1*) (A1*)
binds * bind (V*) *
upstream * - (A7* *
of * - *) *
, * - * *
and * - * *
activates * activate * (V*)
, * - * *
all (DNA* - * (A0*
seven * - * *
rrn * - * *
P1 * - * *
promoters *) - * *)
but * - * *
to * - * *
different * - * *
extents * - * *
. * - * *

The * - * *
reported * - * *
observations * - * *
indicate * - * *
that * - * *
FruR (PTE*) - * *
modulates * - * *
the * - * *
direction * - * *
of * - * *
carbon * - * *
flow * - * *
by * - * *
transcriptional * - (A5*) *
activation * activate (V*) *
of * - * *
genes (DNA*) - (A0*) (A1*)
encoding * encode * (V*)
enzymes (PTE*) - * (A0*)
concerned * - * *
with * - * *
oxidative * - * *
and * - * *
gluconeogenic * - * *
carbon * - * *
flow * - * *
and * - * *
by * - * *
repression (PRC*) - * *
of * - * *
those * - * *
concerned * - * *
with * - * *
fermentative * - * *
carbon * - * *
flow * - * *
. * - * *

Balancing * balance (V*)
cross-repression * - (A0*)
appears * - *
to * - *
be * - *
dependent * - *
on * - *
cAMP * - *
and * - *
the * - *
cAMP * - *
regulator * - *
protein * - *
( * - *
CRP * - *
) * - *
. * - *

Both * - *
RFX1 (PTE* - (A1*
and * - *
3 *) - *)
did * - *
not * - *
down-regulate * downregulate (V*)
the * - (A0*
transactivity * - *)
in * - *
neuronal (ORG* - (A2*
cells *) - *)
. * - *

We * - *
propose * - *
an * - (A5*
NO-mediated * - *
mechanism * - *)
of * - *
hmp (DNA*) - (A0*)
regulation * regulation (V*)
by * - *
which * - *
E * - *
. * - *
coli * - *
responds * - *
to * - *
NO * - *
challenge * - *
. * - *

A * - *
particularly * - *
astonishing * - *
discovery * - *
is * - *
the * - *
direct * - *
participation * - *
of * - *
the * - (A1*
transporter * - *)
in * - *
transcriptional * - (A5*)
control * control (V*)
of * - *
the (DNA* - (A0*
mal * - *
regulon *) - *)
. * - *

The * - *
Escherichia * - *
coli * - *
CpxA-CpxR * - *
envelope * - *
stress * - *
response * - *
system * - *
regulates * - *
expression * express (V*)
of * - *
the (DNA* - (A0*
porins * - *
ompF * - *
and * - *
ompC *) - *)
. * - *

The (DNA* - (A0*
pfl * - *
operon *) - *)
is * - *
expressed * express (V*)
at * - *
high * - (A9*
levels * - *)
anaerobically * - (A5*)
. * - *

Extensive * - * *
overproduction * - * *
of * - * *
the (PTE* - * *
AdhE * - * *
protein *) - * *
by * - * *
rng (DNA*) - (A0*) *
mutations * mutations (V*) *
depends * - * *
on * - * *
mutations * mutations * (V*)
in * - * (A2*
the (DNA* - * *
cra * - * *
gene *) - * *)
or * - * *
in * - * *
the (DNA* - * *
Cra-box *) - * *
of * - * *
the * - * *
adhE * - * *
promoter * - * *
. * - * *

The * - *
insertion * - *
had * - *
occurred * - *
in * - *
treR (DNA*) - (A1*)
encoding * encode (V*)
the (PTE* - (A0*
repressor *) - *)
of * - *
the * - *
trehalose * - *
system * - *
. * - *

In * - *
gel * - *
shift * - *
assay * - *
, * - *
anti-ref1 (PTE* - *
antibody *) - *
eliminated * - *
formation * form (V*)
of * - *
the (PTE* - (A0*
nCaRE-protein * - *
complex *) - *)
. * - *

On * - *
this * - *
basis * - *
, * - *
the * - *
eclipse * - *
constitutes * - *
the * - *
time * - *
for * - *
methylation * - *
of * - *
the * - *
newly * - *
formed * - *
DNA * - *
strands * - *
( * - *
15 * - *
to * - *
20 * - *
min * - *
at * - *
30 * - *
degrees * - *
C * - *
) * - *
followed * - *
by * - *
the * - *
time * - *
for * - *
DnaA (PTE* - (A1*
protein *) - *)
to * - *
bind * - *
and * - *
activate * activate (V*)
oriC (PTE*) - (A0*)
for * - *
replication * - (A11*)
( * - *
10 * - *
min * - *
) * - *
. * - *

These (DNA* - (A0* (A1*
175 * - * *
genes *) - *) *)
clustered * cluster (V*) *
into * - * *
eight * - (A4* *
expression * - * *
patterns * - *) *
and * - * *
represent * represent * (V*)
genes * - * (A0*
involved * - * *
in * - * *
a * - * *
large * - * *
number * - * *
of * - * *
cell * - * *
processes * - * *)
, * - * *
including * - * *
small * - * *
molecule * - * *
biosynthesis * - * *
, * - * *
macromolecular * - * *
synthesis * - * *
, * - * *
and * - * *
aerobic/anaerobic * - * *
respiration * - * *
and * - * *
fermentation * - * *
. * - * *

Four (DNA* - (A0*
repressor * - *
binding * - *
sites *) - *)
( * - *
-41 * - *
to * - *
-60 * - *
( * - *
OA1 * - *
) * - *
, * - *
-9 * - *
to * - *
-28 * - *
( * - *
OA2 * - *
) * - *
, * - *
+12 * - *
to * - *
-8 * - *
( * - *
OA3 * - *
) * - *
, * - *
and * - *
+52 * - *
to * - *
+33 * - *
( * - *
OA4 * - *
) * - *
) * - *
and * - *
two * - *
cAMP * - *
. * - *
CRP * - *
binding * - *
sites * - *
( * - *
+11 * - *
to * - *
-11 * - *
and * - *
-30 * - *
to * - *
-51 * - *
) * - *
were * - *
found * find (V*)
in * - (A2*
the (DNA* - *
glpACB * - *
promoter * - *
region *) - *)
. * - *

Here * - * *
we * - * *
show * - * *
that * - * *
MelR (PTE*) - (A1*) *
binding * bind (V*) *
to * - * *
this (DNA* - (A7* *
site *) - *) *
can * - * *
downregulate * - * *
expression * express * (V*)
from * - * *
the (DNA* - * (A6*
melR * - * *
promoter *) - * *)
; * - * *
thus * - * *
, * - * *
MelR * - * *
autoregulates * - * *
its * - * *
own * - * *
expression * - * *
. * - * *

A * - * *
mutation * mutation (V*) *
in * - * *
xylR * - * *
completely * - * *
abolished * - * *
expression * express * (V*)
from * - * *
the (DNA* - * (A6*
PA * - * *
and * - * *
PF * - * *
promoters *) - * *)
, * - * *
causing * - * *
a * - * *
defect * - * *
in * - * *
both * - * *
growth * - * *
and * - * *
transport * - * *
. (DNA*) - (A2*) *

These * - * * * *
data * - * * * *
indicate * - * * * *
that * - * * * *
the (PTE* - (A1* (A1* * *
CytR * - * * * *
repressor *) - *) *) * *
relies * rely (V*) * * *
on * - * * * *
the * - (A0* * * *
presence * - * * * *
of * - * * * *
the (PTE* - * * * *
cAMP-CRP * - * * * *
activator * - * * * *
complex *) - *) * * *
to * - * * * *
regulate * regulate * (V*) * *
tsx-p2 (PRC* - * (A0* * *
promoter * - * * * *
activity *) - * *) * *
and * - * * * *
that * - * * * *
the * - * * * *
formation * form * * (V*) *
of * - * * * *
an (PTE* - * * (A0* *
active * - * * * *
repression * - * * * *
complex *) - * * *) *
requires * - * * * *
the * - * * * *
combined * - * * * *
interactions * interact * * * (V*)
of * - * * * *
cAMP-CRP (PTE* - * * * (A1*
and * - * * * *
CytR *) - * * * *)
at * - * * * (A2*
tsx-p2 * - * * * *)
. (DNA*) - * * * *

The (PTE* - (A1*
MalT * - *
protein *) - *)
activates * activate (V*)
transcription (PRC*) - (A0*)
at * - (A2*
all (DNA* - *
mal * - *
promoters *) - *)
. * - *

The (PTE* - *
Escherichia * - *
coli * - *
MelR * - *
protein *) - *
is * - *
a * - *
transcription * - *
activator * - *
that * - *
, * - *
in * - *
the * - *
presence * - *
of * - *
melibiose (EXP*) - *
, * - *
activates * - *
expression * - *
of * - *
the (DNA* - *
melAB * - *
operon *) - *
by * - *
binding * bind (V*)
to * - *
four (DNA* - (A7*
sites *) - *)
located * - *
just * - *
upstream * - *
of * - *
the * - *
melAB * - *
promoter * - *
. * - *

We * - * * * * *
now * - * * * * *
show * - * * * * *
that * - * * * * *
Stat2 (PTE*) - (A1*) * (A0*) (A1*) *
is * - * * * * *
capable * - * * * * *
of * - * * * * *
forming * form (V*) * * * *
a (PTE* - (A0* (A1* * * *
stable * - * * * * *
homodimer *) - *) *) * * *
that * - * * * * *
interacts * interact * (V*) * * *
with * - * * * * *
p48 (PTE*) - * (A1*) * * *
, * - * * * * *
can * - * * * * *
be * - * * * * *
recruited * recruit * * (V*) * *
to * - * * * * *
DNA * - * * (A7*) * *
, * - * * * * *
and * - * * * * *
can * - * * * * *
activate * activate * * * (V*) *
transcription (PRC*) - * * * (A0*) *
, * - * * * * *
raising * - * * * * *
a * - * * * * *
question * - * * * * *
of * - * * * * *
why * - * * * * *
Stat1 (PTE*) - * * * * (A0*)
is * - * * * * *
required * require * * * * (V*)
. * - * * * * *

Nitrate * - *
, * - *
acting * - *
through * - *
the * - *
NarX-NarL * - *
regulatory * - *
system * - *
, * - *
repressed * - *
the * - *
transcription * transcription (V*)
of * - *
all (DNA* - (A0*
three * - *
operons *) - *)
. * - *

The * - *
integration * - *
host * - *
factor * - *
( * - *
IHF (PTE*) - *
) * - *
had * - *
a * - *
direct * - *
effect * - *
on * - *
the * - *
expression * express (V*)
( * - *
in * - (A5*
vivo * - *)
and * - *
in * - *
vitro * - *
) * - *
of * - *
the * - *
hyp (DNA* - (A0*
and * - *
hyc * - *
genes *) - *)
but * - *
not * - *
of * - *
the * - *
fdhF (DNA* - *
gene *) - *
. * - *

The (PTE* - *
regulatory * - *
proteins * - *
OmpR * - *
and * - *
EnvZ *) - *
are * - *
both * - *
required * - *
to * - *
activate * - *
expression * express (V*)
of * - *
the (DNA* - (A0*
genes *) - *)
for * - *
the * - *
major * - *
outer * - *
membrane * - *
porin * - *
proteins * - *
, * - *
OmpF * - *
and * - *
OmpC * - *
, * - *
of * - *
Escherichia * - *
coli * - *
K-12 * - *
. * - *

Analysis * - * * *
of * - * * *
these * - * * *
data * - * * *
demonstrated * - * * *
that * - * * *
the * - * * *
expression * express (V*) * *
of * - * * *
over * - * * *
one-third * - * * *
of * - * * *
the (DNA* - (A0* (A0* *
genes *) - *) *) *
expressed * express * (V*) *
during * - * (A12* *
growth * - * *) *
under * - * * *
aerobic * - * (A3* *
conditions * - * *) *
are * - * * *
altered * - * * *
when * - * * *
E * - * * *
. * - * * *
coli * - * * *
cells * - * * *
transition * - * * *
to * - * * *
an * - * * *
anaerobic * - * * *
growth * - * * *
state * - * * *
, * - * * *
and * - * * *
that * - * * *
the * - * * *
expression * express * * (V*)
of * - * * *
712 * - * * *
( * - * * *
49% * - * * *
) * - * * *
of * - * * *
these (DNA* - * * (A0*
genes *) - * * *)
are * - * * *
either * - * * *
directly * - * * *
or * - * * *
indirectly * - * * *
modulated * - * * *
by * - * * *
FNR (PTE*) - * * *
. * - * * *

Moreover * - * * *
, * - * * *
Dam * - * * *
methylation * methylate (V*) * *
inhibits * - * * *
binding * bind * (V*) *
of * - * * *
Lrp/PapI (PTE*) - * (A1*) *
near * - * * *
the (DNA* - * (A7* *
GATC1028 * - * * *
site *) - * *) *
and * - * * *
alters * - * * *
binding * bind * * (V*)
of * - * * *
Lrp (PTE*) - * * (A1*)
at * - * * *
the (DNA* - * * (A7*
GATC1130 * - * * *
site *) - * * *)
. (PTE*) - (A0*) * *

Altered * - * *
regulation * regulation (V*) *
of * - * *
the (DNA* - (A0* *
recA * - * *
gene *) - *) *
in * - (A2* *
Escherichia (None* - * (A0*
coli * - * *
strains *) - *) *)
carrying * carry * (V*)
a (PTE* - * (A4*
recA-linked * - * *
suppressor *) - * *
of * - * *
lexA * - * *
. (DNA*) - * *)

In * - * *
this * - * *
study * - * *
, * - * *
we * - * *
investigated * - * *
the * - (A1* *
regulatory * - * *
mechanisms * - *) *
that * - * *
govern * govern (V*) *
the * - * *
neuronal * - (A0* (A5*
cell-specific * - * *)
activation * activate *) (V*)
of * - * *
the (DNA* - * (A0*
MAP1A * - * *
5' * - * *
promoter *) - * *)
. * - * *

Recombining * recombine (V*)
an (DNA* - (A0*
inactive * - *
form *) - *)
of * - *
the * - *
cloned * - *
gene * - *
into * - *
the (DNA* - (A7*
chromosome *) - *)
creates * - *
mutants (DNA*) - *
unable * - *
to * - *
transport * - *
shikimate * - *
. * - *

We * - *
found * - *
that * - *
DNA-contacting * - (A0*
residues * - *
in * - *
alpha-CTD * - *)
are * - *
required * require (V*)
for * - *
full (PRC* - (A11*
activation *) - *)
, * - *
and * - *
for * - *
simplicity * - *
, * - *
we * - *
discuss * - *
alpha-CTD (PTE*) - *
as * - *
a * - *
third * - *
activator * - *
of * - *
rhaSR * - *
. * - *

Insertion * insert (V*)
of * - *
transposon (DNA* - (A0*
Tn5 *) - *)
into * - *
the (DNA* - (A7*
marA * - *
locus *) - *)
at * - *
min * - *
34 * - *
. * - *
05 * - *
on * - *
the * - *
chromosome * - *
completely * - *
reverses * - *
the (DNA* - *
Mar * - *
phenotype *) - *
( * - *
A * - *
. * - *
M * - *
. * - *
George * - *
and * - *
S * - *
. * - *
B * - *
. * - *
Levy * - *
, * - *
J * - *
Bacteriol * - *
155 * - *
: * - *
531-540 * - *
, * - *
1983 * - *
) * - *
. * - *

Binding * bind (V*)
of * - *
GntR (PTE*) - (A1*)
to * - *
the (DNA* - (A7*
operators *) - *)
is * - *
eliminated * - *
by * - *
gluconate (EXP*) - *
and * - *
also * - *
by * - *
6-phosphogluconate (EXP*) - *
at * - *
a * - *
10-fold-higher * - *
concentration * - *
. * - *

The (DNA* - (A0*
downstream * - *
glnAp2 * - *
promoter *) - *)
is * - *
sigma * - *
( * - *
54 * - *
) * - *
-dependent * - *
and * - *
is * - *
activated * activate (V*)
by * - *
NtrC-phosphate (PTE*) - (A1*)
. * - *

The * - *
Escherichia * - *
coli * - *
fructose * - *
repressor * - *
, * - *
FruR (PTE*) - *
, * - *
is * - *
known * - *
to * - *
regulate * - *
expression * express (V*)
of * - *
several (DNA* - (A0*
genes *) - *)
concerned * - *
with * - *
carbon * - *
utilization * - *
. * - *

The (DNA* - (A0* *
nagE * - * *
operator *) - *) *
does * - * *
exhibit * exhibit (V*) *
a * - (A4* *
higher * - * *
affinity * - *) *
for * - * *
Mlc (PTE*) - * *
than * - * *
NagC * - * *
, * - * *
but * - * *
no * - * *
regulation * regulation * (V*)
of * - * *
nagE (DNA*) - * (A0*)
by * - * *
physiological * - * (A1*
concentrations * - * *
of * - * *
Mlc * - * *)
was * - * *
detected * - * *
in * - * *
vivo * - * *
. * - * *

Expression * express (V*) * *
of * - * * *
hTAF (PTE* - (A0* (A0* *
( * - * * *
II * - * * *
) *) - * *) *
135 * - *) * *
also * - * * *
stimulates * - * * *
RAR * - * * *
AF-2 * - * * *
activity * - * * *
when * - * * *
a (DNA* - * * *
promoter *) - * * *
with * - * * *
a * - * * *
low-affinity * - * * *
TATA * - * * *
element * - * * *
( * - * * *
TGTA * - * * *
) * - * * *
is * - * * *
used * - * * *
, * - * * *
indicating * - * * *
that * - * * *
hTAF * - * * *
( * - * * *
II * - * * *
) * - * * *
135 * - * * *
overexpression * overexpression * (V*) *
compensates * - * * *
for * - * * *
the * - * * *
low-affinity * - * * *
of * - * * *
TBP * - * * *
for * - * * *
this * - * * *
promoter * - * * *
and * - * * *
may * - * * *
facilitate * - * * *
the * - * * *
recruitment * recruit * * (V*)
of * - * * *
TFIID (PTE*) - * * (A0*)
by * - * * *
the (PTE* - * * (A1*
RAR * - * * *
AF-2 *) - * * *)
. * - * * *

The * - *
effect * effect (V*)
of * - *
HU (PTE*) - (A1*)
was * - *
apparent * - *
only * - *
in * - *
the * - *
presence * - *
of * - *
all * - *
four * - *
glpD * - *
operators * - *
. * - *

Many (DNA* - (A0*
genes *) - *)
appeared * - *
to * - *
be * - *
regulated * regulate (V*)
by * - *
the (PTE* - (A1*
two * - *
transcription * - *
factors *) - *)
in * - *
an * - *
apparently * - *
additive * - *
fashion * - *
, * - *
but * - *
apparent * - *
positive * - *
or * - *
negative * - *
cooperativity * - *
characterized * - *
several * - *
putative * - *
Crp/Fur * - *
interactions * - *
. * - *

Previously * - * *
, * - * *
it * - * *
was * - * *
shown * - * *
that * - * *
OxyR (PTE*) - * *
is * - * *
required * - * *
for * - * *
repression * repress (V*) *
of * - * *
the * - * *
Ag43-encoding * - * *
gene * - * *
, * - * *
agn43 (DNA*) - (A0*) *
, * - * *
and * - * *
that * - * *
Dam-dependent * - * (A5*)
methylation * methylate * (V*)
of * - * *
three * - * (A0*
GATC * - * *
target * - * *
sequences * - * *)
in * - * (A2*
the * - * *
regulatory * - * *
region * - * *)
abrogates * - * *
OxyR * - * *
binding * - * *
. * - * *

In (EXP* - (A1*
vitro * - *
transcription * - *
experiments *) - *)
with * - *
super-coiled * - *
templates * - *
, * - *
however * - *
, * - *
revealed * reveal (V*)
significant (PRC* - (A0*
cAMP-CRP-stimulated * - *
transcription *) - *)
also * - *
by * - *
E * - *
sigma * - *
70 * - *
. * - *

These * - *
results * - *
indicated * - *
that * - *
expression * express (V*)
of * - *
the (DNA* - (A0*
adhE * - *
gene *) - *)
was * - *
regulated * - *
transcriptionally * - *
by * - *
Cra (PTE*) - *
and * - *
posttranscriptionally * - *
by * - *
RNase (PTE* - *
G *) - *
. * - *

The * - *
GR * - *
level * - *
increased * - *
in * - *
both * - *
cytosol * - *
and * - *
nucleus * - *
, * - *
and * - *
endogenous * - (A0*
GR * - *)
was * - *
also * - *
elevated * elevate (V*)
by * - *
14-3-3eta * - (A1*)
in * - (A2*
HeLa * - *
cells * - *)
. * - *

The (DNA* - (A1*
gcvA * - *
locus *) - *)
contains * - *
an * - *
open * - *
reading * - *
frame * - *
of * - *
930 * - *
nucleotides * - *
that * - *
could * - *
encode * encode (V*)
a (PTE* - (A0*
protein *) - *)
with * - *
a * - *
molecular * - *
mass * - *
of * - *
34 * - *
. * - *
4 * - *
kDa * - *
, * - *
consistent * - *
with * - *
the * - *
results * - *
of * - *
minicell * - *
analysis * - *
indicating * - *
that * - *
GcvA * - *
is * - *
a * - *
polypeptide * - *
of * - *
approximately * - *
33 * - *
kDa * - *
. * - *

We * - *
show * - *
that * - *
EKLF (PTE*) - (A1*)
requires * - *
a * - *
SWI/SNF-related * - *
chromatin * - *
remodeling * - *
complex * - *
, * - *
EKLF * - *
coactivator-remodeling * - *
complex * - *
1 * - *
( * - *
E-RC1 (PTE*) - *
) * - *
, * - *
to * - *
generate * generate (V*)
a * - *
DNase (DNA* - (A0*
I * - *
hypersensitive * - *
, * - *
transcriptionally * - *
active * - *
beta-globin * - *
promoter *) - *)
on * - (A2*
chromatin * - *
templates * - *)
in * - (A3*
vitro * - *)
. * - *

Many (DNA* - * *
iron * - * *
transport * - * *
genes *) - * *
and * - * *
several * - * *
carbon * - * *
metabolic * - * *
genes * - * *
are * - * *
subject * - * *
to * - * *
dual * - * *
control * - * *
, * - * *
being * - * *
repressed * - * *
by * - * *
the * - * *
loss * lose (V*) *
of * - * *
Crp (PTE*) - (A0*) *
and * - * *
activated * - * *
by * - * *
the * - * *
loss * lose * (V*)
of * - * *
Fur (PTE*) - * (A0*)
. * - * *

Nitrate (EXP*) - (A1*)
repression * repress (V*)
of * - *
the (DNA* - (A0*
Escherichia * - *
coli * - *
pfl * - *
operon *) - *)
is * - *
mediated * - *
by * - *
the (PTE* - *
dual * - *
sensors * - *
NarQ * - *
and * - *
NarX *) - *
and * - *
the (PTE* - *
dual * - *
regulators * - *
NarL * - *
and * - *
NarP *) - *
. * - *

The (DNA* - (A1* *
latter * - * *
gene *) - *) *
codes * code (V*) *
for * - * *
the * - * *
leucine-responsive * - * *
regulatory * - * *
protein * - * *
( * - * *
Lrp (PTE*) - (A0*) (A1*)
) * - * *
which * - * *
mediates * mediate * (V*)
a * - * (A0*
global * - * *
response * - * *)
of * - * *
the * - * *
bacterium * - * *
to * - * *
leucine * - * *
. * - * *

Integration (PTE* - (A1* (A1*
host * - * *
factor *) - *) *)
binds * bind (V*) *
specifically * - (A5*) *
to * - * *
multiple (DNA* - (A7* *
sites *) - *) *
in * - * *
the * - * *
ompB * - * *
promoter * - * *
of * - * *
Escherichia * - * *
coli * - * *
and * - * *
inhibits * inhibit * (V*)
transcription (PRC*) - * (A0*)
. * - * *

Analysis * - * *
of * - * *
IHF (DNA* - (A0* *
binding * - * *
site *) - *) *
mutations * mutations (V*) *
strongly * - * *
suggested * - * *
that * - * *
IHF (PTE*) - * (A1*)
binding * bind * (V*)
in * - * (A2*
the (DNA* - * *
ompB * - * *
promoter * - * *
region *) - * *)
is * - * *
necessary * - * *
for * - * *
the * - * *
negative * - * *
effects * - * *
seen * - * *
in * - * *
vivo * - * *
. * - * *

The (DNA* - (A1* *
dcuS * - * *
mutation *) - *) *
affected * affect (V*) *
the * - (A0* *
expression * express * (V*)
of * - * *
other (DNA* - * (A0*
genes *) - *) *)
with * - * *
roles * - * *
in * - * *
C4-dicarboxylate * - * *
transport * - * *
or * - * *
metabolism * - * *
. * - * *

The * - *
contribution * - *
of * - *
these * - *
three * - *
additional * - *
promoters * - *
to * - *
the * - *
overall * - *
cydAB * - (A0*)
expression * express (V*)
is * - *
most * - *
relevant * - *
under * - *
aerobic * - *
conditions * - *
. * - *

The (PTE* - *
E2F * - *
family *) - *
of * - *
proteins * - *
is * - *
required * - *
to * - *
establish * - *
the * - *
correct * - *
cell-cycle-dependent * - *
transcription * - *
of * - *
genes * - (A1*)
that * - *
direct * direct (V*)
the * - *
process * - *
of * - *
cell * - (A0*
division * - *)
. * - *

Expression * express (V*) *
from * - * *
the * - * *
downstream * - * *
promoter * - * *
, * - * *
glnAp2 (DNA*) - (A6*) *
, * - * *
requires * - * *
NRI (PTE*) - * *
as * - * *
well * - * *
as * - * *
the (PTE* - * *
glnF * - * *
product *) - * *
; * - * *
full (PRC* - * (A1*
expression *) - * *)
also * - * *
requires * require * (V*)
growth * - * (A0*)
in * - * *
a * - * (A3*
nitrogen-limited * - * *
environment * - * *)
. * - * *

The * - *
ArcA/ArcB * - *
two-component * - *
signal * - *
transduction * - *
system * - *
of * - *
Escherichia * - *
coli * - *
regulates * - *
gene (DNA*) - (A0*)
expression * express (V*)
in * - *
response * - *
to * - *
the * - *
redox * - *
conditions * - *
of * - *
growth * - *
. * - *

These * - *
results * - *
indicate * - *
that * - *
MlrA (PTE*) - (A1*)
is * - *
a * - *
newly * - *
defined * - *
transcriptional * - *
regulator * - *
of * - *
csgD/agfD * - *
that * - *
acts * act (V*)
as * - *
a (PTE* - (A8*
positive * - *
regulator *) - *)
of * - *
RpoS-dependent * - *
curli * - *
and * - *
extracellular * - *
matrix * - *
production * - *
by * - *
E * - *
. * - *
coli * - *
and * - *
S * - *
. * - *
typhimurium * - *
. * - *

The * - *
NarL * - *
protein * - *
also * - *
had * - *
a * - *
reduced * - *
binding * - *
affinity * - *
for * - *
heptamers * - *
adjacent * - *
to * - *
the * - *
7-n-7 * - *
heptamer * - *
pair * - *
, * - *
suggesting * - *
a * - *
decrease * - *
in * - *
cooperative * - (A5*)
interactions * interact (V*)
. * - *

We * - (A1*)
have * - *
cloned * clone (V*)
a (DNA* - (A0*
human * - *
cDNA *) - *)
from * - *
a * - *
new * - *
gene * - *
, * - *
spi-B (DNA*) - (A6*)
, * - *
on * - *
the * - *
basis * - *
of * - *
its * - *
homology * - *
with * - *
the * - *
DNA-binding * - *
domain * - *
of * - *
the * - *
Spi-1/PU * - *
. * - *
1 * - *
putative * - *
oncogene * - *
product * - *
. * - *

The * - * *
results * - * *
presented * - * *
allow * - * *
us * - * *
to * - * *
speculate * - * *
that * - * *
GntR (PTE*) - * *
initiates * - * *
expression * express (V*) *
of * - * *
the (DNA* - (A0* (A0*
GntII * - * *
genes *) - *) *)
, * - * *
followed * - * *
by * - * *
their * - * *
large * - * *
induction * induce * (V*)
by * - * *
GntH (PTE*) - * (A1*)
when * - * (A12*
cells * - * *
were * - * *
grown * - * *)
in * - * *
gluconate * - * (A3*
minimum * - * *
medium * - * *)
. * - * *

Taken * - *
together * - *
, * - *
these * - *
results * - *
strongly * - *
suggest * - *
that * - *
Lrp (PTE*) - *
and * - *
alanine (PTE*) - *
or * - *
leucine (PTE*) - *
act * - *
directly * - *
to * - *
repress * - *
and * - *
induce * - *
, * - *
respectively * - *
, * - *
transcription * transcription (V*)
of * - *
the (DNA* - (A0*
dad * - *
operon *) - *)
. * - *

The * - (A0*
gene * - *)
is * - *
transcribed * transcribe (V*)
counterclockwise * - (A5*)
on * - *
the * - *
standard * - *
Escherichia * - *
coli * - *
map * - *
, * - *
as * - *
is * - *
the * - *
uxuAB * - *
operon * - *
. * - *

Expression * express (V*) * *
of * - * * *
the (DNA* - (A0* * *
shiA * - * * *
gene *) - *) * *
does * - * * *
not * - * * *
appear * - * * *
to * - * * *
be * - * * *
regulated * - * * *
by * - * * *
the (PTE* - * * *
TyrR * - * * *
protein *) - * * *
, * - * * *
a * - * * *
repressor/activator * - * * *
that * - * * *
controls * - * * *
the * - * * *
expression * express * (V*) *
of * - * * *
other (DNA* - * (A0* (A1*
genes *) - * *) *)
involved * involve * * (V*)
with * - * * *
the * - * * (A8*
biosynthesis * - * * *
or * - * * *
transport * - * * *)
of * - * * *
the * - * * *
aromatic * - * * *
amino * - * * *
acids * - * * *
. * - * * *

No * - (A1*
plasmid * - *
functions * - *)
that * - *
act * act (V*)
at * - (A2*
this (DNA* - *
site *) - *)
have * - *
been * - *
identified * - *
. * - *

These * - * * * *
results * - * * * *
indicate * - * * * *
that * - * * * *
( * - * * * *
i * - * * * *
) * - * * * *
both * - * * * *
diamide (EXP*) - (A1*) * * *
and * - * * * *
1 (EXP* - * * * *
, * - * * * *
10-phenanthroline *) - * * * *
induce * induce (V*) * * *
the (DNA* - (A0* * * *
soxRS * - * * * *
regulon *) - *) * * *
anaerobically * - (A5*) * * *
by * - * * * *
stimulation * stimulate * (V*) * *
of * - * * * *
soxS (DNA*) - * (A0* (A0*) *
transcription * transcription * *) (V*) *
; * - * * * *
( * - * * * *
ii * - * * * *
) * - * * * *
diamide * - * * * *
, * - * * * *
but * - * * * *
not * - * * * *
metal * - * * * *
chelators * - * * * *
, * - * * * *
also * - * * * *
induces * - * * * *
MnSOD * - * * * *
biosynthesis * - * * * *
by * - * * * *
a * - * * * *
soxRS-independent * - * * * *
mechanism * - * * * *
, * - * * * *
perhaps * - * * * *
mediated * - * * * *
by * - * * * *
effects * - * * * *
on * - * * * *
fur * - * * * *
, * - * * * *
arcA * - * * * *
, * - * * * *
or * - * * * *
fnr-mediated * - * * * (A5*)
repression * repress * * * (V*)
of * - * * * *
sodA (DNA*) - * * * (A0*)
; * - * * * *
and * - * * * *
( * - * * * *
iii * - * * * *
) * - * * * *
the * - * * * *
soxRS * - * * * *
locus * - * * * *
contains * - * * * *
a * - * * * *
metal-binding * - * * * *
component * - * * * *
and * - * * * *
is * - * * * *
responsive * - * * * *
to * - * * * *
the * - * * * *
redox * - * * * *
status * - * * * *
of * - * * * *
the * - * * * *
cell * - * * * *
. * - * * * *

In * - *
contrast * - *
, * - *
acnB * - (A0*)
expression * express (V*)
is * - *
activated * - *
by * - *
CRP (PTE*) - *
and * - *
repressed * - *
by * - *
ArcA (PTE* - *
, * - *
FruR * - *
and * - *
Fis *) - *
from * - *
PacnB (DNA*) - *
. (PTE*) - *

Strains * - *
of * - *
escherichia * - *
coli * - *
were * - *
constructed * - *
in * - *
which * - *
the (DNA* - (A0*
lacZ * - *
gene *) - *)
is * - *
fused * fuse (V*)
to * - *
cysB (DNA*) - (A7*)
, * - *
the * - *
positive * - *
regulator * - *
gene * - *
of * - *
the * - *
cysteine * - *
regulon * - *
. * - *

Cellular (PTE* - (A0*
protein * - *
BNIP3 *) - *)
is * - *
a * - *
BCL-2 * - *
family * - *
proapoptotic * - *
protein * - *
that * - *
interacts * interact (V*)
with * - *
viral * - *
antiapoptosis * - *
proteins * - *
such * - *
as * - *
adenoviruses (PTE* - (A0*
E1B-19K * - *
and * - *
EBV-BHRF1 *) - *)
and * - *
cellular * - *
antiapoptosis * - *
proteins * - *
such * - *
as * - *
BCL-2 (PTE* - *
and * - *
BCL-xL *) - *
. * - *

This (DNA* - *
operon *) - *
is * - *
also * - *
believed * - *
to * - *
be * - *
regulated * - *
by * - *
catabolite (EXP*) - (A1*)
repression * repress (V*)
. * - *

IHF (PTE*) - (A1*) * *
was * - * * *
shown * - * * *
to * - * * *
bind * bind (V*) * *
at * - * * *
three (DNA* - (A7* * *
sites *) - *) * *
centred * - * * *
at * - * * *
+26 * - * * *
, * - * * *
-17 * - * * *
and * - * * *
-58 * - * * *
in * - * * *
the * - * * *
ndh (DNA*) - * * (A0*)
promoter * - * * *
( * - * * *
Kd * - * * *
= * - * * *
10 * - * * *
( * - * * *
-8 * - * * *
) * - * * *
M * - * * *
) * - * * *
, * - * * *
to * - * * *
prevent * - * * *
open-complex * - * (A0*) *
formation * form * (V*) *
and * - * * *
to * - * * *
repress * - * * *
ndh * - * * *
transcription * transcription * * (V*)
in * - * * (A5*
vitro * - * * *)
. * - * * *

Expression * express (V*) * *
of * - * * *
this (PTE* - (A0* * *
altered * - * * *
binding/interaction * - * * *
domain *) - *) * *
interferes * - * * *
with * - * * *
TNFalpha (PTE*) - * (A0*) *
induction * induce * (V*) *
, * - * * *
indicating * - * * *
an * - * * *
interaction * interact * * (V*)
of * - * * *
this (PTE* - * * (A0*
splice * - * * *
variant *) - * * *)
with * - * * *
the (PTE* - * * (A0*
active * - * * *
AP1/NF-AT * - * * *
complex *) - * * *)
at * - * * (A2*
this (DNA* - * * *
promoter *) - * * *)
. * - * * *

Alanine (PTE*) - *
or * - *
leucine (PTE*) - *
completely * - *
( * - *
for * - *
Tr1 * - *
and * - *
Tr2 * - *
) * - *
or * - *
partially * - *
( * - *
for * - *
Tr3 * - *
) * - *
reversed * - *
Lrp (PTE*) - (A1*)
inhibition * inhibit (V*)
. * - *

Transcription * transcribe (V*) *
of * - * *
gntT (DNA*) - (A0*) *
is * - * *
activated * - * *
by * - * *
binding * bind * (V*)
of * - * *
the (PTE* - * (A0*
cyclic * - * *
AMP * - * *
( * - * *
cAMP * - * *
) * - * *
-cAMP * - * *
receptor * - * *
protein * - * *
( * - * *
CRP * - * *
) * - * *
complex *) - * *)
to * - * *
a (DNA* - * (A7*
CRP * - * *
binding * - * *
site *) - * *)
positioned * - * *
at * - * *
-71 * - * *
upstream * - * *
of * - * *
the * - * *
gntT * - * *
transcription * - * *
start * - * *
site * - * *
. * - * *

Arsenite (EXP*) - *
, * - *
a * - *
thiol-reactive * - *
oxidative * - *
stressor * - *
, * - *
induces * - *
VEGF * - (A0*)
expression * express (V*)
by * - *
a * - *
HIF-1alpha-independent * - *
mechanism * - *
. * - *

Binding * bind (V*) *
to * - * *
the * - * *
upstream * - * *
tor * - * *
boxes * - * *
( * - * *
box1 (DNA*) - (A7*) *
and * - * *
box2 (DNA*) - * *
) * - * *
appears * - * *
to * - * *
be * - * *
stronger * - * *
than * - * *
binding * bind * (V*)
to * - * *
the * - * *
downstream * - * *
tor * - * *
boxes * - * *
( * - * *
box3 (DNA*) - * (A7*)
and * - * *
box4 (DNA*) - * *
) * - * *
since * - * *
only * - * *
the * - * *
upstream * - * *
region * - * *
is * - * *
protected * - * *
at * - * *
the * - * *
lower * - * *
concentration * - * *
of * - * *
TorR * - * *
used * - * *
in * - * *
the * - * *
footprinting * - * *
experiments * - * *
. * - * *

The * - * *
transcriptional * - (A5*) *
regulation * regulation (V*) *
of * - * *
the * - (A0* *
ast (DNA* - * (A0*
operon *) - *) *)
in * - (A2* *
E (ORG* - * *
. * - * *
coli *) - *) *
differs * - * *
from * - * *
that * - * *
in * - * *
Salmonella * - * *
enterica * - * *
serovar * - * *
Typhimurium * - * *
, * - * *
in * - * *
which * - * *
ArgR (PTE*) - * *
is * - * *
required * - * *
for * - * *
ast * - * *
operon * - * *
expression * express * (V*)
. * - * *

It * - * * *
was * - * * *
found * - * * *
that * - * * *
repression * repress (V*) * *
of * - * * *
glpT (DNA*) - (A0*) * *
conferred * - * * *
by * - * * *
binding * bind * (V*) *
of * - * * *
glp (PTE* - * (A1* *
repressor *) - * *) *
to * - * * *
glpA (DNA* - * (A7* *
operators *) - * *) *
was * - * * *
increased * - * * *
about * - * * *
three- * - * * *
to * - * * *
fourfold * - * * *
upon * - * * *
introduction * introduce * * (V*)
of * - * * *
the (DNA* - * * (A0*
remote * - * * *
glpT * - * * *
operators *) - * * *)
. * - * * *

This (PRC* - (A0* *
osmoregulation *) - *) *
is * - * *
mediated * mediate (V*) *
by * - * *
the (PTE* - (A1* (A0*
OmpR * - * *
protein *) - *) *)
, * - * *
a * - * *
positive * - * *
regulator * - * *
of * - * *
both * - * *
genes * - * *
, * - * *
which * - * *
is * - * *
encoded * encode * (V*)
by * - * *
the (DNA* - * (A1*
ompR * - * *
gene *) - * *)
. * - * *

The * - *
involvement * - *
of * - *
IHF * - *
and * - *
cAMP-CRP * - *
, * - *
as * - *
well * - *
as * - *
the * - *
corresponding * - *
putative * - *
cis-acting * - *
elements * - *
, * - *
in * - *
the * - *
expression * express (V*)
of * - *
the (DNA* - (A0*
two * - *
genes *) - *)
was * - *
investigated * - *
by * - *
using * - *
lacZ * - *
operon * - *
fusions * - *
. * - *

MelR (PTE*) - (A1*)
can * - *
bind * bind (V*)
to * - *
Site (DNA*) - (A7*)
1' (DNA*) - *
, * - *
Site (DNA* - *
1 *) - *
, * - *
Site (DNA* - *
2 *) - *
and * - *
Site (DNA* - *
R *) - *
, * - *
in * - *
both * - *
the * - *
absence * - *
and * - *
the * - *
presence * - *
of * - *
melibiose (EXP*) - (A3*)
. * - *

Mutations * mutate (V*)
in * - (A2*
yjfQ * - *)
allowed * - *
us * - *
to * - *
identify * - *
this * - *
gene * - *
as * - *
the * - *
regulator * - *
of * - *
the * - *
operon * - *
yjfS-X * - *
( * - *
ula * - *
operon * - *
) * - *
, * - *
reported * - *
to * - *
be * - *
involved * - *
in * - *
L-ascorbate * - *
metabolism * - *
. (DNA*) - *

The (DNA* - (A1* (A1*
Klebsiella * - * *
rcsB * - * *
locus *) - *) *)
encoded * encode (V*) *
no (PTE* - (A0* *
apparent * - * *
polypeptides *) - *) *
and * - * *
was * - * *
not * - * (A5*
capable * - * *)
by * - * *
itself * - * *
of * - * *
causing * cause * (V*)
the * - * (A0*
overproduction * - * *
of * - * *
colanic * - * *
acid * - * *)
. * - * *

The (DNA* - (A0*
Klebsiella * - *
rcsB * - *
locus *) - *)
may * - *
exert * - *
its * - *
effect * - *
by * - *
preferentially * - *
binding * bind (V*)
a (PTE* - (A0*
negative * - *
regulator *) - *)
of * - *
capsular * - *
biosynthesis * - *
, * - *
possibly * - *
Lon * - *
itself * - *
. * - *

The * - *
suppressor * - (A5*)
mutation * mutation (V*)
was * - *
mapped * - *
in * - (A2*
S (ORG* - *
. * - *
typhimurium *) - *)
at * - *
3 * - *
min * - *
, * - *
closely * - *
linked * - *
to * - *
leu * - *
. * - *

A (PTE* - (A1* *
complex *) - *) *
containing * - * *
ATF4 * - * *
binds * bind (V*) *
a (DNA* - (A7* *
DNA * - * *
element *) - *) *
at * - * *
+1767 * - * *
bp * - * *
relative * - * *
to * - * *
the * - * *
VEGF * - * *
transcription * - * *
start * - * *
site * - * *
, * - * *
and * - * *
DNA * - * (A0*
binding * - * *
activity * - * *)
is * - * *
increased * increase * (V*)
by * - * *
arsenite * - * (A1*
treatment * - * *)
. * - * *

Based * - *
on * - *
this * - *
homology * - *
, * - *
the * - *
observed * - *
inhibitory * - *
effects * - *
of * - *
the * - *
middle * - *
portion * - *
of * - *
antisense * - *
human * - *
p120 * - *
RNA * - *
may * - *
be * - *
related * - *
to * - *
suppression * suppress (V*)
of * - *
mouse (DNA* - (A0*
p120 * - *
expression *) - *)
by * - *
RNA (DNA* - (A1*
: * - *
RNA * - *
duplex * - *
formation *) - *)
. * - *

The (DNA* - (A1*
Escherichia * - *
coli * - *
flhD * - *
operon *) - *)
encodes * encode (V*)
two * - *
genes * - *
, * - *
flhD (DNA*) - (A0*)
and * - *
flhC (DNA*) - *
. * - *

Alteration * alter (V*) *
of * - * *
OT (DNA*) - (A0*) *
did * - * *
not * - * *
significantly * - * *
decrease * - * *
repression * repress * (V*)
of * - * *
either (DNA* - * (A0*
operon *) - * *)
. * - * *

Proteasomal * - *
inhibition * - *
did * - *
not * - *
induce * - *
any * - *
synergistic * - *
effect * - *
on * - *
the * - *
14-3-3eta-induced * - *
increase * - *
in * - *
GR (PTE*) - (A0*)
in * - *
response * - *
to * - *
glucocorticoid * - *
, * - *
and * - *
inhibition * - *
of * - *
translation * - *
did * - *
not * - *
block * - *
elevation * elevate (V*)
of * - *
GR * - *
by * - *
14-3-3eta (PTE*) - (A1*)
, * - *
indicating * - *
that * - *
14-3-3eta * - *
induces * - *
stabilization * - *
of * - *
GR * - *
. * - *

The (PTE* - (A0*
human * - *
nucleolar * - *
p120 * - *
protein *) - *)
is * - *
a * - *
proliferation-associated * - *
antigen * - *
which * - *
is * - *
expressed * express (V*)
in * - (A12*
G1 * - *
and * - *
peaks * - *)
during * - *
the * - *
early * - *
S * - *
phase * - *
of * - *
the * - *
cell * - *
cycle * - *
. * - *

The (DNA* - (A1*
glp * - *
regulon *) - *)
of * - *
Escherichia * - *
coli * - *
encodes * encode (V*)
the (PTE* - (A0*
proteins *) - *)
required * - *
for * - *
utilization * - *
of * - *
sn-glycerol * - *
3-phosphate * - *
and * - *
its * - *
precursors * - *
. * - *

The (PTE* - (A1*
cAMP-catabolite * - *
activator * - *
protein * - *
( * - *
CAP * - *
) * - *
complex *) - *)
is * - *
a * - *
pleiotropic * - *
regulator * - *
that * - *
regulates * regulate (V*)
a * - *
vast * - *
number * - *
of * - *
Escherichia (DNA* - (A0*
coli * - *
genes *) - *)
, * - *
including * - *
those * - *
involved * - *
in * - *
carbon * - *
metabolism * - *
. * - *

Positive * - (A5*)
complementation * complementation (V*)
of * - *
two (DNA* - (A0*
mutant * - *
ompR * - *
genes *) - *)
was * - *
also * - *
observed * - *
in * - *
other * - *
combinations * - *
, * - *
when * - *
the * - *
two * - *
mutations * - *
were * - *
distantly * - *
located * - *
from * - *
each * - *
other * - *
on * - *
the * - *
OmpR * - *
protein * - *
. * - *

This * - *
finding * - *
did * - *
not * - *
, * - *
in * - *
itself * - *
, * - *
rule * - *
out * - *
the * - *
possibility * - *
that * - *
mioC * - (A0*)
transcription * transcription (V*)
must * - *
be * - *
terminated * - *
prior * - *
to * - *
initiation * - *
of * - *
replication * - *
, * - *
since * - *
it * - *
might * - *
normally * - *
be * - *
shut * - *
off * - *
before * - *
initiation * - *
, * - *
and * - *
never * - *
be * - *
limiting * - *
, * - *
even * - *
during * - *
the * - *
eclipse * - *
. * - *

Nucleotide * - *
sequence * - *
and * - *
characterization * - *
of * - *
the * - *
sfs1 (DNA*) - *
gene * - *
: * - *
sfs1 * - *
is * - *
involved * - *
in * - *
CRP*-dependent * - (A5*)
mal (DNA* - (A0*
gene *) - *)
expression * express (V*)
in * - (A2*
Escherichia (ORG* - *
coli *) - *)
. * - *

The * - *
human * - *
, * - *
but * - *
not * - *
the * - *
mouse * - *
, * - *
promoter (DNA*) - (A1*)
also * - *
binds * bind (V*)
C/EBP * - *
homologous * - *
protein * - *
( * - *
CHOP (PTE*) - (A7*)
) * - *
, * - *
which * - *
competes * - *
with * - *
STAF * - *
for * - *
the * - *
same * - *
binding * - *
site * - *
. * - *

We * - *
then * - *
carried * - *
out * - *
a * - *
similar * - *
analysis * - *
for * - *
the * - *
identification * - *
of * - *
genes (DNA*) - (A1*)
that * - *
activate * activate (V*)
the * - (A0*
MARK * - *
pathway * - *)
, * - *
utilizing * - *
the * - *
same * - *
cDNA * - *
resource * - *
. * - *

SNURF (DNA* - (A0*
mRNA *) - *)
is * - *
expressed * express (V*)
in * - (A2*
a * - *
variety * - *
of * - *
human (ORG* - *
and * - *
rat * - *
tissues *) - *)
. * - *

In * - * *
gel * - * *
mobility * - * *
shift * - * *
assays * - * *
, * - * *
hT86 (DNA*) - (A1*) *
attenuated * attenuate (V*) *
the * - (A0* *
intensity * - *) *
of * - * *
the * - * *
retarded * - * *
band * - * *
composed * - * *
of * - * *
the * - * *
octamer * - * *
probe * - * *
and * - * *
Oct-2 (PTE*) - * (A1*)
, * - * *
suggesting * - * *
a * - * *
dominant * - * (A5*
negative * - * *)
effect * effect * (V*)
on * - * *
the * - * (A0*
DNA-binding * - * *
activity * - * *)
of * - * *
Oct-2 * - * *
. * - * *

The (DNA* - (A1*
3' * - *
element *) - *)
binds * bind (V*)
transcription (PTE* - (A7*
factors *) - *
of * - *
the * - *
Sp1 * - *
family * - *)
. * - *

Since * - * *
cAMP * - (A1*) *
has * - * *
previously * - * *
been * - * *
shown * - * *
to * - * *
effectively * - * *
increase * increase (V*) *
the (DNA* - (A0* *
mRNA * - * *
levels *) - *) *
of * - * *
Col2a1 * - * *
and * - * *
other * - * *
specific * - * *
markers * - * *
of * - * *
chondrocyte * - * *
differentiation * - * *
in * - * *
culture * - * *
, * - * *
we * - * *
then * - * *
asked * - * *
whether * - * *
PKA * - * (A0*)
phosphorylation * phosphorylate * (V*)
could * - * *
modulate * - * *
the * - * *
activity * - * *
of * - * *
SOX9 * - * *
. (PTE*) - * *

Collectively * - * *
, * - * *
we * - * *
have * - * *
identified * - * *
and * - * *
characterized * - * *
a * - * *
ubiquitously * - * *
expressed * - * *
RING * - * *
finger * - * *
protein * - * *
, * - * *
SNURF (PTE*) - (A1*) *
, * - * *
that * - * *
may * - * *
function * - * *
as * - * *
a * - * *
bridging * - * *
factor * - * *
and * - * *
regulate * regulate (V*) *
steroid * - (A0* (A3*
receptor-dependent * - * *)
transcription * transcription *) (V*)
by * - * *
a * - * *
mechanism * - * *
different * - * *
from * - * *
those * - * *
of * - * *
previously * - * *
identified * - * *
coactivator * - * *
or * - * *
integrator * - * *
proteins * - * *
. * - * *

The * - *
start * - *
of * - *
the * - *
copA * - *
transcript * - *
was * - *
located * - *
by * - *
primer * - *
extension * - *
mapping * - *
, * - *
and * - *
DNase * - *
I * - *
protection * - *
assays * - *
showed * - *
that * - *
the (PTE* - (A1*
CueR * - *
protein *) - *)
binds * bind (V*)
in * - (A3*
vitro * - *)
to * - *
a (DNA* - (A0*
dyad * - *
symmetrical * - *
sequence *) - *)
within * - *
a * - *
19 * - *
bp * - *
spacer * - *
sequence * - *
in * - *
the * - *
copA * - *
promoter * - *
. * - *

Inactivation * - * * *
of * - * * *
this (DNA* - * * *
site *) - * * *
by * - * * *
insertion * insert (V*) * *
of * - * * *
a (DNA* - (A0* * *
22-bp * - * * *
fragment *) - *) * *
prevents * - * * *
the * - * * *
repression * repress * (V*) *
of * - * * *
ompF (DNA*) - * (A0* (A0*)
expression * express * *) (V*)
conferred * - * * *
by * - * * *
the * - * * *
dominant * - * * *
negative * - * * *
mutation * - * * *
, * - * * *
envZ473 * - * * *
. * - * * *

Transcriptional * - (A5*)
activation * activate (V*)
of * - *
the (DNA* - (A0*
HIV * - *
enhancer *) - *)
was * - *
also * - *
subject * - *
to * - *
regulation * - *
by * - *
recently * - *
cloned * - *
I * - *
kappa * - *
B-alpha * - *
( * - *
MAD-3 (PTE*) - *
) * - *
. * - *

Although * - * * * *
gcvA (DNA*) - (A0*) (A0* (A0* (A0*
expression * express (V*) *) *) *)
appears * - * * * *
to * - * * * *
be * - * * * *
autogenously * - * * * *
regulated * regulate * (V*) * *
over * - * * * *
a * - * (A9* * *
two- * - * * * *
to * - * * * *
threefold * - * * * *
range * - * *) * *
, * - * * * *
it * - * * * *
is * - * * * *
neither * - * * * *
induced * induce * * (V*) *
by * - * * * *
glycine (EXP*) - * * (A1*) *
nor * - * * * *
repressed * repress * * * (V*)
by * - * * * *
inosine (EXP*) - * * * (A1*)
. * - * * * *

Results * - *
of * - *
minicell * - *
analysis * - *
and * - *
complementation * - *
studies * - *
showed * - *
that * - *
this (DNA* - (A1*
region *) - *)
of * - *
the * - *
chromosome * - *
encodes * encode (V*)
at (PTE* - (A0*
least * - *
five * - *
polypeptides *) - *)
. * - *

Mitochondrial * - * *
transcriptional * - * *
factor * - * *
1 * - * *
( * - * *
mtTF1 (PTE*) - (A0*) *
) * - * *
is * - * *
required * require (V*) *
for * - * *
both * - * *
transcription * transcription (A11*) (V*)
and * - * *
replication * - * *
of * - * *
mammalian * - * *
mitochondrial * - * *
DNA * - * *
( * - * *
mtDNA * - * (A0*)
) * - * *
and * - * *
it * - * *
has * - * *
two * - * *
consensus * - * *
sequences * - * *
of * - * *
HMG * - * *
( * - * *
high * - * *
mobility * - * *
group * - * *
) * - * *
boxes * - * *
. * - * *

Identification * - *
of * - *
a * - *
novel * - *
mammalian * - *
member * - *
of * - *
the * - *
NSF/CDC48p/Pas1p/TBP-1 * - *
family * - *
through * - *
heterologous * - (A5*)
expression * express (V*)
in * - (A2*
yeast * - *)
. (ORG*) - *

Mutation * mutate (V*) *
of * - * *
the (DNA* - (A0* *
hns * - * *
gene *) - *) *
in * - * *
E (ORG* - * *
. * - * *
coli *) - * *
has * - * *
resulted * - * *
in * - * *
strong * - * *
expression * express * (V*)
of * - * *
the * - * (A0*
V * - * *
. * - * *
fischeri * - * *
lux * - * *
system * - * *)
at * - * *
low * - * *
cell * - * *
density * - * *
even * - * *
in * - * *
an * - * *
rpoS-deleted * - * *
strain * - * *
of * - * *
E * - * *
. * - * *
coli * - * *
that * - * *
emits * - * *
very * - * *
low * - * *
levels * - * *
of * - * *
luminescence * - * *
. * - * *

Gene (DNA*) - (A0*)
expression * express (V*)
from * - *
multicopy (DNA* - (A6*
T7 * - *
promoter * - *
vectors *) - *)
proceeds * - *
at * - *
single * - *
copy * - *
rates * - *
in * - *
the * - *
absence * - *
of * - *
T7 (PTE* - *
RNA * - *
polymerase *) - *
. * - *

Thus * - * *
, * - * *
transcription * - * *
through * - * *
oriC * - * *
emanating * - * *
from * - * *
the (DNA* - (A0* *
mioC * - * *
gene * - * *
promoter *) - *) *
is * - * *
normally * - * *
inhibited * inhibit (V*) *
prior * - * *
to * - * *
initiation * - * *
of * - * *
replication * - * *
by * - * *
the * - * *
binding * - * *
of * - * *
DnaA * - * *
protein * - * *
, * - * *
but * - * *
replication * - * *
can * - * *
initiate * - * *
with * - * *
the * - * *
proper * - * *
timing * - * *
even * - * *
when * - * *
transcription * - * *
is * - * *
not * - * *
shut * - * *
down * - * *
; * - * *
i * - * *
. * - * *
e * - * *
. * - * *
, * - * *
mioC (DNA*) - * (A1*)
does * - * *
not * - * *
serve * serve * (V*)
as * - * *
a (PTE* - * (A8*
negative * - * *
regulator *) - * *)
of * - * *
initiation * - * *
. * - * *

The (PTE* - (A1*
glp * - *
repressor *) - *)
protected * protect (V*)
an (DNA* - (A0*
extensive * - *
area *) - *)
( * - *
-89 * - *
to * - *
-7 * - *
relative * - *
to * - *
the * - *
start * - *
point * - *
of * - *
transcription * - *
) * - *
, * - *
sufficient * - *
for * - *
the * - *
binding * - *
of * - *
four * - *
repressor * - *
tetramers * - *
. * - *

HOX3D (DNA*) - (A0*) (A0*)
is * - * *
developmentally * - (A5*) *
regulated * regulate (V*) *
during * - (A12* *
embryogenesis * - *) *
and * - * *
is * - * *
activated * activate * (V*)
by * - * *
retinoic * - * *
acid * - * *
( * - * *
RA * - * (A1*)
) * - * *
in * - * (A2*
cultured (ORG* - * *
embryonal * - * *
carcinoma *) - * *
( * - * *
EC * - * *
) * - * *
cells * - * *)
. * - * *

Gel * - *
retardation * - *
and * - *
footprinting * - *
studies * - *
revealed * - *
that * - *
Lrp (PTE*) - (A1*)
binds * bind (V*)
in * - (A5*
vitro * - *)
to * - *
multiple (DNA* - (A7*
sites *) - *
over * - *
a * - *
large * - *
area * - *
in * - *
the (DNA* - *
dad * - *
promoter * - *
region *) - *)
. * - *

For * - *
Escherichia * - *
coli * - *
, * - *
growth * - *
in * - *
the * - *
absence * - *
of * - *
ammonia * - *
is * - *
termed * - *
nitrogen * - *
limited * - *
and * - *
results * - *
in * - *
the * - *
induction * induce (V*)
of * - *
genes (DNA*) - (A0*)
that * - *
assimilate * - *
other * - *
nitrogen * - *
sources * - *
, * - *
a * - *
response * - *
mediated * - *
by * - *
sigma * - *
( * - *
54 * - *
) * - *
and * - *
nitrogen * - *
regulator * - *
I * - *
( * - *
NR * - *
( * - *
I * - *
) * - *
, * - *
also * - *
called * - *
NtrC * - *
) * - *
. * - *

The (DNA* - (A0*
hslJ * - *
gene *) - *)
was * - *
found * - *
to * - *
be * - *
negatively * - (A5*)
regulated * regulate (V*)
by * - *
CysB (PTE*) - (A1*)
and * - *
directly * - *
correlated * - *
with * - *
novobiocin * - *
resistance * - *
of * - *
the * - *
bacterium * - *
. * - *

Immunoblotting * - *
studies * - *
showed * - *
that * - *
both (ORG* - (A1*
human * - *
primary * - *
CD19 * - *
( * - *
+ * - *
) * - *
B *) - *)
and * - *
DAKIKI (ORG* - *
cells *) - *
express * express (V*)
a (PTE* - (A0*
565-kDa * - *
immunoreactive * - *
protein *) - *)
that * - *
is * - *
indistinguishable * - *
in * - *
molecular * - *
size * - *
and * - *
immunoreactivity * - *
from * - *
the * - *
RYR * - *
. * - *

Methylation * methylate (V*)
of * - *
two * - *
GATC * - *
sites * - *
( * - *
GATC1028 (DNA*) - (A0*)
and * - *
GATC1130 (DNA*) - *
) * - *
within * - *
the * - *
pap * - *
regulatory * - *
region * - *
is * - *
differentially * - *
inhibited * - *
in * - *
phase * - *
ON * - *
and * - *
phase * - *
OFF * - *
cells * - *
. * - *

Transcription (PRC*) - (A0*)
was * - *
initiated * initiate (V*)
from * - *
a (DNA* - (A6*
sigma * - *
( * - *
70 * - *
) * - *
-dependent * - *
promoter *) - *)
at * - *
the * - *
G * - *
residue * - *
of * - *
the * - *
upstream * - *
GATC * - *
sequence * - *
. * - *

EnvZ * - *
and * - *
OmpR * - *
, * - *
the * - *
regulatory * - *
proteins * - *
for * - *
ompF (DNA* - (A0*
and * - *
ompC *) - *)
expression * express (V*)
in * - (A2*
Escherichia (ORG* - *
coli *) - *)
, * - *
belong * - *
to * - *
a * - *
modulator-effector * - *
family * - *
of * - *
regulatory * - *
proteins * - *
which * - *
are * - *
essential * - *
for * - *
the * - *
response * - *
to * - *
environmental * - *
signals * - *
. * - *

Lrp (PTE*) - (A1*) (A1*) (A1*)
binds * bind (V*) * *
to * - * * *
two * - * * *
regions * - * * *
in * - * * *
the (DNA* - (A7* * *
dadAX * - * * *
promoter * - * * *
region *) - *) * *
of * - * * *
Escherichia * - * * *
coli * - * * *
to * - * * *
repress * repress * (V*) *
and * - * * *
activate * activate * * (V*)
transcription (PRC*) - * (A0*) (A0*)
directly * - * (A5*) (A5*)
. * - * * *

Our * - * *
data * - * *
suggest * - * *
that * - * *
dyn2 (PTE*) - (A1*) (A1*)
can * - * *
act * act (V*) *
as * - * *
a (PTE* - (A8* *
signal * - * *
transducing * - * *
GTPase *) - *) *
affecting * affect * (V*)
transcriptional (PRC* - * (A0*
regulation *) - * *)
. * - * *

We * - *
interpret * - *
our * - *
results * - *
in * - *
terms * - *
of * - *
a * - *
model * - *
for * - *
ompF (DNA*) - (A0*)
regulation * regulation (V*)
involving * - *
hierarchical * - *
binding * - *
by * - *
phosphorylated * - *
OmpR * - *
and * - *
potential * - *
DNA * - *
looping * - *
. * - *

Ectopic * - (A5*)
expression * express (V*)
of * - *
uvrY (DNA*) - (A0*)
stimulated * - *
biofilm * - *
formation * - *
by * - *
a * - *
csrB-null * - *
mutant * - *
, * - *
indicative * - *
of * - *
a * - *
CsrB-independent * - *
role * - *
for * - *
UvrY * - *
in * - *
biofilm * - *
development * - *
. * - *

Interallelic * - (A5*) *
complementation * complementation (V*) *
of * - * *
characterized * - (A0* *
CysB * - * *
mutants * - * *
I33N * - * *
and * - * *
S277Ter * - *) *
partially * - * *
restored * - * *
the * - * *
repression * - * *
of * - * *
hslJ (DNA*) - * (A0*)
transcription * transcription * (V*)
and * - * *
the * - * *
consequent * - * *
novobiocin * - * *
sensitivity * - * *
, * - * *
but * - * *
did * - * *
not * - * *
complement * - * *
the * - * *
cysteine * - * *
auxotrophy * - * *
. * - * *

It * - * *
was * - * *
found * - * *
that * - * *
the * - * *
repression * - * *
conferred * - * *
by * - * *
binding * bind (V*) *
of * - * *
the (PTE* - (A1* *
glp * - * *
repressor *) - *) *
to * - * *
O (DNA* - (A7* *
( * - * *
D * - * *
) * - * *
1 *) - *) *
and * - * *
O (DNA* - * *
( * - * *
D * - * *
) * - * *
2 *) - * *
was * - * *
increased * - * *
five- * - * *
to * - * *
sevenfold * - * *
upon * - * *
introduction * introduce * (V*)
of * - * *
the (DNA* - * (A0*
internal * - * *
operators *) - * *)
. (PRC*) - * *

In * - *
vitro * - *
gel-shift * - *
experiments * - *
demonstrated * - *
direct * - (A5*)
binding * bind (V*)
of * - *
the (DNA* - (A1*
promoter * - *
DNA *) - *)
to * - *
IHF (PTE*) - (A7*)
and * - *
ArcA-P (PTE*) - *
. * - *

Regulation * - *
of * - *
aldehyde * - (A1*
reductase * - *)
expression * express (V*)
by * - *
STAF (PTE*) - *
and * - *
CHOP (PTE*) - *
. * - *

Changing * change (V*) * * *
either * - * * * *
binding * - * * * *
site (DNA*) - (A0*) * * *
away * - * * * *
from * - * * * *
the * - * * * *
consensus * - * * * *
sequence * - * * * *
caused * - * * * *
a * - * * * *
decrease * decrease * (V*) * *
in * - * * * *
expression (PRC*) - * (A0*) * *
, * - * * * *
suggesting * - * * * *
that * - * * * *
both (DNA* - * * (A1* *
sites *) - * * *) *
are * - * * * *
required * require * * (V*) *
for * - * * * *
normal * - * * (A0* (A5*)
glyA * - * * * *
regulation * regulation * * *) (V*)
. (DNA*) - * * * (A0*)

Collectively * - *
, * - *
these * - *
results * - *
demonstrate * - *
that * - *
uvrY * - *
resides * - *
downstream * - *
from * - *
csrA * - *
in * - *
a * - *
signaling * - *
pathway * - *
for * - *
csrB (DNA*) - (A0*)
and * - *
that * - *
CsrA (PTE*) - *
stimulates * - *
UvrY-dependent * - *
activation * - *
of * - *
csrB * - *
expression * express (V*)
by * - *
BarA-dependent * - *
and * - *
-independent * - *
mechanisms * - *
. * - *

The * - *
alternative * - *
sigma * - *
factor * - *
sigma * - *
( * - *
S * - *
) * - *
( * - *
RpoS (PTE*) - *
) * - *
of * - *
Escherichia * - *
coli * - *
RNA * - *
polymerase * - *
regulates * - *
the * - *
expression * express (V*)
of * - *
stationary * - *
phase * - *
and * - *
stress-response * - *
genes (DNA*) - (A0*)
. * - *

Surprisingly * - *
, * - *
the * - *
FIS * - *
sites * - *
upstream * - *
of * - *
site * - *
I * - *
play * - *
a * - *
much * - *
larger * - *
role * - *
in * - *
transcription * transcription (V*)
from * - *
most (DNA* - (A6*
rrn * - *
P1 * - *
promoters *) - *)
compared * - *
to * - *
rrnB * - *
P1 * - *
. * - *

GadX (PTE*) - * *
activates * - * *
expression * express (V*) *
of * - * *
gadA (DNA*) - (A0*) *
and * - * *
gadBC (DNA*) - * *
at * - * *
any * - * *
pH * - * *
, * - * *
while * - * *
GadW (PTE*) - * *
inhibits * - * *
GadX-dependent * - * (A5*)
activation * activate * (V*)
. * - * *

ompC (DNA*) - (A0*) * *
expression * express (V*) * *
in * - (A2* * *
Escherichia (ORG* - * * *
coli * - * * *
K-12 *) - *) * *
is * - * * *
known * - * * *
to * - * * *
be * - * * *
regulated * - * * *
by * - * * *
the (DNA* - * (A0* *
ompB * - * * *
locus *) - * *) *
, * - * * *
comprising * compose * (V*) *
the (DNA* - * (A4* *
ompR * - * * *
and * - * * *
envZ * - * * *
genes *) - * *) *
, * - * * *
and * - * * *
the (PTE* - * * (A1*
OmpR * - * * *
protein *) - * * *)
is * - * * *
believed * - * * *
to * - * * *
act * act * * (V*)
as * - * * *
a (PTE* - * * (A8*
positive * - * * *
transcriptional * - * * *
factor *) - * * *)
. * - * * *

Taken * - *
together * - *
, * - *
these * - *
data * - *
suggest * - *
that * - *
the (PTE* - (A1*
H-NS * - *
protein *) - *)
inhibits * inhibit (V*)
transcription (PRC*) - (A0*)
in * - *
E (ORG* - (A2*
. * - *
coli *) - *)
of * - *
the * - *
lux * - *
systems * - *
of * - *
all * - *
or * - *
most * - *
luminous * - *
bacteria * - *
at * - *
the * - *
luxC * - *
gene * - *
as * - *
well * - *
as * - *
in * - *
the * - *
luxRI * - *
region * - *
of * - *
the * - *
V * - *
. * - *
fischeri * - *
lux * - *
operon * - *
. * - *

The * - *
ability * - *
of * - *
these (DNA* - (A1*
rcs * - *
genes *) - *)
to * - *
induce * induce (V*)
a (DNA* - (A0*
mucoid * - *
phenotype *) - *)
explains * - *
the * - *
apparent * - *
conjugative * - *
transfer * - *
from * - *
klebsiellae * - *
to * - *
E * - *
. * - *
coli * - *
of * - *
the * - *
ability * - *
to * - *
produce * - *
K21 * - *
or * - *
other * - *
Klebsiella * - *
capsular * - *
polysaccharides * - *
that * - *
are * - *
structurally * - *
and * - *
antigenically * - *
related * - *
to * - *
colanic * - *
acid * - *
. * - *

Tighter * - * * *
Mlc (PTE*) - (A0*) * *
repression * repress (V*) * *
and * - * * *
enhanced * - * * *
CRP (PTE* - * (A3* *
. * - * * *
cAMP *) - * *) *
activation * activate * (V*) *
of * - * * *
ptsG * - * (A0* *
P1 * - * *) *
by * - * * *
Fis (PTE*) - (A1*) (A1*) *
enable * - * * *
cells (ORG*) - * * (A1*)
to * - * * *
regulate * regulate * * (V*)
Mlc (DNA* - * * (A0*
regulon *) - * * *)
efficiently * - * * *
by * - * * *
selectively * - * * *
controlling * - * * (A10*
the * - * * *
concentration * - * * *)
of * - * * *
enzyme * - * * *
IICB * - * * *
( * - * * *
Glc * - * * *
) * - * * *
that * - * * *
modulates * - * * *
Mlc * - * * *
activity * - * * *
. * - * * *

The (DNA* - (A0*
operon *) - *)
is * - *
also * - *
induced * induce (V*)
in * - (A12*
stationary * - *
phase * - *)
. * - *

We * - * *
demonstrate * - * *
here * - * *
that * - * *
human (ORG* - (A1* *
B * - * *
cells *) - *) *
express * express (V*) *
a * - * *
ryanodine * - * *
receptor * - * *
( * - * *
RYR * - (A0*) (A1*)
) * - * *
that * - * *
functions * function * (V*)
as * - * *
a * - * (A8*
Ca2+ * - * *
release * - * *
channel * - * *)
during * - * (A12*
the * - * *
B * - * *
cell * - * *
antigen * - * *
receptor * - * *
( * - * *
BCR * - * *
) * - * *
-stimulated * - * *
Ca2+ * - * *
signaling * - * *
process * - * *)
. * - * *

A * - *
regulatory * - *
link * - *
between * - *
the * - *
synthesis * - *
of * - *
YeiK * - *
( * - *
a * - *
potential * - *
nucleoside * - *
hydrolase * - *
) * - *
and * - *
YeiL * - *
was * - *
inferred * - *
by * - *
showing * - *
that * - *
the (DNA* - (A0*
yeiK * - *
and * - *
yeiL * - *
genes *) - *)
are * - *
divergently * - *
transcribed * transcribe (V*)
from * - *
overlapping (DNA* - (A6*
promoters *) - *)
. * - *

The * - *
galS (DNA*) - (A0*)
mutation * mutation (V*)
also * - *
constitutively * - *
derepressed * - *
an (DNA* - *
mglA * - *
: * - *
: * - *
lacZ * - *
fusion *) - *
, * - *
demonstrating * - *
that * - *
GalS * - *
is * - *
the * - *
mgl * - *
repressor * - *
. * - *

These * - * *
results * - * *
provide * - * *
an * - * *
explanation * - * *
for * - * *
the * - * *
regulation * regulation (V*) *
of * - * *
some (DNA* - (A0* *
operons *) - *) *
by * - * *
NarL (PTE*) - (A1*) *
alone * - (A5*) *
and * - * *
for * - * *
the * - * *
different * - * *
effects * effect * (V*)
of * - * *
NarL (PTE*) - * (A1*)
and * - * *
NarP (PTE*) - * *
at * - * *
common (DNA* - * (A0*
target * - * *
operons *) - * *)
, * - * *
such * - * *
as * - * *
fdnG * - * *
and * - * *
nrfA * - * *
. * - * *

Transcription * transcribe (V*) *
by * - * *
RNA (PTE* - (A1* *
polymerase * - * *
III *) - *) *
involves * - * *
recruitment * recruit * (V*)
of * - * *
the (PTE* - * (A0*
polymerase *) - * *)
by * - * *
template-bound (PTE* - * (A1*
accessory * - * *
factors *) - * *)
, * - * *
followed * - * *
by * - * *
initiation * - * *
, * - * *
elongation * - * *
, * - * *
and * - * *
termination * - * *
steps * - * *
. * - * *

Introduction * introduce (V*) *
of * - * *
a * - (A0* (A0*
cDNA * - * *
expression * - * *
library * - *) *)
prepared * prepare * (V*)
from * - * *
a (ORG* - * (A6*
human * - * *
T-cell * - * *
line *) - * *)
into * - * *
the (ORG* - (A7* *
Oct-2-harboring * - * *
tester * - * *
strain *) - *) *
allowed * - * *
selection * - * *
of * - * *
three * - * *
Lac+clones * - * *
out * - * *
of * - * *
1 * - * *
x * - * *
10 * - * *
( * - * *
5 * - * *
) * - * *
transformants * - * *
. * - * *

Full * - * *
repression * repress (V*) *
of * - * *
the (DNA* - (A0* *
ula * - * *
regulon *) - *) *
requires * - * *
simultaneous * - * *
interaction * interact * (V*)
of * - * *
the (PTE* - * (A0*
repressor *) - * *)
with * - * *
both (DNA* - * (A7*
divergent * - * *
promoters *) - * *)
and * - * *
seems * - * *
to * - * *
be * - * *
dependent * - * *
on * - * *
repressor-mediated * - * *
DNA * - * *
loop * - * *
formation * - * *
, * - * *
which * - * *
is * - * *
helped * - * *
by * - * *
the * - * *
action * - * *
of * - * *
integration * - * *
host * - * *
factor * - * *
. * - * *

Possibly * - *
, * - *
the (PTE* - (A1*
fruR * - *
gene * - *
product *) - *)
acts * act (V*)
as * - *
an (PTE* - (A8*
activator *) - *)
of * - *
the * - *
gene * - *
coding * - *
for * - *
PEP * - *
synthase * - *
. * - *

In * - *
the * - *
group * - *
1 * - *
strains * - *
examined * - *
, * - *
an * - *
RcsAB * - *
box * - *
was * - *
found * - *
immediately * - *
upstream * - *
of * - *
galF (DNA*) - (A0*)
, * - *
a * - *
gene * - *
involved * involve (V*)
in * - *
the * - (A4*
production * - *)
of * - *
sugar * - *
nucleotide * - *
precursors * - *
. * - *

Gel * - * * *
retardation * - * * *
assays * - * * *
showing * - * * *
that * - * * *
the (PTE* - (A1* * *
PaaX * - * * *
regulator *) - *) * *
binds * bind (V*) * *
specifically * - * * *
to * - * * *
the (DNA* - (A7* * *
Pa * - * * *
and * - * * *
Pz * - * * *
promoters *) - *) * *
were * - * * *
complemented * - * * *
with * - * * *
in * - * * *
vivo * - * * *
experiments * - * * *
that * - * * *
indicated * - * * *
a * - * * *
PaaX-mediated * - * (A5*) *
repression * repress * (V*) *
effect * - * * *
on * - * * *
the * - * * *
expression * express * * (V*)
of * - * * *
Pa-lacZ (DNA* - * * (A0*
and * - * * *
Pz-lacZ * - * * *
reporter * - * * *
fusions *) - * * *)
. * - * * *

Moreover * - * * *
, * - * * *
stringent * - * * (A1*
control * - * * *)
, * - * * *
which * - * * *
like * - * * *
FIS (PTE*) - * * *
also * - * * *
regulates * - * * *
the * - * * *
transcription * transcription (V*) * *
of * - * * *
the (DNA* - (A0* * *
stable * - * * *
RNA * - * * *
operons *) - *) * *
, * - * * *
affected * - * * *
the * - * * *
hupB * - * (A0*) *
transcription * transcription * (V*) *
while * - * * *
it * - * * *
had * - * * *
no * - * * *
effect * effect * * (V*)
on * - * * *
hupA (DNA*) - * * (A0*)
. * - * * *

The (PTE* - (A1*
CytR * - *
repressor *) - *)
protects * protect (V*)
a (DNA* - (A0*
DNA * - *
segment *) - *)
that * - *
is * - *
located * - *
between * - *
the * - *
two * - *
CRP * - *
sites * - *
and * - *
partially * - *
overlaps * - *
the * - *
CRP-1 * - *
target * - *
. * - *

EnvZ (PTE*) - (A1*) *
functions * function (V*) *
through * - (A5* *
OmpR * - *) *
to * - * *
control * - * *
porin (DNA* - * (A0*
gene *) - * *)
expression * express * (V*)
in * - * *
Escherichia (ORG* - * *
coli * - * *
K-12 *) - * *
. (PTE*) - * *

Control * - *
of * - *
transcription * transcription (V*)
of * - *
gal (DNA* - (A0*
repressor * - *
and * - *
isorepressor * - *
genes *) - *)
in * - (A2*
Escherichia (ORG* - *
coli *) - *)
. * - *

Surprisingly * - *
hLSIRF (DNA* - (A0*
mRNA *) - *)
was * - *
also * - *
found * - *
in * - *
the * - *
melanoma * - *
line * - *
G361 * - *
and * - *
is * - *
expressed * express (V*)
in * - (A2*
normal (ORG* - *
melanocytes *) - *)
as * - *
well * - *
. * - *

In * - *
vivo * - *
primer * - *
extension * - *
analysis * - *
indicated * - *
that * - *
this * - *
control * - *
is * - *
complex * - *
and * - *
involves * - *
both * - *
positive * - (A5*
and * - *
negative * - *)
effects * effect (V*)
by * - *
cyclic (PTE* - (A1*
AMP-CRP *) - *)
on * - (A2*
multiple (DNA* - *
ompB * - *
promoters *) - *)
. * - *

CsrA (PTE*) - *
indirectly * - *
activates * - *
csrB (DNA*) - (A0*)
transcription * transcription (V*)
, * - *
in * - *
an * - *
apparent * - *
autoregulatory * - *
mechanism * - *
. * - *

Structural * - * *
and * - * *
functional * - * *
properties * - * *
of * - * *
this * - * *
regulatory * - * *
protein * - * *
were * - * *
studied * - * *
through * - * *
complementation * - * *
analysis * - * *
of * - * *
the (DNA* - (A0* *
wild-type * - * *
and * - * *
five * - * *
mutant * - * *
ompR * - * *
genes *) - *) *
that * - * *
exhibited * exhibit (V*) *
differences * - (A4* *
in * - * *
osmoregulation * - *) *
of * - * *
the * - * *
expression * express * (V*)
of * - * *
the (PTE* - * (A0*
OmpF * - * *
and * - * *
OmpC * - * *
proteins *) - * *)
. * - * *

We * - *
found * - *
that * - *
DC272 (None*) - *
carried * - *
a * - *
point * - (A5*)
mutation * mutation (V*)
in * - (A2*
the (DNA* - *
Cra-binding * - *
site *) - *)
of * - *
the * - *
adhE * - *
promoter * - *
. * - *

In * - * *
a * - * *
genetic * - * *
screening * - * *
directed * - * *
to * - * *
identify * - * *
genes * - (A1*) *
involved * involve (V*) *
in * - * *
biofilm * - (A8* *
formation * - *) *
, * - * *
mutations * mutations * (V*)
in * - * *
the (DNA* - * (A0*
cpxA * - * *
gene *) - * *)
were * - * *
found * - * *
to * - * *
reduce * - * *
biofilm * - * *
formation * - * *
by * - * *
affecting * - * *
microbial * - * *
adherence * - * *
to * - * *
solid * - * *
surfaces * - * *
. * - * *

The * - * * *
eukaryotic * - * * *
upstream * - * * *
binding * - * * *
factor * - * * *
( * - * * *
UBF (PTE*) - (A1*) (A1*) *
) * - * * *
, * - * * *
recognizes * recognize (V*) * *
the (DNA* - (A0* * *
ribosomal * - * * *
RNA * - * * *
gene * - * * *
promoter *) - *) * *
and * - * * *
activates * activate * (V*) *
transcription (PRC*) - * (A0*) (A0*)
mediated * mediate * * (V*)
by * - * * *
RNA (PTE* - * * (A1*
polymerase * - * * *
I *) - * * *)
through * - * * *
cooperative * - * * (A5*
interactions * - * * *)
with * - * * *
the * - * * *
species-specific * - * * *
factor * - * * *
, * - * * *
SL1 * - * * *
. * - * * *

Expression * express (V*)
of * - *
the (DNA* - (A0*
Bcl-3 * - *
proto-oncogene *) - *)
suppresses * - *
p53 * - *
activation * - *
. * - *

Dual * - *
regulation * regulation (V*)
of * - *
inaA (DNA*) - (A0*)
by * - *
the * - *
multiple * - *
antibiotic * - *
resistance * - *
( * - *
mar (DNA*) - (A1*)
) * - *
and * - *
superoxide * - *
( * - *
soxRS (DNA*) - (A1*)
) * - *
stress * - *
response * - *
systems * - *
of * - *
Escherichia * - *
coli * - *
. * - *

In * - *
vivo * - *
footprinting * - *
assays * - *
demonstrate * - *
that * - *
a * - (A0*
hypersensitive * - *
band * - *)
was * - *
detected * detect (V*)
at * - *
the * - *
PU * - *
. * - *
1 * - *
site * - *
in * - (A2*
myeloid (ORG* - *
cells *) - *
but * - *
not * - *
in * - *
HeLa * - *)
. * - *

The * - *
capability * - *
for * - *
specific * - (A5*)
transcription (PRC*) - (A0*)
initiation * initiate (V*)
can * - *
be * - *
restored * - *
either * - *
by * - *
the (PTE* - *
natural * - *
subcomplex *) - *
or * - *
by * - *
a (PTE* - *
stable * - *
subcomplex *) - *
composed * - *
of * - *
recombinant * - *
hRPC32 * - *
, * - *
hRPC39 * - *
, * - *
and * - *
hRPC62 * - *
polypeptides * - *
. * - *

The * - *
presence * - *
of * - *
multiple * - *
pH * - *
control * - *
pathways * - *
governing * - *
expression * express (V*)
of * - *
this * - (A0*
acid * - *
resistance * - *
system * - *)
is * - *
thought * - *
to * - *
reflect * - *
different * - *
environmental * - *
routes * - *
to * - *
a * - *
low * - *
pH * - *
. * - *

Characterization * - *
of * - *
the * - *
genomic * - *
structure * - *
, * - *
chromosomal * - *
location * - *
, * - *
promoter * - *
, * - *
and * - *
development * - (A5*)
expression * express (V*)
of * - *
the (PTE* - (A0*
alpha-globin * - *
transcription * - *
factor * - *
CP2 *) - *)
. * - *

The * - *
Escherichia * - *
coli * - *
arginine * - *
repressor * - *
( * - *
ArgR (PTE*) - (A1*)
) * - *
controls * - *
expression * express (V*)
of * - *
the (DNA* - (A0*
arginine * - *
biosynthetic * - *
genes *) - *)
and * - *
acts * - *
as * - *
an (PTE* - (A8*
accessory * - *
protein *) - *)
in * - *
Xer * - *
site-specific * - *
recombination * - *
at * - *
cer * - *
and * - *
related * - *
plasmid * - *
recombination * - *
sites * - *
. * - *

We * - * *
also * - * *
provide * - * *
evidence * - * *
that * - * *
the * - * *
function * - * *
of * - * *
the * - * *
glnL * - * *
product * - * *
is * - * *
to * - * *
mediate * - * *
the * - * *
interconversion * interconvert (V*) *
of * - * *
NRI (PTE*) - (A0*) (A1*)
between * - * *
a * - * *
form * - * *
capable * - * *
of * - * *
activating * activate * (V*)
glnAp2 (DNA*) - * (A0*)
and * - * *
an * - * *
inactive * - * *
form * - * *
in * - * *
response * - * *
to * - * *
changes * - * *
in * - * *
the * - * *
intracellular * - * *
concentration * - * *
of * - * *
ammonia * - * *
. * - * *

GalS (PTE*) - (A0*)
is * - *
itself * - *
autogenously * - (A5*)
regulated * regulate (V*)
and * - *
CRP (PTE* - (A3*
dependent *) - *)
, * - *
while * - *
the * - *
gene * - *
for * - *
GalR * - *
is * - *
constitutive * - *
. * - *

We * - *
have * - *
carried * - *
out * - *
a * - *
large-scale * - *
identification * - *
and * - *
characterization * - *
of * - *
human (DNA* - (A1*
genes *) - *)
that * - *
activate * activate (V*)
the * - (A0*
NF-kappaB * - *
and * - *
MARK * - *
signaling * - *
pathways * - *)
. * - *

Nine (DNA* - (A0*
representative * - *
non-flagellar * - *
promoter * - *
regions *) - *)
were * - *
all * - *
bound * bound (V*)
in * - (A4*
vitro * - *)
by * - *
active (PTE* - (A1*
reconstituted * - *
FlhD *) - *)
( * - *
2 * - *
) * - *
C * - *
( * - *
2 * - *
) * - *
over * - *
the * - *
K * - *
( * - *
D * - *
) * - *
range * - *
38-356 * - *
nM * - *
, * - *
and * - *
of * - *
the * - *
nine * - *
corresponding * - *
chromosomal * - *
promoter-lacZ * - *
fusions * - *
, * - *
those * - *
of * - *
the * - *
four * - *
genes * - *
b1904 * - *
, * - *
b2446 * - *
, * - *
wzz * - *
( * - *
fepE * - *
) * - *
and * - *
gltI * - *
showed * - *
up * - *
to * - *
50-fold * - *
dependence * - *
on * - *
FlhD * - *
( * - *
2 * - *
) * - *
C * - *
( * - *
2 * - *
) * - *
in * - *
vivo * - *
. * - *

Alp (PTE*) - (A1*)
suppression * suppress (V*)
of * - *
Lon (PTE*) - (A0*)
: * - *
dependence * - *
on * - *
the * - *
slpA * - *
gene * - *
. * - *

However * - *
, * - *
in * - *
time * - *
the * - *
extent * - *
of * - *
beta-galactosidase * - *
induction * - *
gradually * - *
declined * - *
suggesting * - *
that * - *
the * - *
prolonged * - *
repressed * - *
transcriptional * - (A1*
state * - *)
triggers * trigger (V*)
epigenetic * - (A0*
inactivation * - *)
. * - *

To * - *
this * - *
end * - *
, * - *
we * - *
have * - *
employed * - *
DNA * - *
microarray * - *
technology * - *
to * - *
identify * - *
genes (DNA*) - (A0*)
involved * involve (V*)
in * - *
the * - (A4*
regulatory * - *
networks * - *)
that * - *
facilitate * - *
the * - *
transition * - *
of * - *
Escherichia * - *
coli * - *
cells * - *
from * - *
an * - *
aerobic * - *
to * - *
an * - *
anaerobic * - *
growth * - *
state * - *
. * - *

The * - *
proposed * - *
structure * - *
of * - *
xyl * - *
promoters * - *
is * - *
consistent * - *
with * - *
the * - *
regulation * - *
of * - *
xyl * - (A0*
gene * - *)
expression * express (V*)
and * - *
with * - *
phenotypes * - *
of * - *
transposon * - *
insertions * - *
obtained * - *
in * - *
the * - *
promoter * - *
regions * - *
. * - *

The (DNA* - (A1* (A0*
Escherichia * - * *
coli * - * *
rhaSR * - * *
operon *) - *) *)
encodes * encode (V*) *
two * - * *
AraC * - * *
family * - * *
transcription * - * *
activators * - * *
, * - * *
RhaS (PTE*) - (A0*) *
and * - * *
RhaR (PTE*) - * *
, * - * *
and * - * *
is * - * *
activated * activate * (V*)
by * - * *
RhaR (PTE*) - * (A1*)
in * - * *
the * - * *
presence * - * *
of * - * *
L-rhamnose (EXP*) - * (A3*)
. * - * *

Upon * - (A12*
induction * - *)
, * - *
complexes (PTE*) - (A0*)
are * - *
observed * observe (V*)
at * - (A2*
the (DNA* - *
2 * - *
x * - *
NF-E2 * - *
consensus * - *
binding * - *
site *) - *)
and * - *
the (DNA* - *
extended * - *
kappa3/AP1 *) - *
( * - *
+ * - *
) * - *
site * - *
of * - *
the * - *
TNFalpha * - *
promoter * - *
. (PRC*) - *

By * - * *
using * - * *
purified * - * *
OmpR (PTE*) - (A1*) *
and * - * *
various * - * *
regions * - * *
of * - * *
the * - * *
ompF (DNA*) - * (A0*)
promoter * - * *
we * - * *
show * - * *
that * - * *
phosphorylation * - * *
causes * - * *
binding * bind (V*) *
of * - * *
OmpR * - * *
to * - * *
a (DNA* - (A7* *
DNA * - * *
region *) - *) *
between * - * *
the * - * *
-40 * - * *
to * - * *
-100 * - * *
region * - * *
of * - * *
the * - * *
ompF * - * *
promoter * - * *
previously * - * *
shown * - * *
to * - * *
be * - * *
important * - * *
for * - * *
ompF * - * *
expression * express * (V*)
. * - * *

acs (DNA*) - (A1*)
encodes * encode (V*)
acetyl-coenzyme (PTE* - (A0*
A * - *
synthetase *) - *)
, * - *
a * - *
high-affinity * - *
enzyme * - *
that * - *
allows * - *
cells * - *
to * - *
scavenge * - *
for * - *
acetate * - *
during * - *
carbon * - *
starvation * - *
. * - *

Nuclear (PTE* - (A1*
receptor * - *
steroidogenic * - *
factor * - *
1 *) - *)
regulates * regulate (V*)
the (DNA* - (A0*
müllerian * - *
inhibiting * - *
substance * - *
gene *) - *)
: * - *
a * - *
link * - *
to * - *
the * - *
sex * - *
determination * - *
cascade * - *
. * - *

Overexpression * overexpress (V*)
of * - *
ATF4 (PTE*) - (A0*)
was * - *
sufficient * - *
to * - *
activate * - *
the (DNA* - *
VEGF * - *
promoter *) - *
, * - *
and * - *
arsenite (EXP*) - *
cooperated * - *
with * - *
exogenous (PTE* - *
ATF4 *) - *
to * - *
further * - *
activate * - *
the * - *
promoter * - *
. * - *

Optimal * - * * *
expression * express (V*) * *
of * - * * *
the (DNA* - (A0* * (A6*
melAB * - * * *
promoter *) - *) * *)
requires * - * * *
Sites * - * * *
1' * - * * *
, * - * * *
Site (DNA* - * * *
1 *) - * * *
, * - * * *
Site (DNA* - * * *
2 *) - * * *
and * - * * *
Site * - * * *
2' * - * * *
; * - * * *
CRP * - * * *
acts * - * * *
as * - * * *
a * - * * *
'bridge' * - * * *
between * - * * *
MelR (PTE*) - * (A1*) *
bound * bound * (V*) *
at * - * * *
Sites (DNA* - * (A7* *
1' * - * * *
and * - * * *
1 * - * * *
and * - * * *
at * - * * *
Sites * - * * *
2 * - * * *
and * - * * *
2' *) - * *) *
, * - * * *
increasing * - * * *
expression * express * * (V*)
from * - * * *
the * - * * *
melAB * - * * *
promoter * - * * *
. (DNA*) - * * *

The * - (A1*
part * - *
of * - *
FREAC-2 * - *)
that * - *
binds * bind (V*)
TBP (PTE*) - (A7*)
was * - *
mapped * - *
to * - *
21 * - *
amino * - *
acids * - *
in * - *
the * - *
C-terminal * - *
end * - *
of * - *
the * - *
forkhead * - *
domain * - *
. (PTE*) - *

Template * - * *
DNA (DNA*) - * (A0*)
and * - * *
RNA * - * *
polymerase * - * *
were * - * *
sufficient * - * *
to * - * *
obtain * obtain (V*) *
transcription (PRC*) - (A0*) *
in * - (A3* *
vitro * - *) *
, * - * *
but * - * *
DNA * - * *
methylation * methylate * (V*)
enhanced * - * *
the * - * *
level * - * *
of * - * *
transcription * - * *
. (PRC*) - * *

Expression * express (V*) *
of * - * *
ptsG (DNA*) - (A0*) (A1*)
encoding * encode * (V*)
the (PTE* - * (A0*
major * - * *
glucose * - * *
transporter *) - * *)
is * - * *
regulated * - * *
by * - * *
ArcA (PTE*) - * *
in * - * *
Escherichia (ORG* - * *
coli *) - * *
. * - * *

The * - (A1*
transcription * - *
factor * - *
sigma * - *
s * - *)
acts * act (V*)
predominantly * - *
as * - *
a * - (A8*
positive * - *
effector * - *)
, * - *
but * - *
it * - *
does * - *
have * - *
a * - *
negative * - *
effect * - *
on * - *
some * - *
genes * - *
. * - *

An (PRC* - (A1*
additional * - *
mutation *) - *)
which * - *
restores * - *
the * - *
phasing * - *
of * - *
the * - *
two * - *
sites * - *
permits * permit (V*)
repression (PRC*) - (A0*)
. * - *

Disruption * disrupt (V*) * *
of * - * * *
narL (DNA*) - (A0*) * *
decreases * - * * *
nitrite (EXP*) - * (A1*) *
induction * induce * (V*) *
of * - * * *
the (DNA* - * (A0* *
nirB * - * * *
promoter *) - * *) *
whilst * - * * *
not * - * * *
suppressing * - * * *
induction * induce * * (V*)
by * - * * *
nitrate (EXP*) - * * (A1*)
, * - * * *
suggesting * - * * *
that * - * * *
there * - * * *
may * - * * *
be * - * * *
a * - * * *
second * - * * *
nitrate-responsive * - * * *
factor * - * * *
. * - * * *

Transcription (PTE* - *
factors *) - *
of * - *
the * - *
NFAT * - *
family * - *
play * - *
a * - *
key * - *
role * - *
in * - *
the * - *
transcription * transcription (V*)
of * - *
cytokine (DNA* - (A0*
genes *) - *)
and * - *
other (DNA* - *
genes *) - *
during * - *
the * - (A12*
immune * - *
response * - *)
. * - *

What * - *
seems * - *
to * - *
be * - *
responsible * - *
for * - *
the * - *
negative * - (A5*)
autoregulation * autoregulate (V*)
of * - *
mazEF (DNA*) - (A0*)
is * - *
an * - *
unusual * - *
DNA * - *
structure * - *
, * - *
which * - *
we * - *
have * - *
called * - *
an * - *
" * - *
alternating * - *
palindrome * - *
. * - *
" * - *
The * - *
middle * - *
part * - *
, * - *
" * - *
a * - *
, * - *
" * - *
of * - *
this * - *
structure * - *
may * - *
complement * - *
either * - *
the * - *
downstream * - *
fragment * - *
, * - *
" * - *
b * - *
, * - *
" * - *
or * - *
the * - *
upstream * - *
fragment * - *
, * - *
" * - *
c * - *
" * - *

Transcriptional * - (A0*
control * - *)
mediated * mediate (V*)
by * - *
the (PTE* - (A1*
ArcA * - *
two-component * - *
response * - *
regulator * - *
protein *) - *)
of * - *
Escherichia * - *
coli * - *
: * - *
characterization * - *
of * - *
DNA * - *
binding * - *
at * - *
target * - *
promoters * - *
. * - *

CAP (PTE* - (A1* (A1*
and * - * *
NagC *) - *) *)
can * - * *
bind * bind (V*) *
simultaneously * - (A5*) *
and * - * *
produce * produce * (V*)
a (PTE* - * (A0*
complex *) - * *)
more * - * *
stable * - * *
than * - * *
the * - * *
binary * - * *
NagC-DNA * - * *
complex * - * *
. * - * *

This * - *
predicts * - *
that * - *
a * - (A0*
17 * - *
bp * - *
spacer * - *
promoter * - *
derivative * - *)
should * - *
be * - *
down-regulated * down-regulated (V*)
by * - *
plasmid * - (A1*
multimerization * - *)
, * - *
and * - *
this * - *
is * - *
confirmed * - *
experimentally * - *
. * - *

Previous * - *
studies * - *
have * - *
shown * - *
that * - *
the (DNA* - *
napF * - *
operon * - *
control * - *
region *) - *
directs * - *
synthesis * synthesize (V*)
of * - *
two (DNA* - (A0*
transcripts *) - *)
whose * - *
5' * - *
ends * - *
differ * - *
by * - *
about * - *
3 * - *
nucleotides * - *
. * - *

Transcription * transcribe (V*) *
of * - * *
ptsG (DNA*) - (A0*) (A1*)
encoding * encode * (V*)
glucose-specific * - * *
permease * - * *
, * - * *
enzyme * - * *
IICB * - * *
( * - * *
Glc (PTE*) - * (A0*)
) * - * *
, * - * *
in * - (A2* *
Escherichia (ORG* - * *
coli *) - *) *
is * - * *
initiated * - * *
from * - * *
two * - * *
promoters * - * *
, * - * *
P1 (DNA* - * *
and * - * *
P2 *) - * *
. * - * *

Closer * - *
examination * - *
of * - *
the * - (A1*
putative * - *
signal * - *
transduction * - *
pathway * - *)
modulating * modulate (V*)
htrA (PRC* - (A0*
transcription *) - *)
has * - *
led * - *
us * - *
to * - *
the * - *
identification * - *
of * - *
two * - *
new * - *
genes * - *
. * - *

Therefore * - *
, * - *
MRL3 (PTE*) - (A0*)
overexpression * overexpression (V*)
seems * - *
to * - *
be * - *
a * - *
property * - *
of * - *
rapidly * - *
dividing * - *
cells * - *
and * - *
is * - *
not * - *
directly * - *
linked * - *
to * - *
oncogenesis * - *
. * - *

The (PTE* - * *
Fnr * - * *
protein *) - * *
is * - * *
required * - * *
for * - * *
Cra-mediated * - (A5*) *
transcriptional * - * *
control * control (V*) *
, * - * *
but * - * *
the (PTE* - * *
ArcA * - * *
protein *) - * *
antagonizes * - * *
the * - * *
response * respond * (V*)
to * - * *
Cra (PTE*) - * (A0*)
. * - * *

Our * - *
data * - *
suggest * - *
that * - *
the * - *
biologic * - *
effects * - *
of * - *
oxLDL * - *
are * - *
coordinated * - *
by * - *
two * - *
sets * - *
of * - *
receptors * - *
, * - *
one * - *
on * - *
the * - *
cell * - *
surface * - *
, * - *
which * - *
binds * - *
and * - *
internalizes * - *
the * - *
particle * - *
, * - *
and * - *
one * - (A0*
in * - *
the * - *
nucleus * - *)
, * - *
which * - *
is * - *
transcriptionally * - (A5*)
activated * activate (V*)
by * - *
its (EXP* - (A1*
component * - *
lipids *) - *)
. * - *

Among * - * *
them * - * *
, * - * *
LexA-binding * - * *
SOS * - * *
boxes * - * *
have * - * *
been * - * *
found * - * *
at * - * *
the * - * *
5' * - * *
end * - * *
of * - * *
the * - * *
cluster * - * *
, * - * *
preceding * - * *
promoters (DNA*) - * *
which * - * *
direct * - * *
the * - * *
expression * express (V*) *
of * - * *
ftsI (DNA*) - (A0*) (A1*)
( * - * *
coding * code * (V*)
for * - * *
PBP3 (PTE*) - * (A0*)
, * - * *
the * - * *
penicillin-binding * - * *
protein * - * *
involved * - * *
in * - * *
septum * - * *
formation * - * *
) * - * *
. * - * *

Analysis * - * *
of * - * *
one * - * *
cDNA * - * *
revealed * - * *
an * - (A1* *
unusual * - * *
splicing * - * *
event * - *) *
involving * involve (V*) *
EZH1 (DNA*) - (A0*) *
and * - * *
a (DNA* - * *
tandemly * - * *
linked * - * *
gene * - * *
GPR2 *) - * *
and * - * *
suggests * - * *
a * - * *
potential * - * *
mechanism * - * *
for * - * *
modifying * modify * (V*)
the (PTE* - * (A0*
EZH1 * - * *
protein *) - * *)
in * - * *
the * - * *
conserved * - * *
C-terminal * - * *
domain * - * *
. * - * *

sigma * - * *
( * - * *
S (PTE*) - * *
) * - * *
is * - * *
also * - * *
required * - * *
for * - * *
the * - * *
transcription * transcription (V*) *
of * - * *
the (DNA* - (A0* (A1*
cryptic * - * *
genes * - * *
csgBA *) - *) *)
that * - * *
encode * encode * (V*)
the (PTE* - * (A0*
subunits *) - * *)
of * - * *
the * - * *
curli * - * *
proteins * - * *
. * - * *

Induction * - *
of * - *
manganese-containing * - *
superoxide * - *
dismutase * - *
in * - *
anaerobic * - *
Escherichia * - *
coli * - *
by * - *
diamide * - *
and * - *
1 * - *
, * - *
10-phenanthroline * - *
: * - *
sites * - *
of * - *
transcriptional * - (A5*)
regulation * regulation (V*)
. * - *

Cross-induction * crossinduct (V*)
of * - *
glc (DNA* - (A0*
and * - *
ace * - *
operons *) - *)
of * - *
Escherichia * - *
coli * - *
attributable * - *
to * - *
pathway * - (A1*
intersection * - *)
. * - *

Molecular * - * *
analysis * - * *
by * - * *
deletion * delete (V*) *
and * - * *
site-directed * - * *
mutagenesis * - * *
of * - * *
the (DNA* - (A0* *
cis-acting * - * *
upstream * - * *
sequence *) - *) *
involved * - * *
in * - * *
activation * activate * (V*)
of * - * *
the (DNA* - * (A0*
ompF * - * *
promoter *) - * *)
in * - * (A2*
Escherichia (ORG* - * *
coli *) - * *)
. * - * *

Spt3 (PTE*) -
is * -
a * -
Saccharomyces * -
cerevisiae * -
transcription * -
factor * -
that * -
is * -
required * -
in * -
vivo * -
for * -
the * -
transcription * -
of * -
a * -
number * -
of * -
RNA (DNA* -
polymerase * -
II-transcribed * -
genes *) -
. * -

We * - * *
studied * - * *
the * - * *
structure * - * *
, * - * *
regulation * regulation (V*) *
and * - * *
expression * express * (V*)
of * - * *
HOX3D (DNA*) - (A0*) (A0*)
, * - * *
a * - * *
human * - * *
homeobox * - * *
gene * - * *
located * - * *
in * - * *
the * - * *
HOX3 * - * *
cluster * - * *
on * - * *
chromosome * - * *
12 * - * *
. * - * *

In * - *
response * - *
to * - *
low * - *
oxygen * - *
levels * - *
, * - *
autophosphorylated * - *
ArcB * - *
phosphorylates * - *
ArcA * - *
, * - *
and * - *
the * - *
resulting * - *
phosphorylated * - *
ArcA * - *
( * - *
ArcA-P (PTE*) - (A1*)
) * - *
functions * function (V*)
as * - *
a (PTE* - (A8*
transcriptional * - *
regulator *) - *)
of * - *
the * - *
genes * - *
necessary * - *
to * - *
maintain * - *
anaerobic * - *
growth * - *
. * - *

The * - (A0*
metabolism * - *
of * - *
D-xylose * - *)
in * - *
Escherichia * - *
coli * - *
K-12 * - *
is * - *
known * - *
to * - *
be * - *
mediated * mediate (V*)
by * - *
the (DNA* - (A1*
xylAB * - *
gene *) - *)
. (EXP*) - *

The (DNA* - (A0* (A0*
astCADBE * - * *
operon *) - *) *)
, * - * *
which * - * *
is * - * *
required * - * *
for * - * *
growth * - * *
with * - * *
arginine * - * (A3*)
as * - * *
the * - * *
sole * - * *
nitrogen * - * *
source * - * *
, * - * *
is * - * *
moderately * - (A5*) *
expressed * express (V*) *
during * - (A12* *
general * - * *
nitrogen * - * *
limitation * - *) *
and * - * *
maximally * - * (A5*)
expressed * express * (V*)
in * - * *
the * - * *
presence * - * *
of * - * *
arginine * - * *
. * - * *

In * - *
this * - *
study * - *
, * - *
we * - *
examine * - *
the * - *
effects * effect (V*)
of * - *
FIS (PTE*) - (A1*)
and * - *
the (DNA* - *
UP * - *
element *) - *
at * - (A2*
the (DNA* - *
other * - *
six * - *
rrn * - *
P1 * - *
promoters *) - *)
. * - *

IclR (PTE*) - (A1*) (A1*) *
binds * bind (V*) * *
to * - * * *
this (DNA* - (A7* * *
IclR * - * * *
box * - * * *
I *) - *) * *
even * - * * *
after * - (A12* * *
formation * - * * *
of * - * * *
the * - * * *
aceB * - * * *
promoter * - * * *
open * - * * *
complex * - *) * *
and * - * * *
, * - * * *
moreover * - * * *
, * - * * *
induces * induce * (V*) *
disassembly * - * (A0* *
of * - * * *
the * - * * *
open * - * * *
complex * - * *) *
, * - * * *
leading * - * * *
to * - * * *
repression * - * * *
of * - * * *
aceB (DNA*) - * * (A0*)
transcription * transcription * * (V*)
. * - * * *

The * - *
chromosome * - *
1 * - *
breakpoints * - *
of * - *
these * - *
patients * - *
lie * - *
within * - *
a * - *
kilobasepair * - *
of * - *
each * - *
other * - *
, * - *
and * - *
thus * - *
define * - *
a * - *
genetic * - *
locus * - *
( * - *
designated * - *
tal (DNA*) - (A0*)
) * - *
involved * involve (V*)
in * - *
T * - (A4*
cell * - *
oncogenesis * - *)
. * - *

Three (PTE* - (A1* *
human * - * *
RNA * - * *
polymerase * - * *
III-specific * - * *
subunits *) - *) *
form * form (V*) *
a (PTE* - (A0* *
subcomplex *) - *) *
with * - * *
a * - * *
selective * - * *
function * - * *
in * - * *
specific * - * (A5*)
transcription (PRC*) - * (A0*)
initiation * initiate * (V*)
. * - * *

Furthermore * - *
, * - *
the * - *
deletion * delete (V*)
of * - *
yhiE (DNA*) - (A0*)
completely * - *
abolished * - *
acid * - *
resistance * - *
in * - *
stationary-phase (ORG* - *
cells *) - *
, * - *
suggesting * - *
that * - *
YhiE * - *
plays * - *
a * - *
critical * - *
role * - *
in * - *
stationary-phase * - *
acid * - *
resistance * - *
. * - *

The * - * *
strategy * - * *
described * - * *
here * - * *
provides * - * *
a * - * *
new * - * *
approach * - * *
for * - * *
studying * - * *
protein-protein * - (A1*) *
interactions * interact (V*) *
that * - * *
govern * - * *
the * - * *
complex * - * *
regulation * - * *
of * - * *
gene (DNA*) - * (A0*)
expression * express * (V*)
. * - * *

The * - *
rearranged * - *
L-myc * - *
fusion * - *
gene * - *
( * - *
RLF (DNA*) - (A1*)
) * - *
encodes * encode (V*)
a (PTE* - (A0*
Zn-15 * - *
related * - *
zinc * - *
finger * - *
protein *) - *)
. * - *

Taken * - *
together * - *
, * - *
these * - *
data * - *
indicate * - *
that * - *
although * - *
the * - *
hya * - *
and * - *
hyb * - *
operons * - *
share * - *
common * - *
regulators * - *
, * - *
there * - *
are * - *
important * - *
differences * - *
in * - *
the * - *
control * - *
of * - *
expression * express (V*)
of * - *
the (DNA* - (A0*
individual * - *
operons *) - *)
. * - *

Three (DNA* - *
adjacent * - *
binding * - *
sites *) - *
for * - *
cAMP * - *
receptor * - *
protein * - *
are * - *
involved * - *
in * - *
the * - *
activation * activate (V*)
of * - *
the (DNA* - (A0*
divergent * - *
malEp-malKp * - *
promoters *) - *)
. * - *

Regulation * - *
of * - *
microcin (DNA* - (A0*
C51 * - *
operon *) - *)
expression * express (V*)
: * - *
the * - *
role * - *
of * - *
global * - *
regulators * - *
of * - *
transcription * - *
. * - *

Transcription * transcribe (V*) * *
from * - * * *
P1 (DNA*) - (A6*) * *
did * - * * *
not * - * * *
affect * - * * *
ArcA-mediated * - * * *
activation * - * * *
or * - * * *
Fnr-mediated * - * (A5*) *
repression * repress * (V*) *
of * - * * *
P2 (DNA*) - * (A0*) *
, * - * * *
indicating * - * * *
that * - * * *
oxygen * - * * (A5*)
regulation * regulation * * (V*)
is * - * * *
exerted * - * * *
on * - * * *
both (DNA* - * * *
promoters *) - * * *
in * - * * *
an * - * * *
independent * - * * *
fashion * - * * *
. * - * * *

In * - *
the * - *
wild-type * - *
strain * - *
grown * - *
in * - *
the * - *
presence * - *
of * - *
DTT * - *
( * - *
10 * - *
mM * - *
) * - *
, * - *
the * - *
uvrA (DNA* - (A0*
gene *) - *)
expression * express (V*)
was * - *
also * - *
repressed * - *
. * - *

Curli (PTE* - (A0*
fibers *) - *)
, * - *
encoded * encode (V*)
by * - *
the (DNA* - (A1*
csgBAC * - *
genes *) - *)
, * - *
promote * - *
biofilm * - *
formation * - *
in * - *
Escherichia * - *
coli * - *
and * - *
other * - *
enterobacteria * - *
. * - *

The * - * *
response * - * *
regulator * - * *
, * - * *
TorR (PTE*) - (A0*) *
, * - * *
has * - * *
recently * - * *
been * - * *
identified * identify (V*) *
as * - * *
the (PTE* - (A4* *
regulatory * - * *
protein *) - *) *
that * - * *
controls * - * *
the * - * *
expression * express * (V*)
of * - * *
the (DNA* - * (A0*
torCAD * - * *
operon *) - * *)
in * - * *
response * - * *
to * - * *
TMAO (EXP*) - * (A3*)
. * - * *

The (PTE* - *
NagC * - *
and * - *
Mlc * - *
proteins *) - *
are * - *
homologous * - *
transcriptional * - *
regulators * - *
that * - *
control * - *
the * - *
expression * express (V*)
of * - *
several * - *
phosphotransferase * - *
system * - *
( * - *
PTS (DNA*) - (A0*)
) * - *
genes (DNA*) - *
in * - (A2*
Escherichia (ORG* - *
coli *) - *)
. * - *

The * - *
compatibility * - *
of * - *
such * - *
promiscuous * - (A5*)
coupling * couple (V*)
with * - *
regulatory * - (A0*
organization * - *)
is * - *
illustrated * - *
in * - *
the * - *
carbohydrate * - *
transport * - *
systems * - *
and * - *
the * - *
succeeding * - *
metabolic * - *
pathways * - *
, * - *
whose * - *
organization * - *
is * - *
comprehensive * - *
in * - *
sending * - *
nutritious * - *
substances * - *
to * - *
the * - *
central * - *
path * - *
of * - *
glycolysis * - *
under * - *
different * - *
environmental * - *
conditions * - *
. * - *

Deletion * - *
analysis * - *
of * - *
the * - *
PU * - *
. * - *
1 * - *
promoter * - *
indicates * - *
that * - *
tissue-specific * - (A0*
functional * - *
elements * - *)
are * - *
encoded * encode (V*)
in * - (A2*
the (DNA* - *
-61 * - *
to * - *
-39 * - *
bp *) - *
and * - *
-7 (DNA* - *
to * - *
+34 * - *
bp * - *
regions *) - *)
. * - *

FNR (PTE*) - (A1*)
binds * bind (V*)
at * - *
an (DNA* - (A7*
FNR * - *
box *) - *)
within * - *
the * - *
hmp * - *
promoter * - *
( * - *
P * - *
( * - *
hmp * - *
) * - *
) * - *
. * - *

These (PRC* - (A1* * * * *
mutations *) - *) * * * *
affected * affect (V*) * * * *
a (DNA* - (A0* * * * *
predicted * - * * * * *
DNA-binding * - * * * * *
domain *) - *) * * * *
of * - * * * * *
Lrp * - * * * * *
and * - * * * * *
mutants * - * * * * *
were * - * * * * *
defective * - * * * * *
DNA-binding * - * * * * *
domain * - * * * * *
of * - * * * * *
Lrp * - * * * * *
and * - * * * * *
mutants * - * * * * *
were * - * * * * *
defective * - * * * * *
both * - * * * * *
in * - * * * * *
activation * activate * (V*) * * *
of * - * * * * *
ilvIH (DNA*) - * (A0* (A0*) * *
expression * express * *) (V*) * *
and * - * * * * *
in * - * * * * *
repression * repress * * * (V*) *
of * - * * * * *
lysU (DNA*) - * * * (A0* (A0*)
expression * express * * * *) (V*)
. * - * * * * *

The * - *
control * - *
of * - *
uvrB * - *
was * - *
found * - *
to * - *
result * - *
from * - *
direct * - (A5*)
repression * repress (V*)
by * - *
the (PTE* - (A1*
lexA * - *
gene * - *
product *) - *)
, * - *
with * - *
the * - *
recA * - *
gene * - *
product * - *
playing * - *
an * - *
indirect * - *
role * - *
. (DNA*) - *

Anaerobic * - (A5*)
induction * induce (V*)
of * - *
hya (PRC* - (A0*
expression *) - *)
was * - *
dependent * - *
on * - *
the * - (A3*
ArcA * - *
and * - *
AppY * - *
regulators * - *)
, * - *
which * - *
confirms * - *
earlier * - *
observations * - *
by * - *
other * - *
authors * - *
. * - *

Under * - *
the * - *
conditions * - *
examined * - *
, * - *
neither * - *
BD73 (PTE* - (A1*
nor * - *
Rev-Erb *) - *)
activated * activate (V*)
reporters (DNA*) - (A0*)
containing * - *
multiple * - *
copies * - *
of * - *
their * - *
common * - *
binding * - *
site * - *
. * - *

SNURF (PTE*) - (A0*)
is * - *
capable * - *
of * - *
interacting * interact (V*)
in * - (A5*
vitro * - *)
with * - *
the * - (A0*
TATA-binding * - *
protein * - *)
, * - *
and * - *
the (PTE* - (A3*
RING * - *
finger * - *
domain *) - *)
is * - *
needed * - *
for * - *
this * - *
interaction * - *
. * - *

In * - *
the * - (A3*
presence * - *
of * - *
meAda * - *)
, * - *
levels * - (A0*
of * - *
transcription * - *)
by * - *
both * - *
forms * - *
of * - *
RNA * - *
polymerase * - *
are * - *
significantly * - *
increased * increase (V*)
. (PRC*) - *

These * - *
results * - *
suggested * - *
that * - *
RFP (PTE*) - (A0*)
may * - *
be * - *
involved * involve (V*)
in * - *
the * - (A4*
epigenetic * - *
gene * - *
silencing * - *
mechanism * - *)
cooperating * - *
with * - *
Polycomb * - *
group * - *
proteins * - *
and * - *
that * - *
EPC * - *
is * - *
a * - *
unique * - *
molecule * - *
with * - *
both * - *
repressive * - *
and * - *
transactivating * - *
activities * - *
. * - *

A * - *
redox * - *
factor * - *
protein * - *
, * - *
ref1 (PTE*) - *
, * - *
is * - *
involved * - *
in * - *
negative * - (A5*)
gene (DNA*) - (A0*)
regulation * regulation (V*)
by * - *
extracellular (EXP* - (A1*
calcium *) - *)
. * - *

In * - * *
contrast * - * *
, * - * *
the (PTE* - * (A1*
FIS * - * *
protein *) - * *)
, * - * *
one * - * *
of * - * *
the * - * *
major * - * *
positive * - * *
regulators * - * *
of * - * *
the * - * *
stable * - * *
RNA * - * *
operons * - * *
, * - * *
stimulated * - * *
the * - * *
transcription * transcription (V*) *
of * - * *
the (DNA* - (A0* *
hupA * - * *
gene *) - *) *
, * - * *
whereas * - * *
it * - * *
repressed * repress * (V*)
that * - * *
of * - * *
the (DNA* - * (A0*
hupB * - * *
gene *) - * *)
. * - * *

The * - * * * *
multidrug * - * * * *
resistance * - * * * *
in * - * * * *
an * - * * * *
acrB * - * * * *
deletion * - * * * *
mutant * - * * * *
caused * - * * * *
by * - * * * *
EvgA (PTE*) - (A0*) * * *
overexpression * overexpression (V*) * * *
was * - * * * *
completely * - * * * *
abolished * - * * * *
by * - * * * *
deletion * delete * (V*) * *
of * - * * * *
yhiUV (DNA*) - * (A0*) * *
, * - * * * *
while * - * * * *
the * - * * * *
emrKY (DNA*) - * * (A0*) *
deletion * delete * * (V*) *
had * - * * * *
no * - * * * *
effect * - * * * *
on * - * * * *
the * - * * * *
increase * - * * * *
in * - * * * *
resistance * - * * * *
by * - * * * *
EvgA (PTE*) - * * * (A0*)
overexpression * overexpression * * * (V*)
. * - * * * *

Unexpectedly * - * *
, * - * *
RFX3 (PTE*) - (A0*) (A1*)
, * - * *
which * - * *
is * - * *
abundantly * - (A5*) *
expressed * express (V*) *
in * - * *
neuronal (ORG* - (A2* *
cells *) - *) *
, * - * *
down-regulated * down-regulated * (V*)
the * - * (A0*
transactivity * - * *)
as * - * *
well * - * *
, * - * *
when * - * *
it * - * *
was (PRC* - * *
expressed *) - * *
in * - * *
non-neuronal (ORG* - * *
cells *) - * (A3*)

The (PTE* - (A1* (A1*
NarL * - * *
protein *) - *) *)
also * - * *
binds * bind (V*) *
to * - * *
these (DNA* - (A7* *
7-2-7 * - * *
sites *) - *) *
but * - * *
, * - * *
unlike * - * *
NarP * - * *
, * - * *
also * - * *
recognizes * recognize * (V*)
heptamers (DNA* - * (A0*
in * - * *
other * - * *
arrangements *) - * *)
. * - * *

hIre1p (DNA*) - (A0*) (A0*)
expressed * express (V*) *
in * - (A2* *
mammalian (ORG* - * *
cells *) - *) *
displayed * display * (V*)
intrinsic * - * (A4*
autophosphorylation * - * *
activity * - * *)
and * - * *
an * - * *
endoribonuclease (PTE*) - * *
activity * - * *
that * - * *
cleaved * - * *
the * - * *
5' * - * *
splice * - * *
site * - * *
of * - * *
yeast * - * *
HAC1 * - * *
mRNA * - * *
, * - * *
a * - * *
substrate * - * *
for * - * *
the * - * *
endoribonuclease * - * *
activity * - * *
of * - * *
yeast * - * *
Ire1p * - * *
. * - * *

The (DNA* - (A0*
CRP * - *
sites *) - *)
were * - *
centered * center (V*)
at * - (A2*
37 (DNA* - *
. * - *
5 * - *
and * - *
60 * - *
. * - *
5 * - *
base * - *
pairs *) - *
upstream * - *
of * - *
the * - *
start * - *
of * - *
transcription * - *)
. * - *

The (DNA* - (A1* * *
region *) - *) * *
within * - * * *
the (DNA* - * * *
Pa * - * * *
and * - * * *
Pz * - * * *
promoters *) - * * *
that * - * * *
is * - * * *
protected * protect (V*) * *
by * - * * *
the (PTE* - (A0* * *
PaaX * - * * *
repressor *) - *) * *
in * - * * *
DNase * - * * *
I * - * * *
footprinting * - * * *
assays * - * * *
contains * - * * *
a * - * * *
conserved * - * * *
15-base * - * * *
pair * - * * *
imperfect * - * * *
palindromic * - * * *
sequence * - * * *
motif * - * * *
that * - * * *
was * - * * *
shown * - * * *
, * - * * *
through * - * * *
mutational * - * * *
analysis * - * * *
, * - * * *
to * - * * *
be * - * * *
indispensable * - * * *
for * - * * *
PaaX (PTE*) - * (A1*) (A1*)
binding * bind * (V*) *
and * - * * *
repression * repress * * (V*)
. * - * * *

We * - * *
show * - * *
that * - * *
nanC (DNA*) - (A0*) (A0*)
expression * express (V*) *
is * - * *
induced * - * *
by * - * *
N-acetylneuraminic * - * *
acid * - * *
and * - * *
modulated * modulate * (V*)
by * - * *
N-acetylglucosamine (PTE*) - * (A1*)
. * - * *

Although * - * *
both * - * *
start * - * *
sites * - * *
are * - * *
NarL * - * *
repressible * - * *
in * - * *
the * - * *
presence * - * *
of * - * *
nitrate * - * *
, * - * *
Fnr (PTE*) - (A1*) *
activates * activate (V*) *
only (DNA* - (A0* *
the * - * *
-188 * - * *
start * - * *
site *) - *) *
and * - * *
Fis (PTE*) - * *
is * - * *
required * - * *
for * - * *
the * - * *
transcription * transcription * (V*)
of * - * *
only (DNA* - * (A0*
the * - * *
-292 * - * *
start * - * *
site *) - * *)
. * - * *

The (DNA* - (A1*
yeiL * - *
open * - *
reading * - *
frame *) - *)
located * - *
at * - *
48 * - *
. * - *
5 * - *
min * - *
( * - *
2254 * - *
kb * - *
) * - *
in * - *
the * - *
nfo-fruA * - *
region * - *
of * - *
the * - *
Escherichia * - *
coli * - *
chromosome * - *
was * - *
predicted * - *
to * - *
encode * encode (V*)
a (PTE* - (A0*
CRP * - *
and * - *
FNR * - *
paralogue *) - *)
capable * - *
of * - *
forming * - *
inter- * - *
or * - *
intra-molecular * - *
disulphide * - *
bonds * - *
and * - *
incorporating * - *
one * - *
iron-sulphur * - *
centre * - *
per * - *
25 * - *
kDa * - *
subunit * - *
. * - *

The (DNA* - (A0* (A0*
three * - * *
most * - * *
upstream * - * *
rot * - * *
promoters *) - *) *)
are * - * *
activated * activate (V*) *
by * - * *
the (PTE* - (A1* *
global * - * *
gene * - * *
regulatory * - * *
cAMP-CRP * - * *
complex *) - *) *
and * - * *
negatively * - * (A5*)
regulated * regulate * (V*)
by * - * *
the (PTE* - * (A1*
CytR * - * *
repressor * - * *
protein *) - * *)
. * - * *

Transcriptional * - (A5*) *
regulation * regulation (V*) *
of * - * *
the (DNA* - (A0* (A1*
sodA * - * *
gene *) - *) *)
, * - * *
a * - * *
member * - * *
of * - * *
the * - * *
soxRS * - * *
regulon * - * *
encoding * encode * (V*)
the * - * *
manganese-containing * - * *
superoxide * - * *
dismutase * - * *
( * - * *
MnSOD (PTE*) - * (A0*)
; * - * *
superoxide * - * *
: * - * *
superoxide * - * *
oxidoreductase * - * *
, * - * *
EC * - * *
1 * - * *
. * - * *
15 * - * *
. * - * *
1 * - * *
. * - * *
1 * - * *
) * - * *
of * - * *
Escherichia * - * *
coli * - * *
, * - * *
was * - * *
examined * - * *
in * - * *
a * - * *
variety * - * *
of * - * *
regulatory * - * *
mutants * - * *
. * - * *

In * - * *
contrast * - * *
, * - * *
mutations (PRC*) - (A0*) *
introduced * introduce (V*) *
into * - (A2* *
the (DNA* - * *
putative * - * *
IHF-binding * - * *
elements *) - *) *
increased * - * *
the * - * *
level * - * *
of * - * *
hpt * - * (A0*)
expression * express * (V*)
. * - * *

These (DNA* - (A0* *
sequences *) - *) *
are * - * *
recognized * recognize (V*) *
by * - * *
at * - * *
least * - * *
three * - * *
regulators * - * *
, * - * *
Gal * - * *
repressor * - * *
( * - * *
GalR (PTE*) - (A1*) *
) * - * *
, * - * *
Gal * - * *
isorepressor * - * *
( * - * *
GalS (PTE*) - * *
) * - * *
and * - * *
cAMP * - * *
receptor * - * *
protein * - * *
( * - * *
CRP (PTE*) - * *
) * - * *
, * - * *
which * - * *
modulate * - * *
transcription * transcription * (V*)
from * - * *
these (DNA* - * (A6*
promoters *) - * *)
. * - * *

A * - *
model * - *
is * - *
proposed * - *
for * - *
the * - *
transcriptional * - (A5*)
regulation * regulation (V*)
of * - *
the (DNA* - (A0*
inversely * - *
oriented * - *
hyp * - *
and * - *
hyc * - *
operons *) - *)
. * - *

Expression * express (V*) *
of * - * *
narL (DNA*) - (A0*) *
does * - * *
not * - * *
require * - * *
the (PTE* - * *
fnr * - * *
gene * - * *
product *) - * *
, * - * *
a * - * *
pleiotropic * - * *
activator * - * *
that * - * *
is * - * *
required * - * *
for * - * *
full * - * *
expression * express * (V*)
of * - * *
narC (DNA*) - * (A0*)
, * - * *
frd (DNA*) - * *
, * - * *
and * - * *
tor (DNA*) - * *
. * - * *

In * - * *
fact * - * *
, * - * *
the * - * *
acid * - (A1*) *
induction * induce (V*) *
of * - * *
gadA (DNA*) - (A0*) *
and * - * *
gadBC (DNA*) - * *
observed * - * *
when * - * *
rich-medium * - * *
cultures * - * *
enter * - * *
stationary * - * *
phase * - * *
corresponds * - * *
to * - * *
the * - * *
acid * - * *
induction * - * *
of * - * *
sigma (PTE* - * (A0*
S *) - * *)
production * produce * (V*)
. * - * *

Both * - * *
the * - * *
pseudo-HPr (PTE*) - (A0*) *
suppressor * - (A5*) *
mutations * mutations (V*) *
at * - (A2* *
3 (DNA* - * *
min *) - *) *
and * - * *
the (PRC* - * (A0*
deletion *) - * *)
extending * extend * (V*)
from * - * *
leu (DNA*) - * (A6*)
had * - * *
an * - * *
additional * - * *
phenotype * - * *
. * - * *

Therefore * - *
, * - *
multiple * - *
systems * - *
( * - *
EnvZ/OmpR * - *
, * - *
Cpx * - *
, * - *
Rcs * - *
, * - *
and * - *
H-NS * - *
) * - *
appear * - *
to * - *
be * - *
involved * - *
in * - *
sensing * - *
environmental * - *
osmolarity * - *
, * - *
leading * - *
to * - *
sophisticated * - *
regulation * regulation (V*)
of * - *
the (DNA* - (A0*
curli * - *
genes *) - *)
. * - *

Our * - *
results * - *
show * - *
that * - *
the * - *
nir * - *
promoter * - *
contains * - *
a * - *
second * - *
IHF * - *
site * - *
at * - *
position * - *
-115 * - *
( * - *
IHF * - *
II * - *
) * - *
and * - *
a * - *
third * - *
Fis * - *
site * - *
at * - *
position * - *
-97 * - *
( * - *
Fis * - *
III * - *
) * - *
, * - *
and * - *
that * - *
IHF (PTE* - (A1*
, * - *
Fis * - *
and * - *
FNR *) - *)
can * - *
bind * bind (V*)
together * - *
to * - *
form * - *
multiprotein (PTE* - (A11*
complexes *) - *)
. * - *

The (DNA* - (A0* *
divergent * - * *
malEFG * - * *
and * - * *
malK-lamB-malM * - * *
operons *) - *) *
in * - (A2* *
Escherichia (ORG* - * *
coli *) - *) *
are * - * *
controlled * control (V*) *
by * - * *
partially (DNA* - (A1* *
overlapping * - * *
promoters *) - *) *
, * - * *
whose * - * (A1*
activity * - * *)
depends * depend * (V*)
on * - * *
the * - * *
presence * - * *
of * - * *
two * - * *
transcriptional * - * *
activators * - * *
, * - * *
MalT (PTE*) - * (A0*)
and * - * *
the * - * *
cAMP * - * *
receptor * - * *
protein * - * *
( * - * *
CRP (PTE*) - * *
) * - * *
. * - * *

CRP-cAMP (PTE*) - (A1*)
inhibits * inhibit (V*)
sigma * - *
( * - *
54 * - *
) * - *
-dependent * - *
glnAp2 (DNA*) - (A0*)
strongly * - *
, * - *
by * - *
21-fold * - (A9*)
. * - *

It * - *
thus * - *
appears * - *
that * - *
the * - *
effectiveness * - *
of * - *
specific * - *
metal * - *
cations * - *
to * - *
act * - *
as * - *
corepressors * - *
with * - *
Fur * - *
varies * - *
with * - *
the (DNA* - (A0*
gene *) - *)
being * - *
regulated * regulate (V*)
by * - *
the (PTE* - (A1*
Fur-metal * - *
complex *) - *)
. * - *

It * - *
was * - *
found * - *
that * - *
the * - *
TCA * - *
cycle * - *
genes * - *
, * - *
icd (DNA*) - (A0*)
, * - *
gltA (DNA*) - *
, * - *
sucC (DNA*) - *
, * - *
and * - *
sdhC (DNA*) - *
are * - *
repressed * repress (V*)
by * - *
ArcA (DNA*) - (A1*)
while * - *
Fnr * - *
has * - *
a * - *
minor * - *
or * - *
no * - *
effect * - *
on * - *
the * - *
expression * - *
of * - *
these * - *
genes * - *
under * - *
microaerobic * - *
conditions * - *
. * - *

marR (PRC* - (A1* (A1* (A1* *
mutations *) - *) *) *) *
that * - * * * *
elevate * elevate (V*) * * *
marRAB * - (A0* * * *
transcription * - *) * * *
and * - * * * *
engender * engender * (V*) * *
multiple * - * (A0* * *
antibiotic * - * * * *
resistance * - * *) * *
elevated * elevate * * (V*) *
inaA (DNA*) - * * (A0* (A0*)
expression * express * * *) (V*)
by * - * * * *
10- * - * * (A9* *
to * - * * * *
20-fold * - * * *) *
over * - * * * *
that * - * * * *
of * - * * * *
the * - * * * *
wild-type * - * * * *
. (PRC*) - * * * *

Results * - * *
indicate * - * *
that * - * *
the * - * *
downstream * - * *
promoter * - * *
( * - * *
P1 * - * *
) * - * *
was * - * *
responsible * - * *
for * - * *
Fnr- * - * *
and * - * *
NarP-regulated (PTE*) - (A5*) *
napF (DNA* - (A0* *
operon *) - *) *
expression * express (V*) *
, * - * *
whereas * - * *
transcription * transcription * (V*)
from * - * *
the * - * *
upstream * - * *
promoter * - * *
( * - * *
P2 (DNA*) - * (A6*)
) * - * *
was * - * *
activated * - * *
only * - * *
weakly * - * *
by * - * *
the (PTE* - * *
Fnr * - * *
protein *) - * *
and * - * *
was * - * *
inhibited * - * *
by * - * *
phospho-NarP (PTE* - * *
and * - * *
-NarL * - * *
proteins *) - * *
. * - * *

EZH1 (DNA*) - (A0*)
is * - *
expressed * express (V*)
as * - *
two (DNA* - (A4*
major * - *
transcripts *) - *)
in * - (A2*
all (ORG* - *
adult * - *
and * - *
fetal * - *
human * - *
tissues *) - *)
surveyed * - *
; * - *
comparison * - *
of * - *
cloned * - *
cDNAs * - *
suggests * - *
that * - *
alternative * - *
splicing * - *
may * - *
account * - *
for * - *
at * - *
least * - *
part * - *
of * - *
the * - *
transcript * - *
size * - *
difference * - *
. * - *

Aldehyde (PTE* - (A0*
reductase *) - *)
thus * - *
becomes * - *
the * - *
fourth * - *
protein-encoding * - *
gene * - *
regulated * regulate (V*)
by * - *
STAF (PTE*) - (A1*)
. * - *

In * - (A2* (A2*
Escherichia (ORG* - * *
coli *) - *) *)
the (DNA* - (A1* (A1*
ompF * - * *
gene *) - *) *)
encodes * encode (V*) *
a (PTE* - (A0* *
major * - * *
outer * - * *
membrane * - * *
porin * - * *
protein *) - *) *
that * - * *
is * - * *
differentially * - * *
regulated * regulate * (V*)
by * - * *
the (PTE* - * (A0*
OmpR * - * *
protein *) - * *)
. * - * *

Isolation * - *
from * - *
Klebsiella * - *
and * - *
characterization * - *
of * - *
two (DNA* - (A1*
rcs * - *
genes *) - *)
that * - *
activate * activate (V*)
colanic * - (A0*
acid * - *
capsular * - *
biosynthesis * - *)
in * - (A2*
Escherichia (ORG* - *
coli *) - *)
. * - *

The * - *
transcription * transcription (V*)
of * - *
the (DNA* - (A0*
corresponding * - *
structural * - *
genes *) - *)
is * - *
activated * - *
by * - *
the * - *
DcuS-DcuR * - *
two-component * - *
system * - *
in * - *
response * - *
to * - *
fumarate * - *
or * - *
its * - *
dicarboxylate * - *
precursors * - *
. * - *

Lack * lack (V*) * *
of * - * * *
either * - (A0* * *
of * - * * *
the * - * * *
two * - * * *
sets * - *) * *
of * - * * *
operators * - * * *
partially * - * * *
relieved * - * * *
the * - * * *
repression (PRC*) repress * (V*) (A0*)
of * - * * *
the * - * (A0* *
other * - * * *
operon * - * *) *
; * - * * *
thus * - * * *
, * - * * *
each (DNA* - * * (A1*
promoter *) - * * *)
is * - * * *
dependent * - * * *
on * - * * *
the * - * * *
UlaR * - * * *
operator * - * * *
sites * - * * *
of * - * * *
the * - * * *
other * - * * *
promoter * - * * *
to * - * * *
enhance * enhance * * (V*)
repression * - * * *
. * - * * *

Inducible * - (A5*)
overexpression * overexpression (V*)
of * - *
the (DNA* - (A0*
Escherichia * - *
coli * - *
gal * - *
operon *) - *)
in * - *
the * - *
absence * - *
of * - *
the (PTE* - (A3*
Gal * - *
repressor *) - *)
is * - *
known * - *
as * - *
ultrainduction * - *
. * - *

ptsG (DNA* - (A0*
P2 *) - *)
transcription * transcription (V*)
was * - *
inhibited * - *
by * - *
Fis (PTE* - *
and * - *
Mlc *) - *
. * - *

A * - * * *
previously * - * * *
described * - * * *
mutation * mutation (V*) * *
in * - (A2*) * *
a * - * * *
leucine-responsive * - * * *
trans-acting * - * * *
factor * - * * *
, * - * * *
LivR (PTE*) - * * *
( * - * * *
J * - * * *
. * - * * *
J * - * * *
. * - * * *
Anderson * - * * *
, * - * * *
S * - * * *
. * - * * *
C * - * * *
. * - * * *
Quay * - * * *
, * - * * *
and * - * * *
D * - * * *
. * - * * *
L * - * * *
. * - * * *
Oxender * - * * *
, * - * * *
J * - * * *
. * - * * *
Bacteriol * - * * *
. * - * * *
126 * - * * *
: * - * * *
80-90 * - * * *
, * - * * *
1976 * - * * *
) * - * * *
, * - * * *
resulted * - * * *
in * - * * *
constitutively (PRC* - * (A5* *
repressed *) - * *) *
expression * express * (V*) *
from * - * * *
the (DNA* - * (A6* *
tdh * - * * *
promoter *) - * *) *
and * - * * *
constitutively (PRC* - * * (A5*
induced *) - * * *)
expression * express * * (V*)
from * - * * *
the (DNA* - * * (A6*
serA * - * * *
promoter *) - * * *)
. * - * * *

It * - *
was * - *
found * - *
that * - *
minichromosomes (DNA*) - (A1*)
possessing * possess (V*)
a * - (A0*
deletion * - *)
in * - *
the (DNA* - (A2*
DnaA * - *
box *) - *)
upstream * - *
of * - *
the * - *
promoter * - *
transcribed * - *
mioC * - *
continuously * - *
and * - *
replicated * - *
with * - *
the * - *
same * - *
timing * - *
as * - *
those * - *
that * - *
either * - *
shut * - *
down * - *
expression * - *
prior * - *
to * - *
initiation * - *
or * - *
lacked * - *
expression * - *
entirely * - *
. * - *

Previous * - * *
studies * - * *
with * - * *
Salmonella * - * *
enterica * - * *
serovar * - * *
Typhimurium * - * *
LT2 * - * *
demonstrated * - * *
that * - * *
transcriptional * - * *
activation * activate (V*) *
of * - * *
the (DNA* - (A0* *
prpBCDE * - * *
operon *) - *) *
requires * - * *
the * - * *
function * function * (V*)
of * - * *
transcription (PTE* - * (A0*
factor * - * *
PrpR * - * *
, * - * *
sigma-54 * - * *
, * - * *
and * - * *
IHF * - * *
. *) - * *)

Transduction * transduce (V*)
of * - *
the (DNA* - (A0*
marA * - *
region *) - *)
from * - *
a (None* - (A6*
Mar * - *
strain *) - *)
, * - *
but * - *
not * - *
a * - *
wild-type * - *
strain * - *
, * - *
led * - *
to * - *
loss (DNA* - *
of * - *
OmpF *) - *
. * - *

In * - * *
this * - * *
study * - * *
, * - * *
the * - * *
regulation * regulation (V*) *
of * - * *
the (DNA* - (A0* (A0*
glc * - * *
operon *) - *) *)
, * - * *
comprising * compose * (V*)
the (DNA* - * (A4*
structural * - * *
genes * - * *
glcDEFGB *) - * *)
, * - * *
was * - * *
analyzed * - * *
at * - * *
the * - * *
molecular * - * *
level * - * *
. * - * *

fruR (DNA*) - (A1*)
probably * - *
codes * code (V*)
for * - *
a (PTE* - (A0*
repressor *) - *)
of * - *
the * - *
fru * - *
operon * - *
. * - *

The (DNA* - (A1* * * *
gal * - * * * *
operon *) - *) * * *
encoding * encode (V*) * * *
the (PTE* - (A0* * * *
enzymes *) - *) * * *
for * - * * * *
galactose * - * * * *
metabolism * - * * * *
has * - * * * *
two (DNA* - * (A0* * *
promoters *) - * *) * *
regulated * regulate * (V*) * *
by * - * * * *
CRP (PTE*) - * (A1*) * *
in * - * * * *
opposite * - * * * *
ways * - * * * *
; * - * * * *
one * - * * * *
( * - * * * *
P1 (DNA*) - * * (A0*) *
) * - * * * *
is * - * * * *
stimulated * stimulate * * (V*) *
and * - * * * *
the * - * * * *
other * - * * * *
( * - * * * *
P2 (DNA*) - * * * (A0*)
) * - * * * *
inhibited * inhibit * * * (V*)
by * - * * * *
CRP (PTE*) - * * (A1*) (A1*)
. * - * * * *

With * - * *
linear * - * *
templates * - * *
, * - * *
cAMP-CRP (PTE*) - (A1*) *
significantly * - * *
stimulates * stimulate (V*) *
E (PRC* - (A0* *
sigma * - * *
s-mediated * - * *
in * - * *
vitro * - * *
transcription *) - *) *
, * - * *
whereas * - * *
transcription (PRC*) - * (A0*)
by * - * *
E * - * *
sigma * - * *
70 * - * *
is * - * *
negligible * - * *
and * - * *
hardly * - * *
stimulated * stimulate * (V*)
by * - * *
cAMP-CRP (PTE*) - * (A1*)
. * - * *

This * - *
induction * - *
was * - *
soxRS * - *
dependent * - *
and * - *
not * - *
mar * - *
dependent * - *
, * - *
whereas * - *
induction * induce (V*)
of * - *
inaA (DNA*) - (A0*)
by * - *
salicylate (EXP*) - (A1*)
was * - *
not * - *
dependent * - *
on * - *
soxRS * - *
. * - *

In * - * * *
addition * - * * *
, * - * * *
deletion * delete (V*) * *
of * - * * *
the * - * * *
distal * - * * *
tor * - * * *
box * - * * *
( * - * * *
box1 (DNA*) - (A0*) * *
) * - * * *
abolishes * - * * *
torC (DNA*) - * (A0*) *
induction * induce * (V*) *
whereas * - * * *
the * - * * *
presence * - * * *
of * - * * *
a * - * * *
DNA * - * * *
fragment * - * * *
starting * - * * *
three * - * * *
bases * - * * *
upstream * - * * *
from * - * * *
box1 * - * * *
suffices * - * * *
for * - * * *
normal * - * * *
torC (DNA*) - * * (A0*)
expression * express * * (V*)
. * - * * *

Northern * - *
blot * - *
analysis * - *
reveals * - *
that * - *
BNIP3alpha (DNA*) - (A0*)
is * - *
expressed * express (V*)
ubiquitously * - (A5*)
in * - (A2*
most (ORG* - *
human * - *
tissues *) - *)
. * - *

A (DNA* - (A0*
binding * - *
site *) - *)
for * - *
DnaA * - *
protein * - *
was * - *
identified * identify (V*)
in * - (A2*
the * - *
regulatory * - *
region * - *)
of * - *
the * - *
aldA * - *
gene * - *
of * - *
Escherichia * - *
coli * - *
. * - *

FIS * - *
activated * - *
rnpB (DNA*) - (A0*)
transcription * transcription (V*)
in * - *
vitro * - *
, * - *
but * - *
the * - *
level * - *
of * - *
activation * - *
was * - *
much * - *
lower * - *
than * - *
that * - *
of * - *
the * - *
rrnB * - *
promoter * - *
for * - *
rRNA * - *
. * - *

It * - *
was * - *
concluded * - *
that * - *
expression * express (V*)
of * - *
the (DNA* - (A0*
uxuR * - *
gene *) - *)
itself * - *
is * - *
repressed * - *
by * - *
its (PTE* - *
own * - *
product *) - *
. * - *

Activation * activate (V*) *
of * - * *
these (DNA* - (A0* *
three * - * *
promoters *) - *) *
occurs * - * *
by * - * *
binding * bind * (V*)
of * - * *
cAMP-CRP (PTE*) - * (A1*)
to * - * *
two (DNA* - * (A7*
sites *) - * *)
separated * - * *
by * - * *
53 * - * *
bp * - * *
. * - * *

The (PRC* - (A1*
increased * - *
activity *) - *)
of * - *
both * - *
promoters * - *
required * require (V*)
the * - *
presence * - *
of * - *
the (DNA* - (A0*
relA * - *
and * - *
spoT * - *
genes *) - *)
, * - *
suggesting * - *
that * - *
ppGpp * - *
plays * - *
a * - *
major * - *
role * - *
in * - *
the * - *
response * - *
to * - *
stationary * - *
phase * - *
. * - *

This * - * * *
latter * - * * *
result * - * * *
indicated * - * * *
that * - * * *
ArcA (PTE*) - * * *
suppresses * - * * *
anaerobic * - (A3*) * *
hyb * - (A0*) * *
expression * express (V*) * *
and * - * * *
that * - * * *
a * - * * *
further * - * * *
factor * - * * *
, * - * * *
which * - * * *
remains * - * * *
to * - * * *
be * - * * *
identified * - * * *
, * - * * *
is * - * * *
involved * - * * *
in * - * * *
controlling * - * * *
anaerobic * - * (A3*) *
induction * induce * (V*) *
of * - * * *
operon (PRC* - * (A0* (A0*)
expression *) express * *) (V*)
. * - * * *

We * - *
therefore * - *
propose * - *
that * - *
Crl (PTE*) - (A1*)
is * - *
a * - *
second * - *
thermosensor * - *
, * - *
besides * - *
DsrA * - *
, * - *
controlling * control (V*)
sigma * - *
( * - *
S * - *
) * - *
activity * - (A0*)
. * - *

inaA (DNA*) - (A0*
expression * - *)
was * - *
estimated * estimate (V*)
from * - *
the * - (A4*
beta-galactosidase * - *
activity * - *)
of * - *
a * - *
chromosomal * - *
inaA1 * - *
: * - *
: * - *
lacZ * - *
transcriptional * - *
fusion * - *
. (PTE*) - *

Footprinting * - * * *
experiments * - * * *
with * - * * *
various * - * * *
probes * - * * *
and * - * * *
transcription * - * * *
assays * - * * *
revealed * - * * *
that * - * * *
Fis (PTE*) - * * *
assists * - * * *
both * - * * *
Mlc (PTE*) - (A0*) * *
repression * repress (V*) * *
and * - * * *
CRP (PTE* - * (A1* *
. * - * * *
cAMP *) - * *) *
activation * activate * (V*) *
of * - * * *
ptsG (DNA* - * (A0* *
P1 *) - * *) *
through * - * * *
the * - * * *
formation * form * * (V*)
of * - * * *
Fis (PTE* - * * (A0*
. * - * * *
CRP * - * * *
. * - * * *
Mlc * - * * *
or * - * * *
Fis * - * * *
. * - * * *
CRP * - * * *
nucleoprotein * - * * *
complexes *) - * * *)
at * - * * (A2*
ptsG (DNA* - * * *
P1 * - * * *
promoter *) - * * *)
depending * - * * *
on * - * * *
the * - * * (A3*
availability * - * * *
of * - * * *
glucose * - * * *)
in * - * * *
the * - * * *
growth * - * * *
medium * - * * *
. (EXP*) - * * *

In * - *
primary * - *
Sertoli * - *
cells * - *
, * - *
the * - *
orphan * - *
nuclear * - *
receptor * - *
, * - *
steroidogenic * - *
factor * - *
1 * - *
( * - *
SF-1 (PTE*) - (A1*)
) * - *
, * - *
regulates * - *
the (DNA* - *
MIS * - *
gene *) - *
by * - *
binding * bind (V*)
to * - *
a (DNA* - (A7*
conserved * - *
upstream * - *
regulatory * - *
element *) - *)
. * - *

Thus * - *
, * - *
gluconate * - *
is * - *
both * - *
an * - *
inducer * - *
and * - *
a * - *
repressor * - *
of * - *
gntT (DNA*) - (A0*)
expression * express (V*)
since * - *
gluconate * - *
is * - *
a * - *
catabolite-repressing * - *
sugar * - *
. * - *

In * - *
parallel * - *
, * - *
the * - *
location * - *
of * - *
the * - *
C-terminal * - *
domain * - *
of * - *
the * - *
RNA * - *
polymerase * - *
alpha * - *
subunit * - *
( * - *
alphaCTD * - *
) * - *
on * - *
DNA * - *
is * - *
shifted * - *
close * - *
to * - *
the * - *
IclR * - *
box * - *
I * - *
, * - *
indicating * - *
that * - *
direct * - (A5*)
interaction * interact (V*)
between * - *
the (PTE* - (A1*
alphaCTD *) - *)
and * - *
the (PTE* - (A1*
IclR * - *
box * - *
I-associated * - *
IclR *) - *)
caused * - *
the (PRC* - *
repression *) - *
. * - *

The (PTE* - (A1* *
cAMP-CRP * - * *
complex *) - *) *
and * - * *
the (PTE* - * *
CytR * - * *
anti-activator *) - * *
bind * bind (V*) *
co-operatively * - (A5*) *
to * - * *
the (DNA* - (A7* *
promoter * - * *
region *) - *) *
forming * form * (V*)
a (PTE* - * (A0*
repression * - * *
complex *) - * *)
that * - * *
overlaps * - * *
the * - * *
sigmaE-dependent * - * *
P3 * - * *
promoter * - * *
and * - * *
the * - * *
sigma70-dependent * - * *
P4 * - * *
and * - * *
P5 * - * *
promoters * - * *
. * - * *

In * - *
contrast * - *
, * - *
the * - *
Fnr-1 * - *
site * - *
has * - *
an * - *
auxiliary * - *
role * - *
in * - *
the * - *
anaerobic * - (A5*)
repression * repress (V*)
of * - *
P1 (DNA*) - (A0*)
, * - *
but * - *
not * - *
of * - *
P2 * - *
. * - *

However * - *
, * - *
in * - *
the * - *
absence * - *
of * - *
FNR (PTE*) - *
, * - *
ndh (DNA*) - (A0*)
expression * express (V*)
is * - *
activated * - *
by * - *
the * - *
amino * - *
acid * - *
response * - *
regulator * - *
( * - *
Arr (PTE*) - *
) * - *
during * - *
anaerobic * - *
growth * - *
in * - *
rich * - *
medium * - *
. * - *

Nitrate * - *
repression * - *
of * - *
hyb * - (A0*)
expression * express (V*)
was * - *
mediated * - *
by * - *
the * - *
NarL/NarX * - *
and * - *
NarP/NarQ * - *
two-component * - *
regulatory * - *
systems * - *
. * - *

Oxidized (EXP* - *
LDL *) - *
regulates * - *
macrophage * - (A0*
gene * - *)
expression * express (V*)
through * - *
ligand * - *
activation * - *
of * - *
PPARgamma * - *
. * - *

All (DNA* - * (A0* (A0*
three * - * * *
promoters *) - * *) *)
had * - * * *
elevated * elevate (V*) * *
activity (PRC*) - (A0*) * *
in * - * * *
the * - * * *
presence * - * * *
of * - * * *
N-acetylgalactosamine (EXP* - (A3* * *
or * - * * *
galactosamine *) - *) * *
, * - * * *
were * - * * *
regulated * regulate * (V*) *
in * - * (A5* *
vivo * - * *) *
by * - * * *
AgaR (PTE*) - * (A1*) *
and * - * * *
possessed * possess * * (V*)
specific (DNA* - * * (A4*
DNA-binding * - * * *
sites *) - * * *)
for * - * * *
AgaR * - * * *
upstream * - * * (A2*
from * - * * *
the * - * * *
start * - * * *
sites * - * * *)
of * - * * *
transcription * - * * *
as * - * * *
determined * - * * *
by * - * * *
DNase * - * * *
I * - * * *
footprinting * - * * *
. * - * * *

Such * - *
T7 * - *
vector * - *
constructs * - *
thus * - *
have * - *
two * - *
especially * - *
useful * - *
properties * - *
: * - *
first * - *
, * - *
they * - *
provide * - *
a * - *
means * - *
for * - *
the * - *
high-level * - *
production * produce (V*)
of * - *
various (PTE* - (A0*
proteins *) - *)
in * - (A2*
E (ORG* - *
. * - *
coli *) - *)
; * - *
second * - *
, * - *
they * - *
offer * - *
a * - *
technically * - *
advantageous * - *
point * - *
of * - *
departure * - *
for * - *
structure-function * - *
studies * - *
of * - *
genes * - *
whose * - *
overexpression * - *
from * - *
multicopy * - *
plasmids * - *
would * - *
normally * - *
be * - *
cytotoxic * - *
. * - *

MAZ (PTE*) - (A1*) *
bound * bound (V*) *
specifically * - (A5*) *
to * - * *
the (DNA* - (A7* *
wild-type * - * *
ME1a1 * - * *
sequence *) - *) *
but * - * *
not * - * *
to * - * *
a * - * *
ME1a1 * - * *
mutant * - * *
that * - * *
also * - * *
failed * - * *
to * - * *
yield * yield * (V*)
P2 (PRC* - * (A0*
activity *) - * *)
. * - * *

Definition * - *
of * - *
nitrite * - *
and * - *
nitrate * - *
response * - *
elements * - *
at * - *
the * - *
anaerobically * - *
inducible * - *
Escherichia * - *
coli * - *
nirB * - *
promoter * - *
: * - *
interactions * interact (V*)
between * - *
FNR (PTE*) - (A1*)
and * - *
NarL (PTE*) - (A1*)
. * - *

Partial (EXP* - *
denaturing * - *
conditions * - *
and * - *
sucrose * - *
gradient * - *
sedimentation * - *
at * - *
high * - *
salt *) - *
result * - *
in * - *
the * - *
dissociation * dissociate (V*)
of * - *
a (PTE* - (A0*
subcomplex *) - *)
that * - *
includes * - *
hRPC32 * - *
, * - *
hRPC39 * - *
, * - *
and * - *
hRPC62 * - *
. * - *

Regulation * regulate (V*)
of * - *
the * - (A0*
ndh * - *
gene * - *)
of * - *
Escherichia * - *
coli * - *
by * - *
integration (PTE* - (A1*
host * - *
factor *) - *)
and * - *
a * - *
novel * - *
regulator * - *
, * - *
Arr (PTE*) - *
. * - *

Transcription * transcribe (V*)
of * - *
the (DNA* - (A0*
cps * - *
operon *) - *)
is * - *
controlled * - *
by * - *
at * - *
least * - *
two * - *
positive * - *
regulators * - *
, * - *
RcsA (PTE*) - *
and * - *
RcsB (PTE*) - *
. * - *

Because * - * *
hmp (DNA* - (A0* *
gene *) - *) *
transcription * transcription (V*) *
is * - * *
repressed * - * *
by * - * *
the (PTE* - * *
O * - * *
( * - * *
2 * - * *
) * - * *
-responsive * - * *
regulator * - * *
FNR *) - * *
, * - * *
we * - * *
investigated * - * *
whether * - * *
FNR (PTE*) - * (A1*)
also * - * *
senses * sense * (V*)
NO (EXP*) - * (A0*)
. * - * *

NagC (PTE* - (A1*
and * - *
Mlc *) - *)
can * - *
bind * bind (V*)
to * - *
each (DNA* - (A7*
others * - *
operator *) - *)
, * - *
at * - *
least * - *
in * - (A3*
vitro * - *)
. * - *

Adding * - * * * *
Stat1 (PTE*) - (A1*) (A1*) * *
increases * increase (V*) * * *
the * - (A0* * * *
affinity * - *) * * *
and * - * * * *
alters * alter * (V*) * *
the * - * (A0* * *
sequence * - * * * *
selectivity * - * *) * *
of * - * * * *
p48-DNA (PTE*) - * * (A1*) *
interactions * interact * * (V*) *
by * - * * * *
contacting * contact * * * (V*)
a * - * * * (A0*
half-site * - * * * *)
of * - * * * *
its * - * * * *
palindromic * - * * * *
recognition * - * * * *
motif * - * * * *
adjacent * - * * * *
to * - * * * *
a (DNA* - * * * (A7*
p48 * - * * * *
interaction * - * * * *
sequence *) - * * * *)
. * - * * * *

These (DNA* - *
changes *) - *
were * - *
completely * - *
reversed * - *
by * - *
insertion * insert (V*)
of * - *
marA (DNA* - (A0*
: * - *
: * - *
Tn5 *) - *)
. * - *

Requirement * - *
of * - *
RSF (PTE* - *
and * - *
FACT *) - *
for * - *
transcription * transcription (V*)
of * - *
chromatin (DNA* - (A0*
templates *) - *)
in * - (A3*
vitro * - *)
. * - *

These * - * * *
results * - * * *
establish * - * * *
the * - * * *
unconventional * - * * *
napF * - * * *
operon * - * * *
control * - * * *
region * - * * *
architecture * - * * *
, * - * * *
in * - * * *
which * - * * *
the (DNA* - (A0* * *
major * - * * *
promoter * - * * *
P1 *) - *) * *
is * - * * *
activated * activate (V*) * *
by * - * * *
the (PTE* - (A1* (A1* *
Fnr * - * * *
protein *) - *) *) *
bound * bound * (V*) *
to * - * * *
a (DNA* - * (A7* (A7*
site *) - * *) *)
centered * - * * *
at * - * * *
-64 * - * * *
. * - * * *
5 * - * * *
with * - * * *
respect * - * * *
to * - * * *
the * - * * *
transcription * - * * *
initiation * - * * *
site * - * * *
, * - * * *
working * - * * *
in * - * * *
conjunction * - * * *
with * - * * *
the (PTE* - * * (A1*
phospho-NarP * - * * *
protein *) - * * *)
bound * bound * * (V*)
to * - * * *
a * - * * *
site * - * * *
centered * - * * *
at * - * * *
-44 * - * * *
. * - * * *
5 * - * * *
. * - * * *

These * - * *
results * - * *
suggest * - * *
that * - * *
although * - * *
BNIP3 (PTE* - (A1* *
and * - * *
BNIP3alpha *) - *) *
may * - * *
promote * promote (V*) *
apoptosis * - (A0*) *
simultaneously * - (A5*) *
in * - (A2* *
most (ORG* - * *
human * - * *
tissues *) - *) *
, * - * *
BNIP3alpha (PTE*) - * (A0*)
may * - * *
play * play * (V*)
a * - * (A4*
more * - * *
universal * - * *
role * - * *)
. * - * *

Under * - * *
anaerobic * - * *
conditions * - * *
the (PTE* - * *
narL * - * *
gene * - * *
product *) - * *
, * - * *
in * - * *
the * - * *
presence * - * *
of * - * *
nitrate * - * *
, * - * *
is * - * *
known * - * *
to * - * *
activate * - * *
transcription * transcription (V*) *
of * - * *
the (DNA* - (A0* (A1*
narC * - * *
operon *) - *) *)
, * - * *
which * - * *
encodes * encode * (V*)
nitrate (PTE* - * (A0*
reductase *) - * *)
. * - * *

Regulation * regulate (V*)
of * - *
wild-type (DNA* - (A0*
nagE *) - *)
by * - *
NagC (PTE*) - (A1*)
is * - *
achieved * - *
because * - *
of * - *
the * - *
chelation * - *
effect * - *
due * - *
to * - *
a * - *
second * - *
high * - *
affinity * - *
NagC * - *
operator * - *
covering * - *
the * - *
nagB * - *
promoter * - *
. * - *

ArcA-P * - *
, * - *
a * - *
global * - *
transcriptional * - *
regulator * - *
, * - *
then * - *
prevents * - *
sdh (DNA*) - (A0*)
and * - *
lct * - *
expression * express (V*)
. (DNA*) - *

Studies * - *
of * - *
in * - (A5*
vivo * - *)
expression * express (V*)
of * - *
the (PTE* - (A0*
outer * - *
membrane * - *
porins *) - *)
during * - (A12*
growth * - *
on * - *
glucose * - *
minimal * - *
medium * - *)
showed * - *
that * - *
the * - *
OmpF/OmpC * - *
ratio * - *
is * - *
higher * - *
in * - *
lrp+ * - *
strains * - *
than * - *
it * - *
is * - *
in * - *
isogenic * - *
lrp * - *
strains * - *
. * - *

Consistent * - * * * *
with * - * * * *
the * - * * * *
previous * - * * * *
notion * - * * * *
that * - * * * *
lrp (DNA*) - (A0*) * * *
is * - * * * *
autoregulated * autoregulate (V*) * * *
, * - * * * *
lrp (DNA*) - * (A0*) (A0* *
expression * express * (V*) *) *
was * - * * * *
derepressed * derepress * * (V*) *
by * - * * * *
these (PRC* - * * (A1* *
mutations *) - * * *) *
and * - * * * *
repressed * - * * * *
by * - * * * *
multi-copy (DNA* - * * * (A0*
plasmids *) - * * * *)
carrying * carry * * * (V*)
lrp+ * - * * * (A4*)
. * - * * * *

Alanine (PTE*) - (A1*) *
or * - * *
leucine (PTE*) - * *
decreased * decrease (V*) *
the * - (A0* *
affinity * - * *
of * - * *
Lrp * - * *
to * - * *
repressor * - * *
sites * - *) *
, * - * *
while * - * *
having * - * *
little * - * *
or * - * *
no * - * *
effect * - * *
on * - * *
the * - * *
binding * bind * (V*)
of * - * *
Lrp (PTE*) - * (A1*)
to * - * *
activator * - * (A7*
sites * - * *)
. * - * *

However * - * *
, * - * *
it * - (A0*) *
is * - * *
not * - * *
regulated * regulate (V*) *
by * - * *
pRB (PTE*) - (A1*) *
, * - * *
p107 (PTE*) - * *
, * - * *
or * - * *
p130 (PTE*) - * *
, * - * *
and * - * *
it * - * (A1*)
is * - * *
unable * - * *
to * - * *
activate * activate * (V*)
transcription (PRC*) - * (A0*)
. * - * *

Using * - *
purified * - *
Escherichia * - *
coli * - *
RNA * - *
polymerase * - *
and * - *
a * - *
cloned * - *
DNA * - *
fragment * - *
carrying * - *
the * - *
entire * - *
melibiose * - *
operon * - *
intergenic * - *
region * - *
, * - *
we * - *
have * - *
demonstrated * - *
in * - *
vitro * - *
open * - *
complex * - *
formation * - *
and * - *
activation * - *
of * - *
transcription * - (A5*)
initiation * initiate (V*)
at * - (A2*
the (DNA* - *
melAB * - *
promoter *) - *)
. * - *

HU (PTE*) - (A1*) *
may * - * *
assist * assist (V*) *
repression (PRC*) - (A0*) *
by * - * *
bending * - * *
the (DNA* - * *
DNA *) - * *
to * - * *
facilitate * - * *
loop * - * (A0*)
formation * form * (V*)
. * - * *

The (DNA* - (A0* * *
dadAX * - * * *
operon *) - *) * *
is * - * * *
expressed * express (V*) * *
by * - * * *
multiple (DNA* - (A1* (A0* (A0*
promoters *) - *) *) *)
that * - * * *
are * - * * *
repressed * repress * (V*) *
by * - * * *
leucine-responsive * - * * *
regulatory * - * * *
protein * - * * *
( * - * * *
Lrp (PTE*) - * (A1*) *
) * - * * *
and * - * * *
activated * activate * * (V*)
by * - * * *
cyclic (PTE* - * * (A1*
AMP-CRP *) - * * *)
. * - * * *

Our * - *
deletion * - *
studies * - *
of * - *
the * - *
fragments * - *
of * - *
ILF * - *
also * - *
suggest * - *
that * - *
the (DNA* - (A1*
C-terminal * - *
region *) - *)
plays * play (V*)
a * - (A0*
regulatory * - *
role * - *)
in * - *
DNA * - *
binding * - *
. * - *

In * - *
addition * - *
, * - *
the * - *
ability * - *
of * - *
a * - *
thiol * - *
antioxidant * - *
, * - *
N-acetylcysteine (EXP*) - *
, * - *
to * - *
inhibit * - *
the * - *
effect * - *
of * - *
arsenite (EXP*) - *
on * - *
VEGF * - (A0*)
expression * express (V*)
coincided * - *
with * - *
its * - *
ability * - *
to * - *
inhibit * - *
phosphorylation * - *
of * - *
eIF2alpha * - *
and * - *
ATF4 * - *
protein * - *
expression * - *
. * - *

A * - *
mechanism * - *
by * - *
which * - *
IHF (PTE*) - *
may * - *
exert * - *
control * - *
over * - *
fimA (DNA*) - (A0*)
expression * express (V*)
is * - *
discussed * - *
. * - *

This * - * *
putative * - * *
stem-loop * - * *
structure * - * *
significantly * - * *
reduces * - * *
transcription * transcription (V*) *
in * - (A2* *
a (DNA* - * *
termination-probe * - * *
vector *) - *) *
and * - * *
may * - * *
contribute * - * *
to * - * *
differential * - * *
expression * express * (V*)
of * - * *
the (DNA* - * (A0*
cps * - * *
genes *) - * *)
. * - * *

IHF (None* - *
mutants *) - *
show * - *
increased * - *
expression * express (V*)
of * - *
OmpC (PTE*) - (A0*)
. * - *

The (DNA* - (A1*
fhlA * - *
gene *) - *)
codes * code (V*)
for * - *
a (PTE* - (A0*
78-kDa * - *
protein *) - *)
. * - *

Differential * - *
control * control (V*)
by * - *
IHF (PTE*) - (A1*)
and * - *
cAMP (PTE*) - *
of * - *
two * - *
oppositely * - *
oriented * - *
genes * - *
, * - *
hpt (DNA*) - (A0*)
and * - *
gcd (DNA*) - *
, * - *
in * - (A2*
Escherichia (ORG* - *
coli *) - *)
: * - *
significance * - *
of * - *
their * - *
partially * - *
overlapping * - *
regulatory * - *
elements * - *
. * - *

We * - *
thus * - *
examined * - *
whether * - *
GntR (PTE*) - *
involves * - *
regulation * regulation (V*)
of * - *
the (DNA* - (A0*
GntII * - *
genes *) - *)
or * - *
not * - *
. * - *

Our * - * *
results * - * *
indicate * - * *
that * - * *
the (DNA* - * *
cpxA * - * *
gene *) - * *
increases * - * *
the * - * *
levels * - * *
of * - * *
csgA (DNA*) - * *
transcription * - * *
by * - * *
dephosphorylation * dephosphorylate (V*) *
of * - * *
CpxR (PTE*) - (A0*) (A1*)
, * - * *
which * - * *
acts * act * (V*)
as * - * *
a (PTE* - * (A8*
negative * - * *
regulator *) - * *)
at * - * *
csgA * - * *
. * - * *

A * - (A9*
twofold * - *)
increase * increase (V*)
in * - *
the (PRC* - (A0*
induction *) - *)
was * - *
observed * - *
during * - (A12*
anaerobic (EXP* - *
growth *) - *)
, * - *
which * - *
was * - *
independent * - *
of * - *
ArcA * - *
or * - *
Fnr * - *
. * - *

Therefore * - * * *
, * - * * *
AlpA * - * * *
acts * - * * *
as * - * * *
a * - * * *
transcriptional * - * * *
regulator * - * * *
of * - * * *
the * - * * *
slpA (DNA*) - * (A0*) *
gene * - * * *
( * - * * *
s * - * * *
) * - * * *
; * - * * *
activation * activate (V*) * (A1*
of * - * * *
slpA * - (A0* * *
transcription * transcription *) (V*) *)
is * - * * *
necessary * - * * *
to * - * * *
suppress * suppress * * (V*)
the * - * * (A0*
phenotypes * - * * *
of * - * * *
a (PRC* - * * *
delta * - * * *
lon * - * * *
mutation *) - * * *)
. * - * * *

In * - *
this * - *
study * - *
, * - *
we * - *
investigated * - *
the * - *
effects * effect (V*)
of * - *
CsgD (PRC* - (A1*
expression *) - *)
from * - *
a * - *
weak * - *
constitutive * - *
promoter * - *
in * - *
the * - *
biofilm * - *
formation-deficient * - *
PHL565 * - *
strain * - *
of * - *
E * - *
. * - *
coli * - *
. * - *

Overexpression * overexpress (V*) *
of * - * *
TFIIB (PTE*) - (A0*) *
potentiates * - * *
activation * activate * (V*)
by * - * *
FREAC-2 (PTE*) - * (A1*)
in * - * *
a * - * *
manner * - * *
dependent * - * *
on * - * *
the * - * *
FREAC-2 * - * *
activation * - * *
domains * - * *
. * - * *

Yet * - *
, * - *
under * - *
these * - *
conditions * - *
, * - *
H-NS * - (A1*)
was * - *
found * - *
to * - *
restore * - *
E * - *
sigma * - *
s * - *
specificity * - *
by * - *
strongly * - *
interfering * interfere (V*)
with * - *
cAMP-CRP/E (PRC* - (A0*
sigma * - *
70-dependent * - *
transcription *) - *)
. * - *

Nitrate (EXP*) - (A1*)
repression * repress (V*)
, * - *
however * - *
, * - *
was * - *
significantly * - *
enhanced * - *
( * - *
sevenfold * - *
) * - *
when * - *
the * - *
cells * - *
were * - *
cultured * - *
in * - *
minimal * - *
medium * - *
. * - *

Based * - *
on * - *
these * - *
results * - *
we * - *
propose * - *
a * - *
model * - *
in * - *
which * - *
the * - *
phosphorylated * - *
state * - *
of * - *
OmpR * - *
modulates * - *
the * - *
expression * express (V*)
of * - *
the (DNA* - (A0*
ompF * - *
and * - *
ompC * - *
genes *) - *)
. * - *

Thus (EXP* - * *
O2 *) - * *
prevents * - * *
induction * induce (V*) *
of * - * *
nitrate (PTE* - (A0* *
, * - * *
fumarate * - * *
, * - * *
and * - * *
Me3NO * - * *
reductases *) - *) *
, * - * *
and * - * *
nitrate (EXP*) - * *
curtails * - * *
the * - * *
induction * induce * (V*)
of * - * *
fumarate (PTE* - * (A0*
and * - * *
Me3NO * - * *
reductases *) - * *)
. * - * *

Although * - *
the * - *
DNA * - *
did * - *
not * - *
show * - *
any * - *
significant * - *
intrinsic * - *
bend * - *
, * - *
MetR * - (A1*
binding * - *)
resulted * result (V*)
in * - *
a * - (A0*
bending * - *
angle * - *)
of * - *
about * - *
33 * - *
degrees * - *
. * - *

In * - *
gel * - *
shift * - *
and * - *
DNase * - *
I * - *
footprinting * - *
assays * - *
, * - *
all * - *
of * - *
these (DNA* - (A0*
genes *) - *)
were * - *
found * - *
to * - *
be * - *
regulated * regulate (V*)
directly * - (A5*)
by * - *
PhoP (PTE*) - (A1*)
. * - *

It * - * *
was * - * *
also * - * *
found * - * *
that * - * *
the (DNA* - (A0* *
iciA * - * *
promoter *) - *) *
contains * contain (V*) *
a * - * *
PhoB * - * *
protein-binding * - * *
sequence * - * *
, * - * *
termed * - * *
the (DNA* - (A4* *
Pho * - * *
box *) - *) *
, * - * *
which * - * *
is * - * *
necessary * - * *
for * - * *
the * - * *
activation * activate * (V*)
of * - * *
genes (DNA*) - * (A0*)
of * - * *
the * - * *
Pho * - * *
regulon * - * *
. * - * *

These * - *
observations * - *
show * - *
that * - *
repression * - *
is * - *
the * - *
result * - *
of * - *
co-operative * - (A5*)
binding * bind (V*)
of * - *
the * - (A1*
repressor * - *)
to * - *
its (DNA* - (A7*
two * - *
sites *) - *)
, * - *
resulting * - *
in * - *
the * - *
formation * - *
of * - *
a * - *
loop * - *
of * - *
DNA * - *
. * - *

Gel * - *
mobility * - *
shift * - *
assays * - *
showed * - *
that * - *
the (PTE* - (A1*
YiaJ * - *
repressor *) - *)
binds * bind (V*)
to * - *
a (DNA* - (A7*
promoter * - *
fragment *) - *)
extending * - *
from * - *
-50 * - *
to * - *
+121 * - *
. * - *

However * - * *
, * - * *
in * - * *
the * - * *
presence * - * *
of * - * *
melibiose (EXP*) - * *
, * - * *
the (DNA* - * *
melR * - * *
promoter *) - * *
can * - * *
still * - * *
be * - * *
partially * - * *
repressed * - * *
by * - * *
MelR (PTE*) - (A1*) *
binding * bind (V*) *
to * - * *
the (DNA* - (A7* (A1*
site *) - *) *)
that * - * *
overlaps * overlap * (V*)
the (DNA* - * (A0*
transcript * - * *
start * - * *
and * - * *
-10 * - * *
region *) - * *)
. * - * *

This * - *
study * - *
was * - *
undertaken * - *
to * - *
clarify * - *
how * - *
the * - *
interplay * - *
between * - *
the * - *
two * - *
regulatory * - *
proteins * - *
, * - *
OmpR * - *
and * - *
CpxR * - *
, * - *
can * - *
affect * - *
the * - *
transcription * transcription (V*)
of * - *
the (DNA* - (A0*
curli * - *
gene *) - *)
in * - *
response * - *
to * - *
variation * - (A3*
of * - *
the * - *
medium * - *
osmolarity * - *)
. * - *

Identification * - *
and * - *
characterization * - *
of * - *
a * - *
two-component * - *
sensor-kinase * - *
and * - *
response-regulator * - *
system * - *
( * - *
DcuS-DcuR (PTE*) - *
) * - *
controlling * - *
gene (DNA*) - (A0*)
expression * express (V*)
in * - *
response * - *
to * - *
C4-dicarboxylates (EXP*) - *
in * - *
Escherichia (ORG* - *
coli *) - *
. * - *

Primer (EXP* - (A10* *
extension * - * *
analysis *) - *) *
was * - * *
used * - * *
to * - * *
determine * determine (V*) *
the * - (A0* *
initiation * - * *
site * - * *
of * - * *
transcription * transcription *) (V*)
of * - * *
both (DNA* - * (A0*
operons *) - * *)
. * - * *

Mutations * mutate (V*) * *
of * - * * *
the * - (A0* * *
two * - * * *
PKA * - * * *
phosphorylation * - * * *
consensus * - * * *
sites * - *) * *
of * - * * *
SOX9 (PTE*) - * * (A1*)
markedly * - * * *
decreased * - * * *
the * - * * *
PKA-Calpha * - * (A0*) *
activation * activate * (V*) (V*)
of * - * * *
this (DNA* - * * (A0*
enhancer *) - * * *)
by * - * * *
SOX9 * - * * *
. * - * * *

The * - *
CRP-cAMP * - *
complex * - *
and * - *
downregulation * downregulate (V*)
of * - *
the (DNA* - (A0*
glnAp2 * - *
promoter *) - *)
provides * - *
a * - *
novel * - *
regulatory * - *
linkage * - *
between * - *
carbon * - *
metabolism * - *
and * - *
nitrogen * - *
assimilation * - *
in * - *
Escherichia * - *
coli * - *
. * - *

The * - *
results * - *
support * - *
the * - *
previously * - *
postulated * - *
ribosomal * - *
binding * - *
site * - *
( * - *
RBS * - *
) * - *
occlusion * - *
model * - *
, * - *
according * - *
to * - *
which * - *
RNase * - (A1*
III * - *
cleavage * - *)
is * - *
required * - *
to * - *
release * release (V*)
the * - (A0*
RBS * - *)
from * - *
a * - *
stem-loop * - *
structure * - *
in * - *
the * - *
long * - *
transcript * - *
. * - *

Expression * express (V*)
of * - *
the * - *
degradative * - *
D-amino * - *
acid * - *
dehydrogenase * - *
( (DNA* - (A0*
dad * - *
) * - *
operon *) - *)
is * - *
known * - *
to * - *
be * - *
increased * - *
when * - *
Escherichia (ORG* - *
coli *) - *
is * - *
grown * - *
in * - *
the * - *
presence * - *
of * - *
D- (PTE* - *
or * - *
L-alanine *) - *
. * - *

Our * - * *
studies * - * *
suggest * - * *
that * - * *
the * - * *
positive * - * *
effect * - * *
of * - * *
Lrp (PTE*) - * *
on * - * *
OmpF (PTE*) - (A0*) *
expression * express (V*) *
stems * - * *
from * - * *
a * - * *
negative * - * *
effect * - * *
of * - * *
Lrp (PTE*) - * *
on * - * *
the * - * *
expression * express * (V*)
of * - * *
micF (DNA*) - * (A0*)
, * - * *
an * - * *
antisense * - * *
RNA * - * *
that * - * *
inhibits * - * *
ompF * - * *
translation * - * *
. * - * *

In * - * *
vivo * - * *
assays * - * *
with * - * *
transcriptional * - * *
lacZ * - * *
fusions * - * *
showed * - * *
that * - * *
FruR (PTE*) - * *
controls * - * *
the * - * *
expression * express (V*) *
of * - * *
FruR (DNA* - (A0* (A1*
operator-containing * - * *
genes *) - *) *)
encoding * encode * (V*)
key (PTE* - * (A0*
enzymes *) - * *)
of * - * *
virtually * - * *
every * - * *
major * - * *
pathway * - * *
of * - * *
carbon * - * *
metabolism * - * *
. * - * *

We * - * *
tested * - * *
whether * - * *
FIS (PTE*) - (A1*) *
binds * bind (V*) *
to * - * *
these * - (A7* *
sites * - *) *
, * - * *
and * - * *
if * - * *
so * - * *
, * - * *
how * - * *
it * - * *
affects * - * *
rnpB (DNA*) - * (A0*)
transcription * transcription * (V*)
. * - * *

We * - *
conclude * - *
that * - *
SOX9 (PTE*) - (A0*)
is * - *
a * - *
target * - *
of * - *
cAMP * - *
signaling * - *
and * - *
that * - *
phosphorylation * phosphorylate (V*)
of * - *
SOX9 * - *
by * - *
PKA (PTE*) - (A1*)
enhances * - *
its * - *
transcriptional * - *
and * - *
DNA-binding * - *
activity * - *
. * - *

Overexpression * overexpress (V*)
of * - *
BNIP3alpha (DNA*) - (A0*)
in * - (A2*
transfected (ORG* - *
cells *) - *)
results * - *
in * - *
apoptosis * - *
and * - *
suppresses * - *
the * - *
antiapoptosis * - *
activity * - *
of * - *
E1B-19K * - *
and * - *
BCL-xL * - *
. * - *

To * - *
study * - *
the * - *
transcriptional * - (A5*)
regulation * regulation (V*)
of * - *
the (DNA* - (A0*
inducible * - *
paa * - *
catabolic * - *
genes *) - *)
, * - *
genetic * - *
and * - *
biochemical * - *
approaches * - *
were * - *
used * - *
. * - *

To * - *
discern * - *
whether * - *
these * - *
two * - *
regions * - *
have * - *
an * - *
in * - *
vivo * - *
function * - *
in * - *
the * - *
anaerobic * - (A5*)
regulation * regulation (V*)
of * - *
cydAB (DNA*) - (A0*)
, * - *
the * - *
Fnr-binding * - *
motifs * - *
were * - *
mutagenized * - *
individually * - *
and * - *
in * - *
combination * - *
. * - *

Evidence * - * *
supporting * - * *
this * - * *
hypothesis * - * *
was * - * *
obtained * - * *
by * - * *
measuring * - * *
the * - * *
degree * - * *
of * - * *
repression * repress (V*) *
of * - * *
the (DNA* - (A0* *
glpTQ * - * *
promoter *) - *) *
in * - (A2* *
constructs * - *) *
containing * contain * (V*)
6- (PRC* - * (A4*
or * - * *
10-bp * - * *
insertions *) - * *)
between * - * *
the * - * *
glpTQ * - * *
and * - * *
glpACB * - * *
operators * - * *
. (DNA*) - * (A0*)

Both * - * *
Fis (PTE*) - * *
and * - * *
IHF (PTE*) - * *
repress * - * *
in * - (A5* *
vivo * - *) *
expression * express (V*) *
from * - * *
pacsP1 (DNA*) - (A6*) *
, * - * *
but * - * *
have * - * *
smaller * - * *
repressive * - * *
effects * - * *
on * - * *
expression * express * (V*)
from * - * *
pnrfA (DNA*) - * (A0*)
. * - * *

The (DNA* - *
glpD * - *
operon *) - *
is * - *
tightly * - *
controlled * - *
by * - *
cooperative * - (A5*)
binding * bind (V*)
of * - *
the (PTE* - (A1*
glp * - *
repressor *) - *)
to * - *
tandem * - *
operators * - *
( * - *
O (DNA* - (A7*
( * - *
D * - *
) * - *
1 *) - *)
and * - *
O (DNA* - *
( * - *
D * - *
) * - *
2 *) - *
) * - *
that * - *
cover * - *
the * - *
-10 * - *
promoter * - *
element * - *
and * - *
30 * - *
bp * - *
downstream * - *
of * - *
the * - *
transcription * - *
start * - *
site * - *
. * - *

The * - * *
introduction * introduce (V*) *
of * - * *
a (DNA* - (A0* *
cysB * - * *
allele *) - *) *
, * - * *
either * - * *
on * - * *
a * - * *
plasmid * - * *
or * - * *
on * - * *
an * - * *
episome * - * *
to * - * *
the (None* - (A7* *
fusion * - * *
strains *) - *) *
, * - * *
resulted * - * *
in * - * *
the * - * *
decrease * decrease * (V*)
of * - * *
beta-galactosidase * - * (A0*
activity * - * *)
. * - * *

Purified (PTE* - * *
UvrY * - * *
protein *) - * *
stimulated * - * *
csrB-lacZ (DNA*) - (A0*) *
expression * express (V*) *
approximately * - * *
sixfold * - * *
in * - * *
S-30 * - * *
transcription-translation * - * *
reactions * - * *
, * - * *
revealing * - * *
a * - * *
direct * - * *
effect * - * *
of * - * *
UvrY (PTE*) - * *
on * - * *
csrB (DNA*) - * (A0*)
transcription * transcription * (V*)
. * - * *

Expression * express (V*)
from * - *
the * - *
upstream * - *
promoter * - *
, * - *
glnAp1 (DNA*) - (A6*)
, * - *
requires * - *
the (PTE* - *
catabolite * - *
activating * - *
protein *) - *
, * - *
is * - *
repressed * - *
by * - *
nitrogen * - *
regulator * - *
I * - *
( * - *
NRI (PTE*) - *
) * - *
, * - *
the * - *
product * - *
of * - *
glnG * - *
, * - *
and * - *
produces * - *
a (DNA* - *
transcript *) - *
with * - *
an * - *
untranslated * - *
leader * - *
of * - *
187 * - *
nucleotides * - *
. * - *

In * - *
vitro * - *
transcription * - *
experiments * - *
demonstrated * - *
that * - *
the (PTE* - *
FlhD/FlhC * - *
complex *) - *
is * - *
a * - *
transcriptional * - *
activator * - *
required * - *
for * - *
the * - *
transcription * transcription (V*)
of * - *
the (DNA* - (A0*
three * - *
class * - *
II * - *
operons *) - *)
examined * - *
in * - *
vitro * - *
. * - *

When * - *
MelR * - (A3*
is * - *
pre-bound * - *)
, * - *
CRP (PTE*) - (A1*)
is * - *
able * - *
to * - *
bind * bind (V*)
to * - *
a (DNA* - (A7*
target *) - *)
located * - *
between * - *
MelR * - *
at * - *
positions * - *
-62 * - *
. * - *
5 * - *
and * - *
-100 * - *
. * - *
5 * - *
. * - *

Here * - *
, * - *
new * - *
insight * - *
is * - *
brought * - *
to * - *
the * - *
regulation * regulation (V*)
of * - *
the (DNA* - (A0*
acid * - *
response *) - *)
in * - (A2*
Escherichia (ORG* - *
coli *) - *)
. * - *

Oct-2 (PTE*) - (A0*) * (A1*)
expressed * express (V*) * *
in * - (A2* * *
this (ORG* - * * *
tester * - * * *
strain *) - *) * *
represses * - * * *
the * - * * *
expression * express * (V*) *
of * - * * *
the (DNA* - * (A0* *
reporter * - * * *
gene *) - * *) *
and * - * * *
changes * change * * (V*)
the * - * * (A0*
phenotype * - * * *)
of * - * * *
the * - * * *
cell * - * * *
from * - * * *
Lac+to * - * * *
Lac- * - * * *
. * - * * *

To * - *
understand * - *
how * - *
the * - *
synthesis * synthesize (V*)
of * - *
this (PTE* - (A0*
protein *) - *)
is * - *
coordinated * - *
, * - *
we * - *
studied * - *
the * - *
transcription (PRC*) - *
control * - *
of * - *
the (DNA* - *
two * - *
hup * - *
genes *) - *
. * - *

Mar (None* - (A1* (A1*
mutants *) - *) *)
of * - * *
an * - * *
ompF-lacZ * - * *
operon * - * *
fusion * - * *
strain * - * *
expressed * express (V*) *
50 * - (A9* *
to * - * *
75% * - *) *
of * - * *
the * - (A0* *
beta-galactosidase * - * *
activity * - *) *
of * - * *
the * - * *
isogenic * - * *
non-Mar * - * *
parental * - * *
strain * - * *
, * - * *
while * - * *
Mar * - * *
mutants * - * *
of * - * *
a * - * *
protein * - * *
fusion * - * *
strain * - * *
expressed * express * (V*)
less * - * (A9*
than * - * *
10% * - * *)
of * - * *
the * - * (A0*
enzyme * - * *
activity * - * *)
in * - * *
the * - * *
non-Mar * - * *
strain * - * *
. * - * *

14-3-3eta (PTE*) - *
Inhibited * - *
ligand-induced * - (A5*)
down-regulation * down-regulation (V*)
of * - *
GR (PTE*) - (A0*)
. * - *

P (DNA* - *
( * - *
cer * - *
) *) - *
is * - *
active * - *
in * - *
plasmid * - *
multimers * - *
and * - *
directs * - *
transcription * transcription (V*)
of * - *
a * - *
short * - *
RNA * - *
, * - *
Rcd (DNA*) - (A0*)
, * - *
which * - *
appears * - *
to * - *
inhibit * - *
cell * - *
division * - *
. * - *

Like * - *
Rev-Erb * - *
, * - *
BD73 (PTE*) - (A1*)
binds * bind (V*)
as * - *
a * - (A5*
monomer * - *)
to * - *
a (DNA* - (A7*
DNA * - *
sequence *) - *)
which * - *
consists * - *
of * - *
a * - *
specific * - *
A/T-rich * - *
sequence * - *
upstream * - *
of * - *
the * - *
consensus * - *
hexameric * - *
half-site * - *
specified * - *
by * - *
the * - *
P * - *
box * - *
of * - *
the * - *
DNA-binding * - *
domain * - *
. * - *

The * - *
strict * - *
statistical * - *
analyses * - *
that * - *
we * - *
have * - *
performed * - *
on * - *
our * - *
data * - *
allow * - *
us * - *
to * - *
predict * - *
that * - *
1139 (DNA* - (A0*
genes *) - *)
in * - *
the * - *
E * - *
. * - *
coli * - *
genome * - *
are * - *
regulated * regulate (V*)
either * - *
directly * - (A5*
or * - *
indirectly * - *)
by * - *
the (PTE* - (A1*
ArcA * - *
protein *) - *)
with * - *
a * - *
99% * - *
confidence * - *
level * - *
. * - *

Transcriptional * - (A1*)
regulation * - *
in * - *
response * - *
to * - *
oxygen (EXP*) - *
and * - *
nitrate (EXP*) - *
of * - *
the * - *
operons * - *
encoding * encode (V*)
the * - (A0*
[ * - *
NiFe * - *
] * - *
hydrogenases * - *
1 * - *
and * - *
2 * - *)
of * - *
Escherichia * - *
coli * - *
. * - *

When * - * *
the (PTE* - (A1* *
MazE * - * *
. * - * *
MazF * - * *
complex *) - *) *
binds * bind (V*) *
either * - * *
of * - * *
these (DNA* - (A7* *
arms *) - *) *
of * - * *
the * - * *
alternating * - * *
palindrome * - * *
, * - * *
strong * - * *
negative * - * (A5*)
autoregulation * autoregulate * (V*)
results * - * *
. * - * *

We * - *
have * - *
determined * - *
that * - *
the (DNA* - (A0*
glnA * - *
gene *) - *)
of * - *
the * - *
complex * - *
glnALG * - *
operon * - *
of * - *
Escherichia * - *
coli * - *
is * - *
transcribed * transcribe (V*)
from * - *
tandem (DNA* - (A6*
promoters *) - *)
. * - *

To * - *
isolate * - *
cDNA (ORG* - (A1*
clones *) - *)
that * - *
dominantly * - (A5*)
inhibit * inhibit (V*)
the * - (A0*
DNA-binding * - *
activity * - *)
of * - *
Oct-2 * - *
, * - *
chosen * - *
as * - *
a * - *
representative * - *
factor * - *
, * - *
we * - *
have * - *
developed * - *
a * - *
novel * - *
screening * - *
system * - *
. * - *

The (DNA* - (A1*
gene *) - *)
is * - *
predicted * - *
to * - *
encode * encode (V*)
a (PTE* - (A0*
protein *) - *)
of * - *
438 * - *
amino * - *
acids * - *
and * - *
lies * - *
adjacent * - *
to * - *
the * - *
amn * - *
gene * - *
. * - *

These * - * *
results * - * *
indicated * - * *
that * - * *
the (DNA* - (A0* (A0*
lrp * - * *
gene *) - *) *)
is * - * *
not * - * *
only * - * *
feedback * - (A5*) *
regulated * regulate (V*) *
by * - * *
Lrp (PTE*) - (A1*) *
but * - * *
is * - * *
also * - * *
controlled * control * (V*)
by * - * *
H-NS (PTE* - * (A1*
protein *) - * *)
. * - * *

The (PTE* - *
NarL * - *
and * - *
NarP * - *
proteins *) - *
are * - *
homologous * - *
response * - *
regulators * - *
of * - *
Escherichia * - *
coli * - *
that * - *
control * - *
the * - *
expression * express (V*)
of * - *
several (DNA* - (A0*
operons *) - *)
in * - *
response * - *
to * - *
nitrate (EXP*) - (A3*)
and * - *
nitrite (EXP*) - *
. * - *

We * - *
report * - *
for * - *
the * - *
first * - *
time * - *
the * - *
cloning * - *
of * - *
a (DNA* - (A1*
complete * - *
cDNA *) - *)
encoding * encode (V*)
the * - *
human * - *
TFIID * - *
subunit * - *
hTAF (PTE*) - *
( (PTE*) - *
II (PTE*) - (A0*)
) (PTE*) - *
135 * - *
( * - *
hTAF * - *
( * - *
II * - *
) * - *
130 (PTE*) - *
) * - *
. * - *

DNase (EXP* - (A10*
I * - *
footprinting * - *
studies *) - *)
identified * identify (V*)
five (DNA* - (A0*
potential * - *
binding * - *
sites *) - *)
for * - *
the * - *
wild-type * - *
NarL * - *
protein * - *
in * - *
the * - *
pfl * - *
promoter-regulatory * - *
region * - *
. * - *

The (DNA* - (A0* *
regulon *) - *) *
is * - * *
negatively * - (A9*) *
regulated * regulate (V*) *
by * - * *
a (PTE* - (A1* (A0*
repressor *) - *) *)
of * - * *
the * - * *
DeoR * - * *
family * - * *
which * - * *
is * - * *
encoded * encode * (V*)
by * - * *
the (DNA* - * (A1*
constitutive * - * *
gene * - * *
ulaR *) - * *)
located * - * *
downstream * - * *
of * - * *
ulaG * - * *
. * - * *

However * - *
, * - *
csgD (PRC* - (A0*
repression *) - *)
in * - *
response * - *
to * - *
high * - *
sucrose * - *
content * - *
is * - *
not * - *
mediated * mediate (V*)
by * - *
CpxR * - *
but * - *
by * - *
the (PTE* - (A1*
global * - *
regulatory * - *
protein * - *
H-NS *) - *)
. * - *

Transcription * transcribe (V*)
in * - (A2*
the (DNA* - *
cluster *) - *)
proceeds * - *
in * - *
the * - *
same * - *
direction * - *
as * - *
the * - *
progress * - *
of * - *
the * - *
replication * - *
fork * - *
along * - *
the * - *
chromosome * - *
. * - *

The * - *
expression * express (V*)
of * - *
the (DNA* - (A0*
csgBA * - *
genes *) - *)
is * - *
regulated * - *
in * - *
response * - *
to * - *
a * - *
multitude * - *
of * - *
physiological * - *
signals * - *
. * - *

Expression * express (V*)
from * - *
both (DNA* - (A6*
promoters *) - *)
was * - *
found * - *
to * - *
increase * - *
as * - *
the * - *
cells * - *
enter * - *
stationary * - *
phase * - *
. * - *

Deletion * - *
analyses * - *
of * - *
the * - *
regulatory * - *
region * - *
showed * - *
that * - *
a * - (A0*
101-nucleotide * - *
region * - *)
of * - *
the * - *
agn43 * - *
regulatory * - *
region * - *
containing * contain (V*)
the (DNA* - (A4*
promoter *) - *)
and * - *
this * - *
OxyR * - *
binding * - *
region * - *
was * - *
sufficient * - *
for * - *
Dam- * - *
and * - *
OxyR-dependent * - *
phase * - *
variation * - *
. * - *

Induction * induce (V*) *
of * - * *
a (PRC* - (A0* *
mutation *) - *) *
in * - * *
the (DNA* - (A2* *
lacI * - * *
gene *) - *) *
will * - * *
result * - * *
in * - * *
the * - * *
loss * - * *
of * - * *
transcriptional * - * *
repression * repress * (V*)
of * - * *
the (DNA* - * (A0*
lacZ * - * *
gene *) - * *)
in * - * *
mutated (ORG* - * (A2*
cells *) - * *)
. * - * *

The * - *
similar * - *
pattern * - *
of * - *
regulation * regulation (V*)
of * - *
the * - (A0*
Glc * - *
and * - *
Ace * - *
systems * - *)
by * - *
IHF (PTE*) - (A1*)
and * - *
ArcA-P (PTE*) - *
ensures * - *
their * - *
effective * - *
cross-induction * - *
. * - *

The (DNA* - (A0* *
uxuAB * - * *
operon *) - *) *
is * - * *
composed * compose (V*) *
of * - * *
two (DNA* - (A4* *
genes *) - *) *
coding * - * *
for * - * *
enzymes (PTE*) - * (A0*)
involved * involve * (V*)
in * - * *
hexuronate * - * (A4*
degradation * - * *)
. * - * *

It * - * *
was * - * *
observed * - * *
that * - * *
an * - * *
increase * increase (V*) *
in * - * *
the * - (A0* *
copy * - * *
number * - * *
of * - * *
the (DNA* - * *
uxuR * - * *
gene *) - *) *
results * - * *
in * - * *
an * - * *
increased * - * *
repression * - * *
of * - * *
beta-galactosidase * - * (A0*)
synthesis * synthesize * (V*)
. * - * *

When * - * *
both (DNA* - (A0* *
genes *) - *) *
were * - * *
disrupted * disrupt (V*) *
, * - * *
galS (DNA*) - * (A0*)
expression * express * (V*)
was * - * *
further * - * *
elevated * - * *
. * - * *

Moreover * - *
, * - *
one * - *
of * - *
the (PTE* - *
cAMP-CRP * - *
complexes *) - *
is * - *
involved * - *
in * - *
the * - *
activation * activate (V*)
of * - *
both * - *
a (DNA* - (A0*
Class * - *
I * - *
and * - *
a * - *
Class * - *
II * - *
promoter *) - *)
. * - *

Subsequent * - *
introduction * - (A0*)
of * - *
the * - *
lacI * - *
gene * - *
into * - *
IIB1 * - *
cells * - *
resulted * result (V*)
in * - *
correct (PRC* - (A4*
transcriptional * - *
repression *) - *)
of * - *
the * - *
lacZ * - *
gene * - *
that * - *
could * - *
be * - *
alleviated * - *
by * - *
IPTG * - *
, * - *
an * - *
allosteric * - *
inducer * - *
of * - *
lacI * - *
repression * - *
. * - *

Complementation * - *
was * - *
carried * - *
out * - *
with * - *
combinations * - *
of * - *
a (ORG* - (A1*
host * - *
strain *) - *)
and * - *
a (DNA* - *
plasmid *) - *
, * - *
each * - *
of * - *
which * - *
carried * carry (V*)
either * - *
the (DNA* - (A0*
wild-type * - *
or * - *
a * - *
mutant * - *
ompR * - *
gene *) - *)
. * - *

ME1a1 (DNA*) - (A0*)
, * - *
a * - *
16-base-pair * - *
nuclear * - *
factor * - *
binding * - *
site * - *
residing * - *
between * - *
the * - *
c-MYC * - *
P1 * - *
and * - *
P2 * - *
transcription * - *
initiation * - *
sites * - *
, * - *
is * - *
required * require (V*)
for * - *
P2 (PRC* - (A11*
activity *) - *)
. * - *

Further * - *
studies * - *
with * - *
acn-lacZ * - *
gene * - *
fusions * - *
and * - *
a * - *
wider * - *
range * - *
of * - *
transcription * - *
regulators * - *
indicated * - *
that * - *
acnA * - (A0*)
expression * express (V*)
is * - *
initiated * - *
by * - *
sigma (PTE* - *
38 *) - *
from * - *
P1acnA (DNA*) - *
, * - *
and * - *
from * - *
P2acnA (DNA*) - *
it * - *
is * - *
activated * - *
directly * - *
or * - *
indirectly * - *
by * - *
CRP (PTE*) - *
, * - *
FruR (PTE*) - *
, * - *
Fur (PTE*) - *
and * - *
SoxRS (PTE*) - *
, * - *
and * - *
repressed * - *
by * - *
ArcA (PTE*) - *
and * - *
FNR (PTE*) - *
. * - *

We * - * *
describe * - * *
here * - * *
a * - * *
novel * - * *
member * - * *
of * - * *
the * - * *
bZIP * - * *
family * - * *
of * - * *
DNA-binding * - * *
proteins * - * *
, * - * *
designated * - * *
E4BP4 (PTE*) - (A0*) *
, * - * *
that * - * *
displays * display (V*) *
an * - (A4* (A0*
unusual * - * *
DNA-binding * - * *
specificity * - *) *)
which * - * *
overlaps * overlap * (V*)
that * - * (A4*
of * - * *
the * - * *
activating * - * *
transcription * - * *
factor * - * *
family * - * *)
of * - * *
factors * - * *
. * - * *

Regulation * - *
of * - *
transcription * transcription (V*)
of * - *
cell (DNA* - (A0*
division * - *
genes *) - *)
in * - *
the * - *
Escherichia * - *
coli * - *
dcw * - *
cluster * - *
. * - *

Functional * - (A0* *
activation * - * *
of * - * *
an (DNA* - * *
HIV * - * *
reporter * - * *
plasmid *) - *) *
by * - * *
p49/p65 * - * *
in * - (A2* *
transiently * - * *
transfected * - * *
Jurkat * - * *
T-leukemia * - * *
cells * - *) *
was * - * *
also * - * *
inhibited * inhibit (V*) *
by * - * *
coexpression * coexpress (A1* (V*)
of * - * *
MAD-3 * - *) *
. (PTE*) - * (A0*)

Moreover * - * *
, * - * *
the * - * *
introduction * introduce (V*) *
of * - * *
mutations (PRC*) - (A0*) *
into * - (A2* *
possible (DNA* - * *
GntR-binding * - * *
elements *) - *) *
revealed * - * *
that * - * *
both (PTE* - * (A0*
regulators *) - * *)
share * share * (V*)
at * - * *
least * - * *
one * - * *
of * - * *
the (DNA* - * (A4*
elements *) - * *)
. * - * *

Using * - * *
a (DNA* - (A7* *
previously * - * *
derived * - * *
consensus * - * *
sequence *) - *) *
for * - * *
FruR (PTE*) - (A1*) *
binding * bind (V*) *
, * - * *
additional * - * *
potential * - * *
operators * - * *
were * - * *
identified * - * *
and * - * *
tested * - * *
for * - * *
FruR (PTE*) - * (A1*)
binding * bind * (V*)
in * - * *
DNA * - * *
band * - * *
migration * - * *
retardation * - * *
assays * - * *
. * - * *

RET (PTE* - (A1*
finger * - *
protein *) - *)
is * - *
a * - *
transcriptional * - *
repressor * - *
and * - *
interacts * interact (V*)
with * - *
enhancer (DNA*) - (A8*)
of * - *
polycomb * - *
that * - *
has * - *
dual * - *
transcriptional * - *
functions * - *
. * - *

We * - * *
show * - * *
that * - * *
the * - * *
negative * - * *
effect * - * *
of * - * *
the * - * *
cpxA * - * *
mutation * - * *
on * - * *
biofilm * - * *
formation * - * *
results * - * *
from * - * *
a * - * *
decreased * - (A5*) *
transcription * transcription (V*) *
of * - * *
the (PTE* - (A0* (A0*
curlin *) - *) *)
encoding * encode * (V*)
csgA (DNA* - * (A1*
gene *) - * *)
. * - * *

The * - * *
results * - * *
show * - * *
that * - * *
dcuA (DNA*) - (A0*) *
is * - * *
constitutively * - (A5*) *
expressed * express (V*) *
whereas * - * *
dcuB * - * (A0*)
expression * express * (V*)
is * - * *
highly * - * *
regulated * - * *
. * - * *

We * - * * *
used * - * * *
an * - * * *
ast-lacZ * - * * *
fusion * - * * *
to * - * * *
show * - * * *
that * - * * *
arginine * - (A1*) * *
stimulates * stimulate (V*) * *
expression (PRC*) - (A0*) * *
, * - * * *
that (PTE* - * * *
ArgR *) - * * *
, * - * * *
the * - * * *
arginine * - * * *
repressor * - * * *
, * - * * *
enhances * - * * *
expression * express * (V*) *
from * - * * *
both * - * (A6* *
promoters * - * *) *
but * - * * *
is * - * * *
not * - * * *
essential * - * * *
, * - * * *
and * - * * *
that * - * * *
transcription * transcription * * (V*)
by * - * * *
the * - * * *
two * - * * *
forms * - * * *
of * - * * *
the (PTE* - * * (A1*
RNA * - * * *
polymerase *) - * * *)
is * - * * *
competitive * - * * (A5*)
and * - * * *
mutually * - * * *
exclusive * - * * *
. * - * * *

We * - *
also * - *
demonstrate * - *
that * - *
this (PTE* - (A1*
repressor *) - *)
regulates * regulate (V*)
the (DNA* - (A0*
nearby * - *
yjfR * - *
gene *) - *)
, * - *
which * - *
in * - *
this * - *
way * - *
constitutes * - *
a * - *
regulon * - *
with * - *
the * - *
ula * - *
operon * - *
. * - *

Surprisingly * - * * *
, * - * * *
IHF (PTE*) - (A0*) * *
binding * bind (V*) * *
at * - * * *
the * - (A2* * *
IHF * - * * *
II * - * * *
site * - *) * *
increases * - * * *
FNR-dependent * - * (A5*) *
activation * activate * (V*) *
by * - * * *
decreasing * - * * *
the (PRC* - * * (A0*
repression *) - * * *)
mediated * mediate * * (V*)
by * - * * *
IHF * - * * (A1*
and * - * * *
Fis * - * * *
binding * - * * *)
at * - * * *
the * - * * *
other * - * * *
sites * - * * *
. * - * * *

Mutations (PRC*) - * (A1*)
at * - * *
the (DNA* - (A1* *
mouse * - * *
locus *) - *) *
encoding * encode (V*) *
microphthalmia-associated * - * *
transcription * - * *
factor * - * *
( * - * *
Mitf (PTE*) - (A0*) *
) * - * *
affect * affect * (V*)
the * - * (A0*
development * - * *
of * - * *
many (ORG* - * *
cell * - * *
types *) - * *)
, * - * *
including * - * *
retinal * - * *
pigment * - * *
epithelium * - * *
( * - * *
RPE * - * *
) * - * *
, * - * *
melanocytes * - * *
, * - * *
mast * - * *
cells * - * *
, * - * *
and * - * *
osteoclasts * - * *
. * - * *

The * - *
level * - *
of * - *
activation * - *
is * - *
comparable * - *
to * - *
that * - *
of * - *
v-jun * - *
and * - *
the * - (A0*
activity * - *
of * - *
both * - *)
is * - *
further * - *
stimulated * stimulate (V*)
by * - *
v-fos (PTE*) - (A1*)
. (DNA*) - *

Our * - * *
findings * - * *
suggest * - * *
that * - * *
the (DNA* - * *
marA * - * *
locus *) - * *
directly * - * *
or * - * *
indirectly * - * *
increases * - * *
micF (DNA*) - (A0*) *
expression * express (V*) *
, * - * *
causing * - * *
a * - * *
posttranscriptional * - * (A5*)
decrease * decrease * (V*)
in * - * *
ompF (DNA* - * (A0*
mRNA *) - * *)
and * - * *
reduced * - * *
amounts * - * *
of * - * *
OmpF * - * *
. * - * *

The (DNA* - (A0*
locations *) - *)
of * - *
the (DNA* - *
binding * - *
sites *) - *
for * - *
the * - *
glp * - *
repressor * - *
and * - *
for * - *
cAMP * - *
. * - *
CRP * - *
in * - *
the * - *
control * - *
regions * - *
of * - *
these * - *
operons * - *
were * - *
determined * determine (V*)
by * - *
DNase (EXP* - (A10*
I * - *
footprinting *) - *)
. * - *

The (DNA* - (A0*
region *) - *)
protected * protect (V*)
by * - *
the (PTE* - (A1*
cAMP * - *
. * - *
CRP * - *
complex *) - *)
contained * - *
tandem * - *
sequences * - *
resembling * - *
the * - *
consensus * - *
sequence * - *
for * - *
CRP * - *
binding * - *
. * - *

Thus * - *
, * - *
the * - *
minimal * - *
factor * - *
requirements * - *
for * - *
activator-dependent * - (A5*)
transcription * transcription (V*)
on * - *
chromatin * - (A0*
templates * - *)
in * - (A3*
vitro * - *)
have * - *
been * - *
defined * - *
. * - *

Mutations * mutate (V*) * *
in * - (A2* * *
either (DNA* - * (A1* *
the * - * * *
himA-or * - * * *
the * - * * *
himD *) - *) *) *
( * - * * *
hip * - * * *
) * - * * *
gene * - * * *
, * - * * *
which * - * * *
encode * encode * (V*) *
the (PTE* - * (A0* *
alpha * - * * *
and * - * * *
beta * - * * *
subunits *) - * *) *
of * - * * *
IHF * - * * *
, * - * * *
respectively * - * * *
, * - * * *
prevented * - * * *
phase * - * * *
variation * - * * *
and * - * * *
locked * - * * *
expression * express * * (V*)
of * - * * *
fimA (DNA*) - * * (A0*)
in * - * * *
either * - * * *
the * - * * *
" * - * * *
on * - * * *
" * - * * *
or * - * * *
" * - * * *
off * - * * *
" * - * * *
phase * - * * *
. * - * * *

In * - * *
cells * - * *
growing * - * *
in * - * *
minimal * - * *
medium * - * *
containing * - * *
glucose * - * *
, * - * *
expression * express (V*) *
of * - * *
ss-galactosidase * - (A0* *
activity * - *) *
from * - * *
an (DNA* - (A6* *
aldA-lacZ * - * *
fusion * - * *
gene *) - *) *
was * - * *
suppressed * - * *
by * - * *
oversupply * - * *
of * - * *
DnaA (PTE* - * *
protein *) - * *
and * - * *
was * - * *
enhanced * - * *
by * - * *
reducing * reduce * (V*)
the (PTE* - * (A0*
free * - * *
DnaA * - * *
level *) - * *)
. (ORG*) - * *

In * - * *
Escherichia * - * *
coli * - * *
, * - * *
the * - * *
ferric * - * *
uptake * - * *
regulator * - * *
( * - * *
Fur (PTE*) - * *
) * - * *
controls * - * *
expression * express (V*) *
of * - * *
the (DNA* - (A0* *
iron * - * *
regulon *) - *) *
in * - * *
response * - * *
to * - * *
iron * - * *
availability * - * *
while * - * *
the * - * *
cyclic * - * *
AMP * - * *
receptor * - * *
protein * - * *
( * - * *
Crp (PTE*) - * *
) * - * *
regulates * - * *
expression * express * (V*)
of * - * *
the (DNA* - * (A0*
carbon * - * *
regulon *) - * *)
in * - * *
response * - * *
to * - * *
carbon * - * *
availability * - * *
. * - * *

Regulation * regulate (V*)
of * - *
Escherichia (DNA* - (A0*
coli * - *
K-12 * - *
hexuronate * - *
system * - *
genes *) - *)
: * - *
exu * - *
regulon * - *

All (PTE* - * (A1*
three * - * *
regulators *) - * *)
negatively * - * *
modulate * - * *
the * - * *
expression * express (V*) *
of * - * *
osmY (DNA*) - (A0*) *
, * - * *
and * - * *
they * - * *
act * act * (V*)
independently * - * (A8*
from * - * *
sigma * - * *
s * - * *)
. * - * *

CRP (PTE*) - (A1*)
binding * bind (V*)
to * - *
these (DNA* - (A7*
sites *) - *)
is * - *
not * - (A5*
cooperative * - *)
, * - *
even * - *
though * - *
they * - *
are * - *
adjacent * - *
and * - *
located * - *
on * - *
the * - *
same * - *
face * - *
of * - *
the * - *
DNA * - *
double * - *
helix * - *
. * - *

Thus * - *
, * - *
cytidine * - *
interferes * - *
with * - *
the * - *
cooperative * - *
DNA * - *
binding * bind (V*)
of * - *
cAMP-CRP (PTE* - (A1*
and * - *
CytR *) - *)
to * - *
tsx-p2 (DNA*) - (A7*)
. * - *

Deletion * - *
mutants * - *
of * - *
the (DNA* - (A1*
gene *) - *)
that * - *
lack * lack (V*)
the (PTE* - (A0*
best * - *
conserved * - *
region * - *
in * - *
the * - *
activating * - *
domain *) - *)
are * - *
poorly * - *
active * - *
. * - *

Transcription * transcribe (V*) * *
of * - * * *
rpoH (DNA*) - (A0*) (A1*) *
, * - * * *
encoding * encode * (V*) *
the * - * * *
Escherichia * - * * *
coli * - * * *
heat-shock * - * * *
regulator * - * * *
sigma32 (PTE*) - * (A0*) (A0*)
, * - * * *
is * - * * *
negatively * - * * (A5*)
controlled * control * * (V*)
by * - * * *
the (PTE* - * * (A1*
cAMP-CRP/CytR * - * * *
nucleoprotein * - * * *
complex *) - * * *)
. * - * * *

Additionally * - *
, * - *
GntH (PTE*) - *
exerts * - *
negative * - (A5*)
control * control (V*)
of * - *
the (DNA* - (A0*
GntI * - *
genes *) - *)
via * - *
the (DNA* - *
same * - *
binding * - *
element *) - *
as * - *
that * - *
of * - *
GntR * - *
. * - *

Expression * express (V*) *
of * - * *
the (DNA* - (A0* (A1*
genes *) - *) *)
coding * code * (V*)
for * - * *
the (PTE* - * (A0*
Escherichia * - * *
coli * - * *
integration * - * *
host * - * *
factor *) - * *)
are * - * *
controlled * - * *
by * - * *
growth * - * *
phase * - * *
, * - * *
rpoS (PTE*) - * *
, * - * *
ppGpp (EXP*) - * *
and * - * *
by * - * *
autoregulation (PRC*) - * *
. * - * *

Here * - * *
we * - * *
show * - * *
that * - * *
the * - * *
three * - * *
CNC-bZIP * - * *
members * - * *
NF-E2 (PTE*) - (A0*) (A1*)
, * - * *
Nrf1 (PTE*) - * *
and * - * *
Nrf2 (PTE*) - * *
are * - * *
constitutively * - (A5*) *
expressed * express (V*) *
in * - (A2* *
the (ORG* - * *
murine * - * *
mast * - * *
cell * - * *
line * - * *
CPII *) - *) *
and * - * *
that * - * *
they * - * *
form * form * (V*)
transcription (PTE* - * (A0*
factor * - * *
complexes *) - * *)
with * - * *
several * - * (A1*
AP1 * - * *
binding * - * *
proteins * - * *)
. * - * *

The (EXP* - *
oxidative * - *
stressor * - *
arsenite *) - *
activates * - *
vascular * - (A0*
endothelial * - *
growth * - *
factor * - *
mRNA * - *)
transcription * transcription (V*)
by * - *
an * - *
ATF4-dependent * - *
mechanism * - *
. * - *

The * - *
homeobox * - *
gene * - *
GBX2 (DNA*) - (A1*)
, * - *
a * - *
target * - *
of * - *
the * - *
myb * - *
oncogene * - *
, * - *
mediates * mediate (V*)
autocrine * - (A0*)
growth * - *
and * - *
monocyte * - *
differentiation * - *
. * - *

We * - *
have * - *
used * - *
fluorescence * - *
in * - *
situ * - *
hybridization * - *
( * - *
FISH * - *
) * - *
to * - *
perform * - *
precise * - *
chromosomal * - *
mapping * - *
of * - *
the (DNA* - (A1*
genes *) - *)
encoding * encode (V*)
the * - *
transcription * - *
factors * - *
c-rel (PTE*) - (A0*)
, * - *
NF-kappa (PTE* - *
Bp50 *) - *
, * - *
NF-kappa (PTE* - *
Bp65 *) - *
, * - *
and * - *
lyt-10 (PTE*) - *
. * - *

Both * - * * *
csgD (DNA*) - (A0*) * *
and * - * * *
csgBA (DNA*) - * * *
transcription * transcription (V*) * *
, * - * * *
required * - * * *
for * - * * *
expression * express * (V*) *
of * - * * *
curli * - * (A0*) *
, * - * * *
were * - * * *
inactive * - * * *
in * - * * *
an * - * * *
mlrA * - * * *
mutant * - * * *
grown * - * * *
under * - * * *
conditions * - * * (A1*)
that * - * * *
promote * promote * * (V*)
curli * - * * (A0*
production * - * * *)
. * - * * *

It * - *
is * - *
now * - *
well * - *
established * - *
that * - *
the (DNA* - (A0*
sigmaE * - *
regulon *) - *)
of * - *
Escherichia * - *
coli * - *
is * - *
induced * induce (V*)
by * - *
misfolding * - (A1*
of * - *
proteins * - *)
in * - *
the * - *
periplasm * - *
and * - *
the * - *
outer * - *
membrane * - *
. (PTE*) - *

Using * - * *
single-copy * - * *
P * - * *
( * - * *
mcc * - * *
) * - * *
-lac * - * *
transcriptional * - * *
fusion * - * *
( * - * *
the (DNA* - (A0* *
promoter * - * *
region *) - *) *
of * - * *
the * - * *
microcin * - * *
C51 * - * *
operon * - * *
fused * fuse (V*) *
to * - * *
a (DNA* - (A0* *
promoterless * - * *
lac * - * *
operon *) - *) *
in * - (A2* *
lambda (ORG* - * *
phage *) - *) *
) * - * *
, * - * *
we * - * *
showed * - * *
that * - * *
transcription * transcription * (V*)
from * - * *
the (DNA* - * (A6*
microcin * - * *
operon * - * *
promoter *) - * *)
is * - * *
dependent * - * *
on * - * *
sigma * - * *
( * - * *
s * - * *
) * - * *
( * - * *
RpoS * - * *
) * - * *
factor * - * *
. * - * *

In * - *
this * - *
report * - *
we * - *
show * - *
that * - *
, * - *
in * - *
the * - *
absence * - *
of * - *
any * - *
transcriptional * - *
factor * - *
, * - *
aidB (DNA*) - (A0*)
is * - *
efficiently * - *
transcribed * transcribe (V*)
in * - (A10*
vitro * - *)
by * - *
the (PTE* - (A1*
sigma * - *
s *) - *)
, * - *
but * - *
not * - *
by * - *
the * - *
sigma * - *
70 * - *
, * - *
form * - *
of * - *
RNA * - *
polymerase * - *
holoenzyme * - *
. * - *

Phosphorylation * - (A1*)
of * - *
SOX9 * - *
by * - *
cyclic * - *
AMP-dependent * - *
protein * - *
kinase * - *
A * - *
enhances * enhance (V*)
SOX9's * - (A0*
ability * - *)
to (PRC* - (A11*
transactivate *) - *)
a * - *
Col2a1 * - *
chondrocyte-specific * - *
enhancer * - *
. * - *

In * - *
addition * - *
, * - *
it * - *
was * - *
discovered * - *
that * - *
RpoS (PTE*) - (A1*)
activates * activate (V*)
adhE (PRC* - (A0*
transcription *) - *)
at * - (A2*
both (DNA* - *
start * - *
sites *) - *)
. * - *

A (DNA* - (A1* (A0*
cDNA *) - *) *)
encoding * encode (V*) *
a (PTE* - (A0* *
477-amino * - * *
acid * - * *
zinc * - * *
finger * - * *
protein *) - *) *
designated * - * *
MAZ * - * *
( * - * *
MYC-associated * - * *
zinc * - * *
finger * - * *
protein * - * *
) * - * *
was * - * *
cloned * clone * (V*)
from * - * *
a (ORG* - * (A6*
HeLa * - * *
lambda * - * *
gt11 * - * *
library *) - * *)
by * - * *
screening * - * *
with * - * *
a * - * *
concatamerized * - * *
ME1a1 * - * *
binding * - * *
site * - * *
probe * - * *
. * - * *

These * - * *
data * - * *
provide * - * *
evidence * - * *
that * - * *
cross-regulatory * - (A5*) *
interactions * interact (V*) *
between * - * *
mammalian (DNA* - (A0* *
homeogenes *) - *) *
take * - * *
place * - * *
in * - * *
cultured * - * *
cells * - * *
, * - * *
thus * - * *
raising * - * *
the * - * *
possibility * - * *
that * - * *
a * - * (A0*
regulatory * - * *
network * - * *)
may * - * *
exist * exist * (V*)
in * - * (A3*
vivo * - * *)
. * - * *

These (PRC* - (A1* *
mutations *) - *) *
suppressed * suppress (V*) *
the (DNA* - (A0* *
defects *) - *) *
in * - (A2* *
a (None* - * (A0*
ptsH * - * *
mutant *) - *) *)
which * - * *
lacks * lack * (V*)
HPr (PTE*) - * (A4*)
, * - * *
one * - * *
of * - * *
the * - * *
enzymes * - * *
of * - * *
the * - * *
phosphoenolpyruvate * - * *
: * - * *
carbohydrate * - * *
phosphotransferase * - * *
system * - * *
. * - * *

The * - *
expression * express (V*)
of * - *
adhE (DNA*) - (A0*)
is * - *
dependent * - *
on * - *
both * - *
transcriptional * - *
and * - *
posttranscriptional * - *
controls * - *
and * - *
is * - *
about * - *
10-fold * - *
higher * - *
during * - *
anaerobic * - *
than * - *
during * - *
aerobic * - *
growth * - *
. * - *

CRP (PTE*) - (A1*) *
and * - * *
RhaR (PTE*) - * *
could * - * *
each * - * *
partially * - * *
activate * activate (V*) *
transcription (PRC*) - (A0*) (A0*)
in * - * *
the * - * *
absence * - * *
of * - * *
the (PTE* - (A3* *
other * - * *
two * - * *
activators *) - *) *
, * - * *
and * - * *
alpha-CTD (PTE*) - * (A1*)
was * - * *
not * - * *
capable * - * *
of * - * *
activation * activate * (V*)
alone * - * *
. * - * *

In * - * *
addition * - * *
, * - * *
the * - * *
positive * - (A5*) *
effect * effect (V*) *
of * - * *
CsgD (PTE*) - (A1*) *
on * - * *
biofilm * - (A0* *
formation * - *) *
might * - * *
be * - * *
enhanced * - * *
by * - * *
repression * repress * (V*)
of * - * *
the (DNA* - * (A0*
fecR * - * *
gene *) - * *)
. * - * *

Unexpectedly * - * * *
, * - * * *
a * - * * *
mutation * mutation (V*) * *
in * - (A2* * *
the (DNA* - * (A1* *
fnr * - * * *
gene *) - *) *) *
( * - * * *
encoding * encode * (V*) *
a (PTE* - * (A0* *
global * - * * *
regulator *) - * *) *
involved * - * * *
in * - * * *
anaerobic * - * * (A3*)
metabolism * - * * *
) * - * * *
also * - * * *
alleviated * - * * *
the * - * * *
anaerobic * - * * *
repressions * repressions * * (V*)
. * - * * *

Transient * - *
transfections * - *
were * - *
performed * - *
to * - *
analyze * - *
the * - *
effects * - *
of * - *
the (PTE* - *
BCL6 * - *
protein *) - *
on * - *
luciferase (PTE*) - (A0*)
expression * express (V*)
driven * - *
by * - *
the * - *
HIV-1 * - *
long * - *
terminal * - *
repeat * - *
( * - *
LTR (DNA*) - *
) * - *
sequences * - *
. * - *

We * - *
suggest * - *
that * - *
the * - *
combined * - *
presence * - *
of * - *
the (DNA* - *
two * - *
promoters *) - *
, * - *
the * - *
alternating * - *
palindrome * - *
structure * - *
and * - *
the * - *
factor * - *
for * - *
inversion * - *
stimulation-binding * - *
site * - *
, * - *
all * - *
permit * - *
the * - *
expression * express (V*)
of * - *
the * - (A0*
mazEF * - *
module * - *)
to * - *
be * - *
sensitively * - *
regulated * - *
under * - *
various * - *
growth * - *
conditions * - *
. * - *

Negative * - *
regulation * - *
of * - *
DNA * - *
repair * - *
gene * - *
( * - *
uvrA (DNA*) - (A0*)
) * - *
expression * express (V*)
by * - *
ArcA/ArcB * - *
two-component * - *
system * - *
in * - *
Escherichia (ORG* - *
coli *) - *
. * - *

Footprinting * - *
and * - *
gel-retardation * - *
experiments * - *
unambiguously * - *
demonstrated * - *
that * - *
TorR (PTE*) - (A1*)
binds * bind (V*)
to * - *
the (DNA* - (A0*
torC * - *
regulatory * - *
region *) - *)
. * - *

This * - * *
acid * - * *
resistance * - * *
was * - * *
abolished * - * *
by * - * *
deletion * delete (V*) *
of * - * *
ydeP (DNA*) - (A0*) *
, * - * *
ydeO (DNA*) - * *
, * - * *
or * - * *
yhiE (DNA*) - * *
, * - * *
which * - * *
was * - * *
induced * - * *
by * - * *
EvgA (PTE*) - * (A0*)
overexpression * overexpression * (V*)
. * - * *

We * - *
also * - *
found * - *
that * - *
there * - *
was * - *
another (PTE* - (A0*
protein * - *
( * - *
s * - *
) *) - *)
interacting * interact (V*)
with * - *
nCaREs (PTE* - (A0*
and * - *
ref1 *) - *)
. * - *

Thus * - *
, * - *
arsenite-induced * - *
up-regulation * - *
of * - *
VEGF * - (A0*
gene * - *)
transcription * transcription (V*)
occurs * - *
by * - *
an * - *
ATF4-dependent * - *
mechanism * - *
. * - *

As * - *
in * - *
the * - *
case * - *
of * - *
the * - *
GntI * - *
genes * - *
, * - *
such * - *
a * - *
cross-regulation * crossregulate (V*)
between * - *
the (PTE* - (A1*
GntI * - *
and * - *
GntII *) - *)
via * - *
the * - *
two * - *
regulators * - *
may * - *
be * - *
important * - *
for * - *
cells * - *
to * - *
grow * - *
with * - *
gluconate * - *
. * - *

It * - * * *
is * - * * *
possible * - * * *
that * - * * *
Fnr * - * * *
also * - * * *
indirectly * - * * *
affects * - * * *
some * - * * *
of * - * * *
the * - * * *
other * - * * *
members * - * * *
of * - * * *
the * - * * *
arcA * - * * *
modulon * - * * *
, * - * * *
e * - * * *
. * - * * *
g * - * * *
. * - * * *
, * - * * *
cyoABCDE (DNA*) - (A1*) * *
( * - * * *
encoding * encode (V*) * *
the (PTE* - (A0* * *
cytochrome * - * * *
o * - * * *
complex *) - *) * *
) * - * * *
, * - * * *
cydAB (DNA*) - * (A1*) *
( * - * * *
encoding * encode * (V*) *
the (PTE* - * (A0* *
cytochrome * - * * *
d * - * * *
complex *) - * *) *
) * - * * *
, * - * * *
and * - * * *
sodA (DNA*) - * * (A1*)
( * - * * *
encoding * encode * * (V*)
the (PTE* - * * (A0*
manganese-dependent * - * * *
superoxide * - * * *
dismutase *) - * * *)
) * - * * *
. * - * * *

Subsequent * - * *
genetic * - * *
analysis * - * *
revealed * - * *
that * - * *
this * - * *
phenotype * - * *
is * - * *
dependent * - * *
on * - * *
phosphorylation * - * *
of * - * *
the * - * *
response * - * *
regulator * - * *
CpxR * - * *
and * - * *
that * - * *
activation * activate (V*) *
of * - * *
CpxA (DNA*) - (A0*) *
in * - * *
wild-type (ORG* - (A2* *
cells *) - *) *
results * - * *
in * - * *
similar * - * *
regulation * - * *
of * - * *
porin * - * (A0*)
expression * express * (V*)
. * - * *

However * - *
, * - *
the * - *
Rcs * - *
system * - *
can * - *
potentially * - *
influence * - *
levels * - *
of * - *
capsular * - *
polysaccharide * - *
production * - *
by * - *
increasing * - *
galF (DNA*) - (A0*)
transcription * transcription (V*)
and * - *
influencing * - *
the * - *
available * - *
pool * - *
of * - *
biosynthetic * - *
precursors * - *
. * - *

Stationary-phase * - (A5*) * *
induction * induce (V*) * *
of * - * * *
osmY * - (A0*) * *
in * - (A2* * *
minimal * - * * *
medium * - *) * *
can * - * * *
be * - * * *
explained * - * * *
by * - * * *
stimulation * stimulate * (V*) *
by * - * * *
sigma (PTE* - * (A1* *
s *) - * *) *
combined * - * * *
with * - * * *
a * - * * *
relief * - * * *
of * - * * *
Lrp (PTE*) - * * (A1*)
repression * repress * * (V*)
. * - * * *

We * - *
conclude * - *
that * - *
the * - *
nrfA-acs * - *
intergenic * - *
region * - *
is * - *
folded * - *
into * - *
an * - *
ordered * - *
nucleoprotein * - *
structure * - *
that * - *
permits * - *
the (DNA* - (A0*
two * - *
divergent * - *
promoters *) - *)
to * - *
be * - *
regulated * regulate (V*)
independently * - (A5*)
in * - *
response * - *
to * - *
different * - (A3*
physiological * - *
signals * - *)
. * - *

Transcription * transcribe (V*) *
of * - * *
the (DNA* - (A0* (A1*
genes *) - *) *)
encoding * encode * (V*)
the (PTE* - * (A0*
glutamate * - * *
decarboxylases *) - * *)
and * - * *
the (PTE* - * *
substrate-product * - * *
antiporter *) - * *
required * - * *
for * - * *
this * - * *
system * - * *
is * - * *
induced * - * *
under * - * *
a * - * *
variety * - * *
of * - * *
conditions * - * *
, * - * *
including * - * *
the * - * *
stationary * - * *
phase * - * *
and * - * *
a * - * *
low * - * *
pH * - * *
. * - * *

Hence * - * *
, * - * *
tal * - (A1* *
and * - * *
lyl-1 * - *) *
encode * encode (V*) *
a (PTE* - (A0* *
distinct * - * *
family * - * *
of * - * *
helix-loop-helix * - * (A0*
proteins *) - *) *)
involved * involve * (V*)
in * - * *
the * - * (A4*
malignant * - * *
development * - * *)
of * - * *
lymphocytes * - * *
. * - * *

This * - * *
permitted * - * *
the * - * *
construction * - * *
of * - * *
single-copy (DNA* - (A10* *
lacZ * - * *
operon * - * *
fusions *) - *) *
, * - * *
which * - * *
were * - * *
used * - * *
to * - * *
examine * examine (V*) *
the * - (A0* *
transcriptional * - * *
regulation * regulation *) (V*)
of * - * *
the (DNA* - * (A0*
two * - * *
operons *) - * *)
. * - * (A5*)

CsrA (PTE*) - (A0* (A1*) (A1*)
activity * - *) * *
is * - * * *
antagonized * antagonize (V*) * *
by * - * * *
the (DNA* - (A1* (A0* *
untranslated * - * * *
RNA * - * * *
CsrB *) - *) *) *
, * - * * *
to * - * * *
which * - * * *
it * - * * *
binds * bind * (V*) *
and * - * * *
forms * form * * (V*)
a (PTE* - * * (A0*
globular * - * * *
ribonucleoprotein * - * * *
complex *) - * * *)
. * - * * *

This * - *
latter * - *
site * - *
has * - *
been * - *
reported * - *
to * - *
be * - *
important * - *
for * - *
ompF (DNA*) - (A0*)
repression * repress (V*)
. * - *

The (PTE* - * *
human * - * *
RNA * - * *
Pol * - * *
III * - * *
core *) - * *
lacking * - * *
the * - * *
subcomplex * - * *
functions * - * *
in * - * *
transcription (PRC*) - (A0*) *
elongation * elongate (V*) *
and * - * *
termination * - * *
following * - * *
nonspecific * - * (A5*)
initiation * initiate * (V*)
on * - * *
a * - * (A0*
tailed * - * *
template * - * *)
, * - * *
but * - * *
fails * - * *
to * - * *
show * - * *
promoter-dependent * - * *
transcription (PRC*) - * *
initiation * - * *
in * - * *
conjunction * - * *
with * - * *
accessory * - * *
factors * - * *
. * - * *

The * - *
degree * - *
of * - *
catabolite (EXP*) - (A5*)
repression * repress (V*)
for * - *
each * - *
of * - *
the * - *
operons * - *
was * - *
assessed * - *
using * - *
a * - *
similar * - *
system * - *
. * - *

In * - *
particular * - *
, * - *
the (DNA* - (A0*
HMG * - *
boxes *) - *)
encoded * encode (V*)
by * - *
the (DNA* - (A1*
two * - *
TCF * - *
genes *) - *)
are * - *
virtually * - *
identical * - *
. * - *

Spinal * - *
muscular * - *
atrophy * - *
( * - *
SMA (None*) - (A4*)
) * - *
is * - *
a * - *
common * - *
motor * - *
neuron * - *
degenerative * - *
disease * - *
that * - *
results * result (V*)
from * - *
reduced * - (A0*
levels * - *)
of * - *
, * - *
or * - *
mutations (PRC*) - *
in * - *
, * - *
the * - *
Survival * - *
of * - *
Motor (PTE* - *
Neurons *) - *
( * - *
SMN * - *
) * - *
protein * - *
. * - *

Two (None* - (A0*
soxRS * - *
constitutive * - *
mutants *) - *)
that * - *
were * - *
tested * - *
showed * show (V*)
elevated * - (A4*
levels * - *
of * - *
inaA * - *)
. (PTE*) - *

The (DNA* - (A1* *
clyA * - * *
gene *) - *) *
encodes * encode (V*) *
a (PTE* - (A0* (A0*
novel * - * *
haemolysin *) - *) *)
that * - * *
is * - * *
not * - * *
expressed * express * (V*)
by * - * *
wild-type (ORG* - * (A1*
E * - * *
. * - * *
coli *) - * *)
under * - * *
tested * - * (A3*
laboratory * - * *
conditions * - * *)
. * - * *

Expression * express (V*) (A0*)
of * - * *
the * - * *
fumarate * - * *
reductase * - * *
( * - * *
frdABCD (DNA*) - (A0*) *
) * - * *
operon * - * *
and * - * *
the * - * *
aerobic * - * *
C4-dicarboxylate * - * *
transporter * - * *
( * - * *
dctA (DNA*) - * *
) * - * *
gene * - * *
were * - * *
induced * induce * (V*)
22- * - * (A9*
and * - * *
4-fold * - * *)
, * - * *
respectively * - * *
, * - * *
by * - * *
the (PTE* - * (A1*
DcuS-DcuR * - * *
system *) - * *)
in * - * *
the * - * *
presence * - * *
of * - * *
C4-dicarboxylates (EXP*) - * (A3*)
. * - * *

We * - * *
conclude * - * *
that * - * *
the (PTE* - (A1* *
BCL6 * - * *
protein *) - *) *
can * - * *
bind * bind (V*) *
to * - * *
the (DNA* - (A0* *
HIV-1 * - * *
promoter-enhancer * - * *
region *) - *) *
and * - * *
contains * - * *
a * - * *
domain * - * *
upstream * - * *
of * - * *
its (PTE* - * *
zinc * - * *
fingers *) - * *
that * - * *
can * - * *
repress * - * *
transcription * transcription * (V*)
from * - * *
the (DNA* - * (A6*
HIV-1 * - * *
LTR *) - * *)
. * - * *

All (PTE* - *
previously * - *
identified * - *
E2F * - *
proteins *) - *
can * - *
act * - *
in * - *
a * - *
similar * - *
manner * - *
; * - *
depending * - *
on * - *
whether * - *
or * - *
not * - *
they * - *
are * - *
associated * - *
with * - *
the * - *
cell * - *
cycle * - *
inhibitors * - *
the * - *
retinoblastoma * - *
protein * - *
( * - *
pRB * - *
) * - *
, * - *
p107 * - *
, * - *
or * - *
p130 * - *
, * - *
they * - *
can * - *
either * - *
repress * - *
or * - *
activate * - *
the * - *
transcription * transcription (V*)
of * - *
E2F-responsive (DNA* - (A0*
genes *) - *)
. * - *

The (PTE* - (A1*
global * - *
regulatory * - *
protein * - *
FruR *) - *)
modulates * modulate (V*)
the * - (A0*
direction * - *
of * - *
carbon * - *
flow * - *)
in * - (A2*
Escherichia (ORG* - *
coli *) - *)
. * - *

This * - * *
implies * - * *
that * - * *
prothymosin * - (A0* (A0*
alpha * - *) *)
and * - * *
parathymosin * - * *
are * - * *
involved * involve (V*) (V*)
in * - * *
transcription (PRC*) - (A4*) *
and * - * *
replication * - * (A4*)
, * - * *
respectively * - * *
. * - * *

Mutations * mutate (V*)
in * - *
any * - *
of * - *
the (DNA* - (A0*
three * - *
high-affinity * - *
binding * - *
sites *) - *)
reduced * - *
both * - *
malEp (PRC* - *
and * - *
malKp * - *
activity *) - *
. * - *

These * - *
results * - *
suggest * - *
that * - *
the * - *
ArcA/ArcB * - *
two-component * - *
system * - *
works * - *
to * - *
negatively * - *
regulate * - *
uvrA (DNA* - (A0*
gene *) - *)
expression * express (V*)
. * - *

The (PTE* - (A0* *
monomeric * - * *
beta * - * *
subunit *) - *) *
is * - * *
ubiquitously * - (A5*) *
expressed * express (V*) *
, * - * *
whereas * - * *
expression * express * (V*)
of * - * *
the (PTE* - * (A0*
three * - * *
alpha * - * *
subunits *) - * *)
isolated * - * *
previously * - * *
seems * - * *
to * - * *
be * - * *
restricted * - * *
mainly * - * *
to * - * *
hematopoietic * - * *
tissues * - * *
. * - * *

Thus * - * * * * * *
, * - * * * * * *
ISGF3 (PTE* - (A1* * * * * *
assembly *) - *) * * * * *
involves * involve (V*) * * * * *
p48 (PTE*) - (A0*) (A1*) * * * *
functioning * - * * * * * *
as * - * * * * * *
an (PTE* - * * * * * *
adaptor * - * * * * * *
protein *) - * * * * * *
to * - * * * * * *
recruit * recruit * (V*) * * * *
Stat1 (PTE*) - * (A0*) * * * *
and * - * * * * * *
Stat2 (PTE*) - * * * * * *
to * - * * * * * *
an (DNA* - * (A7* * * * *
IFN-alpha-stimulated * - * * * * * *
response * - * * * * * *
element *) - * *) * * * *
, * - * * * * * *
Stat2 (PTE*) - * * (A1*) (A1*) * *
contributes * contribute * * (V*) * * *
a * - * * (A0* * * *
potent * - * * * * * *
transactivation * - * * * * * *
domain * - * * *) * * *
but * - * * * * * *
is * - * * * * * *
unable * - * * * * * *
to * - * * * * * *
directly * - * * * (A5*) * *
contact * contact * * * (V*) * *
DNA (DNA*) - * * * (A0*) * *
, * - * * * * * *
while * - * * * * * *
Stat1 (PTE*) - * * * * (A1*) (A1*)
stabilizes * stabilize * * * * (V*) *
the (PTE* - * * * * (A0* *
heteromeric * - * * * * * *
complex *) - * * * * *) *
by * - * * * * * *
contacting * contact * * * * * (V*)
DNA (DNA*) - * * * * * (A0*)
directly * - * * * * * (A5*)
. * - * * * * * *

A * - *
scheme * - *
was * - *
devised * - *
to * - *
select * - *
mutants (None*) - *
that * - *
exhibited * - *
high * - (A5*
constitutive * - *)
expression * express (V*)
of * - *
the (DNA* - (A0*
tdh * - *
promoter *) - *)
. * - *

A (DNA* - (A0*
strong * - *
CAP * - *
binding * - *
site *) - *)
exists * exist (V*)
between * - (A2*
the (DNA* - *
two * - *
operator * - *
sites *) - *)
. * - *

Expression * express (V*)
of * - *
micF (DNA*) - (A0*)
, * - *
which * - *
lowers * - *
ompF * - *
mRNA * - *
levels * - *
, * - *
was * - *
elevated * - *
in * - *
Mar (None* - *
strains *) - *
, * - *
as * - *
revealed * - *
by * - *
a * - *
micF-lacZ * - *
fusion * - *
. * - *

Interaction * interact (V*)
at * - *
a * - *
distance * - *
between * - *
multiple (DNA* - (A1*
operators *) - *)
controls * - *
the (DNA* - *
adjacent * - *
, * - *
divergently * - *
transcribed * - *
glpTQ-glpACB * - *
operons *) - *
of * - *
Escherichia * - *
coli * - *
K-12 * - *
. * - *

The (DNA* - (A0* (A0*
gntT * - * *
gene *) - *) *)
of * - * *
Escherichia * - * *
coli * - * *
is * - * *
specifically * - * *
induced * induce (V*) *
by * - * *
gluconate (EXP*) - (A1*) *
and * - * *
repressed * repress * (V*)
via * - * *
catabolite * - * (A5*
repression * - * *)
. * - * *

In * - *
Northern * - *
blot * - *
analysis * - *
, * - *
a (DNA* - (A0*
single * - *
transcript *) - *)
of * - *
approximately * - *
5 * - *
kb * - *
was * - *
highly * - *
expressed * express (V*)
in * - (A2*
spleen * - *
and * - *
peripheral * - *
blood * - *
lymphocyte * - *)
. (ORG*) - *

Hierarchical * - *
control * - *
of * - *
anaerobic * - *
gene * - *
expression * - *
in * - *
Escherichia * - *
coli * - *
K-12 * - *
: * - *
the * - *
nitrate-responsive * - *
NarX-NarL * - *
regulatory * - *
system * - *
represses * - *
synthesis * synthesize (V*)
of * - *
the * - (A0*
fumarate-responsive * - *
DcuS-DcuR * - *
regulatory * - *
system * - *)
. * - *

These * - *
studies * - *
have * - *
implications * - *
for * - *
the * - *
control * - *
of * - *
gene * - *
expression * express (V*)
of * - *
unlinked (DNA* - (A0*
multigene * - *
families *) - *)
. * - *

The (DNA* - (A0*
promoter * - *
P * - *
( * - *
cer * - *
) *) - *)
, * - *
located * - *
centrally * - *
within * - *
cer * - *
, * - *
is * - *
also * - *
required * require (V*)
for * - *
stable * - (A11*
plasmid * - *
maintenance * - *)
. * - *

A * - (A0* (A1* *
sequence * - * * *
motif * - *) *) *
, * - * * *
conserved * - * * *
between * - * * *
the * - * * *
E * - * * *
. * - * * *
coli * - * * *
cps * - * * *
promoter * - * * *
and * - * * *
the * - * * *
Erwinia * - * * *
amylovora * - * * *
ams * - * * *
promoter * - * * *
and * - * * *
previously * - * * *
shown * - * * *
to * - * * *
be * - * * *
the * - * * *
RcsA-RcsB * - * * *
binding * - * * *
site * - * * *
, * - * * *
was * - * * *
identified * identify (V*) * *
in * - (A2* * *
the (DNA* - * * *
rcsA * - * * *
promoter * - * * *
region *) - *) * *
and * - * * *
shown * - * * *
to * - * * *
be * - * * *
required * require * (V*) *
for * - * * *
high-level * - * (A0* *
expression * express * *) (V*)
of * - * * *
rcsA (DNA*) - * * (A0*)
. * - * * *

In * - *
contrast * - *
, * - *
in * - *
the * - *
case * - *
of * - *
cydAB * - *
, * - *
for * - *
which * - *
ArcA-P (PTE*) - (A0*)
is * - *
expected * - *
to * - *
function * function (V*)
as * - *
a (PTE* - (A4*
transcriptional * - *
activator *) - *)
, * - *
two * - *
discrete * - *
binding * - *
sites * - *
have * - *
been * - *
identified * - *
upstream * - *
of * - *
a * - *
known * - *
promoter * - *
, * - *
and * - *
activation * - *
from * - *
these * - *
sites * - *
is * - *
likely * - *
to * - *
be * - *
mediated * - *
by * - *
a * - *
mechanism * - *
typical * - *
of * - *
the * - *
type * - *
I * - *
class * - *
of * - *
prokaryotic * - *
transcriptional * - *
activators * - *
. * - *

This * - * * *
inhibition * - * * *
was * - * * *
reversed * - * * *
by * - * * *
increasing * - * * *
the * - * * *
concentration * - * * *
of * - * * *
OmpR (PTE*) - * * *
, * - * * *
a * - * * *
positive * - * * *
activator * - * * *
required * - * * *
for * - * * *
ompF (DNA*) - (A0*) * *
expression * express (V*) * *
, * - * * *
suggesting * - * * *
that * - * * *
IHF (PTE*) - * * *
may * - * * *
inhibit * - * * *
ompF (DNA*) - * (A0*) *
transcription * transcription * (V*) *
by * - * * *
altering * - * * *
how * - * * *
OmpR (PTE*) - * * (A1*)
interacts * interact * * (V*)
with * - * * *
the (DNA* - * * (A1*
ompF * - * * *
promoter *) - * * *)
. * - * * *

We * - * * * *
propose * - * * * *
therefore * - * * * *
that * - * * * *
a * - * * * *
physiological * - * * * *
role * - * * * *
of * - * * * *
CRP-cAMP (PTE*) - (A1*) * * *
activation * activate (V*) * * *
of * - * * * *
glnAp1 (DNA*) - (A0*) * * *
is * - * * * *
to * - * * * *
partially * - * * * *
compensate * - * * * *
for * - * * * *
CRP-cAMP (PTE*) - * (A1*) * *
downregulation * downregulate * (V*) * *
of * - * * * *
glnAp2 (DNA*) - * (A0*) * *
, * - * * * *
allowing * - * * * *
a * - * * * *
low * - * * * *
but * - * * * *
non-negligible * - * * * *
level * - * * * *
of * - * * * *
expression * express * * (V*) *
of * - * * * *
the (DNA* - * * (A0* (A0*
important * - * * * *
genes *) - * * *) *)
transcribed * transcribe * * * (V*)
from * - * * * *
it * - * * * *
. * - * * * *

Band-shift * - *
assays * - *
with * - *
purified * - *
CpxR (PTE*) - (A1*)
proteins * - *
indicate * - *
that * - *
CpxR * - *
binds * bind (V*)
to * - *
the (DNA* - (A7*
csgD * - *
promoter * - *
region *) - *)
at * - *
multiple * - *
sites * - *
that * - *
are * - *
ideally * - *
positioned * - *
to * - *
explain * - *
the * - *
csg * - *
repression * - *
activity * - *
of * - *
CpxR * - *
. * - *

In * - * *
this * - * *
report * - * *
we * - * *
present * - * *
evidence * - * *
that * - * *
there * - * *
is * - * *
a * - * *
regulatory * - * *
loop * - * *
involving * - * *
cross-repression * crossrepress (V*) *
of * - * *
two * - * *
AraC-like * - * *
regulators * - * *
, * - * *
GadX (PTE*) - (A0*) *
and * - * *
GadW (PTE*) - * *
, * - * *
that * - * *
can * - * *
either * - * *
assist * - * *
or * - * *
interfere * - * *
with * - * *
GadE * - * (A1*)
activation * activate * (V*)
of * - * *
the (DNA* - * (A0*
gad * - * *
decarboxylase * - * *
and * - * *
antiporter * - * *
genes *) - * *)
, * - * *
depending * - * *
on * - * *
the * - * *
culture * - * *
conditions * - * *
. * - * *

Using * - *
DNase * - *
I * - *
footprinting * - *
, * - *
we * - *
demonstrated * - *
that * - *
CpxR (PTE*) - (A1*)
binds * bind (V*)
upstream * - (A7*)
of * - *
both * - *
the (DNA* - *
ompF * - *
and * - *
ompC * - *
promoters *) - *
. * - *

The * - * (A0*
transposon * - * *)
giving * - * *
rise * - * *
to * - * *
the * - * *
altered * - * *
expression * express (V*) *
of * - * *
lysU (DNA*) - (A0*) *
was * - * *
found * - * *
inserted * insert * (V*)
within * - * (A2*
lrp * - * *)
. (DNA*) - * *

The * - * *
addition * add (V*) *
of * - * *
IHF (PTE*) - (A0*) *
to * - * *
a (EXP* - (A7* *
purified * - * *
in * - * *
vitro * - * *
transcription * - * *
system *) - *) *
inhibited * - * *
transcription * transcription * (V*)
from * - * *
two (DNA* - * (A6*
of * - * *
the * - * *
three * - * *
ompC * - * *
promoters *) - * *)
. * - * *

These * - * *
findings * - * *
are * - * *
consistent * - * *
with * - * *
previous * - * *
observations * - * *
that * - * *
acnA (DNA*) - (A0*) *
is * - * *
specifically * - * *
subject * - * *
to * - * *
SoxRS-mediated * - (A3*) *
activation * activate (V*) *
, * - * *
whereas * - * *
acnB (DNA*) - * (A1*)
encodes * encode * (V*)
the (PTE* - * (A0*
major * - * *
aconitase *) - * *)
that * - * *
is * - * *
synthesized * - * *
earlier * - * *
in * - * *
the * - * *
growth * - * *
cycle * - * *
than * - * *
AcnA * - * *
. * - * *

The (DNA* - (A0* (A0*
P5 * - * *
promoter *) - *) *)
is * - * *
not * - * *
Fnr (PTE*) - (A1*) *
regulated * regulate (V*) *
and * - * *
is * - * *
only * - * *
weakly * - * *
activated * activate * (V*)
by * - * *
ArcA (PTE*) - * (A1*)
. * - * *

The * - *
napF * - *
operon * - *
control * - *
region * - *
exhibits * - *
unusual * - *
organization * - *
of * - *
DNA * - *
binding * - *
sites * - *
for * - *
the (PTE* - (A1*
transcription * - *
regulators * - *
Fnr * - *
and * - *
NarP *) - *)
, * - *
which * - *
activate * activate (V*)
transcription (PRC*) - (A0*)
in * - *
response * - *
to * - *
anaerobiosis * - (A3*
and * - *
nitrate * - *)
, * - *
respectively * - *
. * - *

In * - * (A2*
Escherichia (ORG* - * *
coli *) - * *)
, * - * *
glnA (DNA*) - (A1*) (A0*)
( * - * *
encoding * encode (V*) *
glutamine (PTE* - (A0* *
synthetase *) - *) *
) * - * *
is * - * *
transcribed * transcribe * (V*)
from * - * *
two * - * *
promoters * - * *
( * - * *
glnAp1 (DNA*) - * (A6*)
and * - * *
glnAp2 (DNA*) - * *
) * - * *
. * - * *

ptsG (DNA*) - (A0*)
transcription * transcription (V*)
was * - *
induced * - *
when * - *
wild-type (ORG* - *
cells *) - *
were * - *
grown * - *
in * - *
the * - *
presence * - *
of * - *
glucose (EXP*) - *
. * - *

Activation (PTE* - (A0* *
domain * - * *
1 *) - *) *
consists * - * *
of * - * *
the * - * *
most * - * *
C-terminal * - * *
23 * - * *
amino * - * *
acids * - * *
of * - * *
FREAC-2 * - * *
and * - * *
contains * contain (V*) *
a (PTE* - (A4* (A0*
sequence * - * *
motif *) - *) *)
conserved * conserve * (V*)
in * - * (A2*
an (PTE* - * *
activation * - * *
domain *) - * *)
of * - * *
another * - * *
forkhead * - * *
protein * - * *
, * - * *
FREAC-1 * - * *
. * - * *

NagC (PTE*) - (A1*) * *
binding * bind (V*) * *
produces * - * * *
a * - * * *
series * - * * *
of * - * * *
DNase * - * * *
I * - * * *
hypersensitive * - * * *
sites * - * * *
separated * - * * *
by * - * * *
9 * - * * *
to * - * * *
11 * - * * *
bp * - * * *
in * - * * *
the * - * * *
region * - * * *
between * - * * *
the * - * * *
two * - * * *
NagC * - * * *
binding * - * * *
sites * - * * *
, * - * * *
supporting * - * * *
a * - * * *
model * - * * *
where * - * * *
the (PTE* - * (A1* (A1*
NagC * - * * *
proteins *) - * *) *)
bind * bind * (V*) *
co-operatively * - * (A5*) *
to * - * * *
these (DNA* - * (A7* *
two * - * * *
sites *) - * *) *
on * - * * *
the * - * * *
DNA * - * * *
and * - * * *
interact * interact * * (V*)
to * - * * *
form * - * * *
a * - * * *
DNA * - * * *
loop * - * * *
. * - * * *

Aspartate * - * (A1*) *
is * - * * *
one * - * * *
of * - * * *
several * - (A0* * *
attractant * - * * *
ligands * - *) * *
normally * - * * *
sensed * sense (V*) * *
by * - * * *
Tar (PTE*) - (A1*) * *
and * - * * *
it * - * * *
interacts * interact * (V*) *
with * - * * *
Taz * - * (A1*) *
to * - * * *
induce * - * * *
OmpR-dependent * - * * (A5*)
transcription * transcription * * (V*)
from * - * * *
the * - * * *
ompC * - * * *
promoter--albeit * - * * *
with * - * * *
reduced * - * * *
sensitivity * - * * *
relative * - * * *
to * - * * *
the * - * * *
chemotactic * - * * *
response * - * * *
it * - * * *
evokes * - * * *
via * - * * *
Tar * - * * *
. (DNA*) - * * (A6*)

spi-B (DNA*) - (A0*)
, * - *
like * - *
spi-1 (DNA*) - *
, * - *
was * - *
found * - *
to * - *
be * - *
expressed * express (V*)
in * - (A2*
various (ORG* - *
murine * - *
and * - *
human * - *
hematopoietic * - *
cell * - *
lines *) - *)
except * - *
T * - *
lymphoid * - *
cell * - *
lines * - *
. * - *

Recent * - * *
studies * - * *
have * - * *
revealed * - * *
that * - * *
interactions * interact (V*) *
between * - * *
transcription (PTE* - (A1* *
factors *) - *) *
play * - * *
an * - * *
important * - * *
role * - * *
in * - * *
regulation * - * *
of * - * *
gene (DNA*) - * (A0*)
expression * express * (V*)
in * - * (A2*
eukaryotic (ORG* - * *
cells *) - * *)
. * - * *

NagC (PTE*) - (A1*) * *
represses * repress (V*) * *
nagE (DNA*) - (A0*) (A1*) *
, * - * * *
encoding * encode * (V*) *
the (PTE* - * (A0* *
N * - * * *
: * - * * *
-acetylglucosamine-specific * - * * *
transporter *) - * *) *
, * - * * *
while * - * * *
Mlc * - * * (A1*)
represses * repress * * (V*)
three * - * * *
PTS * - * * *
operons * - * * *
, * - * * *
ptsG (DNA*) - * * (A0*)
, * - * * *
manXYZ (DNA*) - * * *
and * - * * *
ptsHIcrr (DNA*) - * * *
, * - * * *
involved * - * * *
in * - * * *
the * - * * *
uptake * - * * *
of * - * * *
glucose * - * * *
. * - * * *

Whereas * - * *
sigma (PTE* - (A0* *
s *) - *) *
, * - * *
Lrp (PTE*) - * *
, * - * *
CRP (PTE*) - * *
, * - * *
and * - * *
IHF (PTE*) - * *
are * - * *
clearly * - * *
involved * involve (V*) *
in * - * *
stationary-phase (PRC* - (A4* *
induction *) - *) *
, * - * *
none * - * *
of * - * *
these * - * *
regulators * - * *
is * - * *
essential * - * *
for * - * *
osmotic * - * (A5*)
regulation * regulation * (V*)
of * - * *
osmY (DNA*) - * (A0*)
. * - * *

Polymerases (PTE*) - (A1*) (A1*)
that * - * *
initiate * initiate (V*) *
transcription (PRC*) - (A0*) *
with * - * *
RSF * - * *
can * - * *
only * - * *
extend * extend * (V*)
their (DNA* - * (A0*
transcripts *) - * *)
in * - * *
the * - * *
presence * - * *
of * - * *
FACT (PTE*) - * (A3*)
( * - * *
facilitates * - * *
chromatin * - * *
transcription * - * *
) * - * *
. * - * *

Escherichia * - * *
coli * - * *
group * - * *
1 * - * *
capsules * - * *
are * - * *
important * - * *
virulence * - * *
determinants * - * *
, * - * *
yet * - * *
little * - * *
is * - * *
known * - * *
about * - * *
the * - * *
transcriptional * - * *
organization * organize (V*) *
or * - * *
regulation * regulation * (V*)
of * - * *
their * - * *
biosynthetic * - * *
( (DNA* - (A0* (A0*
cps * - * *
) * - * *
operons *) - *) *)
. * - * *

The (DNA* - (A0*
upstream * - *
region *) - *)
of * - *
the * - *
human * - *
homeobox * - *
gene * - *
HOX3D * - *
is * - *
a * - *
target * - *
for * - *
regulation * regulation (V*)
by * - *
retinoic (PTE* - (A1*
acid * - *
and * - *
HOX * - *
homeoproteins *) - *)
. * - *

Some * - *
amino * - *
acids * - *
( * - *
Leu (PTE*) - *
, * - *
Met (PTE*) - *
, * - *
Val (PTE*) - *
and * - *
Ser (PTE*) - *
) * - *
reduced * - *
GFP (PTE*) - (A0*)
expression * express (V*)
, * - *
which * - *
in * - *
the * - *
case * - *
of * - *
leucine (PTE*) - *
is * - *
likely * - *
attributed * - *
to * - *
a * - *
direct * - *
effect * - *
on * - *
the * - *
receptor * - *
, * - *
rather * - *
than * - *
an * - *
indirect * - *
effect * - *
through * - *
the * - *
leucine * - *
responsive * - *
protein * - *
( * - *
Lrp * - *
) * - *
. * - *

Our * - * *
results * - * *
suggest * - * *
a * - * *
unique * - * *
repression * - * *
model * - * *
, * - * *
in * - * *
which * - * *
one (PTE* - (A1* (A1*
Fnr * - * *
dimer *) - *) *)
bound * bound (V*) *
to * - * *
one * - * *
single * - * *
site * - * *
( * - * *
Fnr-2 (DNA*) - (A7*) *
) * - * *
is * - * *
sufficient * - * *
to * - * *
downregulate * downregulate * (V*)
transcription (PRC*) - * (A0*)
from * - * *
four (DNA* - * (A6*
cydAB * - * *
promoters *) - * *)
. * - * *

spi-B (DNA*) - (A1*)
codes * code (V*)
for * - *
a (PTE* - (A0*
protein *) - *)
of * - *
262 * - *
amino * - *
acids * - *
presenting * - *
43% * - *
overall * - *
identity * - *
with * - *
Spi-1 * - *
. * - *

The (PTE* - (A0*
dimeric * - *
histone-like * - *
protein * - *
HU *) - *)
, * - *
one * - *
of * - *
the * - *
most * - *
abundant * - *
DNA * - *
binding * - *
proteins * - *
of * - *
Escherichia * - *
coli * - *
, * - *
is * - *
encoded * encode (V*)
by * - *
two * - *
closely * - *
related * - *
but * - *
unlinked * - *
genes * - *
, * - *
hupA (DNA*) - (A1*)
and * - *
hupB (DNA*) - *
. * - *

Thus * - *
, * - *
these (PTE* - (A1*
two * - *
orphans *) - *)
may * - *
require * require (V*)
an * - *
as * - *
yet * - (A0*
unidentified * - *
ligand * - *)
or * - *
other * - *
signal * - *
for * - *
such (PRC* - (A11*
activation *) - *)
. * - *

Transcriptional * - *
control * - *
of * - *
the (DNA* - (A1*
himA * - *
and * - *
the * - *
himD/hip * - *
genes *) - *)
coding * code (V*)
for * - *
the (PTE* - (A0*
two * - *
subunits *) - *)
of * - *
the * - *
integration * - *
host * - *
factor * - *
( * - *
IHF * - *
) * - *
was * - *
investigated * - *
. * - *

Chromosomal * - *
localization * - *
of * - *
genes (DNA*) - (A1*)
encoding * encode (V*)
the * - *
transcription * - *
factors * - *
, * - *
c-rel (PTE*) - (A0*)
, * - *
NF-kappa (PTE* - *
Bp50 *) - *
, * - *
NF-kappa (PTE*) - *
Bp65 (PTE*) - *
, * - *
and * - *
lyt-10 (PTE*) - *
by * - *
fluorescence * - *
in * - *
situ * - *
hybridization * - *
. * - *

The * - * *
sensor-regulator * - * *
pair * - * *
, * - * *
ArcB-ArcA (PTE*) - (A1*) *
, * - * *
is * - * *
responsible * - * *
for * - * *
the * - * *
microaerobic * - (A5*) *
activation * activate (V*) *
of * - * *
the (DNA* - (A0* (A0*
cydAB * - * *
operon *) - *) *)
, * - * *
whereas * - * *
the (PTE* - * *
anaerobic * - * *
regulator * - * *
Fnr *) - * *
represses * - * *
its * - * *
expression * express * (V*)
in * - * *
the * - * *
absence * - * *
of * - * *
oxygen (EXP*) - * *
. * - * *

In * - * *
vivo * - * *
and * - * *
in * - * *
vitro * - * *
experiments * - * *
are * - * *
reported * - * *
demonstrating * - * *
that * - * *
the * - * *
catabolite * - * *
repressor-activator * - * *
( * - * *
Cra (PTE*) - * *
) * - * *
protein * - * *
( * - * *
formerly * - * *
designated * - * *
FruR * - * *
) * - * *
regulates * - * *
expression * express (V*) *
of * - * *
the (DNA* - (A0* (A1*
cydAB * - * *
operon *) - *) *)
of * - * *
Escherichia * - * *
coli * - * *
encoding * encode * (V*)
cytochrome (PTE* - * (A0*
d * - * *
oxidase *) - * *)
. * - * *

We * - *
propose * - *
that * - *
SF-1 (PTE*) - (A1*)
regulates * regulate (V*)
MIS (DNA*) - (A0*)
in * - (A5*
vivo * - *)
and * - *
participates * - *
directly * - *
in * - *
the * - *
process * - *
of * - *
mammalian * - *
sex * - *
determination * - *
. * - *

Eukaryotes * - *
respond * - *
to * - *
the * - *
presence * - *
of * - *
unfolded * - *
protein * - *
in * - *
the * - *
endoplasmic * - *
reticulum * - *
( * - *
ER * - *
) * - *
by * - *
up-regulating * - *
the * - *
transcription * - *
of * - *
genes (DNA*) - (A1*)
encoding * encode (V*)
ER (PTE* - (A0*
protein * - *
chaperones *) - *)
, * - *
such * - *
as * - *
BiP * - *
. * - *

Transcriptional * - (A5*)
regulation * regulation (V*)
of * - *
the * - *
aconitase * - *
genes * - *
( * - *
acnA (DNA*) - (A0*)
and * - *
acnB (DNA*) - *
) * - *
of * - *
Escherichia * - *
coli * - *
. * - *

Expression * express (V*) * *
of * - * * *
sdhCDAB (DNA*) - (A0*) (A1*) *
( * - * * *
encoding * encode * (V*) *
succinate (PTE* - * (A0* *
dehydrogenase *) - * *) *
) * - * * *
and * - * * *
lctD (DNA*) - * * (A1*)
( * - * * *
encoding * encode * * (V*)
the (PTE* - * * (A0*
flavin-linked * - * * *
L-lactate * - * * *
dehydrogenase *) - * * *)
) * - * * *
is * - * * *
elevated * - * * *
aerobically * - * * *
and * - * * *
repressed * - * * *
anaerobically * - * * *
in * - * * *
Escherichia (ORG* - * * *
coli *) - * * *
. * - * * *

The * - *
production * produce (V*)
of * - *
repressor (PTE* - (A0*
proteins *) - *)
and * - *
of * - *
a (PTE* - *
Trp * - *
repressor-LacZ * - *
chimera *) - *
was * - *
readily * - *
detected * - *
, * - *
at * - *
levels * - *
comparable * - *
to * - *
those * - *
of * - *
haploid * - *
trpR+ * - *
or * - *
tyrR+ * - *
E * - *
. * - *
coli * - *
strains * - *
. * - *

We * - *
have * - *
identified * - *
two * - *
new * - *
isoforms * - *
of * - *
the * - *
transcription * - *
factor * - *
NFAT1 * - *
( * - *
previously * - *
termed * - *
NFATp * - *
) * - *
that * - *
are * - *
the * - (A0*
predominant * - *
isoforms * - *)
expressed * express (V*)
in * - (A2*
murine (ORG* - *
and * - *
human * - *
T * - *
cells *) - *)
. * - *

Purified (PTE* - *
FHLA *) - *
, * - *
the * - *
transcriptional * - *
activator * - *
of * - *
the * - *
formate * - *
regulon * - *
from * - *
Escherichia * - *
coli * - *
, * - *
is * - *
able * - *
to * - *
efficiently * - *
stimulate * - *
transcription * transcription (V*)
from * - *
the (DNA* - (A6*
sigma * - *
54-dependent * - *
promoters *) - *)
of * - *
the * - *
fdhF * - *
, * - *
hyp * - *
, * - *
and * - *
hyc * - *
transcriptional * - *
units * - *
. * - *

Experiments * - *
presented * - *
here * - *
indicate * - *
that * - *
Bcl-3 (DNA*) - *
is * - *
inducible * - *
by * - *
DNA * - *
damage * - *
and * - *
is * - *
required * - *
for * - *
the * - *
induction * - *
of * - *
Hdm2 * - (A0*
gene * - *)
expression * express (V*)
and * - *
the * - *
suppression * - *
of * - *
persistent * - *
p53 * - *
activity * - *
. * - *

While * - * *
expression * express (V*) *
of * - * *
the (PTE* - (A0* (A1*
full-length * - * *
SUPT3H *) - *) *)
is * - * *
unable * - * (A5*)
to * - * *
complement * complement * (V*)
an (PRC* - * (A0*
spt3Delta * - * *
mutation *) - * *)
, * - * *
expression * - * *
of * - * *
a (DNA* - * *
human-yeast * - * *
chimeric * - * *
gene *) - * *
that * - * *
contains * - * *
42% * - * *
human * - * *
sequences * - * *
can * - * *
partially * - * *
complement * - * *
an * - * *
spt3Delta * - * *
mutation * - * *
. * - * *

Characterization * - *
of * - *
the (DNA* - (A1*
gntT * - *
gene *) - *)
encoding * encode (V*)
a (PTE* - (A0*
high-affinity * - *
gluconate * - *
permease *) - *)
in * - (A2*
Escherichia (ORG* - *
coli *) - *)
. * - *

In * - *
addition * - *
, * - *
it * - *
has * - *
been * - *
found * - *
that * - *
AP-2 (PTE*) - (A1*)
binds * bind (V*)
to * - *
the (PTE* - (A0*
SV40 * - *
T-antigen *) - *)
. * - *

Stat2 (PTE*) - * (A1*)
is * - * *
a (PTE* - * *
transcriptional * - * *
activator *) - * *
that * - * *
requires * - * *
sequence-specific * - (A5*) *
contacts * contact (V*) *
provided * - * *
by * - * *
stat1 (PTE*) - * *
and * - * *
p48 (PTE*) - * *
for * - * *
stable * - * *
interaction * interact * (V*)
with * - * *
DNA (DNA*) - * (A1*)
. * - * *

A * - (A0*
subset * - *)
also * - *
requires * - *
the (PTE* - (A3*
cyclic * - *
AMP * - *
receptor * - *
protein *) - *)
for * - *
transcription * transcription (V*)
. * - *

We * - *
have * - *
isolated * - *
a (None* - *
strain *) - *
carrying * - *
a * - *
fusion * fuse (V*)
of * - *
the (DNA* - (A0*
beta-galactosidase * - *
structural * - *
gene *) - *)
to * - *
the (DNA* - (A4*
promoter *) - *
of * - *
the (DNA* - *
uxuR * - *
regulatory * - *
gene *) - *)
with * - *
the * - *
aid * - *
of * - *
the * - *
Casadaban * - *
Mud * - *
( * - *
Aprlac (DNA*) - (A10*)
) * - *
phage * - *
. * - *

The (DNA* - (A0*
ula * - *
regulon *) - *)
, * - *
responsible * - *
for * - *
the * - *
utilization * - *
of * - *
L-ascorbate * - *
in * - *
Escherichia * - *
coli * - *
, * - *
is * - *
formed * form (V*)
by * - *
two * - *
divergently * - *
transcribed * - *
operons * - *
, * - *
ulaG (DNA* - (A1*
and * - *
ulaABCDEF *) - *)
. * - *

Overexpression * overexpress (V*)
of * - *
the (DNA* - (A0*
sfs1 * - *
gene *) - *)
in * - (A2*
MK2001 * - *)
resulted * - *
in * - *
a * - *
10-fold * - *
increase * - *
of * - *
amylomaltase * - *
, * - *
which * - *
was * - *
still * - *
dependent * - *
on * - *
MalT * - *
. (ORG*) - *

In * - *
addition * - *
, * - *
the (DNA* - *
OmpC- * - *
phenotype *) - *
of * - *
certain * - *
strains * - *
is * - *
completely * - *
suppressed * - *
by * - *
a * - *
mutation * mutation (V*)
in * - (A2*
IHF * - *)
. (PTE*) - *

Operators (DNA*) - (A1*)
in * - *
the * - *
control * - *
regions * - *
of * - *
operons * - *
concerned * - *
with * - *
carbon * - *
metabolism * - *
bound * bound (V*)
FruR (PTE*) - (A7*)
, * - *
while * - *
those * - *
in * - *
operons * - *
not * - *
concerned * - *
with * - *
carbon * - *
metabolism * - *
did * - *
not * - *
. * - *

GBX2 (DNA*) - (A0*) *
activation * activate (V*) *
by * - * *
c-Myb (PTE*) - (A1*) *
requires * - * *
signal * - * *
transduction * - * *
emanating * - * *
from * - * *
the * - * *
cell * - * *
surface * - * *
while * - * *
the (DNA* - * (A1*
leukemogenic * - * *
AMV * - * *
v-Myb *) - * *)
constitutively * - * (A5*)
induces * induce * (V*)
the (DNA* - * (A0*
GBX2 * - * *
gene *) - * *)
. * - * *

Stationary-phase * - (A5*) *
induction * induce (V*) *
of * - * *
osmY (DNA*) - (A0*) *
in * - (A2* *
rich * - * *
medium * - *) *
is * - * *
mediated * - * *
by * - * *
the * - * *
combined * - * *
action * - * *
of * - * *
sigma (PTE* - * *
s *) - * *
, * - * *
Lrp (PTE*) - * (A1*)
, * - * *
cAMP-CRP (PTE*) - * *
, * - * *
and * - * *
IHF (PTE*) - * *
, * - * *
with * - * *
the * - * *
latter * - * *
three * - * *
proteins * - * *
acting * act * (V*)
as * - * *
transition (PTE* - * (A8*
state * - * *
regulators *) - * *)
. * - * *

The (DNA* - (A1*
rot * - *
gene *) - *)
in * - (A2*
Escherichia (ORG* - *
coli *) - *)
encodes * encode (V*)
PPIase (PTE* - (A0*
A *) - *)
, * - *
a * - *
periplasmic * - *
peptidyl-prolyl * - *
cis-trans * - *
isomerase * - *
with * - *
homology * - *
to * - *
the * - *
cyclophilin * - *
family * - *
of * - *
proteins * - *
. * - *

Expression * express (V*)
of * - *
the (DNA* - (A0*
himD/hip * - *
and * - *
himA * - *
genes *) - *)
was * - *
found * - *
to * - *
be * - *
subject * - *
to * - *
negative * - *
autoregulation * - *
. * - *

Furthermore * - * *
, * - * *
constitutive * - * *
expression * express (V*) *
of * - * *
Bcl-3 (DNA*) - (A0*) *
suppresses * - * *
DNA * - * *
damage-induced * - * *
p53 * - * *
activation * - * *
and * - * *
inhibits * - * *
p53-induced * - * *
apoptosis * - * *
through * - * *
a * - * *
mechanism * - * *
that * - * *
is * - * *
at * - * *
least * - * *
partly * - * *
dependent * - * *
on * - * *
the * - * *
up-regulation * upregulate * (V*)
of * - * *
Hdm2 (DNA*) - * (A0*)
. * - * *

Previously * - *
, * - *
we * - *
demonstrated * - *
that * - *
homocysteine (EXP*) - *
, * - *
an * - *
endoplasmic * - *
reticulum * - *
stressor * - *
, * - *
increases * - *
VEGF * - (A0*)
transcription * transcription (V*)
by * - *
a * - *
mechanism * - *
dependent * - *
upon * - *
activating * - *
transcription * - *
factor * - *
ATF4 * - *
. * - *

Our * - * *
results * - * *
also * - * *
show * - * *
that * - * *
GalS (PTE*) - (A1*) (A1*)
, * - * *
like * - * *
its * - * *
homolog * - * *
, * - * *
GalR * - * *
, * - * *
is * - * *
a * - * *
dimeric * - * *
protein * - * *
which * - * *
in * - * *
binding * bind (V*) *
to * - * *
the (DNA* - (A0* *
bipartite * - * *
operators *) - *) *
of * - * *
the * - * *
gal * - * *
operon * - * *
selectively * - * (A5*)
represses * repress * (V*)
its (DNA* - * (A0*
P1 * - * *
promoter *) - * *)
. * - * *

Here * - *
it * - *
is * - *
demonstrated * - *
that * - *
rot (DNA*) - (A0*)
is * - *
expressed * express (V*)
in * - *
a * - (A5*
complex * - *
manner * - *)
from * - *
four (DNA* - (A6*
overlapping * - *
promoters *) - *)
and * - *
that * - *
the * - *
rot * - *
regulatory * - *
region * - *
is * - *
unusually * - *
compact * - *
, * - *
containing * - *
a * - *
close * - *
array * - *
of * - *
sites * - *
for * - *
DNA-binding * - *
proteins * - *
. * - *

Gel * - *
retardation * - *
assays * - *
and * - *
DNase * - *
I * - *
protection * - *
experiments * - *
showed * - *
that * - *
IHF (PTE*) - (A1*)
binds * bind (V*)
to * - *
two (DNA* - (A7*
sites *) - *)
in * - *
the * - *
ompF * - *
promoter * - *
region * - *
centered * - *
at * - *
positions * - *
-180 * - *
and * - *
-60 * - *
relative * - *
to * - *
the * - *
start * - *
of * - *
transcription * - *
. * - *

The * - * *
addition * add (V*) *
of * - * *
IHF (PTE*) - (A0*) *
to * - * *
a (EXP* - (A7* *
purified * - * *
in * - * *
vitro * - * *
transcription * - * *
system *) - *) *
strongly * - * *
and * - * *
specifically * - * *
inhibited * - * *
ompF (DNA*) - * (A0*)
transcription * transcription * (V*)
. * - * *

Indeed * - *
, * - *
GntR (PTE*) - (A1*)
binds * bind (V*)
to * - *
two (DNA* - (A7*
consensus * - *
gnt * - *
operator * - *
sites *) - *)
; * - *
one * - *
overlaps * - *
the * - *
-10 * - *
region * - *
of * - *
the * - *
gntT * - *
promoter * - *
, * - *
and * - *
the * - *
other * - *
is * - *
centered * - *
at * - *
+120 * - *
with * - *
respect * - *
to * - *
the * - *
transcriptional * - *
start * - *
site * - *
. * - *

The (DNA* - (A0*
regulatory * - *
region *) - *)
is * - *
characterized * - *
by * - *
a * - *
sigma * - *
70-like * - *
-10 * - *
promoter * - *
region * - *
and * - *
contains * contain (V*)
potential (DNA* - (A4*
binding * - *
sites *) - *)
for * - *
Lrp * - *
, * - *
CRP * - *
, * - *
and * - *
IHF * - *
. * - *

Although * - *
the * - *
exact * - *
function * - *
of * - *
this * - *
protein * - *
has * - *
not * - *
been * - *
determined * - *
, * - *
these * - *
structural * - *
features * - *
suggest * - *
that * - *
ATBF1 (PTE*) - (A1*)
plays * play (V*)
a * - (A8*
transcriptional * - *
regulatory * - *
role * - *)
. * - *

In * - * *
this * - * *
report * - * *
, * - * *
we * - * *
performed * - * *
ligand * - * *
fishing * - * *
experiments * - * *
by * - * *
using * - * *
the (DNA* - * (A7*
promoters *) - * *)
of * - * *
ptsHIcrr * - * *
and * - * *
ptsG * - * *
as * - * *
bait * - * *
to * - * *
find * - * *
out * - * *
new (PTE* - * *
factors *) - * *
involved * - * *
in * - * *
the * - * *
transcriptional * - * *
regulation * regulation (V*) *
of * - * *
the (EXP* - (A0* *
phosphoenolpyruvate *) - * *
: * - * *
sugar * - * *
phosphotransferase * - * *
system * - *) *
in * - * *
Escherichia (ORG* - * *
coli *) - * *
, * - * *
and * - * *
we * - * *
found * - * *
that * - * *
the (PTE* - * (A1*
anaerobic * - * *
regulator * - * *
ArcA *) - * *)
specifically * - * (A5*)
binds * bind * (V*)
to * - * *
the * - * *
promoters * - * *
. * - * *

By * - * *
using * - * *
lacZ * - * *
fusions * - * *
, * - * *
it * - * *
was * - * *
possible * - * *
to * - * *
localize * localize (V*) *
the (DNA* - (A0* *
DNA * - * *
sequences *) - *) *
required * - * *
to * - * *
mediate * - * *
nitrate (EXP*) - * (A1*)
repression * repress * (V*)
to * - * *
the (DNA* - (A7* *
pfl * - * *
promoter-regulatory * - * *
region *) - *) *
. * - * *

Regulation * regulate (V*)
of * - *
gadA (DNA*) - (A0*)
and * - *
gadBC (DNA*) - *
by * - *
either (PTE* - (A1*
regulator *) - *)
requires * - *
an (DNA* - *
upstream * - *
, * - *
20-bp * - *
GAD * - *
box * - *
sequence *) - *
. * - *

Our * - * *
Southwestern * - * *
cloning * - * *
revealed * - * *
that * - * *
a * - * *
redox * - * *
factor * - * *
protein * - * *
( * - * *
ref1 (PTE*) - (A1*) (A0*)
) * - * *
, * - * *
which * - * *
was * - * *
known * - * *
to * - * *
activate * activate (V*) *
several (PTE* - (A0* *
transcription * - * *
factors *) - *) *
via * - * *
alterations * - (A5* *
of * - * *
their * - * *
redox * - * *
state * - *) *
, * - * *
belonged * belong * (V*)
to * - * *
an (PTE* - * (A4*
nCaRE * - * *
binding * - * *
protein *) - * *)
. * - * *

Transcriptional * - (A5*)
regulation * regulation (V*)
of * - *
the (DNA* - (A0*
divergent * - *
paa * - *
catabolic * - *
operons *) - *)
for * - *
phenylacetic * - *
acid * - *
degradation * - *
in * - (A2*
Escherichia (ORG* - *
coli *) - *)
. * - *

We * - *
demonstrate * - *
that * - *
at (PTE* - (A1*
least * - *
two * - *
nucleoid-associated * - *
factors *) - *)
bind * bind (V*)
to * - *
the (DNA* - (A7*
nrfA-acs * - *
intergenic * - *
region *) - *)
. * - *

We * - * *
propose * - * *
that * - * *
the * - * *
effect * effect (V*) *
of * - * *
ppGpp (EXP*) - (A1*) *
on * - * *
himA (DNA* - (A0* *
P4 *) - *) *
is * - * *
mediated * - * *
via * - * *
RpoS (PTE*) - * *
whereas * - * *
the (DNA* - * (A0*
himD/hip * - * *
promoter *) - * *)
is * - * *
affected * affect * (V*)
by * - * *
ppGpp (EXP*) - * (A1*)
independently * - * (A3*
of * - * *
RpoS * - * *)
. (PTE*) - * *

Cooperative * - *
interaction * - *
between * - *
Cra (PTE*) - *
and * - *
Fnr (PTE*) - *
in * - *
the * - *
regulation * regulation (V*)
of * - *
the (DNA* - (A0*
cydAB * - *
operon *) - *)
of * - *
Escherichia * - *
coli * - *
. * - *

This (DNA* - (A0*
operon *) - *)
is * - *
negatively * - (A5*)
controlled * control (V*)
by * - *
the (PTE* - (A1*
uxuR * - *
and * - *
exuR * - *
regulatory * - *
gene * - *
products *) - *)
. * - *

We * - *
found * - *
that * - *
among * - *
changes * - *
in * - *
the * - *
outer * - *
membrane * - *
of * - *
Mar * - *
mutants * - *
, * - *
porin (PTE* - (A0*
OmpF *) - *)
was * - *
greatly * - (A5*)
reduced * reduce (V*)
, * - *
although * - *
Mar * - *
mutants * - *
were * - *
more * - *
resistant * - *
than * - *
cells * - *
lacking * - *
only * - *
OmpF * - *
. * - *

Overproduction * overproduce (V*)
of * - *
the (PTE* - (A0*
AdhE * - *
protein *) - *)
by * - *
rng (None* - (A1*
mutants *) - *)
was * - *
found * - *
to * - *
depend * - *
on * - *
the * - *
genetic * - *
background * - *
of * - *
strains * - *
derived * - *
from * - *
DC272 * - *
( * - *
adhC81 * - *
) * - *
or * - *
MC1061 * - *
. * - *

The * - *
UV * - *
light * - *
inducibility * - *
of * - *
the (DNA* - (A7*
uvrB * - *
operon *) - *)
of * - *
Escherichia * - *
coli * - *
K-12 * - *
was * - *
previously * - *
demonstrated * - *
by * - *
exploiting * - *
a * - *
strain * - *
in * - *
which * - *
the (DNA* - (A0*
gene *) - *
for * - *
the (PTE* - *
enzyme * - *
beta-galactosidase *) - *)
was * - *
inserted * insert (V*)
into * - *
the * - *
uvrB * - *
operon * - *
. * - *

The * - *
strong * - *
sequence * - *
conservation * - *
suggest * - *
potential * - *
roles * - *
for * - *
EZH1 * - *
in * - *
human * - *
development * - *
as * - *
a * - *
transcriptional * - *
regulator * - *
and * - *
as * - *
a * - *
component * - *
of * - *
protein (PTE* - (A1*
complexes *) - *)
that * - *
stably * - *
maintain * maintain (V*)
heterochromatin * - (A0*)
. * - *

Primer * - *
extension * - *
and * - *
lacZ-operon * - *
fusion * - *
analyses * - *
revealed * - *
that * - *
gntT * - *
has * - *
one (DNA* - (A0*
strong * - *
and * - *
two * - *
weak * - *
promoters *) - *)
, * - *
all * - *
of * - *
which * - *
are * - *
regulated * regulate (V*)
positively * - (A5*)
by * - *
cAMP-CRP (PTE*) - (A1*)
and * - *
negatively * - *
by * - *
GntR (PTE*) - *
. * - *

Higher (PTE* - (A1* *
GadX * - * *
levels *) - *) *
, * - * *
in * - * *
turn * - * *
, * - * *
repress * repress (V*) *
gadW (DNA*) - (A0*) *
and * - * *
contribute * - * *
to * - * *
induction * induce * (V*)
of * - * *
the (DNA* - * (A0*
gad * - * *
decarboxylase * - * *
genes *) - * *)
. * - * *

These * - *
data * - *
suggest * - *
that * - *
the * - (A0*
transcriptional * - *
control * - *)
carried * - *
out * - *
by * - *
Spt3 * - *
has * - *
been * - *
conserved * conserve (V*)
from * - (A2*
yeast * - *
to * - *
human * - *)
. (ORG*) - *

Crl (PTE*) - (A1*)
, * - *
a * - *
low * - *
temperature-induced * - *
protein * - *
in * - (A2*
Escherichia (ORG* - *
coli *) - *)
that * - *
binds * bind (V*)
directly * - (A5*)
to * - *
the (PTE* - (A7*
stationary * - *
phase * - *
sigma * - *
subunit *) - *)
of * - *
RNA * - *
polymerase * - *
. * - *

In * - *
contrast * - *
, * - *
the * - *
anaerobic * - (A3*)
repression * repress (V*)
of * - *
ethanol (PTE* - (A0*
dehydrogenase *) - *)
by * - *
nitrate (EXP*) - (A1*)
does * - *
not * - *
require * - *
the (PTE* - *
narL * - *
product *) - *
. * - *

Under * - *
anaerobic (EXP* - (A3*
conditions *) - *)
ndh (DNA*) - (A0*)
is * - *
repressed * repress (V*)
by * - *
the * - *
regulator * - *
of * - *
fumarate * - *
and * - *
nitrate * - *
reduction * - *
( * - *
FNR (PTE*) - (A1*)
) * - *
. * - *

Comparable * - * *
studies * - * *
with * - * *
fum-lacZ * - * *
fusions * - * *
indicated * - * *
that * - * *
transcription * transcription (V*) *
of * - * *
fumC (DNA*) - (A0*) *
, * - * *
but * - * *
not * - * *
of * - * *
fumA (DNA*) - * *
or * - * *
fumB (DNA*) - * *
, * - * *
is * - * *
initiated * - * *
by * - * *
RNA (PTE* - * (A0*
polymerase *) - * *)
containing * contain * (V*)
sigma (PTE* - * (A4*
38 *) - * *)
. * - * *

Transcription * transcribe (V*)
initiation * - *
at * - (A6*
the (DNA* - *
Escherichia * - *
coli * - *
nirB * - *
promoter *) - *)
is * - *
induced * - *
by * - *
anaerobic * - *
growth * - *
and * - *
further * - *
increased * - *
by * - *
the * - *
presence * - *
of * - *
nitrite (EXP*) - *
or * - *
nitrate (EXP*) - *
in * - *
the * - *
growth * - *
medium * - *
. * - *

Therefore * - *
, * - *
Oct4 (PTE*) - (A1*)
also * - *
determines * determine (V*)
paracrine * - (A0*
growth * - *
factor * - *
signaling * - *)
from * - *
stem * - *
cells * - *
to * - *
the * - *
trophectoderm * - *
. * - *

Plasmid (DNA* - (A0* * (A0* *
multimers *) - *) * *) *
, * - * * * *
that * - * * * *
arise * arise (V*) * * *
through * - * * * *
recA-dependent (PRC* - (A10* (A5* * *
homologous * - * *) * *
recombination *) recombine *) (V*) * *
, * - * * * *
are * - * * * *
normally * - * * * *
converted * convert * * (V*) *
to * - * * * *
monomers * - * * * *
by * - * * * *
a (PRC* - * * (A1* (A1*
site-specific * - * * * *
recombination * - * * * *
system *) - * * *) *)
that * - * * * *
acts * act * * * (V*)
at * - * * * (A2*)
a * - * * * *
specific * - * * * *
plasmid * - * * * *
site * - * * * *
( * - * * * *
cer (DNA*) - * * * *
in * - * * * *
ColE1 * - * * * *
) * - * * * *
. * - * * * *

Disruption * disrupt (V*) *
of * - * *
a (DNA* - (A0* *
12-bp * - * *
presumptive * - * *
target * - * *
sequence *) - *) *
found * - * *
in * - * *
this * - * *
region * - * *
of * - * *
tdh * - * *
resulted * - * *
in * - * *
constitutively (PRC* - * (A5*
derepressed *) - * *)
expression * express * (V*)
from * - * *
the (DNA* - * (A6*
tdh * - * *
promoter *) - * *)
. * - * *

An (DNA* - (A0*
additional * - *
IHF-binding * - *
site *) - *)
was * - *
found * find (V*)
upstream * - (A2*
of * - *
the (DNA* - *
himD/hip * - *
promoter *) - *)
. * - *

We * - * *
establish * - * *
here * - * *
that * - * *
the * - (A0* *
Cpx * - * *
pathway * - *) *
is * - * *
activated * activate (V*) *
at * - * *
both * - (A4* *
transcriptional * - * *
and * - * *
posttranscriptional * - * *
levels * - *) *
in * - * *
response * - * *
to * - * *
a * - (A3* *
high * - * *
osmolarity * - * *
medium * - *) *
and * - * *
that * - * *
CpxR (PTE*) - * *
represses * - * *
csgD (DNA*) - * (A0*)
expression * express * (V*)
in * - * *
high-salt-content * - * *
medium * - * *
, * - * *
resulting * - * *
in * - * *
low * - * *
curli * - * *
production * - * *
. * - * *

Regulation * regulate (V*)
of * - *
HU (PTE* - (A0*
alpha *) - *)
and * - *
HU (PTE* - *
beta *) - *
by * - *
CRP (PTE*) - (A1*)
and * - *
FIS (PTE*) - *
in * - (A7*
Escherichia (ORG* - *
coli *) - *)
. * - *

Mutations (PRC*) - (A1*) * *
affecting * affect (V*) * *
the * - (A0* * *
BarA/UvrY * - * * *
two-component * - * * *
signal * - * * *
transduction * - * * *
system * - *) * *
decreased * - * * *
csrB (DNA*) - * (A0*) *
transcription * transcription * (V*) *
but * - * * *
did * - * * *
not * - * * *
affect * - * * *
csrA'-'lacZ (DNA*) - * * (A0*)
expression * express * * (V*)
. * - * * *

Its * - *
mRNA * - *
was * - *
present * - *
in * - (A2*
all (ORG* - *
human * - *
tissues *) - *)
tested * - *
except * - *
for * - *
kidney * - *
, * - *
as * - *
a * - *
doublet * - *
of * - *
approximately * - *
2 * - *
. * - *
5 * - *
and * - *
2 * - *
. * - *
7 * - *
kilobases * - *
, * - *
along * - *
with * - *
differentially * - (A5*)
expressed * express (V*)
minor (DNA* - (A0*
species *) - *)
. * - *

We * - *
previously * - *
reported * - *
the * - *
cloning * - *
of * - *
a * - *
murine * - *
lymphocyte-specific * - *
IRF * - *
( * - *
mLSIRF (DNA*) - (A0*)
) * - *
, * - *
which * - *
was * - *
rapidly * - *
induced * induce (V*)
following * - *
B- * - *
or * - *
T-cell * - *
receptor * - *
crosslinking * - *
. * - *

In * - * *
addition * - * *
, * - * *
the (DNA* - (A0* (A1*
pleiotropic * - * *
phenotypes *) - *) *)
conferred * confer (V*) *
by * - * *
a * - * *
particular * - * *
envZ * - * *
mutation * - * *
( * - * *
envZ473 (PRC*) - (A1*) *
) * - * *
required * require * (V*)
the * - * (A0*
presence * - * *
of * - * *
functional (PTE* - * *
OmpR * - * *
protein *) - * *)
. * - * *

This * - * *
study * - * *
shows * - * *
that * - * *
the * - * *
same * - * *
product * - * *
plays * - * *
a * - * *
role * - * *
in * - * *
the * - * *
repression * repress (V*) *
by * - * *
nitrate (EXP*) - (A1*) *
of * - * *
the * - * *
operons * - * *
( * - * *
frd (DNA*) - (A0*) (A1*)
and * - * *
tor (DNA*) - * *
) * - * *
that * - * *
encode * encode * (V*)
fumarate (PTE* - * (A0*
and * - * *
Me3NO * - * *
reductases *) - * *)
. * - * *

Although * - *
some * - *
transcriptional * - *
control * - *
may * - *
have * - *
been * - *
present * - *
, * - *
OmpF (PTE*) - (A0*)
reduction * reduce (V*)
appeared * - *
to * - *
occur * - *
primarily * - *
by * - *
a * - *
posttranscriptional * - *
mechanism * - *
. * - *

Cloning * - *
and * - *
mapping * - *
of * - *
SMARCA5 (DNA*) - (A1*)
encoding * encode (V*)
hSNF2H (PTE*) - (A0*)
, * - *
a * - *
novel * - *
human * - *
homologue * - *
of * - *
Drosophila * - *
ISWI * - *
. * - *

Only * - * * *
NERF-2 (PTE*) - (A1*) * *
and * - * * *
ELF-1 (PTE*) - * * *
, * - * * *
and * - * * *
not * - * * *
NERF-1a * - * * *
and * - * * *
NERF-1b * - * * *
, * - * * *
function * function (V*) * *
as * - * * *
transcriptional (PTE* - (A8* * *
activators *) - *) * *
of * - * * *
the * - * * *
lyn * - * * *
and * - * * *
blk * - * * *
gene * - * * *
promoters * - * * *
, * - * * *
although * - * * *
all * - * (A1* *
isoforms * - * * *
of * - * * *
NERF * - * *) *
bind * bind * (V*) *
with * - * * *
affinities * - * * *
similar * - * * *
to * - * * *
those * - * * *
of * - * * *
ELF-1 * - * * *
to * - * * *
a * - * * *
variety * - * * *
of * - * * *
Ets (DNA* - * (A7* *
binding * - * * *
sites *) - * *) *
in * - * * *
, * - * * *
among * - * * *
others * - * * *
, * - * * *
the (DNA* - * * (A0*
blk * - * * *
, * - * * *
lck * - * * *
, * - * * *
lyn * - * * *
, * - * * *
mb-1 * - * * *
, * - * * *
and * - * * *
immunoglobulin * - * * *
H * - * * *
genes *) - * * *)
and * - * * *
are * - * * *
expressed * express * * (V*)
at * - * * *
similar * - * * *
levels * - * * *
. (PTE*) - * * *

Responses * respond (V*) *
to * - * *
type (PTE* - (A0* *
I * - * *
IFN *) - *) *
( * - * *
alpha * - * *
and * - * *
beta * - * *
) * - * *
also * - * *
require * - * *
Stat2 (PTE*) - * (A1*)
and * - * *
the (PTE* - * *
IFN * - * *
regulatory * - * *
factor * - * *
family * - * *
protein * - * *
p48 *) - * *
, * - * *
which * - * *
form * form * (V*)
a * - * *
heterotrimeric * - * *
transcription * - * *
complex * - * *
with * - * *
Stat1 (PTE* - * (A1*
termed * - * *
ISGF3 *) - * *)
. * - * *

Anomalous (PTE* - (A1*
DnaA * - *
protein *) - *)
binding * bind (V*)
to * - *
the (DNA* - (A7*
regulatory * - *
region *) - *)
of * - *
the * - *
Escherichia * - *
coli * - *
aldA * - *
gene * - *
. * - *

Gel * - *
electrophoresis * - *
studies * - *
with * - *
circularly * - *
permuted * - *
ompF * - *
promoter * - *
fragments * - *
indicated * - *
that * - *
IHF * - (A1*
binding * - *)
strongly * - (A5*)
increased * increase (V*)
a * - (A0*
small * - *
intrinsic * - *
bend * - *)
in * - *
the * - *
ompF * - *
promoter * - *
region * - *
. * - *

Glucose * - (A0*
effects * - *)
mediated * mediate (V*)
by * - *
other (PTE* - (A1*
global * - *
regulators *) - *)
cannot * - *
be * - *
ruled * - *
out * - *
with * - *
the * - *
present * - *
information * - *
. * - *

The * - * * *
interferon (PTE*) - * (A0*) *
regulatory * - * * *
factor * - * * *
( * - * * *
IRF (DNA*) - (A1*) * *
) * - * * *
genes * - * * *
encode * encode (V*) * *
a (PTE* - (A0* * *
family * - * * *
of * - * * *
transcription (PTE* - * * *
factors *) - *) * *
involved * - * * *
in * - * * *
the * - * * *
transcriptional * - * (A5*) *
regulation * regulation * (V*) *
of * - * * *
interferon * - * * *
and * - * * *
the (DNA* - * * *
interferon * - * * *
stimulated * - * * *
genes *) - * * *
through * - * * *
recognition * recognize * * (V*)
of * - * * *
the (DNA* - * * (A0*
interferon * - * * *
stimulated * - * * *
response * - * * *
element *) - * * *)
. * - * * *

CRP * - * *
and * - * *
cAMP * - * *
appear * - * *
to * - * *
influence * - * *
GadX-GadW * - (A1*) *
cross-repression * crossrepress (V*) *
from * - * *
outside * - * *
the * - * *
loop * - * *
by * - * *
inhibiting * - * *
production * produce * (V*)
of * - * *
RpoS (PTE*) - * (A0*)
. * - * *

( * - *
1 * - *
) * - *
for * - *
the * - (A5*
T7 * - *
RNA * - *
polymerase-driven * - *)
overexpression * overexpression (V*)
of * - *
proteins (PTE*) - (A0*)
in * - (A2*
Escherichia (ORG* - *
coli *) - *)
. * - *

Bax (PTE*) - (A0*)
is * - *
encoded * encode (V*)
by * - *
six (DNA* - (A1*
exons *) - *)
and * - *
demonstrates * - *
a * - *
complex * - *
pattern * - *
of * - *
alternative * - *
RNA * - *
splicing * - *
that * - *
predicts * - *
a * - *
21 * - *
kd * - *
membrane * - *
( * - *
alpha * - *
) * - *
and * - *
two * - *
forms * - *
of * - *
cytosolic * - *
protein * - *
( * - *
beta * - *
and * - *
gamma * - *
) * - *
. * - *

A * - *
variety * - *
of * - *
cellular (PTE* - (A1*
proteins *) - *)
bind * bind (V*)
to * - *
cellular (DNA* - (A7*
and * - *
viral * - *
enhancer * - *
elements *) - *)
. * - *

Transcription * transcribe (V*)
of * - *
fdhF (DNA*) - (A0*)
, * - *
the * - *
gene * - *
coding * - *
for * - *
the * - *
80-kilodalton * - *
( * - *
kDa * - *
) * - *
selenopeptide * - *
of * - *
formate * - *
dehydrogenase * - *
, * - *
was * - *
not * - *
detected * - *
in * - *
an (None* - *
fhlA * - *
genetic * - *
background *) - *
. * - *

This * - (A0*
binding * - *)
was * - *
reduced * reduce (V*)
by * - *
alanine (PTE*) - (A1*)
or * - *
leucine (PTE*) - *
. * - *

Using * - *
the * - *
complex * - *
structure * - *
of * - *
bone * - *
morphogenetic * - *
protein-2 * - *
bound * - *
to * - *
its * - *
type * - *
I * - *
receptor * - *
( * - *
ALK3 * - *
) * - *
as * - *
a * - *
guide * - *
, * - *
we * - *
introduced * - *
extracellular * - *
domain * - *
mutations * - *
in * - *
the * - *
context * - *
of * - *
the * - *
truncated * - *
ALK4 * - *
( * - *
ALK4-trunc * - *
) * - *
construct * - *
and * - *
assessed * - *
the * - *
ability * - *
of * - *
the (DNA* - *
mutants *) - *
to * - *
inhibit * - *
activin (PTE*) - (A0*)
function * function (V*)
. * - *

Major (DNA* - (A0*
monocistronic * - *
transcripts *) - *)
were * - *
identified * identify (V*)
for * - *
aspA (DNA*) - (A4*)
and * - *
dcuA (DNA*) - *
, * - *
as * - *
well * - *
as * - *
a * - *
minor * - *
species * - *
possibly * - *
corresponding * - *
to * - *
an * - *
aspA-dcuA * - *
cotranscript * - *
. * - *

It * - *
is * - *
not * - *
known * - *
how * - *
the (ORG* - (A1*
cell *) - *)
regulates * regulate (V*)
the (PTE* - (A0*
cellular * - *
concentrations *) - *)
of * - *
these * - *
essential * - *
elements * - *
of * - *
the * - *
division * - *
system * - *
. * - *

Moreover * - *
, * - *
overexpression * overexpression (V*)
of * - *
GalF (PTE*) - (A0*)
gave * - *
rise * - *
to * - *
a * - *
two- * - *
to * - *
threefold * - *
increase * - *
in * - *
cell-free * - *
as * - *
well * - *
as * - *
cell-associated * - *
capsule * - *
, * - *
without * - *
affecting * - *
cps * - *
: * - *
: * - *
lacZ * - *
activity * - *
. * - *

IclR * - *
is * - *
a * - *
repressor * - *
for * - *
the (DNA* - (A1*
Escherichia * - *
coli * - *
aceBAK * - *
operon *) - *)
, * - *
which * - *
encodes * encode (V*)
isocitrate * - *
lyase * - *
( * - *
aceB (DNA*) - (A0*)
) * - *
, * - *
malate * - *
synthase * - *
( * - *
aceA (DNA*) - *
) * - *
and * - *
isocitrate * - *
dehydroge-nase * - *
kinase/phosphorylase * - *
( * - *
aceK (DNA*) - *
) * - *
in * - *
the * - *
glyoxylate * - *
bypass * - *
. * - *

In * - * *
the * - * *
case * - * *
of * - * *
the * - * *
aceBAK * - * *
operon * - * *
, * - * *
IclR (PTE*) - (A1*) *
binds * bind (V*) *
to * - * *
IclR (DNA* - (A7* *
box * - * *
II *) - *) *
between * - * *
-52 * - * *
and * - * *
-19 * - * *
of * - * *
the * - * *
aceB * - * *
promoter * - * *
and * - * *
interferes * - * *
with * - * *
binding * bind * (V*)
of * - * *
the (PTE* - * (A1*
RNA * - * *
polymerase *) - * *)
to * - * *
this (DNA* - * (A7*
promoter *) - * *)
. * - * *

Strains (ORG*) - (A1*) *
overproducing * overproduce (V*) *
the (PTE* - (A0* *
NagC * - * *
protein *) - *) *
have * - * *
been * - * *
used * - * *
to * - * *
investigate * - * *
the * - * *
binding * bind * (V*)
of * - * *
repressor (PTE*) - * (A1*)
to * - * *
the (DNA* - * (A7*
intergenic * - * *
nagE-B * - * *
regulatory * - * *
region *) - * *)
. * - * *

We * - *
also * - *
report * - *
the * - *
identification * - *
of * - *
a * - *
subset * - *
of * - *
these (DNA* - (A0*
genes *) - *)
that * - *
are * - *
regulated * regulate (V*)
by * - *
a * - *
global * - *
regulatory * - *
protein * - *
for * - *
anaerobic * - *
metabolism * - *
, * - *
FNR (PTE*) - (A1*)
. * - *

Escherichia * - *
coli * - *
gene (DNA*) - (A0*)
expression * express (V*)
responsive * - *
to * - *
levels * - *
of * - *
the * - *
response * - *
regulator * - *
EvgA * - *
. * - *

By * - * * *
activating * activate (V*) * *
glnAp1 (DNA*) - (A0*) * *
and * - * * *
downregulating * downregulate * (V*) *
glnAp2 (DNA*) - * (A0*) *
, * - * * *
the * - * * *
overall * - * * *
effect * - * * *
of * - * * *
CRP-cAMP (PTE*) - * * *
on * - * * *
glnA * - * * (A0*)
expression * express * * (V*)
is * - * * *
an * - * * *
approximately * - * * *
fourfold * - * * *
reduction * - * * *
, * - * * *
which * - * * *
correlates * - * * *
with * - * * *
the * - * * *
reduction * - * * *
of * - * * *
gamma-glutamyl * - * * *
transferase * - * * *
activities * - * * *
in * - * * *
the * - * * *
cells * - * * *
. * - * * *

Escherichia * - *
coli * - *
integration * - *
host * - *
factor * - *
( * - *
IHF * - *
) * - *
is * - *
a (PTE* - *
DNA-binding * - *
protein *) - *
that * - *
participates * - *
in * - *
gene (DNA*) - (A0*)
regulation * regulation (V*)
, * - *
site-specific (PRC* - *
recombination *) - *
, * - *
and * - *
other * - *
processes * - *
in (DNA* - (A2*
E (ORG* - *
. * - *
coli *) - *)
and * - *
some * - *
of * - *
its * - *
bacteriophages (DNA*) - *
and * - *
plasmids (DNA*) - *
. * - *

These * - *
results * - *
suggest * - *
that * - *
DnaA (PTE* - *
protein *) - *
negatively * - *
regulates * - *
expression * express (V*)
of * - *
the (DNA* - (A0*
aldA * - *
gene *) - *)
under * - *
these * - *
conditions * - *
. * - *

This * - *
increases * - *
the * - *
occupation * occupy (V*)
of * - *
the (DNA* - (A0*
two * - *
downstream * - *
sites *) - *)
for * - *
MelR * - *
, * - *
which * - *
is * - *
essential * - *
for * - *
transcription (PRC*) - *
. * - *

Organization * - * *
and * - * *
regulation * regulation (V*) *
of * - * *
the (DNA* - (A0* *
D-xylose * - * *
operons *) - *) *
in * - (A2* *
Escherichia (ORG* - * *
coli * - * *
K-12 *) - *) *
: * - * *
XylR (PTE*) - * (A0*)
acts * act * (V*)
as * - * *
a (PTE* - * (A4*
transcriptional * - * *
activator *) - * *)
. * - * *

Changes * - *
in * - *
cAMP-CRP * - *
levels * - *
affected * - *
only * - *
the * - *
expression * express (V*)
of * - *
the (DNA* - (A0*
ulaABCDEF * - *
operon *) - *)
. * - *

The (DNA* - (A1* (A0* * *
gene *) - *) *) * *
encoding * encode (V*) * * *
the * - * * * *
periplasmic * - * * * *
cyclophilin * - * * * *
homologue * - * * * *
, * - * * * *
PPIase (PTE* - (A0* * * *
A *) - *) * * *
, * - * * * *
in * - (A2* * * *
Escherichia (ORG* - * * * *
coli *) - *) * * *
, * - * * * *
is * - * * * *
expressed * express * (V*) * *
from * - * * * *
four (DNA* - * (A6* * *
promoters *) - * *) * *
, * - * * * *
three (DNA*) - * * (A0*) (A0*)
of * - * * * *
which * - * * * *
are * - * * * *
activated * activate * * (V*) *
by * - * * * *
the (PTE* - * * (A1* *
cAMP-CRP * - * * * *
complex *) - * * *) *
and * - * * * *
negatively * - * * * (A5*)
regulated * regulate * * * (V*)
by * - * * * *
the (PTE* - * * * (A1*
CytR * - * * * *
repressor *) - * * * *)
. * - * * * *

Cloning * - * *
and * - * *
analysis * analysis (V*) *
of * - * *
the (DNA* - (A0* (A1*
shiA * - * *
gene *) - *) *)
, * - * *
which * - * *
encodes * encode * (V*)
the (PTE* - * (A0*
shikimate * - * *
transport * - * *
system *) - * *)
of * - * *
escherichia * - * *
coli * - * *
K-12 * - * *
. * - * *

This * - * * *
report * - * * *
describes * - * * *
the * - * * *
role * - * * *
this * - (A1* * *
DNA * - * * *
sequence * - *) * *
plays * play (V*) * *
in * - * * *
autoregulation * autoregulate (A8*) (V*) *
and * - * * *
expression * express * * (V*)
of * - * * *
gcvA * - * (A0*) (A0*)
. * - * * *

This * - *
fragment * - *
is * - *
shown * - *
to * - *
contain * - *
at (DNA* - (A1*
least * - *
one * - *
cis-element *) - *)
that * - *
is * - *
capable * - *
of * - *
interacting * interact (V*)
with * - *
recombinant (PTE* - (A1*
WT-1 *) - *)
. * - *

In * - *
a * - *
recent * - *
study * - *
, * - *
we * - *
have * - *
identified * - *
a (DNA* - (A1*
fifth * - *
DNA * - *
site *) - *)
for * - *
MelR * - *
that * - *
overlaps * overlap (V*)
the (DNA* - (A0*
melR * - *
promoter * - *
transcript * - *
start * - *
and * - *
-10 * - *
region *) - *)
. * - *

These * - * *
studies * - * *
also * - * *
show * - * *
that * - * *
the * - * *
cyclic * - * *
AMP * - * *
receptor * - * *
protein * - * *
( * - * *
CRP (PTE*) - (A1*) *
) * - * *
interacts * interact (V*) *
with * - * *
the (DNA* - (A1* *
melAB * - * *
promoter *) - *) *
and * - * *
increases * - * *
MelR-dependent * - * (A5*
transcription * - * *)
activation * activate * (V*)
. * - * *

Studies * - *
with * - *
an * - *
ndh-lacZ * - *
fusion * - *
confirmed * - *
that * - *
IHF (PTE*) - *
represses * - *
ndh (DNA*) - (A0*)
expression * express (V*)
in * - (A5*
vivo * - *)
. * - *

The (PTE* - (A0*
hydrogenase * - *
1 * - *
and * - *
hydrogenase * - *
2 * - *
enzymes *) - *)
are * - *
encoded * encode (V*)
by * - *
the (DNA* - (A1*
polycistronic * - *
hyaABCDEF * - *
and * - *
hybOABCDEFG * - *
operons *) - *)
, * - *
respectively * - *
. * - *

Thus * - * * * *
, * - * * * *
induction * induce (V*) (A1* * (A0*
of * - * * * *
multiple * - * * * *
antibiotic * - * * * *
resistance * - * * * *
and * - * * * *
inaA * - * *) * *)
by * - * * * *
salicylate (EXP*) - (A1*) * * *
occurs * occur * (V*) * *
via * - * * * *
mar (DNA*) - * (A5*) * *
and * - * * * *
an * - * (A0* * *
unidentified * - * * * *
pathway * - * *) * *
, * - * * * *
while * - * * * *
induction * induce * * (V*) *
by * - * * * *
paraquat (EXP*) - * * (A1*) *
occurs * occur * * * (V*)
via * - * * * *
soxRS (DNA*) - * * * (A5*)
. (DNA*) - (A0*) * (A0*) *

Oxygen * - (A5*)
regulation * regulation (V*)
of * - *
the * - *
Escherichia * - *
coli * - *
cytochrome * - *
d * - *
oxidase * - *
( * - *
cydAB (DNA*) - (A0*)
) * - *
operon * - *
: * - *
roles * - *
of * - *
multiple * - *
promoters * - *
and * - *
the * - *
Fnr-1 * - *
and * - *
Fnr-2 * - *
binding * - *
sites * - *
. * - *

Null * - * *
mutations * - * *
in * - * *
either * - * *
gene * - * *
exhibit * - * *
no * - * *
phenotype * - * *
, * - * *
because * - * *
of * - * *
cross-induction * crossinduct (V*) (V*)
of * - * *
the (DNA* - (A0* *
ace * - * *
operon *) - *) *
by * - * *
glycolate (EXP*) - (A1*) *
and * - * *
the (DNA* - * (A0*
glc * - * *
operon *) - * *)
by * - * *
acetate (EXP*) - * (A1*)
. * - * *

The * - *
increased * - *
concentration * - *
of * - *
the * - *
isorepressor * - *
when * - *
inducer * - *
is * - *
present * - *
may * - *
facilitate * - *
early * - *
shutoff * shutoff (V*)
of * - *
the (DNA* - (A0*
isorepressor-regulated * - *
genes *) - *)
of * - *
the * - *
gal * - *
regulon * - *
when * - *
inducer * - *
( * - *
substrate * - *
) * - *
concentration * - *
falls * - *
. * - *

We * - *
found * - *
that * - *
GadW (PTE*) - (A1*)
represses * repress (V*)
the (DNA* - (A0*
decarboxylase * - *
genes *) - *)
in * - *
minimal * - (A3*
medium * - *)
and * - *
that * - *
growth * - *
under * - *
acidic * - *
conditions * - *
lowers * - *
the * - *
intracellular * - *
cAMP * - *
levels * - *
. * - *

Thus * - * * *
, * - * * *
IHF (PTE*) - * * *
plays * - * * *
a * - * * *
dual * - * * *
role * - * * *
in * - * * *
controlling * - * * *
fimA (DNA*) - (A0*) * *
expression * express (V*) * *
: * - * * *
it * - * * *
is * - * * *
required * - * * *
both * - * * *
for * - * * *
inversion * inverst * (V*) *
of * - * * *
the * - * (A0* *
fimA * - * * *
control * - * * *
region * - * *) *
and * - * * *
for * - * * *
efficient * - * * *
expression * express * * (V*)
from * - * * *
the (DNA* - * * (A6*
fimA * - * * *
promoter *) - * * *)
. * - * * *

One * - * *
of * - * *
them * - * *
, * - * *
hT86 (DNA*) - (A1*) (A1*)
, * - * *
encoding * encode (V*) *
a (PTE* - (A0* *
putative * - * *
zinc * - * *
finger * - * *
protein *) - *) *
was * - * *
found * - * *
to * - * *
derepress * derepress * (V*)
beta-galactosidase * - * (A0*
activity * - * *)
in * - * (A2*
the (ORG* - * *
Oct-2-harboring * - * *
tester * - * *
strain *) - * *)
at * - * *
the * - * *
transcriptional * - * *
level * - * *
. * - * *

Full-length (PTE* - (A1*
BCL6 *) - *)
significantly * - *
repressed * repress (V*)
luciferase * - (A0*
activity * - *)
compared * - *
with * - *
multiple * - *
controls * - *
. * - *

The * - *
function * - *
of * - *
OmpR * - *
appears * - *
to * - *
be * - *
the * - *
enhancement * - *
of * - *
a * - *
basal * - *
level * - *
of * - *
ompC (DNA*) - (A0*)
expression * express (V*)
. * - *

Mutation * mutate (V*) * *
in * - (A2* * *
rpoS * - *) * *
, * - * * *
known * - * * *
to * - * * *
be * - * * *
induced * induce * (V*) *
upon * - * (A12* *
entry * - * * *
to * - * * *
stationary * - * * *
phase * - * *) *
, * - * * *
dramatically * - * * *
reduced * - * * *
the * - * * *
growth-phase * - * * *
response * - * * *
of * - * * *
the * - * * *
himA * - * * *
P4 * - * * *
promoter * - * * *
but * - * * *
had * - * * *
only * - * * *
a * - * * *
small * - * * *
effect * - * * *
on * - * * *
the * - * * *
induction * induce * * (V*)
of * - * * *
the (DNA* - * * (A0*
himD/hip * - * * *
promoter *) - * * *)
. (PTE*) - * (A0*) *

The * - * *
start * - * *
site * - * *
of * - * *
transcription * transcription (V*) *
of * - * *
the (DNA* - (A0* (A0*
ppsA * - * *
gene *) - *) *)
, * - * *
whose * - * *
expression * express * (V*)
is * - * *
controlled * - * *
by * - * *
the (PTE* - * *
regulatory * - * *
protein * - * *
FruR *) - * *
in * - * *
Escherichia * - * *
coli * - * *
, * - * *
was * - * *
determined * - * *
by * - * *
primer * - * *
extension * - * *
of * - * *
in * - * *
vivo * - * *
transcripts * - * *
. * - * *

It * - * *
is * - * *
transcribed * - * *
divergently * - * *
from * - * *
fimB (DNA*) - (A0*) *
, * - * *
a * - * *
gene * - * *
involved * involve (V*) *
in * - * *
the * - (A4* *
site-specific * - * *
inversion * - *) *
of * - * *
the * - * *
region * - * *
controlling * - * *
transcription * transcription * (V*)
of * - * *
the (DNA* - * (A0*
fimbrial * - * *
structural * - * *
genes *) - * *)
but * - * *
is * - * *
separated * - * *
from * - * *
it * - * *
by * - * *
one * - * *
of * - * *
the * - * *
largest * - * *
intergenic * - * *
regions * - * *
in * - * *
E * - * *
. * - * *
coli * - * *
. * - * *

Here * - *
, * - *
a * - *
further * - *
dissection * - *
of * - *
the * - *
rpoH (DNA*) - (A0*)
regulatory * - *
region * - *
has * - *
revealed * - *
that * - *
an * - *
additional * - *
transcription * - *
control * - *
exists * - *
that * - *
appears * - *
to * - *
link * - *
rpoH * - *
expression * express (V*)
to * - *
nucleoside * - *
metabolism * - *
. * - *

EvgA (PTE*) - (A0*)
overexpression * overexpression (V*)
conferred * - *
acid * - *
resistance * - *
to * - *
exponentially * - *
growing * - *
cells (ORG*) - *
. * - *

These * - * *
results * - * *
, * - * *
together * - * *
with * - * *
other * - * *
observations * - * *
, * - * *
support * - * *
the * - * *
view * - * *
that * - * *
the * - * *
OmpR * - * *
protein * - * *
has * - * *
a * - * *
two-domain * - * *
structure * - * *
, * - * *
each (PTE* - (A0* *
domain *) - *) *
exhibiting * exhibit (V*) *
a * - (A4* *
different * - * *
role * - * *
in * - * *
the * - * *
expression * express *) (V*)
of * - * *
the (PTE* - * (A0*
OmpF * - * *
and * - * *
OmpC * - * *
proteins *) - * *)
, * - * *
and * - * *
that * - * *
this * - * *
protein * - * *
takes * - * *
a * - * *
multimeric * - * *
structure * - * *
as * - * *
a * - * *
functional * - * *
unit * - * *
. * - * *

In * - * *
contrast * - * *
, * - * *
sites * - (A3* (A3*
upstream * - * *
of * - * *
the * - * *
promoters * - *) *)
did * - * *
not * - * *
appear * - * *
to * - * *
be * - * *
necessary * - * *
for * - * *
repression * repress (V*) *
, * - * *
but * - * *
were * - * *
required * - * *
for * - * *
activation * activate * (V*)
by * - * *
Lrp (PTE*) - * (A1*)
plus * - * *
alanine (PTE*) - * (A1*)
or * - * *
leucine (PTE*) - * *
of * - * *
one * - * *
of * - * *
the * - * *
major * - * *
dad * - * *
promoters * - * *
, * - * *
P2 (DNA*) - * (A0*)
. * - * *

Expression * express (V*) *
of * - * *
the (DNA* - (A0* (A1*
ompF * - * *
and * - * *
ompC * - * *
genes *) - *) *)
, * - * *
which * - * *
encode * encode * (V*)
the * - * *
major * - * *
outer * - * *
membrane * - * *
proteins * - * *
, * - * *
OmpF * - * (A0*
and * - * *
OmpC * - * *)
, * - * *
respectively * - * *
, * - * *
is * - * *
affected * - * *
in * - * *
a * - * *
reciprocal * - * *
manner * - * *
by * - * *
the * - * *
osmolarity * - * *
of * - * *
the * - * *
growth * - * *
medium * - * *
. * - * *

The (PRC* - (A0*
repression *) - *)
is * - *
initiated * initiate (V*)
by * - *
autophosphorylation * - (A1*
of * - *
the * - *
sensor * - *
protein * - *
ArcB * - *)
, * - *
followed * - *
by * - *
phosphoryl * - *
group * - *
transfer * - *
to * - *
the * - *
regulator * - *
ArcA * - *
. * - *

Analysis * - *
of * - *
mlrA-lac * - *
operon * - *
fusions * - *
demonstrated * - *
that * - *
mlrA (DNA*) - (A0*)
was * - *
positively * - (A5*)
regulated * regulate (V*)
by * - *
rpoS (PTE*) - (A1*)
. * - *

The * - * *
requirement * - * *
of * - * *
induction * - * *
can * - * *
be * - * *
eliminated * - * *
by * - * *
mutation * mutation (V*) *
of * - * *
a * - * *
new * - * *
locus * - * *
, * - * *
galS (DNA*) - (A0*) *
, * - * *
resulting * - * *
in * - * *
constitutive * - * (A5*
and * - * *
ultrainduced * - * *
levels * - * *)
of * - * *
gal (DNA*) - * (A0*)
expression * express * (V*)
. * - * *

Lrp * - (A1*)
strongly * - *
and * - *
cooperatively * - *
binds * - *
to * - *
multiple * - *
sites * - *
located * - *
between * - *
positions * - *
-14 * - *
and * - *
-102 * - *
( * - *
in * - *
a * - *
way * - *
that * - *
suggests * - *
DNA * - *
wrapping * - *
around * - *
multiple * - *
Lrp * - *
molecules * - *
) * - *
and * - *
moderately * - *
stimulates * stimulate (V*)
in (PRC* - (A0*
vitro * - *
transcription *) - *)
, * - *
especially * - *
with * - *
E * - *
sigma * - *
s * - *
. * - *

Growth * - *
of * - *
Escherichia * - *
coli * - *
in * - *
the * - *
presence * - *
of * - *
nitrate * - *
or * - *
nitrite * - *
led * - *
to * - *
a * - *
45% * - (A9*)
decrease * decrease (V*)
in * - *
expression (PRC*) - (A0*)
when * - (A12*
cells * - *
were * - *
cultivated * - *
in * - *
rich * - *
medium * - *)
. * - *

The * - *
homology * - *
domain * - *
of * - *
tal * - *
is * - *
especially * - *
related * - *
to * - *
that * - *
of * - *
lyl-1 (DNA*) - (A0*)
, * - *
a * - *
gene * - *
on * - *
chromosome * - *
19 * - *
that * - *
has * - *
also * - *
been * - *
implicated * implicate (V*)
in * - *
T * - (A4*
cell * - *
oncogenesis * - *)
. * - *

The (DNA* - (A1* (A0* (A0* (A0*
dcuB * - * * * *
gene *) - *) *) *) *)
of * - * * * *
Escherichia * - * * * *
coli * - * * * *
encodes * encode (V*) * * *
an (PTE* - (A0* * * *
anaerobic * - * * * *
C4-dicarboxylate * - * * * *
transporter *) - *) * * *
that * - * * * *
is * - * * * *
induced * induce * (V*) * *
anaerobically * - * * * *
by * - * * * *
FNR (PTE*) - * (A1*) * *
, * - * * * *
activated * activate * * (V*) *
by * - * * * *
the (PTE* - * * (A1* *
cyclic * - * * * *
AMP * - * * * *
receptor * - * * * *
protein *) - * * *) *
, * - * * * *
and * - * * * *
repressed * repress * * * (V*)
in * - * * * *
the * - * * * *
presence * - * * * *
of * - * * * *
nitrate (EXP*) - * * * (A3*)
by * - * * * *
NarL (PTE*) - * * * (A1*)
. * - * * * *

These * - * (A1* *
complex * - * * *
control * - * * *
circuits * - * *) *
impose * - * * *
tight * - * * *
rein * - * * *
over * - * * *
expression * express (V*) * *
of * - * * *
the (DNA* - (A0* * *
gadA * - * * *
and * - * * *
gadBC * - * * *
system *) - *) * *
yet * - * * *
provide * provide * (V*) *
flexibility * - * (A0*) *
for * - * * *
inducing * induce * * (V*)
acid * - * * (A0*
resistance * - * * *)
under * - * * *
many * - * * *
conditions * - * * *
that * - * * *
presage * - * * *
acid * - * * (A3*
stress * - * * *)
. * - * * *

As * - * * *
most * - * * *
of * - * * *
the * - * * *
highly * - * * *
similar * - * * *
proteins * - * * *
are * - * * *
considered * - * * *
to * - * * *
have * - * * *
diverged * - * * *
from * - * * *
a * - * * *
common * - * * *
ancestral * - * * *
protein * - * * *
, * - * * *
this * - * * *
finding * - * * *
strongly * - * * *
suggests * - * * *
the * - * * *
possibility * - * * *
that * - * * *
descendant (PTE* - (A0* * *
regulatory * - * * *
proteins *) - *) * *
have * - * * *
been * - * * *
promiscuously * - (A5*) * *
coupled * couple (V*) * *
with * - * * *
descendant (DNA* - (A0* * *
operons *) - *) * *
, * - * * *
independently * - * * *
of * - * * *
their * - * * *
ancestral * - * * *
regulator-regulon * - * * *
relationship * - * * *
, * - * * *
and * - * * *
that * - * * *
some * - * * *
of * - * * *
the * - * * *
couplings * - * * *
have * - * * *
been * - * * *
fixed * - * * *
by * - * * *
selection * - * * *
to * - * * *
form * form * (V*) *
the * - * (A0* *
present * - * * *
system * - * *) *
of * - * * *
transcriptional * - * * (A5*)
regulation * regulation * * (V*)
. * - * * *

Furthermore * - * *
, * - * *
in * - * *
strains * - * *
that * - * *
slightly * - * *
overproduce * - * *
CytR * - * *
, * - * *
transcription * transcription (V*) *
from * - * *
P3 (DNA*) - (A6*) *
, * - * *
P4 (DNA*) - * *
and * - * *
P5 (DNA*) - * *
is * - * *
reduced * - * *
even * - * *
further * - * *
( * - * *
approximately * - * *
10-fold * - * *
) * - * *
, * - * *
and * - * *
repression (PRC*) - * (A0*)
can * - * *
be * - * *
fully * - * *
neutralized * neutralize * (V*)
by * - * *
the * - * *
addition * - * *
of * - * *
the * - * *
inducer * - * *
cytidine (EXP*) - * (A3*)
to * - * *
the * - * *
growth * - * *
medium * - * *
. * - * *

CueR (PTE*) - (A1*) *
binding * bind (V*) *
occurs * - * *
in * - * *
vitro * - * *
in * - * *
both * - * *
the * - * *
presence * - * *
and * - * *
the * - * *
absence * - * *
of * - * *
RNA (PTE* - * *
polymerase *) - * *
with * - * *
or * - * *
without * - * *
copper (EXP* - * *
ions *) - * *
present * - * *
but * - * *
, * - * *
in * - * *
the * - * *
presence * - * *
of * - * *
CueR (PTE*) - * (A3*)
, * - * *
RNA * - * *
polymerase * - * *
and * - * *
copper * - * *
ions * - * *
, * - * *
permanganate-sensitive (PTE* - * (A0*
transcription * - * *
complexes *) - * *)
were * - * *
formed * form * (V*)
. * - * *

Overproduction * overproduce (V*) * *
of * - * * *
AdhE (PTE*) - (A0*) * *
in * - (A2* * *
the (None* - * * *
MC1061 * - * * *
background *) - *) * *
was * - * * *
reversed * - * * *
to * - * * *
the * - * * *
wild-type * - * * *
levels * - * * *
by * - * * *
introduction * introduce * (V*) *
of * - * * *
a (DNA* - * (A0* (A1*
plasmid *) - * *) *)
carrying * carry * * (V*)
the (DNA* - * * (A0*
cra * - * * *
( * - * * *
+ * - * * *
) * - * * *
gene *) - * * *)
. * - * * *

The * - * *
lacZ * - * *
transcriptional * - * *
fusions * - * *
of * - * *
different * - * *
fragments * - * *
of * - * *
the * - * *
promoter * - * *
demonstrated * - * *
that * - * *
binding * bind (V*) *
of * - * *
cAMP-Crp (PTE*) - (A1*) *
to * - * *
the (DNA* - (A7* *
Crp * - * *
site * - * *
1 *) - *) *
, * - * *
centered * - * *
at * - * *
-106 * - * *
, * - * *
is * - * *
essential * - * *
for * - * *
yiaK-S * - * (A0*)
expression * express * (V*)
. * - * *

A * - * *
mutant * - * *
defective * - * *
in * - * *
GTP * - * *
binding * - * *
does * - * *
not * - * *
trigger * - * *
apoptosis * - * *
, * - * *
indicating * - * *
that * - * *
increased * - * *
levels * - * *
of * - * *
dyn2 * - * *
. * - * *
GTP * - * *
, * - * *
rather * - * *
than * - * *
protein (PTE* - (A1* *
levels *) - *) *
per * - * *
se * - * *
, * - * *
are * - * *
required * - * *
to * - * *
transduce * transduce (V*) *
signals * - (A0*) (A1*)
that * - * *
activate * activate * (V*)
p53 (PTE*) - * (A0*)
. * - * *

Mizuno * - * * *
, * - * * *
Gene * - * * *
54 * - * * *
: * - * * *
57-64 * - * * *
, * - * * *
1987 * - * * *
) * - * * *
, * - * * *
and * - * * *
the * - * * *
fact * - * * *
that * - * * *
mutations (PRC*) - (A1*) * *
altering * - * * *
integration * - * * *
host * - * * *
factor * - * * *
result * result (V*) * *
in * - * * *
constitutive * - (A0* * *
ompF * - * * *
expression * express *) (V*) *
( * - * * *
P * - * * *
. * - * * *
Tsui * - * * *
, * - * * *
V * - * * *
. * - * * *
Helu * - * * *
, * - * * *
and * - * * *
M * - * * *
. * - * * *
Freundlich * - * * *
, * - * * *
J * - * * *
. * - * * *
Bacteriol * - * * *
. * - * * *
170 * - * * *
: * - * * *
4950-4953 * - * * *
, * - * * *
1988 * - * * *
) * - * * *
, * - * * *
we * - * * *
propose * - * * *
that * - * * *
the * - * * *
negative * - * * (A5*)
regulation * regulation * * (V*)
of * - * * *
ompF (DNA*) - * (A0*) *
involves * - * * *
a * - * * *
DNA * - * * *
loop * - * * *
structure * - * * *
. (DNA*) - * * (A0*)

We * - *
suggest * - *
that * - *
other (PTE* - (A0*
IRF * - *
family * - *
members *) - *)
may * - *
participate * - *
in * - *
signaling * - *
pathways * - *
by * - *
interacting * interact (V*)
with * - *
as (PTE* - (A0*
yet * - *
unidentified * - *
regulatory * - *
subunits *) - *)
analogous * - *
to * - *
ISGF3 * - *
alpha * - *
. * - *

Cotransfection * - * *
studies * - * *
indicated * - * *
that * - * *
RFX1 (PTE*) - (A0*) (A1*)
, * - * *
which * - * *
is * - * *
expressed * express (V*) *
ubiquitously * - (A5*) *
, * - * *
down-regulated * down-regulated * (V*)
the * - * (A0*
MAP1A (DNA* - * *
5' * - * *
promoter *) - * *
activity * - * *)
in * - * *
non-neuronal (ORG* - * *
cells *) - * *
. * - * *

We * - *
also * - *
reconstituted * - *
transcription * transcription (V*)
from * - *
both (DNA* - (A0*
promoters *) - *)
with * - *
purified * - *
components * - *
, * - *
which * - *
confirmed * - *
the * - *
accessory * - *
role * - *
of * - *
ArgR * - *
for * - *
the * - *
sigma * - *
( * - *
54 * - *
) * - *
-dependent * - *
promoter * - *
. * - *

Mutations * mutate (V*) * *
in * - * * *
the (DNA* - (A0* * *
putative * - * * *
NarL-binding * - * * *
site *) - *) * *
at * - (A2* * *
the (DNA* - * * *
nirB * - * * *
promoter *) - *) * *
decrease * - * * *
FNR-dependent * - * (A5* *
anaerobic * - * *) *
induction * induce * (V*) *
, * - * * *
suggesting * - * * *
that * - * * *
NarL (PTE*) - * * *
acts * - * * *
as * - * * *
a * - * * *
helper * - * * *
to * - * * *
FNR * - * * *
during * - * * *
transcription (PRC*) - * * (A0*)
activation * activate * * (V*)
. * - * * *

To * - *
our * - *
knowledge * - *
, * - *
the (DNA* - (A1*
csiD * - *
promoter *) - *)
is * - *
the * - *
first * - *
characterized * - *
promoter * - *
which * - *
is * - *
not * - *
only * - *
exclusively * - *
dependent * - *
on * - *
sigma * - *
s-containing * - *
RNA * - *
polymerase * - *
( * - *
E * - *
sigma * - *
s * - *
) * - *
, * - *
but * - *
also * - *
requires * require (V*)
an (PTE* - (A0*
activator *) - *)
, * - *
cAMP-CRP * - *
. * - *

Here * - * *
we * - * *
show * - * *
that * - * *
RFP (PTE*) - (A1*) *
interacts * interact (V*) *
with * - * *
Enhancer (DNA* - (A8* *
of * - * *
Polycomb *) - *) *
( * - * *
EPC * - * *
) * - * *
and * - * *
strongly * - * *
represses * - * *
the (DNA* - * (A0*
gene *) - * *)
transcription * transcription * (V*)
. * - * *

Transcription * - (A5*)
activation * activate (V*)
at * - *
the (DNA* - (A0*
Escherichia * - *
coli * - *
melAB * - *
promoter *) - *)
: * - *
the * - *
role * - *
of * - *
MelR * - *
and * - *
the * - *
cyclic * - *
AMP * - *
receptor * - *
protein * - *
. * - *

The (DNA* - (A1*
tal * - *
gene *) - *)
undergoes * - *
chromosome * - *
translocation * - *
in * - *
T * - *
cell * - *
leukemia * - *
and * - *
potentially * - *
encodes * encode (V*)
a (PTE* - (A0*
helix-loop-helix * - *
protein *) - *)
. * - *

The * - * * *
hslJ * - * * *
promoter * - * * *
region * - * * *
was * - * * *
defined * - * * *
by * - * * *
employing * - * * *
different * - * * *
hslJ-lacZ * - * * *
operon * - * * *
fusions * - * * *
, * - * * *
and * - * * *
transcription * transcription (V*) * *
of * - * * *
the (DNA* - (A0* (A0* (A0*
hslJ * - * * *
gene *) - *) *) *)
was * - * * *
shown * - * * *
to * - * * *
be * - * * *
subject * - * * *
to * - * * *
both * - * * *
repression * repress * (V*) *
imposed * - * * *
by * - * * *
the (PTE* - * (A1* *
CysB * - * * *
regulator *) - * *) *
and * - * * *
direct * - * * (A5*
or * - * * *
indirect * - * * *
autogenous * - * * *
negative * - * * *)
control * control * * (V*)
. * - * * *

Nitrate (PRC* - (A0* * * *
regulation *) - *) * * *
is * - * * * *
mediated * mediate (V*) * * *
by * - * * * *
the * - (A1* * * *
NarX-NarL * - * * * *
two-component * - * * * *
system * - *) * * *
, * - * * * *
which * - * * * *
activates * - * * * *
the * - * * * *
transcription * transcription * (V*) * *
of * - * * * *
operons (DNA*) - * (A0*) (A1*) *
encoding * encode * * (V*) *
nitrate (PTE* - * * (A0* *
respiration * - * * * *
enzymes *) - * * *) *
and * - * * * *
represses * - * * * *
the * - * * * *
transcription * transcription * * * (V*)
of * - * * * *
operons * - * * * (A0*)
for * - * * * *
other * - * * * (A11*
anaerobic * - * * * *
respiratory * - * * * *
enzymes * - * * * *)
, * - * * * *
including * - * * * *
enzymes * - * * * *
involved * - * * * *
in * - * * * *
fumarate * - * * * *
respiration * - * * * *
. * - * * * *

inactivation * inactivate (V*) * *
of * - * * *
lrp (DNA*) - (A0*) * *
causes * - * * *
an * - * * *
increased * - * * *
activity * - * * *
of * - * * *
the * - * * *
lysU (DNA*) - * * (A0*)
promoter * - * * *
, * - * * *
whatever * - * * *
the * - * * *
growth * - * * *
conditions * - * * *
assayed * - * * *
, * - * * *
( * - * * *
ii * - * * *
) * - * * *
insertion * insert * (V*) *
of * - * * *
a (DNA* - * (A0* *
wild-type * - * * *
lrp * - * * *
gene *) - * *) *
into * - * * *
a (DNA* - * (A7* *
multi-copy * - * * *
plasmid *) - * *) *
significantly * - * * *
reduces * - * * *
lysU * - * * *
expression * express * * (V*)
, * - * * *
and * - * * *
( * - * * *
iii * - * * *
) * - * * *
sensitivity * - * * *
of * - * * *
the * - * * *
lysU * - * * *
promoter * - * * *
to * - * * *
the * - * * *
presence * - * * *
of * - * * *
leucine * - * * *
in * - * * *
the * - * * *
growth * - * * *
medium * - * * *
is * - * * *
abolished * - * * *
in * - * * *
the * - * * *
lrp * - * * *
context * - * * *
. * - * * *

The * - *
data * - *
indicate * - *
a * - *
wider * - *
FlhD * - *
( * - *
2 * - *
) * - *
C * - *
( * - *
2 * - *
) * - *
regulon * - *
, * - *
in * - *
which * - *
non-flagellar (DNA* - (A0*
genes *) - *)
are * - *
bound * - *
and * - *
activated * activate (V*)
directly * - (A5*
, * - *
albeit * - *
less * - *
strongly * - *)
, * - *
by * - *
the * - (A1*
same * - *
mechanism * - *)
as * - *
that * - *
regulating * - *
the * - *
flagella * - *
gene * - *
hierarchy * - *
. * - *

The (DNA* - (A1*
dcuA * - *
and * - *
dcuB * - *
genes *) - *)
of * - *
Escherichia * - *
coli * - *
encode * encode (V*)
homologous (PTE* - (A0*
proteins *) - *)
that * - *
appear * - *
to * - *
function * - *
as * - *
independent * - *
and * - *
mutually * - *
redundant * - *
C4-dicarboxylate * - *
transporters * - *
during * - *
anaerobiosis * - *
. * - *

Expression * express (V*) *
of * - * *
yiaJ (DNA*) - (A0*) *
is * - * *
autogenously * - * *
regulated * - * *
and * - * *
reduced * - * *
by * - * *
the * - * *
binding * bind * (V*)
of * - * *
Crp-cAMP (PTE*) - * (A1*)
to * - * *
the (DNA* - * (A7*
Crp * - * *
site * - * *
1 *) - * *
of * - * *
the * - * *
yiaK-S * - * *
promoter * - * *)
. * - * *

H-NS (PTE* - *
protein *) - *
represses * - *
transcription * transcription (V*)
of * - *
the * - (A0*
lux * - *
systems * - *)
of * - *
Vibrio * - *
fischeri * - *
and * - *
other * - *
luminous * - *
bacteria * - *
cloned * - *
into * - *
Escherichia * - *
coli * - *
. * - *

PU * - *
. * - *
1 * - *
( * - *
Spi-1 (PTE*) - (A0*)
) * - *
, * - *
a * - *
member * - *
of * - *
the * - *
Ets * - *
transcription * - *
factor * - *
family * - *
, * - *
is * - *
predominantly * - *
expressed * express (V*)
in * - (A2*
myeloid * - *
( * - *
granulocytes * - *
, * - *
monocytes * - *
and * - *
macrophages * - *
) * - *
and * - *
B * - *
cells * - *)
. (ORG*) - *

This (DNA* - * * (A1*
promoter *) - * * *)
directs * - * * *
the * - * * *
expression * express (V*) * *
of * - * * *
the (DNA* - (A0* * *
reporter * - * * *
gene *) - *) * *
in * - * * *
EC (ORG* - * * *
cells *) - * * *
after * - * * *
induction * induce * (V*) *
with * - * * *
RA * - * (A1*) *
, * - * * *
and * - * * *
binds * bind * * (V*)
RA-induced * - * * (A7*
nuclear * - * * *
factor * - * * *
( * - * * *
s * - * * *
) * - * * *)
through * - * * *
a (DNA* - * * (A10*
conserved * - * * *
palindromic * - * * *
sequence *) - * * *)
located * - * * *
approximately * - * * *
100 * - * * *
bp * - * * *
upstream * - * * *
of * - * * *
the * - * * *
transcription * - * * *
start * - * * *
site * - * * *
. * - * * *

Alignment * - * * * *
of * - * * * *
FruR (PTE*) - (A1*) * * *
operators * - * * * *
revealed * - * * * *
that * - * * * *
the (DNA* - (A7* * * *
consensus * - * * * *
sequence *) - *) * * *
for * - * * * *
FruR (PTE*) - * (A1*) (A1*) *
binding * bind (V*) * * *
is * - * * * *
the * - * * * *
same * - * * * *
for * - * * * *
operons (DNA*) - * (A0*) (A0*) *
that * - * * * *
are * - * * * *
activated * activate * (V*) * *
and * - * * * *
repressed * repress * * (V*) *
by * - * * * *
FruR * - * * * *
and * - * * * *
permitted * - * * * *
formulation * formulate * * * (V*)
of * - * * * *
a (DNA* - * * * (A0*
revised * - * * * *
FruR-binding * - * * * *
consensus * - * * * *
sequence *) - * * * *)
. * - * * * *

Here * - * *
we * - * *
report * - * *
further * - * *
characterization * - * *
of * - * *
agn43 (DNA*) - (A0*) (A0*)
transcription * transcription (V*) *
and * - * *
its * - * *
regulation * regulation * (V*)
. * - * *

Action * - *
at * - *
a * - *
distance * - *
for * - *
glp (PTE* - *
repressor *) - *
control * - *
of * - *
glpTQ (DNA*) - (A0*)
transcription * transcription (V*)
in * - (A2*
Escherichia (ORG* - *
coli * - *
K-12 *) - *)
. * - *

Interestingly * - *
, * - *
FIS (PTE*) - (A1*)
bound * bound (V*)
not * - *
only * - *
to * - *
the * - (A7*
upstream * - *
region * - *
of * - *
the (DNA* - *
promoter *) - *)
, * - *
but * - *
also * - *
to * - *
the * - *
region * - *
from * - *
+4 * - *
to * - *
+18 * - *
. * - *

SMN (PRC* - (A1*
mutants *) - *)
found * - *
in * - (A2*
SMA (ORG* - *
patients *) - *)
cannot * - *
stimulate * stimulate (V*)
splicing * - (A0*)
. * - *

Ectopic * - *
expression * express (V*)
of * - *
GBX2 (DNA*) - (A0*)
in * - (A2*
growth (ORG* - *
factor-dependent * - *
myeloblasts *) - *)
induces * - *
monocytic * - *
features * - *
and * - *
independence * - *
from * - *
exogenous * - *
cytokines * - *
, * - *
reflecting * - *
distinct * - *
features * - *
of * - *
AMV-transformed * - *
cells * - *
. * - *

Positive * - (A5*
and * - *
negative * - *)
transcriptional * - (A5*)
regulation * regulation (V*)
of * - *
the (DNA* - (A0*
Escherichia * - *
coli * - *
gluconate * - *
regulon * - *
gene * - *
gntT *) - *)
by * - *
GntR (PTE* - (A1*
and * - *
the * - *
cyclic * - *
AMP * - *
( * - *
cAMP * - *
) * - *
-cAMP * - *
receptor * - *
protein * - *
complex *) - *)
. * - *

We * - *
have * - *
isolated * - *
complementary (DNA* - (A1*
DNA * - *
clones *) - *)
encoding * encode (V*)
a * - *
novel * - *
orphan * - *
member * - *
of * - *
the * - *
nuclear * - *
receptor * - *
superfamily * - *
, * - *
termed (PTE* - (A0*
BD73 *) - *)
. * - *

Each * - *
of * - *
the (DNA* - *
glpACB * - *
operators *) - *
contributed * - *
to * - *
repression * repress (V*)
of * - *
both (DNA* - (A0*
operons *) - *)
. * - *

Previous * - * *
work * - * *
has * - * *
shown * - * *
that * - * *
integration * - * *
host * - * *
factor * - * *
( * - * *
IHF * - * *
) * - * *
mutants (None*) - * *
have * - * *
increased * - * *
expression * express (V*) *
and * - * *
altered * - * *
osmoregulation * osmoregulate * (V*)
of * - * *
OmpF (PTE*) - (A0*) (A0*)
, * - * *
a * - * *
major * - * *
Escherichia * - * *
coli * - * *
outer * - * *
membrane * - * *
protein * - * *
. * - * *

We * - *
have * - *
identified * - *
an * - *
additional * - *
gene * - *
, * - *
torT * - *
, * - *
located * - *
just * - *
downstream * - *
from * - *
the * - *
torR * - *
gene * - *
, * - *
which * - *
is * - *
necessary * - *
for * - *
torCAD (DNA* - (A0*
structural * - *
operon *) - *)
expression * express (V*)
. * - *

Overproduction * overproduce (V*)
of * - *
one (PTE* - (A0*
or * - *
the * - *
other * - *
of * - *
the * - *
subunits *) - *)
has * - *
been * - *
shown * - *
to * - *
induce * - *
the * - *
SOS * - *
response * - *
and * - *
mucoidy * - *
. * - *

Enhanced * - (A5*)
expression * express (V*)
of * - *
iciA-lacZ (DNA*) - (A0*)
was * - *
dependent * - *
upon * - *
the * - *
PhoB * - *
protein * - *
. * - *

In * - * *
comparison * - * *
, * - * *
four * - (A1* (A0*
representative * - * *
flagella * - * *
class * - * *
II (DNA* - * *
promoters *) - *) *)
bound * bound (V*) *
FlhD (PTE* - (A7* *
( * - * *
2 * - * *
) * - * *
C * - * *
( * - * *
2 * - * *
) *) - *) *
in * - * *
the * - * *
K * - * *
( * - * *
D * - * *
) * - * *
range * - * *
12-43 * - * *
nM * - * *
and * - * *
were * - * *
upregulated * upregulate * (V*)
in * - * *
vivo * - * *
30- * - * *
to * - * *
990-fold * - * (A9*
. * - * *)

Using * - * * *
in * - * * *
vivo * - * * *
reporter * - * * *
assays * - * * *
, * - * * *
we * - * * *
showed * - * * *
that * - * * *
disruption * disruption (V*) * *
of * - * * *
DNA (DNA* - (A0* (A0* *
sites *) - *) *) *
for * - * * *
FIS * - * * *
or * - * * *
deletion * delete * (V*) *
of * - * * *
DNA * - * * *
sites * - * * *
for * - * * *
IHF * - * * *
increases * - * * *
acs (DNA*) - * * (A0*)
transcription * transcription * * (V*)
. * - * * *

We * - * * *
showed * - * * *
that * - * * *
the (PTE* - (A1* * *
Spi-B * - * * *
protein *) - *) * *
is * - * * *
able * - * * *
to * - * * *
bind * bind (V*) * *
the * - * * *
purine-rich * - * * *
sequence * - * * *
( * - * * *
PU (DNA* - (A7* * *
box *) - *) * *
) * - * * *
recognized * - * * *
by * - * * *
Spi-1/PU * - * * *
. * - * * *
1 * - * * *
and * - * * *
to * - * * *
activate * - * * *
transcription * transcription * (V*) *
of * - * * *
a (DNA* - * (A0* (A0*
reporter * - * * *
plasmid *) - * *) *)
containing * contain * * (V*)
PU (DNA* - * * (A4*
boxes *) - * * *)
. * - * * *

Introduction * introduce (V*)
of * - *
these (PRC* - (A0*
mutations * - *
or * - *
deletions *) - *)
was * - *
always * - *
accompanied * - *
by * - *
disappearance * - *
of * - *
PEP * - *
synthase * - *
activity * - *
. * - *

This (DNA* - (A0* (A0* *
operon *) - *) *) *
, * - * * *
activated * activate (V*) * *
by * - * * *
growth * - * * *
on * - * * *
glycolate (EXP*) - (A1*) * *
, * - * * *
is * - * * *
transcribed * transcribe * (V*) *
as * - * * *
a * - * * *
single * - * * *
message * - * * *
and * - * * *
is * - * * *
under * - * * *
the * - * * *
positive * - * * *
control * - * * *
of * - * * *
GlcC (PTE*) - * * (A0*)
encoded * encode * * (V*)
by * - * * *
a (DNA* - * * (A1*
divergent * - * * *
gene *) - * * *)
. * - * * *

These * - *
results * - *
demonstrate * - *
that * - *
propionate * - *
metabolism * - *
is * - *
subject * - *
to * - *
catabolite * - *
repression * - *
by * - *
the * - *
global * - *
transcriptional * - *
regulator * - *
CRP * - *
and * - *
that * - *
this (PRC* - *
regulation *) - *
is * - *
effected * - *
through * - *
control * control (V*)
of * - *
both * - *
the * - *
regulator (DNA* - (A0*
gene * - *
prpR *) - *)
and * - *
the (DNA* - *
prpBCDE * - *
operon *) - *
itself * - *
. * - *

When * - * * *
expressed * express (V*) * *
as * - * * *
a * - * * *
fusion * - * * *
protein * - * * *
in * - (A2* * *
a (DNA* - * * *
pMAL-c * - * * *
vector *) - *) * *
, * - * * *
MAZ (PTE*) - (A0*) (A1*) *
binds * bind * (V*) *
with * - * (A5* *
specificity * - * *) *
to * - * * *
a (DNA* - * * *
GA * - * (A7* *
box * - * * *
sequence *) - * *) *
( * - * * *
GGGAGGG * - * * *
) * - * * *
found * - * * *
in * - * * *
the * - * * *
c-MYC * - * * *
P2 * - * * *
promoter * - * * *
, * - * * *
to * - * * *
the (DNA* - * * *
P2 * - * * *
attenuator * - * * *
region *) - * * *
within * - * * *
the * - * * *
gene's * - * * *
first * - * * *
exon * - * * *
, * - * * *
and * - * * *
to * - * * *
a (DNA* - * * *
related * - * * *
sequence *) - * * *
involved * - * * *
in * - * * *
the * - * * *
transcriptional (PRC*) - * * (A5*)
termination * terminate * * (V*)
of * - * * *
the (DNA* - * * (A0*
C2 * - * * *
gene *) - * * *)
. * - * * *

Curli * - *
production * - *
is * - *
dependent * - *
on * - *
the (PTE* - (A1*
CsgD * - *
transcription * - *
activator *) - *)
, * - *
which * - *
also * - *
promotes * promote (V*)
cellulose * - (A0*
biosynthesis * - *)
. * - *

To * - * *
address * - * *
the * - * *
mechanisms * - * *
of * - * *
activation * activate (V*) *
by * - * *
CRP (PTE*) - (A1*) *
and * - * *
the * - * *
RNA * - * *
polymerase * - * *
alpha-subunit * - * *
C-terminal * - * *
domain * - * *
( * - * *
alpha-CTD (PTE*) - * *
) * - * *
at * - (A2* *
rhaSR * - *) *
, * - * *
we * - * *
tested * - * *
the * - * *
effects * - * *
of * - * *
alanine * - * *
substitutions * - * *
in * - * *
CRP (PTE*) - * (A1*)
activating * activate * (V*)
regions (DNA* - * (A0*
1 * - * *
and * - * *
2 *) - * *)
, * - * *
overexpression * - * *
of * - * *
a * - * *
truncated * - * *
version * - * *
of * - * *
alpha * - * *
( * - * *
alpha-Delta235 * - * *
) * - * *
, * - * *
and * - * *
alanine * - * *
substitutions * - * *
throughout * - * *
alpha-CTD * - * *
. (DNA*) - * *

However * - *
, * - *
our * - *
data * - *
suggest * - *
that * - *
the (PTE* - (A0*
activating * - *
domain *) - *)
is * - *
not * - *
confined * confine (V*)
exclusively * - (A5*)
to * - (A2*
the * - *
conserved * - *
regions * - *)
. * - *

Gene (DNA*) - (A0*)
expression * express (V*)
in * - *
the * - (A3*
absence * - *
of * - *
T7 (PTE* - *
RNA * - *
polymerase *) - *)
was * - *
evaluated * - *
either * - *
directly * - *
using * - *
lacZ (EXP* - *
reporter * - *
systems *) - *
or * - *
indirectly * - *
by * - *
observing * - *
the (EXP* - *
susceptibility * - *
of * - *
plasmid-bearing * - *
tester * - *
strains * - *
to * - *
inhibition * - *
by * - *
an * - *
aromatic * - *
amino * - *
acid * - *
analog *) - *
. * - *

Lrp (PTE*) - (A1*) *
( * - * *
leucine-responsive * - * *
regulatory * - * *
protein * - * *
) * - * *
is * - * *
a * - * *
global * - * *
transcription * - * *
factor * - * *
of * - * *
Escherichia * - * *
coli * - * *
and * - * *
regulates * regulate (V*) *
, * - * *
negatively * - * *
or * - * *
positively * - * *
, * - * *
many (DNA* - (A0* *
genes *) - *) *
including * - * *
lysU (DNA*) - (A0*) (A1*)
, * - * *
which * - * *
encodes * encode * (V*)
lysyl-tRNA (PTE* - * (A0*
synthetase *) - * *)
. * - * *

Transcription * transcribe (V*) *
of * - * *
the (DNA* - (A0* (A1*
rnpB * - * *
gene *) - *) *)
encoding * encode * (V*)
M1 (DNA* - * (A0*
RNA *) - * *)
, * - * *
the * - * *
catalytic * - * *
subunit * - * *
of * - * *
E * - * *
. * - * *
coli * - * *
RNase * - * *
P * - * *
, * - * *
rapidly * - * *
declines * - * *
under * - * *
stringent * - * *
conditions * - * *
, * - * *
as * - * *
does * - * *
that * - * *
of * - * *
other * - * *
stable * - * *
RNAs * - * *
. * - * *

The * - * *
expression * express (V*) *
of * - * *
dcuB (DNA*) - (A0*) *
is * - * *
entirely * - * *
consistent * - * *
with * - * *
a * - * *
primary * - * *
role * - * *
for * - * *
DcuB (PTE*) - * (A1*)
in * - * *
mediating * mediate * (V*)
C4-dicarboxylate * - * (A0*
transport * - * *)
during * - * *
anaerobic * - * *
fumarate * - * *
respiration * - * *
. * - * *

The (DNA* - (A1*
hyf * - *
operon *) - *)
is * - *
located * - *
at * - *
55 * - *
. * - *
8-56 * - *
. * - *
0 * - *
min * - *
and * - *
encodes * encode (V*)
a * - (A0*
putative * - *
nine-subunit * - *
hydrogenase * - *
complex * - *)
( * - *
hydrogenase * - *
four * - *
or * - *
Hyf * - *
) * - *
, * - *
a * - *
potential * - *
formate- * - *
and * - *
sigma * - *
54-dependent * - *
transcriptional * - *
activator * - *
, * - *
HyfR * - *
( * - *
related * - *
to * - *
FhlA * - *
) * - *
, * - *
and * - *
a * - *
possible * - *
formate * - *
transporter * - *
, * - *
FocB * - *
( * - *
related * - *
to * - *
FocA * - *
) * - *
. * - *

Evidence * - *
is * - *
accumulating * - *
that * - *
some (PTE* - *
of * - *
them *) - *
are * - *
also * - *
participating * - *
in * - *
induced * - *
gene (DNA*) - (A0*)
expression * express (V*)
in * - *
the (ORG* - *
adult *) - *
. * - *

In * - *
addition * - *
three * - *
of * - *
the * - *
residues * - *
required * - *
for * - *
activin (PTE*) - (A0*)
binding * bind (V*)
to * - *
ALK4 (PTE*) - (A7*)
are * - *
conserved * - *
on * - *
the * - *
type * - *
I * - *
TGF-beta * - *
receptor * - *
ALK5 * - *
, * - *
suggesting * - *
the * - *
corresponding * - *
region * - *
on * - *
ALK5 * - *
may * - *
be * - *
important * - *
for * - *
TGF-beta * - *
binding * - *
. * - *

Dose-dependent * - (A5*) * *
up-regulation * upregulate (V*) * *
of * - * * *
P (DNA* - (A0* * *
( * - * * *
hmp * - * * *
) *) - *) * *
in * - (A3* * *
vivo * - *) * *
by * - * * *
NO (EXP* - (A1* * *
concentrations *) - *) * *
of * - * * *
pathophysiological * - * * *
relevance * - * * *
is * - * * *
abolished * - * * *
by * - * * *
fnr (DNA*) - * (A0*) *
mutation * mutation * (V*) *
, * - * * *
and * - * * *
NO (EXP*) - * * *
also * - * * *
modulates * - * * *
expression * express * * (V*)
from * - * * *
model (DNA* - * * (A6*
FNR-regulated * - * * *
promoters *) - * * *)
. * - * * *

Synthesis * synthesize (V*)
of * - *
the (PTE* - (A0*
[ * - *
NiFe * - *
] * - *
hydrogenases * - *
1 * - *
and * - *
2 *) - *)
of * - *
Escherichia * - *
coli * - *
is * - *
induced * - *
in * - *
response * - *
to * - *
anaerobiosis * - *
and * - *
is * - *
repressed * - *
when * - *
nitrate (EXP*) - *
is * - *
present * - *
in * - *
the * - *
growth * - *
medium * - *
. * - *

To * - *
learn * - *
more * - *
about * - *
the * - *
respective * - *
roles * - *
of * - *
the (DNA* - (A0*
dcu * - *
genes *) - *)
, * - *
the * - *
environmental * - *
and * - *
regulatory * - *
factors * - *
influencing * - *
their * - *
expression * express (V*)
were * - *
investigated * - *
by * - *
generating * - *
and * - *
analyzing * - *
single-copy * - *
dcuA- * - *
and * - *
dcuB-lacZ * - *
transcriptional * - *
fusions * - *
. * - *

Furthermore * - *
, * - *
cells * - *
with * - *
defects * - *
in * - *
cya * - *
or * - *
crp * - *
exhibited * - *
reduced * - *
transcriptional * - *
activation * activate (V*)
of * - *
prpR (DNA* - (A0*
and * - *
prpBCDE *) - *)
in * - *
Escherichia (ORG* - (A2*
coli *) - *)
. * - *

In * - *
addition * - *
, * - *
derepression * - *
of * - *
TreC * - *
by * - *
itself * - *
caused * - *
induction * - *
of * - *
the * - *
maltose * - *
system * - *
, * - *
and * - *
a * - *
mutant * - *
lacking * - *
TreC * - *
was * - *
reduced * - *
in * - *
the * - *
uninduced * - *
level * - *
of * - *
mal (DNA* - (A0*
gene *) - *)
expression * express (V*)
indicating * - *
synthesis * - *
of * - *
endogenous * - *
inducer * - *
by * - *
TreC * - *
. * - *

In * - *
contrast * - *
, * - *
the * - (A0*
PR * - *
promoter * - *)
was * - *
not * - *
regulated * regulate (V*)
by * - *
these (EXP* - (A1*
sugars *) - *)
. * - *

Repression * repress (V*) *
of * - * *
the (DNA* - (A0* *
Escherichia * - * *
coli * - * *
melR * - * *
promoter *) - *) *
by * - * *
MelR (PTE*) - (A1*) *
: * - * *
evidence * - * *
that * - * *
efficient (PRC* - * (A11*
repression *) - * *)
requires * require * (V*)
the * - * *
formation * - * *
of * - * *
a * - * (A1*
repression * - * *
loop * - * *)
. * - * *

To * - *
our * - *
knowledge * - *
, * - *
this * - *
is * - *
the * - *
first * - *
report * - *
showing * - *
intron-dependent * - *
methylation * - *
of * - *
humanpre-tRNA * - *
Leu * - *
( * - *
CAA * - *
) * - *
and * - *
identification * - *
of * - *
human (DNA* - (A1*
gene *) - *)
encoding * encode (V*)
tRNA (PTE* - (A0*
methylase *) - *)
responsible * - *
for * - *
this * - *
reaction * - *
. * - *

Autoregulation * autoregulate (V*) *
of * - * *
PurR * - (A0* *
repressor * - * *
synthesis * - *) *
and * - * *
involvement * - * *
of * - * *
purR * - * *
in * - * *
the * - * *
regulation * - * *
of * - * *
purB (DNA*) - * (A0*)
, * - * *
purC (DNA*) - * *
, * - * *
purL (DNA*) - * *
, * - * *
purMN (DNA*) - * *
and * - * *
guaBA (DNA*) - * *
expression * express * (V*)
in * - * (A2*
Escherichia (ORG* - * *
coli *) - * *)
. * - * *

MalK (PTE*) - (A1*)
, * - *
the * - *
energy-transducing * - *
subunit * - *
of * - *
the * - *
transport * - *
system * - *
, * - *
acts * act (V*)
phenotypically * - *
as * - *
a (PTE* - (A8*
repressor *) - *)
of * - *
MalT * - *
, * - *
the * - *
transcriptional * - *
activator * - *
of * - *
the * - *
mal * - *
genes * - *
. * - *

The (DNA* - (A1*
gene *) - *)
encoding * encode (V*)
GcvA (PTE*) - (A0*)
, * - *
the * - *
trans-acting * - *
regulatory * - *
protein * - *
for * - *
the * - *
Escherichia * - *
coli * - *
glycine * - *
cleavage * - *
enzyme * - *
system * - *
, * - *
has * - *
been * - *
sequenced * - *
. * - *

Overproduction * overproduce (V*) *
of * - * *
sigma70 (PTE*) - (A0*) *
decreased * - * *
Pmcc-directed (DNA*) - * (A5*)
transcription * transcription * (V*)
, * - * *
presumably * - * *
as * - * *
a * - * *
result * - * *
of * - * *
competition * - * *
of * - * *
sigma * - * *
factors * - * *
for * - * *
the * - * *
limited * - * *
amount * - * *
of * - * *
core * - * *
RNA * - * *
polymerase * - * *
. * - * *

Finally * - * * * *
, * - * * * *
overexpression * overexpression (V*) * * *
of * - * * * *
wild-type (DNA* - (A0* * * *
hIre1p *) - *) * * *
constitutively * - * * * *
activated * - * * * *
a (DNA* - * * * *
reporter * - * * * *
gene *) - * * * *
under * - * * * *
transcriptional * - * * * (A5*)
control * - * * * *
of * - * * * *
the * - * * * *
rat * - * * * *
BiP * - * * * *
promoter * - * * * *
, * - * * * *
whereas * - * * * *
expression * express * (V*) * *
of * - * * * *
a (DNA* - * (A0* (A1* *
catalytically * - * * * *
inactive * - * * * *
hIre1p *) - * *) *) *
acted * - * * * *
in * - * * * *
a * - * * * *
trans-dominant-negative * - * * * *
manner * - * * * *
to * - * * * *
prevent * prevent * * (V*) *
transcriptional * - * * (A0* *
activation * activate * * *) (V*)
of * - * * * *
the (DNA* - * * * (A0*
BiP * - * * * *
promoter *) - * * * *)
in * - * * * *
response * - * * * *
to * - * * * *
ER * - * * * (A3*
stress * - * * * *)
induced * - * * * *
by * - * * * *
inhibition * - * * * *
of * - * * * *
N-linked * - * * * *
glycosylation * - * * * *
. * - * * * *

Binding (DNA* - (A0*
sites *) - *)
for * - *
the * - *
Nag * - *
repressor * - *
overlap * overlap (V*)
the (DNA* - (A4*
transcription * - *
start * - *
sites *) - *)
of * - *
the * - *
divergent * - *
nagE * - *
and * - *
nagB * - *
genes * - *
, * - *
such * - *
that * - *
the * - *
centres * - *
of * - *
the * - *
sites * - *
are * - *
separated * - *
by * - *
nine * - *
turns * - *
of * - *
the * - *
B-DNA * - *
helix * - *
. * - *

In * - *
addition * - *
, * - *
dcuB (DNA*) - (A0*)
is * - *
strongly * - (A5*)
induced * induce (V*)
by * - *
C4-dicarboxylates * - (A1*)
, * - *
suggesting * - *
that * - *
dcuB * - *
is * - *
under * - *
the * - *
control * - *
of * - *
an * - *
uncharacterized * - *
C4-dicarboxylate-responsive * - *
gene * - *
regulator * - *
. * - *

The * - *
yjdHG * - *
genes * - *
( * - *
redesignated * - *
dcuSR * - *
) * - *
appear * - *
to * - *
constitute * - *
an (DNA* - (A1*
operon *) - *)
encoding * encode (V*)
a * - *
two-component * - *
sensor-regulator * - *
system * - *
( * - *
DcuS-DcuR (PTE*) - (A0*)
) * - *
. * - *

Induction (PRC*) - (A0*)
is * - *
attenuated * attenuate (V*)
in * - *
similar * - *
transfection * - *
studies * - *
of * - *
the * - *
mouse * - *
promoter * - *
. * - *

The * - *
production * produce (V*)
of * - *
C51 (PTE* - (A0*
microcin *) - *)
decreased * - *
or * - *
was * - *
absent * - *
in * - (A2*
rpoS (None* - *
, * - *
crp * - *
and * - *
cya * - *
mutant * - *
cells *) - *)
. * - *

Here * - * *
, * - * *
we * - * *
show * - * *
that * - * *
glnAp2 * - (A0*) *
expression * express (V*) *
is * - * *
affected * - * *
by * - * *
different (EXP* - * *
carbon * - * *
sources *) - * *
and * - * *
that * - * *
the (PTE* - * (A1*
CRP-cAMP * - * *
complex *) - * *)
inhibits * inhibit * (V*)
the (DNA* - * (A0*
glnAp2 * - * *
promoter * - * *
activity *) - * *)
. * - * *

Remarkably * - *
, * - *
a (None* - *
narP * - *
mutant *) - *
lacked * - *
anaerobic * - (A5*)
induction * induce (V*)
of * - *
hyb (PRC* - (A0*
expression *) - *)
, * - *
even * - *
in * - *
the * - *
absence * - *
of * - *
added * - (A3*
nitrate * - *)
. * - *

These * - * * * *
results * - * * * *
lead * - * * * *
us * - * * * *
to * - * * * *
conclude * - * * * *
that * - * * * *
EnvZ * - * * * *
and * - * * * *
OmpR * - * * * *
act * - * * * *
in * - * * * *
sequential * - * * * *
fashion * - * * * *
to * - * * * *
activate * - * * * *
porin (DNA* - (A0* * * *
gene *) - *) * * *
expression * express (V*) * * *
; * - * * * *
i * - * * * *
. * - * * * *
e * - * * * *
. * - * * * *
, * - * * * *
EnvZ (PTE*) - * (A1*) (A1*) *
modifies * modify * (V*) * *
or * - * * * *
in * - * * * *
some * - * * * *
way * - * * * *
directs * direct * * (V*) *
OmpR (PTE*) - * (A0*) (A0*) (A1*)
, * - * * * *
which * - * * * *
in * - * * * *
turn * - * * * *
acts * act * * * (V*)
at * - * * * (A2*
the (DNA* - * * * *
appropriate * - * * * *
porin * - * * * *
gene * - * * * *
promoter *) - * * * *
. * - * * * *)

While * - *
Bcl-3 * - (A0*)
expression * express (V*)
in * - *
cancer * - *
was * - *
originally * - *
thought * - *
to * - *
be * - *
limited * - *
to * - *
B-cell * - *
lymphomas * - *
with * - *
a * - *
14 * - *
; * - *
19 * - *
chromosomal * - *
translocation * - *
, * - *
more * - *
recent * - *
evidence * - *
indicates * - *
that * - *
expression * - *
of * - *
this * - *
presumptive * - *
oncoprotein * - *
is * - *
significantly * - *
more * - *
widespread * - *
in * - *
cancer * - *
. * - *

The (DNA* - (A1*
two * - *
internal * - *
operators *) - *)
bound * bound (V*)
the (PTE* - (A7*
glp * - *
repressor *) - *)
in * - *
the * - *
presence * - *
or * - *
absence * - *
of * - *
the * - *
tandem * - *
operators * - *
( * - *
O (DNA* - (A3*
( * - *
D * - *
) * - *
1 *) - *)
and * - *
O (DNA* - *
( * - *
D * - *
) * - *
2 *) - *
) * - *
in * - (A5*
vitro * - *)
, * - *
as * - *
shown * - *
by * - *
DNase * - *
I * - *
footprinting * - *
. * - *

Repression * repress (V*) * *
takes * - * * *
place * - * * *
by * - * * *
the (PTE* - (A1* * *
formation * - * * *
of * - * * *
a * - * (A0* *
CytR/cAMP-CRP/DNA * - * * *
nucleoprotein * - * * *
complex *) - *) *) *
consisting * consist * (V*) *
of * - * * *
the (PTE* - * (A4* *
two * - * * *
cAMP-CRP * - * * *
molecules *) - * *) *
and * - * * *
CytR (PTE*) - * * (A1*)
bound * bound * * (V*)
in * - * * (A2*
between * - * * *)
. * - * * *

A (DNA* - *
distant * - *
upstream * - *
site *) - *
involved * - *
in * - *
the * - *
negative * - (A5*)
regulation * regulation (V*)
of * - *
the (DNA* - (A0*
Escherichia * - *
coli * - *
ompF * - *
gene *) - *)
. * - *

To * - *
examine * - *
the * - *
function * - *
of * - *
14-3-3eta * - *
in * - *
the * - *
glucocorticoid-dependent * - *
signal * - *
pathway * - *
, * - *
we * - *
studied * - *
the * - *
regulatory * - *
role * - *
of * - *
14-3-3eta * - *
in * - *
ligand-induced * - (A0*
GR * - *
transcriptional * - *)
activation * activate (V*)
. * - *

However * - * *
, * - * *
neither * - * *
overexpression * overexpression (V*) *
of * - * *
the (PTE* - (A0* *
transcriptional * - * *
activator * - * *
RcsB *) - *) *
nor * - * *
an * - * *
rcsB * - * (A5*)
: * - * *
: * - * *
aadA * - * *
chromosomal * - * *
insertion * insert * (V*)
altered * - * *
the * - * *
level * - * *
of * - * *
transcription * - * *
measured * - * *
by * - * *
cps * - * *
: * - * *
: * - * *
lacZ * - * *
fusions * - * *
. * - * *

Alpha * - (A1*
interferon * - *)
stimulates * - *
transcription (PRC*) - *
by * - *
converting * convert (V*)
the (PTE* - (A0*
positive * - *
transcriptional * - *
regulator * - *
ISGF3 *) - *)
from * - *
a * - (A6*
latent * - *)
to * - *
an * - (A7*
active * - *
form * - *)
. * - *

Nitrate * - (A1*)
repression * repress (V*)
of * - *
the (DNA* - (A0*
hya * - *
operon *) - *)
was * - *
mediated * - *
by * - *
both * - *
NarL (PTE*) - *
and * - *
NarP (PTE*) - *
. * - *

The * - * *
homeobox * - * *
gene * - * *
GBX2 (DNA*) - (A0*) *
was * - * *
identified * identify (V*) *
as * - * *
a (DNA* - (A4* *
target * - * *
gene *) - * *
of * - * *
the (PTE* - * (A0*
v-Myb * - * *
oncoprotein *) - *) *)
encoded * encode * (V*)
by * - * *
the * - * *
avian * - * *
myeloblastosis * - * *
virus * - * *
( * - * *
AMV (ORG*) - * (A1*)
) * - * *
. * - * *

The (PTE* - (A1* * *
Fis * - * * *
protein *) - *) * *
binds * bind (V*) * *
to * - * * *
a (DNA* - (A0* * (A7*
site *) - *) * *)
centred * - * * *
at * - * * *
position * - * * *
-15 * - * * *
( * - * * *
in * - * * *
relation * - * * *
to * - * * *
pnrfA (DNA*) - * (A0*) *
transcription * transcription * (V*) *
) * - * * *
, * - * * *
whereas * - * * *
the (PTE* - * * (A1*
IHF * - * * *
protein *) - * * *)
binds * bind * * (V*)
to * - * * *
a * - * * *
site * - * * *
centred * - * * *
at * - * * *
position * - * * *
-54 * - * * *
. * - * * *

Transcription * transcribe (V*)
of * - *
naked (DNA* - (A0*
DNA *) - *)
in * - (A3*
vitro * - *)
requires * - *
the (PTE* - *
general * - *
transcription * - *
factors *) - *
and * - *
RNA (PTE* - *
polymerase * - *
II *) - *
. * - *

It * - *
has * - *
been * - *
shown * - *
that * - *
Crl (PTE*) - (A1*)
stimulates * stimulate (V*)
the * - (A0*
activity * - *)
of * - *
sigma * - *
( * - *
S * - *
) * - *
, * - *
leading * - *
to * - *
an * - *
increased * - *
transcription * - *
rate * - *
of * - *
a * - *
subset * - *
of * - *
genes * - *
of * - *
the * - *
rpoS * - *
regulon * - *
in * - *
stationary * - *
phase * - *
. * - *

Transcriptional * - (A5*) *
regulation * regulation (V*) *
and * - * *
organization * - * *
of * - * *
the (DNA* - (A0* (A1*
dcuA * - * *
and * - * *
dcuB * - * *
genes *) - *) *)
, * - * *
encoding * encode * (V*)
homologous (PTE* - * (A0*
anaerobic * - * *
C4-dicarboxylate * - * *
transporters *) - * *)
in * - * *
Escherichia * - * *
coli * - * *
. * - * *

Differential * - (A0*
splicing * - *)
involves * involve (V*)
an * - *
alternative * - *
exon * - *
( * - *
IX (DNA*) - (A4*)
) * - *
and * - *
three (DNA* - *
splice * - *
acceptor * - *
sites *) - *
in * - *
exon * - *
X * - *
. * - *

Sequence * - *
analysis * - *
of * - *
the (DNA* - (A0*
operons *) - *)
that * - *
were * - *
repressed * repress (V*)
by * - *
CRP (PTE*) - (A1*)
revealed * - *
different * - *
mechanisms * - *
for * - *
CRP * - *
inhibition * - *
. * - *

Moreover * - *
, * - *
transient * - *
cotransfection * - *
assays * - *
suggested * - *
that * - *
MITF-A (PTE*) - *
activated * - *
transcription * transcription (V*)
of * - *
the (DNA* - (A0*
tyrosinase *) - *
and * - *
tyrosinase-related * - *
protein * - *
1 * - *
genes * - *)
. * - *

The * - *
cell * - *
type-specific * - *
down-regulation * - *
, * - *
however * - *
, * - *
does * - *
not * - *
depend * - *
simply * - *
on * - *
which (PTE* - (A1*
RFX *) - *)
interacts * interact (V*)
with * - *
the * - (A8*
elements * - *)
, * - *
but * - *
seems * - *
to * - *
depend * - *
on * - *
underlying * - *
profound * - *
mechanisms * - *
. * - *

Furthermore * - *
, * - *
in * - (A2*
a (None* - *
delta * - *
envZ * - *
strain *) - *
of * - *
E * - *
. * - *
coli * - *)
, * - *
containing * - *
the * - *
envZ * - *
Val-243 * - *
plasmid * - *
, * - *
ompC (DNA*) - (A0*)
expression * express (V*)
is * - *
elevated * - *
7-fold * - *
relative * - *
to * - *
that * - *
found * - *
in * - *
cells * - *
carrying * - *
the * - *
wild-type * - *
envZ * - *
plasmid * - *
. * - *

The (PTE* - (A1* (A1* *
product *) - *) *) *
of * - * * *
this * - * * *
gene * - * * *
binds * bind (V*) * *
an (DNA* - (A7* * (A4*
AP-1 * - * * *
site *) - *) * *)
and * - * * *
upon * - * (A12* *
cotransfection * - * *) *
stimulates * stimulate * (V*) *
the * - * (A0* *
activity * - * * *
of * - * * *
a (DNA* - * * (A0*
promoter *) - * *) *)
that * - * * *
bears * bear * * (V*)
an * - * * *
AP-1 * - * * *
site * - * * *
. * - * * *

This * - * * *
regulation * regulation (V*) * *
and * - * * *
the * - * * *
control * - * * *
by * - * * *
GntH (PTE*) - (A1*) * *
were * - * * *
examined * - * * *
by * - * * *
using * - * * *
single-copy (EXP* - * * *
LACZ * - * * *
operon * - * * *
fusions *) - * * *
and * - * * *
by * - * * *
RT-PCR (EXP*) - * * *
, * - * * *
suggesting * - * * *
positive * - * (A5*) *
and * - * * *
negative * - * * *
regulation * regulation * (V*) *
by * - * * *
GntR (PTE*) - * (A1*) *
and * - * * *
positive * - * * (A5*)
regulation * regulation * * (V*)
by * - * * *
GntH (PTE*) - * * (A1*)
. * - * * *

In * - *
combination * - *
, * - *
the (PTE* - (A1*
cAMP-CRP * - *
and * - *
CytR * - *
proteins *) - *)
bind * bind (V*)
cooperatively * - (A5*)
to * - *
tsx-p2 (DNA*) - (A7*)
, * - *
and * - *
the * - *
nucleoprotein * - *
complex * - *
formed * - *
covers * - *
a * - *
region * - *
of * - *
78 * - *
bp * - *
extending * - *
from * - *
the * - *
CRP-2 * - *
site * - *
close * - *
to * - *
the * - *
-10 * - *
region * - *
. * - *

Northern * - * *
blotting * - * *
confirmed * - * *
that * - * *
dcuA (DNA*) - (A0*) *
( * - * *
and * - * *
aspA (DNA*) - * *
) * - * *
is * - * *
expressed * express (V*) *
under * - * *
both * - (A3* *
aerobic * - * *
and * - * *
anaerobic * - * *
conditions * - *) *
and * - * *
that * - * *
dcuB (DNA*) - * (A0*)
( * - * *
and * - * *
fumB (DNA*) - * *
) * - * *
is * - * *
induced * induce * (V*)
anaerobically * - * (A3*)
. * - * *

I * - *
think * - *
TFBRR * - *
is * - *
right * - *
because * - *
binding * bind (V*)
to * - *
the (DNA* - (A7*
human * - *
AFP * - *
gene * - *
enhancer *) - *)
does * - *
not * - *
necessarily * - *
mean * - *
positive * - *
regulation * - *
of * - *
AFP * - *
. * - *

ISGF3 (PTE* - (A1* * *
gamma *) - *) * *
serves * serve (V*) * *
as * - * * *
the (PTE* - (A8* * *
DNA * - * * *
recognition * - * * *
subunit *) - *) * *
, * - * * *
while * - * * *
ISGF3 (PTE* - * (A0* *
alpha *) - * *) *
, * - * * *
which * - * * *
appears * - * * *
to * - * * *
consist * - * * *
of * - * * *
three * - * * *
polypeptides * - * * *
, * - * * *
is * - * * *
a * - * * *
target * - * * *
for * - * * *
alpha * - * * *
interferon * - * * *
signaling * - * * *
and * - * * *
serves * - * * *
as * - * * *
a (PTE* - * * *
regulatory * - * * *
component *) - * * *
whose * - * * *
activation * activate * (V*) *
is * - * * *
required * - * * *
to * - * * *
form * form * * (V*)
ISGF3 (PTE*) - * * (A0*)
. * - * * *

DNA * - * *
binding * - * *
sites * - * *
for * - * *
the * - * *
Mlc * - * *
and * - * *
NagC * - * *
proteins * - * *
: * - * *
regulation * regulation (V*) *
of * - * *
nagE (DNA*) - (A0*) (A1*)
, * - * *
encoding * encode * (V*)
the (PTE* - * (A0*
N-acetylglucosamine-specific * - * *
transporter *) - * *)
in * - * (A2*
Escherichia (ORG* - * *
coli *) - * *)
. * - * *

The * - *
effect * - *
of * - *
Lrp * - *
was * - *
not * - *
seen * - *
in * - *
a (None* - *
strain *) - *
containing * - *
a * - *
deletion * delete (V*)
of * - *
micF (DNA*) - (A0*)
. * - *

Study * - * * *
of * - * * *
the * - * * *
promoter-lacZ * - * * *
gene * - * * *
fusions * - * * *
introduced * - * * *
into * - * * *
the * - * * *
chromosome * - * * *
indicated * - * * *
that * - * * *
galS (DNA*) - (A0*) * *
expression * express (V*) * *
was * - * * *
elevated * - * * *
in * - * * *
cells * - * * *
in * - * * *
which * - * * *
the (DNA* - * (A0* *
normal * - * * *
galS * - * * *
gene *) - * *) *
was * - * * *
interrupted * interrupt * (V*) *
, * - * * *
but * - * * *
not * - * * *
in * - * * *
cells (None*) - * * *
in * - * * *
which * - * * *
the (DNA* - * * (A0*
galR * - * * *
gene *) - * * *)
was * - * * *
deleted * delete * * (V*)
. * - * * *

Expression * express (V*)
of * - *
the (DNA* - (A0*
glc * - *
operon *) - *)
is * - *
strongly * - *
dependent * - *
on * - *
the * - *
integration * - *
host * - *
factor * - *
( * - *
IHF (PTE*) - (A3*)
) * - *
and * - *
is * - *
repressed * - *
by * - *
the * - *
global * - *
respiratory * - *
regulator * - *
ArcA-P (PTE*) - *
. * - *

These * - * *
results * - * *
indicate * - * *
that * - * *
the * - * *
expression * express (V*) *
of * - * *
the (DNA* - (A0* (A0*
uxuR * - * *
gene *) - *) *)
is * - * *
repressed * repress * (V*)
by * - * *
its (PTE* - * (A1*
own * - * *
product *) - * *)
but * - * *
also * - * *
by * - * *
the (PTE* - * (A1*
exuR * - * *
repressor *) - * *)
. * - * *

A (PTE* - (A1*
nuclear * - *
protein * - *
( * - *
s * - *
) *) - *)
in * - (A2*
a * - *
wide * - *
variety * - *
of * - *
cells * - *)
bound * bound (V*)
to * - *
the * - *
specific * - *
DNA * - *
elements * - *
( * - *
negative * - *
Ca2+ * - *
responsive * - *
elements * - *
, * - *
nCaREs (DNA*) - (A7*)
) * - *
in * - *
the * - *
human * - *
PTH * - *
gene * - *
in * - *
sequence-specific * - (A5*
and * - *
Ca2+e * - *
concentration-dependent * - *
manners * - *)
. (ORG*) - *

These * - * *
results * - * *
indicate * - * *
that * - * *
CRP * - * *
and * - * *
cAMP * - * *
can * - * *
mediate * - * *
pH * - * *
control * - * *
over * - * *
gadX (DNA*) - (A0*) *
expression * express (V*) *
and * - * *
, * - * *
indirectly * - * *
, * - * *
expression * express * (V*)
of * - * *
the (DNA* - * (A0*
decarboxylase * - * *
genes *) - * *)
. * - * *

We * - *
also * - *
found * - *
that * - *
CRP (PTE*) - (A1*)
, * - *
RhaR (PTE*) - *
, * - *
and * - *
alpha-CTD (PTE*) - *
each * - *
have * - *
synergistic * - *
effects * effect (V*)
on * - *
activation (PRC*) - (A0*)
by * - *
the * - *
others * - *
, * - *
suggesting * - *
direct * - *
or * - *
indirect * - *
interactions * - *
among * - *
all * - *
three * - *
. * - *

Nrf1 (PTE*) - (A1*)
in * - *
a * - *
complex * - *
with * - *
fosB (PTE*) - *
, * - *
c-jun (PTE*) - *
, * - *
junD (PTE*) - *
and * - *
ATF2 (PTE*) - *
forms * form (V*)
the (PTE* - (A0*
AP1 * - *
component *) - *)
at * - (A2*
the (DNA* - *
TNF * - *
alpha * - *
promoter *) - *)
in * - *
stimulated (ORG* - *
mast * - *
cells *) - *
. * - *

The * - *
regulation * regulation (V*)
of * - *
the (DNA* - (A0*
Escherichia * - *
coli * - *
mazEF * - *
promoter *) - *)
involves * - *
an * - *
unusual * - *
alternating * - *
palindrome * - *
. * - *

Studies * - *
with * - *
the * - *
FNR-activated * - *
and * - *
amino-acid-inducible * - *
asparaginase * - *
II * - *
gene * - *
( * - *
ansB * - *
) * - *
showed * - *
that * - *
IHF (PTE*) - (A1*)
and * - *
a * - *
component * - *
of * - *
the * - *
Arr-containing * - *
fraction * - *
( * - *
but * - *
not * - *
HU * - *
) * - *
interact * interact (V*)
with * - *
the (DNA* - (A1*
corresponding * - *
ansB * - *
promoter *) - *)
. * - *

Our * - *
results * - *
indicate * - *
that * - *
CsgD (PTE*) - *
can * - *
modulate * - *
cellulose * - *
biosynthesis * - *
through * - *
activation * activate (V*)
of * - *
the (DNA* - (A0*
yoaD * - *
gene *) - *)
. * - *

The * - *
two * - *
major * - *
porins * - *
of * - *
Escherichia * - *
coli * - *
K-12 * - *
strains * - *
, * - *
OmpC (PTE* - (A0*
and * - *
OmpF *) - *)
, * - *
are * - *
inversely * - (A5*)
regulated * regulate (V*)
with * - *
respect * - *
to * - *
one * - *
another * - *
. * - *

Leucine-responsive * - *
protein * - *
Lrp (PTE*) - *
and * - *
histone-like * - *
protein * - *
H-NS (PTE*) - *
repressed * - *
P * - *
( * - *
mcc * - *
) * - *
-lac (DNA*) - (A0*)
expression * express (V*)
in * - *
the * - *
exponential * - *
and * - *
decelerating * - *
phases * - *
of * - *
growth * - *
. * - *

The (PTE* - *
sdiA * - *
gene * - *
product *) - *
is * - *
the * - *
first * - *
factor * - *
thus * - *
far * - *
identified * - *
that * - *
specifically * - *
regulates * - *
expression * express (V*)
of * - *
this (DNA* - (A0*
key * - *
group * - *
of * - *
cell * - *
division * - *
genes *) - *)
. * - *

Consistent * - *
with * - *
these * - *
findings * - *
, * - *
in * - (A5*
vitro * - *)
transcription * transcription (V*)
was * - *
stimulated * - *
18-fold * - *
by * - *
the (PTE* - *
addition * - *
of * - *
preformed * - *
, * - *
heterodimeric * - *
NFKB2 * - *
( * - *
p49 * - *
) * - *
/RelA * - *
( * - *
p65 * - *
) * - *
protein * - *
. *) - *

However * - *
, * - *
at * - *
least * - *
for * - *
the * - *
classical * - *
porins * - *
OmpF * - *
and * - *
OmpC * - *
, * - *
our * - *
results * - *
show * - *
that * - *
the * - (A1*
Cpx * - *
envelope * - *
stress * - *
response * - *
system * - *)
plays * play (V*)
a * - (A0*
role * - *
in * - *
regulating * - *
their (PRC* - *
expression *) - *)
. (PRC*) - *

Using * - *
random * - *
Tn10 * - *
insertion * - *
mutagenesis * - *
, * - *
we * - *
isolated * - *
an * - *
Escherichia * - *
coli * - *
mutant * - *
strain * - *
affected * - *
in * - *
the * - *
regulation * regulation (V*)
of * - *
lysU (DNA*) - (A0*)
, * - *
the * - *
gene * - *
encoding * - *
the (PTE* - *
inducible * - *
form * - *
of * - *
lysyl-tRNA * - *
synthetase *) - *
. * - *

We * - * * *
characterized * - * * *
four (None* - (A1* * *
tsx-p2 * - * * *
mutants *) - *) * *
exhibiting * exhibit (V*) * *
a (DNA* - (A0* * *
reduced * - * * *
response *) - *) * *
to * - * * *
CytR * - * * *
; * - * * *
three (None*) - * * *
carried * - * * *
mutations * mutations * (V*) *
in * - * (A2* *
the (DNA* - * * *
CRP-2 * - * * *
site *) - * *) *
, * - * * *
and * - * * *
one (None*) - * * *
carried * - * * *
a * - * * *
mutation * mutation * * (V*)
in * - * * (A2*
the (DNA* - * * *
region *) - * * *
between * - * * *
CRP-1 * - * * *
and * - * * *
the * - * * *
-10 * - * * *
sequence * - * * *)
. * - * * *

Overexpression * overexpress (V*) *
of * - * *
RcsB (PTE*) - (A0*) *
was * - * *
found * - * *
to * - * *
result * - * *
in * - * *
a * - * *
threefold * - * *
increase * - * *
in * - * *
transcription * transcription * (V*)
of * - * *
a (DNA* - * (A0*
galF * - * *
: * - * *
: * - * *
lacZ * - * *
chromosomal * - * *
fusion *) - * *)
. * - * *

Fusions * - * (A10*)
that * - * *
brought * - * *
lac (DNA* - (A0* *
gene *) - *) *
expression * express (V*) *
under * - * *
the * - * *
control * - * *
of * - * *
transcriptional * - * *
and * - * *
translational * - * *
signals * - * *
within * - * *
the * - * *
uxuR * - * *
gene * - * *
were * - * *
used * - * *
to * - * *
study * study * (V*)
uxuR (PRC* - * (A0*
regulation *) - * *)
. * - * *

cysB (DNA* - *
mutants *) - *
showed * - *
upregulation * upregulate (V*)
of * - *
the (DNA* - (A0*
hslJ * - *
: * - *
: * - *
lacZ * - *
gene * - *
fusion *) - *)
and * - *
exhibited * - *
increased * - *
novobiocin * - *
resistance * - *
. * - *

Regulated * - * *
expression * express (V*) *
in * - (A5* *
vitro * - *) *
of * - * *
genes (DNA*) - (A0*) (A1*)
coding * code * (V*)
for * - * *
formate (PTE* - * (A0*
hydrogenlyase * - * *
components *) - * *)
of * - * *
Escherichia * - * *
coli * - * *
. * - * *

We * - *
also * - *
demonstrate * - *
that * - *
the (EXP* - (A0*
phosphate * - *
group *) - *)
can * - *
, * - *
in * - *
turn * - *
, * - *
be * - *
transferred * transfer (V*)
to * - *
the (PTE* - (A7*
transcription * - *
activator * - *
protein * - *
OmpR *) - *)
. * - *

The * - *
expression * express (V*)
of * - *
beta-galactosidase (PTE*) - (A0*)
from * - *
a * - (A6*
lac * - *
transcriptional * - *
fusion * - *
to * - *
slpA * - *)
is * - *
increased * - *
six- * - *
to * - *
eightfold * - *
when * - *
the * - *
alpA+ * - *
gene * - *
is * - *
present * - *
on * - *
a * - *
multicopy * - *
plasmid * - *
. (DNA*) - *

However * - * *
, * - * *
some (DNA* - (A0* *
operons *) - *) *
are * - * *
regulated * regulate (V*) *
by * - * *
NarL (PTE*) - (A1*) *
alone * - (A5*) *
, * - * *
whereas * - * *
others (DNA*) - * (A0*)
are * - * *
controlled * control * (V*)
by * - * *
both * - * *
NarL (PTE*) - * (A1*)
and * - * *
NarP (PTE*) - * *
. * - * *

The * - *
expression * - *
ratios * - *
of * - *
a * - *
total * - *
of * - *
232 * - *
genes * - *
were * - *
<0 * - *
. * - *
75 * - *
in * - *
all * - *
three * - *
strains * - *
( * - *
the * - *
supplemental * - *
data * - *
are * - *
shown * - *
at * - *
http * - *
: * - *
//www * - *
. * - *
nara * - *
. * - *
kindai * - *
. * - *
ac * - *
. * - *
jp/nogei/seiken/array * - *
. * - *
html * - *
) * - *
, * - *
suggesting * - *
that * - *
the * - *
PhoP/PhoQ * - *
system * - *
is * - *
involved * - *
directly * - *
or * - *
indirectly * - *
in * - *
the * - *
transcription * transcription (V*)
of * - *
these (DNA* - (A0*
genes *) - *)
. * - *

Dlx-2 (DNA*) - (A0*)
( * - *
also * - *
called * - *
Tes-1 * - *
) * - *
, * - *
a * - *
mammalian * - *
member * - *
of * - *
the * - *
Distal-less * - *
family * - *
of * - *
homeobox * - *
genes * - *
, * - *
is * - *
expressed * express (V*)
during * - (A12*
murine * - *
fetal * - *
development * - *)
in * - (A2*
spatially * - *
restricted * - *
domains * - *
of * - *
the (ORG* - *
forebrain *) - *)
. * - *

EZH1 (DNA*) - (A1*)
encodes * encode (V*)
a (PTE* - (A0*
protein *) - *)
of * - *
747 * - *
amino * - *
acids * - *
that * - *
displays * - *
55% * - *
amino * - *
acid * - *
identity * - *
overall * - *
( * - *
70% * - *
similarity * - *
) * - *
with * - *
Drosophila * - *
E * - *
( * - *
z * - *
) * - *
. * - *

The (PTE* - (A1* (A1* (A1*
GcvA * - * * *
protein *) - *) *) *)
both * - * * *
activates * activate (V*) * *
and * - * * *
represses * repress * (V*) *
the (DNA* - (A0* (A0* *
gcv * - * * *
operon *) - *) *) *
and * - * * *
negatively * - * * (A5*)
regulates * regulate * * (V*)
its (PRC* - * * (A0*
own * - * * *
transcription *) - * * *)
. * - * * *

In * - * *
contrast * - * *
, * - * *
two (DNA* - (A1* *
unlinked * - * *
E * - * *
. * - * *
coli * - * *
genes *) - *) *
that * - * *
encode * encode (V*) *
functions * - (A0*) *
required * - * *
for * - * *
cer-mediated * - * (A5*
site-specific * - * *)
recombination * recombine * (V*)
have * - * *
been * - * *
identified * - * *
. * - * *

We * - * *
show * - * *
that * - * *
the * - * *
expression * express (V*) *
of * - * *
this * - (A0* *
module * - *) *
is * - * *
positively * - * *
regulated * - * *
by * - * *
the * - * *
factor * - * *
for * - * *
inversion * - * (A5*)
stimulation * stimulate * (V*)
. * - * *

Capsule (PRC* - * (A0*
( * - * *
cps * - * *
) * - * *
gene * - * *
expression *) express (V*) *)
in * - (A2* *
Escherichia (ORG* - * *
coli *) - *) *
is * - * *
controlled * control * (V*)
by * - * *
a * - * *
complex * - * *
network * - * *
of * - * *
regulators (PTE*) - * (A1*)
. (DNA*) - (A0*) *

Molecular * - *
analysis * - *
of * - *
the * - *
regulation * regulation (V*)
of * - *
csiD (DNA*) - (A1*)
, * - *
a * - *
carbon * - *
starvation-inducible * - *
gene * - *
in * - *
Escherichia * - *
coli * - *
that * - *
is * - *
exclusively * - *
dependent * - *
on * - *
sigma * - *
s * - *
and * - *
requires * - *
activation * - *
by * - *
cAMP-CRP * - *
. * - *

We * - *
report * - *
here * - *
that * - *
Fis * - *
, * - *
one * - *
of * - *
the * - *
nucleoid-associated * - *
proteins * - *
, * - *
plays * - *
a * - *
key * - *
role * - *
in * - *
glucose (EXP*) - (A1*)
induction * induce (V*)
of * - *
Mlc (DNA* - (A0*
regulon *) - *)
. * - *

The * - *
amino * - *
acid * - *
sequence * - *
deduced * - *
from * - *
the * - *
cDNA * - *
revealed * - *
that * - *
this * - *
is * - *
the * - *
largest * - *
DNA-binding * - *
protein * - *
( * - *
306 * - *
kDa * - *
) * - *
known * - *
to * - *
date * - *
, * - *
containing * - *
four * - *
homeodomains * - *
, * - *
17 * - *
zinc * - *
finger * - *
motifs * - *
, * - *
and * - *
a (PTE* - *
number * - *
of * - *
segments *) - *
potentially * - *
involved * - *
in * - *
transcriptional * - (A5*)
regulation * regulation (V*)
. * - *

beta-Galactosidase * - *
assays * - *
of * - *
various * - *
rhaS-lacZ * - *
promoter * - *
fusions * - *
combined * - *
with * - *
mobility * - *
shift * - *
assays * - *
indicated * - *
that * - *
a * - *
cyclic * - *
AMP * - *
receptor * - *
protein * - *
( * - *
CRP (DNA*) - *
) * - *
site (DNA*) - *
located * - *
at * - *
-111 * - *
. * - *
5 * - *
is * - *
also * - *
required * - *
for * - *
full * - *
activation * - *
of * - *
rhaSR * - (A0*)
expression * express (V*)
. * - *

CAP (PTE*) - (A1*)
and * - *
Nag (PTE* - *
repressor *) - *
binding * bind (V*)
to * - *
the (DNA* - (A7*
regulatory * - *
regions *) - *)
of * - *
the * - *
nagE-B * - *
and * - *
manX * - *
genes * - *
of * - *
Escherichia * - *
coli * - *
. * - *

An (EXP* - *
artificial * - *
increase * - *
in * - *
ppGpp *) - *
in * - *
exponentially (ORG* - *
growing * - *
cells *) - *
induced * - *
a * - *
rapid * - *
increase * increase (V*)
in * - *
himA (DNA* - (A0*
P4 * - *
and * - *
himD/hip * - *
mRNA * - *
levels *) - *)
. * - *

Dual * - *
overlapping * - *
promoters * - *
control * - *
napF * - *
( * - *
periplasmic * - *
nitrate * - *
reductase * - *
) * - *
operon (DNA*) - (A0*)
expression * express (V*)
in * - (A2*
Escherichia (ORG* - *
coli * - *
K-12 *) - *)
. * - *

dad (DNA*) - (A0*)
expression * express (V*)
in * - (A2*
a (None* - *
dad-lacZ * - *
operon * - *
fusion * - *
strain *) - *)
was * - *
increased * - *
four- * - *
to * - *
sevenfold * - *
when * - *
cells (ORG*) - *
were * - *
grown * - *
in * - *
minimal * - *
medium * - *
containing * - *
alanine (PTE* - *
or * - *
leucine *) - *
. * - *

The (DNA* - (A1*
adjacent * - *
, * - *
divergently * - *
transcribed * - *
glpACB * - *
and * - *
glpTQ * - *
operons *) - *)
of * - *
Escherichia * - *
coli * - *
encode * encode (V*)
the (PTE* - (A0*
anaerobic * - *
glycerol * - *
3-phosphate * - *
dehydrogenase *) - *)
and * - *
glycerol (PTE* - *
3-phosphate * - *
transporter/phosphodiesterase *) - *
, * - *
respectively * - (A5*)
. * - *

Comparison * - *
of * - *
the * - *
deduced * - *
amino * - *
acid * - *
sequence * - *
of * - *
NERF * - *
with * - *
those * - *
of * - *
other * - *
members * - *
of * - *
the * - *
Ets * - *
family * - *
reveals * - *
that * - *
the * - *
level * - *
of * - *
homology * - *
to * - *
ELF-1 (PTE*) - *
, * - *
which * - *
is * - *
involved * - *
in * - *
the * - *
regulation * regulation (V*)
of * - *
several (DNA* - (A0*
T- * - *
and * - *
B-cell-specific * - *
genes *) - *)
, * - *
is * - *
highest * - *
. * - *

In * - * *
contrast * - * *
, * - * *
narL (None* - * *
narP * - * *
and * - * *
narX * - * *
narQ * - * *
double * - * *
null * - * *
mutants *) - * *
were * - * *
devoid * - * *
of * - * *
nitrate (EXP*) - (A1*) *
regulation * regulation (V*) *
when * - * *
cultured * - * *
in * - * *
rich * - * *
medium * - * *
but * - * *
they * - * *
retained * - * *
some * - * *
nitrate (EXP*) - * (A1*)
repression * repress * (V*)
( * - * *
1 * - * *
. * - * *
3-fold * - * *
) * - * *
when * - * *
grown * - * *
in * - * *
minimal * - * *
medium * - * *
. * - * *

The (DNA* - (A1*
adhE * - *
gene *) - *)
of * - *
Escherichia * - *
coli * - *
, * - *
located * - *
at * - *
min * - *
27 * - *
on * - *
the * - *
chromosome * - *
, * - *
encodes * encode (V*)
the (PTE* - (A0*
bifunctional * - *
NAD-linked * - *
oxidoreductase *) - *)
responsible * - *
for * - *
the * - *
conversion * - *
of * - *
acetyl-coenzyme * - *
A * - *
to * - *
ethanol * - *
during * - *
fermentative * - *
growth * - *
. * - *

DNase * - * * * *
I * - * * * *
footprinting * - * * * *
and * - * * * *
in * - * * * *
vitro * - * * * *
transcription (PRC*) - * * * (A0*)
assays * - * * * *
indicated * - * * * *
that * - * * * *
IclR (PTE*) - (A1*) * (A1*) *
binds * bind (V*) * * *
to * - * * * *
an (DNA* - (A7* (A0* * *
IclR * - * * * *
box *) - *) *) * *
( * - * * * *
-21 * - * * * *
to * - * * * *
+14 * - * * * *
) * - * * * *
, * - * * * *
which * - * * * *
overlaps * overlap * (V*) * *
the (DNA* - * (A4* * *
iclR * - * * * *
promoter *) - * *) * *
and * - * * * *
thus * - * * * *
competes * compete * * (V*) *
with * - * * * *
the (PTE* - * * (A1* *
RNA * - * * * *
polymerase *) - * * *) *
for * - * * * *
DNA * - * * * *
binding * - * * * *
, * - * * * *
leading * - * * * *
to * - * * * *
transcription * - * * * *
repression * repress * * * (V*)
. * - * * * *

Transcription * -
occurs * -
from * -
four * -
promoters * -
( * -
P1 (DNA*) -
, * -
P3 (DNA*) -
, * -
P4 (DNA*) -
and * -
P5 (DNA*) -
) * -
and * -
is * -
modulated * -
by * -
several * -
factors * -
including * -
( * -
i * -
) * -
two * -
sigma * -
factors * -
( * -
sigma70 (PTE*) -
and * -
sigmaE (PTE*) -
) * -
; * -
( * -
ii * -
) * -
the (PTE* -
global * -
regulator * -
CRP *) -
; * -
and * -
( * -
iii * -
) * -
the (PTE* -
DnaA * -
protein *) -
. * -

The (DNA* - (A0* (A0*
dcuB * - * *
gene *) - *) *)
is * - * *
strongly * - (A5*) *
activated * activate (V*) *
anaerobically * - (A3*) *
by * - * *
FNR (PTE*) - (A1*) *
, * - * *
repressed * repress * (V*)
in * - * *
the * - * *
presence * - * *
of * - * *
nitrate (EXP*) - * (A3*)
by * - * *
NarL (PTE*) - * (A1*)
, * - * *
and * - * *
subject * - * *
to * - * *
cyclic * - * *
AMP * - * *
receptor * - * *
protein * - * *
( * - * *
CRP * - * *
) * - * *
-mediated * - * *
catabolite * - * *
repression * - * *
. * - * *

A * - *
chromosomal * - *
transcriptional * - *
lacZ * - *
fusion * - *
( * - *
csi-5 * - *
: * - *
: * - *
lacZ * - *
) * - *
was * - *
used * - *
to * - *
study * - *
the * - *
regulation * regulation (V*)
of * - *
osmY (DNA*) - (A0*)
. * - *

In * - *
agreement * - *
with * - *
these * - *
findings * - *
, * - *
we * - *
now * - *
present * - *
evidence * - *
that * - *
transcriptional (DNA* - (A0*
( * - *
operon * - *
) * - *
fusions *) - *)
of * - *
lacZ+ * - *
to * - *
ompC * - *
and * - *
micF * - *
are * - *
negatively * - (A5*)
regulated * regulate (V*)
by * - *
Lrp (PTE*) - (A1*)
. * - *

Expression * express (V*)
of * - *
glnA (DNA*) - (A0*)
in * - (A2*
Escherichia (ORG* - *
coli *) - *)
is * - *
regulated * - *
at * - *
tandem (DNA* - *
promoters *) - *
. * - *

Synthesis * synthesize (V*)
of * - *
formate (PTE* - (A0*
dehydrogenase *) - *)
coupled * - *
to * - *
formate * - *
hydrogenlyase * - *
activity * - *
in * - (A2*
Escherichia (ORG* - *
coli *) - *)
was * - *
found * - *
to * - *
require * - *
the (PTE* - *
product * - *
of * - *
the * - *
fhlA * - *
gene *) - *
. * - *

Evidence * - *
for * - *
regulation * regulation (V*)
by * - *
Wilms' * - *
tumor * - *
suppressor * - *
gene * - *
( * - *
WT-1 (DNA*) - (A1*)
) * - *
and * - *
p53 (DNA*) - *
. * - *

The * - *
participation * - *
of * - *
several * - *
adjacent * - *
bound * - *
CRP * - *
molecules * - *
in * - *
the * - *
activation * activate (V*)
of * - *
a (DNA* - (A0*
promoter *) - *)
is * - *
an * - *
unprecedented * - *
observation * - *
and * - *
might * - *
involve * - *
molecular * - *
mechanisms * - *
quite * - *
different * - *
from * - *
those * - *
used * - *
in * - *
the * - *
other * - *
CRP-controlled * - *
promoters * - *
. * - *

A (DNA*) - * *
gearbox * - * *
promoter * - * *
, * - * *
ftsQ1p (DNA*) - (A1*) *
, * - * *
forms * form (V*) *
part * - * *
of * - * *
the * - (A0* *
signals * - *) *
regulating * - * *
the * - * *
transcription * transcription * (V*)
of * - * *
ftsQ (DNA*) - * (A0*)
, * - * *
A * - * *
and * - * *
Z (DNA*) - * *
. * - * *

Action * - * *
at * - * *
a * - * *
distance * - * *
for * - * *
negative * - * *
control * - * *
of * - * *
transcription * transcription (V*) *
of * - * *
the (DNA* - (A0* (A1*
glpD * - * *
gene *) - *) *)
encoding * encode * (V*)
sn-glycerol (PTE* - * (A0*
3-phosphate * - * *
dehydrogenase *) - * *)
of * - * *
Escherichia * - * *
coli * - * *
K-12 * - * *
. * - * *

Salicylate (EXP*) - (A1*)
, * - *
an * - *
inducer * - *
of * - *
marRAB * - *
and * - *
of * - *
an * - *
unidentified * - *
mar-independent * - *
antibiotic * - *
resistance * - *
system * - *
, * - *
induced * induce (V*)
inaA (DNA*) - (A0*)
by * - *
6-fold * - (A9*)
. * - *

The (DNA* - (A1*
glpK * - *
gene *) - *)
encodes * encode (V*)
glycerol (PTE* - (A0*
kinase *) - *)
. * - *

BCL6 (PTE*) - *
can * - *
repress * - *
transcription * transcription (V*)
from * - *
the (DNA* - (A6*
human * - *
immunodeficiency * - *
virus * - *
type * - *
I * - *
promoter/enhancer * - *
region *) - *)
. * - *

Formation * form (V*)
of * - *
the (PTE* - (A0*
cAMP-CRP-CytR * - *
DNA * - *
nucleoprotein * - *
complex *) - *)
in * - (A3*
vitro * - *)
was * - *
perturbed * - *
in * - *
each * - *
mutant * - *
. * - *

htrA (DNA*) - (A1*) *
belongs * - * *
to * - * *
this * - * *
regulon * - * *
and * - * *
encodes * encode (V*) *
a (PTE* - (A0* *
periplasmic * - * *
protease *) - *) *
involved * - * *
in * - * *
the * - * *
degradation * degradate * (V*)
of * - * *
misfolded (PTE* - * (A0*
proteins *) - * *)
. * - * *

PhoB-dependent * - (A5*)
transcriptional * - (A5*)
activation * activate (V*)
of * - *
the (DNA* - (A0*
iciA * - *
gene *) - *)
during * - (A12*
starvation * - *)
for * - *
phosphate * - *
in * - *
Escherichia * - *
coli * - *
. * - *

This * - *
paper * - *
describes * - *
the * - *
isolation * - *
of * - *
a * - *
Tn10 * - *
mutant * - *
in * - *
which * - *
the * - *
160-fold * - *
induction * - *
of * - *
dcuB (DNA*) - (A0*)
expression * express (V*)
by * - *
C4-dicarboxylates (EXP*) - *
is * - *
absent * - *
. * - *

Translation * translate (V*)
of * - *
rpoS (DNA* - (A0*
mRNA *) - *)
is * - *
controlled * - *
by * - *
a * - *
cascade * - *
of * - *
interacting * - *
factors * - *
, * - *
including * - *
Hfq * - *
, * - *
H-NS * - *
, * - *
dsrA * - *
RNA * - *
, * - *
LeuO * - *
, * - *
and * - *
oxyS * - *
RNA * - *
that * - *
seem * - *
to * - *
modulate * - *
the * - *
stability * - *
of * - *
a * - *
region * - *
of * - *
secondary * - *
structure * - *
in * - *
the * - *
ribosome-binding * - *
region * - *
of * - *
the * - *
gene's * - *
mRNA * - *
. * - *

In * - *
vivo * - *
experiments * - *
showed * - *
that * - *
IHF * - *
is * - *
a * - *
negative * - *
effector * - *
of * - *
ompB (DNA*) - (A0*)
expression * express (V*)
in * - (A2*
growing (ORG* - *
cells *) - *)
. * - *

Moreover * - * * *
, * - * * *
we * - * * *
found * - * * *
by * - * * *
gene * - * * *
fusion * - * * *
and * - * * *
Northern * - * * *
blot * - * * *
hybridization * - * * *
that * - * * *
the * - * * *
" * - * * *
histone-like * - * * *
" * - * * *
protein * - * * *
, * - * * *
H-NS (PTE*) - (A1*) * *
, * - * * *
bound * bound (V*) * *
specifically * - * * *
to * - * * *
a (DNA* - (A7* * *
promoter * - * * *
segment *) - * * *
of * - * * *
lrp * - *) * *
in * - (A5* * *
vitro * - *) * *
, * - * * *
and * - * * *
the * - * * *
level * - * * *
of * - * * *
lrp (DNA*) - * * (A0*
expression * express * (V*) *)
increased * increase * * (V*)
in * - * * (A2*
the (None* - * * *
hns * - * * *
null * - * * *
mutant *) - * * *)
. (DNA*) - * (A0*) *

Further * - *
, * - *
experiments * - *
with * - *
an * - *
antisense-ref * - *
cDNA * - *
expression * - *
vector * - *
introduced * - *
into * - *
cultured * - *
cells * - *
suggested * - *
that * - *
DNA * - *
( * - *
nCaRE * - *
) * - *
-ref1 * - *
interaction * - *
led * - *
to * - *
Ca2+e-mediated * - (A5*
transcriptional * - *)
suppression * suppress (V*)
. * - *

Constitutive * - (A5*)
expression * express (V*)
of * - *
the (PTE* - (A0*
CsgD * - *
protein *) - *)
results * - *
in * - *
altered * - *
transcription * - *
patterns * - *
for * - *
at * - *
least * - *
24 * - *
novel * - *
genes * - *
, * - *
in * - *
addition * - *
to * - *
the * - *
previously * - *
identified * - *
CsgD-dependent * - *
genes * - *
. * - *

A (PRC* - (A1* * * *
chromosomal * - * * * *
deletion *) - *) * * *
of * - * * * *
gcvA * - * * * *
resulted * - * * * *
in * - * * * *
the * - * * * *
inability * - * * * *
of * - * * * *
cells * - * * * *
to * - * * * *
activate * activate (V*) * * *
the * - (A0* * * *
expression * express *) (V*) * *
of * - * * * *
a (DNA* - * (A0* * *
gcvT-lacZ * - * * * *
gene * - * * * *
fusion *) - * *) * *
when * - * * * *
grown * - (A3* * * *
in * - * * * *
the * - * * * *
presence * - * * * *
of * - * * * *
glycine * - *) * * *
and * - * * * *
an * - * * * *
inability * - * * * *
to * - * * * *
repress * repress * * (V*) *
gcvT-lacZ (DNA*) - * * (A0* (A0*)
expression * express * * *) (V*)
when * - * * * *
grown * - * * (A3* *
in * - * * * *
the * - * * * *
presence * - * * * *
of * - * * * *
inosine * - * * *) *
. (EXP*) - * * * *

A * - *
yeiL-lacZ * - *
transcriptional * - *
fusion * - *
showed * - *
that * - *
aerobic * - (A5*)
yeiL * - (A0*)
expression * express (V*)
increases * - *
at * - *
least * - *
sixfold * - *
during * - *
stationary * - *
phase * - *
, * - *
requires * - *
RpoS (PTE*) - *
, * - *
and * - *
is * - *
positively * - *
autoregulated * - *
by * - *
YeiL (PTE*) - *
, * - *
positively * - *
activated * - *
by * - *
Lrp (PTE*) - *
( * - *
and * - *
IHF (PTE*) - *
in * - *
the * - *
absence * - *
of * - *
FNR (PTE*) - *
) * - *
and * - *
negatively * - *
regulated * - *
by * - *
FNR (PTE*) - *
. * - *

In * - *
conclusion * - *
, * - *
we * - *
propose * - *
that * - *
7-2-7 (DNA* - (A0*
sites *) - *)
are * - *
preferred * prefer (V*)
by * - *
both * - *
NarL (PTE*) - (A1*)
and * - *
NarP (PTE*) - *
. * - *

It * - * *
was * - * *
also * - * *
demonstrated * - * *
that * - * *
the (DNA* - (A1* *
nucleotides *) - *) *
extending * - * *
from * - * *
position * - * *
-111 * - * *
to * - * *
-92 * - * *
play * play (V*) *
a * - (A8* *
role * - * *
in * - * *
stimulation * - *) *
of * - * *
the * - * *
ompF (DNA*) - * (A0*)
expression * express * (V*)
. * - * *

Transcription * transcribe (V*) * *
from * - * * *
different * - * * *
promoters * - * * *
of * - * * *
the * - * * *
gal * - * * *
regulon * - * * *
, * - * * *
galP1 (DNA*) - (A6*) * *
, * - * * *
galP2 (DNA*) - * * *
and * - * * *
mglP (DNA*) - * * *
, * - * * *
was * - * * *
examined * - * * *
by * - * * *
primer (EXP* - * * *
extension *) - * * *
and * - * * *
reverse (EXP* - * (A5*) *
transcription *) transcription * (V*) *
of * - * * *
mRNA (DNA*) - * (A0*) *
isolated * - * * *
from * - * * *
strains (None*) - * * *
containing * - * * *
mutations * mutations * * (V*)
in * - * * (A2*
galR (DNA* - * * *
and/or * - * * *
galS *) - * * *)
. * - * * *

PU (DNA* - (A0* *
. * - * *
1 *) - *) *
is * - * *
upregulated * upregulate (V*) *
early * - (A12* *
during * - * *
commitment * - * *
of * - * *
multipotential (ORG* - * *
progenitors *) - *) *
to * - * *
the * - * *
myeloid * - * *
lineages * - * *
and * - * *
inhibition * inhibit * (V*)
of * - * *
PU * - * (A0*
. * - * *
1 * - * *
function * - * *)
in * - * (A2*
human (ORG* - * *
CD34+ * - * *
progenitors *) - * *)
prior * - * (A12*
to * - * *
this (PRC* - * *
upregulation *) - * *)
blocks * - * *
myeloid * - * *
colony * - * *
formation * - * *
. * - * *

Expression * express (V*) *
of * - * *
the (DNA* - (A0* *
yiaK-S * - * *
operon *) - *) *
is * - * *
controlled * - * *
in * - * *
the (ORG* - * *
wild-type * - * *
strain *) - * *
by * - * *
a (PTE* - * (A0*
repressor *) - * *)
encoded * encode * (V*)
by * - * *
yiaJ (DNA*) - * (A1*)
. * - * *

Therefore * - * *
, * - * *
experiments * - * *
were * - * *
performed * - * *
to * - * *
determine * - * *
whether * - * *
the * - * *
continued * - * *
presence * - * *
of * - * *
mioC * - (A1*) *
transcription * transcription (V*) *
during * - * *
the * - * *
process * - * *
of * - * *
initiation * - * (A0*)
altered * - * *
the * - * *
timing * time * (V*)
of * - * *
initiation * - * *
. * - * *

However * - *
, * - *
when * - *
present * - *
in * - *
the * - *
same * - *
cell * - *
with * - *
rcsA (DNA*) - *
, * - *
either * - *
in * - *
cis * - *
or * - *
in * - *
trans * - *
, * - *
rcsB (DNA*) - *
caused * - *
expression * express (V*)
of * - *
mucoidy (DNA*) - (A0*)
in * - (A2*
E (ORG* - *
. * - *
coli *) - *)
at * - *
all * - (A3*
growth * - *
temperatures * - *)
. * - *

Studies * - *
employing * - *
a * - *
dcuA * - *
dcuB * - *
dcuC * - *
triple * - *
mutant * - *
unable * - *
to * - *
transport * - *
C4-dicarboxylates * - *
anaerobically * - *
revealed * - *
that * - *
C4-dicarboxylate * - *
transport * - *
is * - *
not * - *
required * - *
for * - *
C4-dicarboxylate-responsive * - (A5*)
gene (DNA*) - (A0*)
regulation * regulation (V*)
. * - *

For * - *
analysis * - *
of * - *
the * - *
NF-kappaB * - *
signaling * - *
pathway * - *
, * - *
we * - *
introduced * - *
each * - *
of * - *
the (DNA* - *
cDNAs *) - *
into * - *
human * - *
embryonic * - *
kidney * - *
293 * - *
cells * - *
and * - *
examined * - *
whether * - *
it * - *
activated * - *
the * - *
transcription * transcription (V*)
of * - *
a (DNA* - (A0*
luciferase * - *
reporter * - *
gene *) - *)
driven * - *
by * - *
a * - *
promoter * - *
containing * - *
the * - *
consensus * - *
NF-kappaB * - *
binding * - *
sites * - *
. * - *

We * - *
have * - *
isolated * - *
a (DNA* - (A1*
novel * - *
cDNA *) - *)
encoding * encode (V*)
a (PTE* - (A0*
peptide *) - *)
with * - *
86% * - *
sequence * - *
homology * - *
to * - *
hSNF2L * - *
protein * - *
, * - *
a * - *
previously * - *
isolated * - *
human * - *
homologue * - *
of * - *
Drosophila * - *
ISWI * - *
. * - *

An * - *
immunopurification * - *
approach * - *
has * - *
been * - *
used * - *
to * - *
demonstrate * - *
that * - *
human * - *
RNA * - *
Pol * - *
III * - *
is * - *
composed * - *
of * - *
16 * - *
subunits * - *
, * - *
some * - (A0*
of * - *
which * - *)
are * - *
apparently * - *
modified * modify (V*)
in * - (A2*
HeLa (ORG* - *
cells *) - *)
. * - *

A * - *
12-cistron * - *
Escherichia * - *
coli * - *
operon * - *
( * - *
hyf (DNA*) - (A1*)
) * - *
encoding * encode (V*)
a * - (A0*
putative * - *
proton-translocating * - *
formate * - *
hydrogenlyase * - *
system * - *)
. * - *

Dimerization * - (A1* * *
of * - * * *
NF-KB2 * - * * *
with * - * * *
RelA * - * * *
( * - * * *
p65 * - * * *
) * - *) * *
regulates * regulate (V*) * *
DNA * - (A0* * *
binding * - *) * *
, * - * * *
transcriptional * - * (A5*) *
activation * activate * (V*) *
, * - * * *
and * - * * *
inhibition * inhibit * * (V*)
by * - * * *
an * - * * *
I * - * * *
kappa * - * * *
B-alpha * - * * *
( * - * * *
MAD-3 (PTE*) - * * (A1*)
) * - * * *
. (PTE*) - * * *

Finally * - * *
, * - * *
the * - * *
loss * lose (V*) *
of * - * *
both (PTE* - (A0* *
Crp * - * *
and * - * *
Fur *) - *) *
activated * - * *
a * - * *
heterogeneous * - * *
group * - * *
of * - * *
genes * - * *
under * - * *
sigmaS (PTE* - * (A3*
control *) - * *)
encoding * encode * (V*)
, * - * *
for * - * *
example * - * *
, * - * *
the (PTE* - * (A0*
cyclopropane * - * *
fatty * - * *
acid * - * *
synthase * - * *
, * - * *
Cfa * - * *
, * - * *
the * - * *
glycogen * - * *
synthesis * - * *
protein * - * *
, * - * *
GlgS * - * *
, * - * *
the * - * *
30S * - * *
ribosomal * - * *
protein * - * *
, * - * *
S22 * - * *
, * - * *
and * - * *
the * - * *
mechanosensitive * - * *
channel * - * *
protein * - * *
, * - * *
YggB * - * *
. *) - * *)

Glucose * - (A1*)
represses * repress (V*)
the (DNA* - (A0*
ula * - *
regulon *) - *)
via * - *
at * - *
least * - *
two * - *
mechanisms * - *
, * - *
one * - *
dependent * - *
on * - *
cyclic * - *
AMP * - *
( * - *
cAMP * - *
) * - *
-cAMP * - *
receptor * - *
protein * - *
( * - *
CRP * - *
) * - *
and * - *
the * - *
other * - *
( * - *
possibly * - *
inducer * - *
exclusion * - *
) * - *
independent * - *
of * - *
it * - *
. * - *

Inactivation * inactivate (V*) *
of * - * *
fecR (DNA*) - (A0*) *
results * - * *
in * - * *
significant * - * *
increases * - * *
in * - * *
both * - * *
cell * - * *
aggregation * - * *
and * - * *
biofilm * - * *
formation * - * *
, * - * *
while * - * *
the * - * *
effects * effect * (V*)
of * - * *
cspA (DNA*) - * (A1*)
are * - * *
not * - * *
as * - * *
strong * - * *
in * - * *
the * - * *
conditions * - * *
tested * - * *
. * - * *

A * - * * *
second * - * * *
promoter * - * * *
( * - * * *
pacsP1 (DNA*) - * * (A0*)
) * - * * *
, * - * * *
which * - * * *
directs * - * * *
transcription * transcription (V*) * *
into * - * * *
the (DNA* - * * *
adjacent * - * * *
gene *) - * * *
encoding * encode * (V*) *
acetyl (PTE* - * (A0* *
coenzyme * - * * *
A * - * * *
synthetase *) - * *) *
( * - * * *
acs * - (A7*) (A1*) *
) * - * * *
, * - * * *
is * - * * *
overlapping * overlap * * (V*)
and * - * * *
divergent * - * * *
to * - * * *
pnrfA (DNA*) - * * (A4*)
. * - * * *

Thus * - *
, * - *
the (DNA* - *
ast * - *
operon *) - *
exhibits * - *
nitrogen * - (A5*
source-specific * - *)
induction * induce (V*)
that * - *
is * - *
unique * - *
for * - *
an * - *
NR * - *
( * - *
I * - *
) * - *
-dependent * - *
gene * - *
. * - *

AP-2 * - (A0*
activity * - *)
is * - *
mediated * mediate (V*)
by * - *
both * - *
the * - (A1*
state * - *
of * - *
cellular * - *
differentiation * - *)
and * - *
changes * - *
in * - *
signal * - *
transduction * - *
pathways * - *
, * - *
suggesting * - *
a * - *
potential * - *
role * - *
of * - *
AP-2 * - *
in * - *
the * - *
regulation * - *
of * - *
diverse * - *
cellular * - *
processes * - *
. * - *

The * - *
heritable * - *
stability * - *
in * - *
Escherichia * - *
coli * - *
of * - *
the * - *
multicopy * - *
plasmid * - *
ColE1 * - *
and * - *
its * - *
natural * - *
relatives * - *
requires * - *
that * - *
the (DNA* - (A0*
plasmids *) - *)
be * - *
maintained * maintain (V*)
in * - *
the * - (A4*
monomeric * - *
state * - *)
. * - *

Thus * - *
, * - *
it * - *
is * - *
concluded * - *
that * - *
ref1 (PTE*) - (A1*)
possesses * possess (V*)
transcription * - (A8*
repressor * - *
activity * - *)
in * - *
addition * - *
to * - *
its * - *
function * - *
as * - *
a * - *
transcriptional * - *
auxiliary * - *
protein * - *
. * - *

In * - *
studies * - *
on * - *
the * - *
regulation * - *
of * - *
gene * - (A0*)
expression * express (V*)
of * - *
mtTF1 (PTE*) - (A0*)
, * - *
we * - *
examined * - *
the * - *
steady * - *
state * - *
level * - *
of * - *
the * - *
mRNA * - *
in * - *
cultured * - *
HeLa * - *
cells * - *
. * - *

These * - *
results * - *
suggest * - *
that * - *
transcription * transcription (V*)
of * - *
the (DNA* - (A0*
fadL * - *
gene *) - *)
is * - *
osmotically * - *
regulated * - *
by * - *
the (PTE* - *
OmpR-EnvZ * - *
two-component * - *
system *) - *
. * - *

The (None* - (A10* *
uxuR-lacZ * - * *
fusion * - * *
strain *) - *) *
was * - * *
also * - * *
used * - * *
to * - * *
examine * examine (V*) *
the * - (A0* *
regulation * - * *
of * - * *
expression * express *) (V*)
from * - * *
the (DNA* - * (A6*
uxuR * - * *
promoter *) - * *)
. * - * *

Factor * - *
for * - *
inversion * - *
stimulation * - *
( * - *
FIS * - *
) * - *
, * - *
the * - *
Escherichia * - *
coli * - *
protein * - *
, * - *
is * - *
a * - *
positive * - *
regulator * - *
of * - *
the * - *
transcription * - *
of * - *
genes (DNA*) - (A1*)
that * - *
encode * encode (V*)
stable (DNA* - *
RNA * - *
species *) - *
, * - *
such * - *
as * - *
rRNA (DNA*) - (A0*)
and * - *
tRNA (DNA*) - *
. * - *

A * - *
secondary * - *
IclR * - *
binding * - *
site * - *
( * - *
IclR (DNA* - (A0*
box * - *
I *) - *)
) * - *
was * - *
identified * identify (V*)
between * - (A2*
-125 (DNA* - *
and * - *
-99 *) - *
of * - *
the (DNA* - *
aceB * - *
promoter *) - *)
. * - *

Escherichia * - *
coli * - *
RcsA (PTE*) - (A1*)
, * - *
a * - *
positive * - *
activator * - *
of * - *
colanic * - *
acid * - *
capsular * - *
polysaccharide * - *
synthesis * - *
, * - *
functions * - *
To * - *
activate * activate (V*)
its (PRC* - (A0*
own * - *
expression *) - *)
. * - *

A * - * *
strain * - * *
of * - * *
E * - * *
. * - * *
coli * - * *
bearing * - * *
a * - * *
fusion * - * *
of * - * *
the * - * *
soxS (DNA*) - * (A0*)
promoter * - * *
to * - * *
lacZ * - * *
was * - * *
used * - * *
to * - * *
demonstrate * - * *
that * - * *
both * - * *
diamide (EXP*) - * *
and * - * *
1 (EXP* - * *
, * - * *
10-phenanthroline *) - * *
caused * - * *
anaerobic * - (A5*) *
activation * activate (V*) *
of * - * *
soxS * - (A0* *
transcription * transcription *) (V*)
. * - * *

Multiple (PRC* - (A0* *
regulation *) - *) *
involved * involve (V*) *
in * - * *
the * - (A4* *
expression * express * (V*)
of * - * *
the (DNA* - * (A0*
uxuR * - * *
regulatory * - * *
gene *) - *) *)
in * - * (A2*
Escherichia (ORG* - * *
coli * - * *
K-12 *) - * *)
. * - * *

Trimeric (PTE* - (A1*
ArgR *) - *)
is * - *
impaired * - *
in * - *
its * - *
ability * - *
to * - *
repress * repress (V*)
the (DNA* - (A0*
arginine * - *
biosynthetic * - *
genes *) - *)
and * - *
in * - *
Xer * - *
site-specific * - *
recombination * - *
. * - *

Regulation * regulate (V*)
of * - *
the (DNA* - (A0*
ompC * - *
gene *) - *)
of * - *
Escherichia * - *
coli * - *
. * - *

NO * - *
sensing * - *
by * - *
FNR * - *
: * - *
regulation * regulation (V*)
of * - *
the * - *
Escherichia * - *
coli * - *
NO-detoxifying * - *
flavohaemoglobin * - *
, * - *
Hmp (PTE*) - (A0*)
. * - *

The * - * *
ArcAB * - * *
two-component * - * *
system * - * *
of * - * *
Escherichia * - * *
coli * - * *
regulates * - * *
the * - * *
aerobic/anaerobic * - * *
expression * express (V*) *
of * - * *
genes (DNA*) - (A0*) (A1*)
that * - * *
encode * encode * (V*)
respiratory (PTE* - * (A0*
proteins *) - * *)
whose * - * *
synthesis * - * *
is * - * *
coordinated * - * *
during * - * *
aerobic/anaerobic * - * *
cell * - * *
growth * - * *
. * - * *

The * - *
roles * - *
of * - *
the (DNA* - (A1*
marRAB *) - *
( * - *
multiple * - *
antibiotic * - *
resistance * - *
) * - *
operon * - *)
and * - *
soxRS (DNA*) - (A1*
( * - *
superoxide * - *
response * - *
) * - *
genes * - *)
in * - *
the * - *
regulation * regulation (V*)
of * - *
inaA (DNA*) - (A0*)
, * - *
an * - *
unlinked * - *
weak-acid-inducible * - *
gene * - *
, * - *
were * - *
studied * - *
. * - *

A * - *
strain * - *
lacking * - *
Lrp * - *
had * - *
high-level * - (A5*
constitutive * - *)
dad (DNA*) - (A0*)
expression * express (V*)
. * - *

In * - * *
Escherichia * - * *
coli * - * *
, * - * *
the (DNA* - (A1* (A0*
rpoH * - * *
gene *) - *) *)
encoding * encode (V*) *
the (PTE* - (A0* *
essential * - * *
heat-shock * - * *
regulator * - * *
sigma32 *) - *) *
, * - * *
is * - * *
expressed * express * (V*)
in * - * *
a * - * (A5*
complex * - * *
manner * - * *)
. * - * *

A (DNA* - (A1* *
plasmid *) - *) *
carrying * - * *
the * - * *
dcuSR * - * *
operon * - * *
restored * restore (V*) *
the * - (A0* *
C4-dicarboxylate * - * *
inducibility * - * *
of * - * *
dcuB * - * *
expression * express *) (V*)
in * - (A2* (A2*
the (None* - * *
dcuS * - * *
mutant *) - *) *)
to * - * *
levels * - * *
exceeding * - * *
those * - * *
of * - * *
the * - * *
dcuS+ * - * *
strain * - * *
by * - * *
approximately * - * *
1 * - * *
. * - * *
8-fold * - * *
. (DNA*) - * (A0*)

We * - *
believe * - *
this * - *
binding * - *
is * - *
required * - *
to * - *
generate * generate (V*)
a (PTE* - (A0*
higher * - *
order * - *
protein-DNA * - *
complex *) - *)
within * - (A2*
the * - *
recombinational * - *
synapse * - *)
. * - *

E-RC1 (PTE*) - (A0*)
contains * contain (V*)
BRG1 (PTE* - (A4*
, * - *
BAF170 * - *
, * - *
BAF155 * - *
, * - *
and * - *
INI1 * - *
( * - *
BAF47 * - *
) * - *
homologs *) - *)
of * - *
yeast * - *
SWI/SNF * - *
subunits * - *
, * - *
as * - *
well * - *
as * - *
a * - *
subunit * - *
unique * - *
to * - *
higher * - *
eukaryotes * - *
, * - *
BAF57 * - *
, * - *
which * - *
is * - *
critical * - *
for * - *
chromatin * - *
remodeling * - *
and * - *
transcription * - *
with * - *
EKLF * - *
. * - *

Immunocytochemical * - * *
analysis * - * *
indicates * - * *
that * - * *
recombinant (PTE* - (A1* *
NFAT1 *) - *) *
localizes * - * *
in * - * *
the * - * *
cytoplasm * - * *
of * - * *
transiently * - * *
transfected * - * *
T * - * *
cells * - * *
and * - * *
translocates * translocate (V*) *
into * - * *
the (ORG* - (A7* *
nucleus *) - *) *
in * - * *
a * - (A5* *
CsA-sensitive * - * *
manner * - *) *
following * - * *
ionomycin (EXP*) - * (A1*)
stimulation * stimulate * (V*)
. * - * *

A (PTE* - * *
supramolecular * - * *
transcription * - * *
complex *) - * *
is * - * *
proposed * - * *
which * - * *
involves * - * *
the * - * *
binding * bind (V*) *
of * - * *
IHF (PTE*) - (A1*) *
to * - * *
a (DNA* - (A7* *
site *) - *) *
located * - * *
between * - * *
the * - * *
UAS * - * *
and * - * *
the * - * *
promoter * - * *
responsible * - * *
for * - * *
transcription * transcription * (V*)
of * - * *
the (DNA* - * (A0*
hyc * - * *
operon *) - * *)
. * - * *

For * - *
example * - *
, * - *
ompR1 * - *
, * - *
a * - *
deletion * - *
mutation * - *
with * - *
an * - *
OmpF- * - *
OmpC- * - *
phenotype * - *
, * - *
was * - *
dominant * - *
to * - *
OmpF+ (DNA* - (A0*
or * - *
OmpC+ * - *
phenotypes *) - *)
conferred * confer (V*)
by * - *
other (DNA* - (A1*
ompR * - *
genes *) - *)
. * - *

We * - *
examined * - *
the * - *
transcriptional * - *
capability * - *
of * - *
the * - *
ompC (DNA*) - (A0*)
gene * - *
in * - *
vitro * - *
and * - *
found * - *
that * - *
RNA (PTE* - (A1*
polymerase *) - *)
could * - *
transcribe * transcribe (V*)
ompC * - *
without * - (A3*
a * - *
requirement * - *
for * - *
other (PTE* - *
transcriptional * - *
factors *) - *)
. * - *

A * - (A1* *
rise * - * *
in * - * *
extracellular (EXP* - * *
calcium *) - *) *
( * - * *
Ca2+e * - * *
) * - * *
suppresses * suppress (V*) *
not * - * *
only * - * *
secretion * - (A0*) *
of * - * *
parathyroid * - * *
hormone * - * *
( * - * *
PTH * - * *
) * - * *
but * - * *
also * - * *
expression * express * (V*)
of * - * *
the (DNA* - * (A0*
PTH * - * *
gene *) - * *)
to * - (A11* *
ensure * - * *
constant * - * *
plasma * - * *
Ca2+ * - * *
level * - *) *
. * - * *

14-3-3eta (PTE*) - (A1*)
Enhanced * enhance (V*)
the * - (A0*
transcriptional * - *
activity * - *
of * - *
GR * - *)
, * - *
and * - *
the * - *
levels * - *
of * - *
GR (PTE*) - *
were * - *
higher * - *
in * - *
cells * - *
transfected * - *
with * - *
the * - *
14-3-3eta * - *
expression * - *
vector * - *
in * - *
response * - *
to * - *
glucocorticoid * - *
. * - *

Disruption * disrupt (V*) * *
of * - * * *
sdiA (DNA*) - (A0*) (A1*) *
, * - * * *
which * - * * *
encodes * encode * (V*) *
a * - * (A0* *
LuxR * - * * *
homologue * - * *) *
, * - * * *
decreased * - * * *
the * - * * *
expression * express * * (V*)
of * - * * *
uvrY'-'lacZ (DNA* - * * (A0*
and * - * * *
csrB-lacZ * - * * *
fusions *) - * * *)
but * - * * *
did * - * * *
not * - * * *
affect * - * * *
csrA'-'lacZ (DNA*) - * * *
. * - * * *

Here * - *
we * - *
examine * - *
the * - *
biochemical * - *
basis * - *
for * - *
the * - *
transcriptional * - (A5*)
regulation * regulation (V*)
of * - *
HIV (ORG*) - (A0*)
by * - *
NFKB2 (PTE*) - (A1*)
. * - *

In * - (A2*)
heterologous * - *
( * - *
HeLa (ORG* - *
) * - *
cells *) - *
, * - *
MIS (DNA* - (A0*
gene *) - *)
activation * activate (V*)
by * - *
SF-1 (PTE*) - (A1*)
requires * - *
removal * - *
of * - *
the * - *
SF-1 * - *
ligand-binding * - *
domain * - *
, * - *
implicating * - *
a * - *
Sertoli * - *
cell-specific * - *
ligand * - *
or * - *
cofactor * - *
. * - *

Escherichia (PTE* - (A0* *
coli * - * *
RNase * - * *
G *) - *) *
encoded * encode (V*) *
by * - * *
the (DNA* - (A1* *
rng * - * *
gene *) - *) *
is * - * *
involved * - * *
in * - * *
degradation * degradate * (V*)
of * - * *
adhE (DNA* - * (A0*
mRNA *) - * *)
. * - * *

The * - *
quaternary * - *
structure * - *
of * - *
regulatory * - *
proteins * - *
undoubtedly * - *
plays * - *
an * - *
important * - *
role * - *
in * - *
the * - *
initiation * initiate (V*)
of * - *
transcription (PRC*) - (A0*)
and * - *
DNA (PRC* - *
replication *) - *
. * - *

These * - * *
observations * - * *
are * - * *
consistent * - * *
with * - * *
the * - * *
hypothesis * - * *
that * - * *
P (DNA* - (A0* *
( * - * *
cer * - * *
) *) - *) *
activation * activate (V*) *
involves * - * *
realignment * realign * (V*)
of * - * *
the (DNA* - * (A0*
-35 * - * *
and * - * *
-10 * - * *
sequences *) - * *)
within * - * (A2*
a (PTE* - * *
recombinational * - * *
synaptic * - * *
complex *) - * *)
. * - * *

Finally * - *
, * - *
the * - *
sexually * - (A5*
dimorphic * - *)
expression * express (V*)
of * - *
SF-1 * - (A0*)
during * - (A12*
development * - *
coincides * - *)
with * - *
MIS (DNA*) - *
expression * - *
and * - *
müllerian * - *
duct * - *
regression * - *
. * - *

These * - *
studies * - *
also * - *
showed * - *
that * - *
the (PTE* - (A1*
cAMP-Crp * - *
complex *) - *)
can * - *
bind * bind (V*)
to * - *
two (DNA* - (A7*
different * - *
sites *) - *)
. * - *

Inactivation * inactivate (V*) * *
of * - * * *
this (DNA* - (A0* * *
gene *) - *) * *
renders * - * * *
constitutive * - * * *
the * - * * *
expression * express * (V*) *
of * - * * *
the (DNA* - * (A0* *
ula * - * * *
operon *) - * *) *
, * - * * *
indicating * - * * *
that * - * * *
YjfQ (PTE*) - * * (A1*)
acts * act * * (V*)
as * - * * *
a (PTE* - * * (A8*
repressor *) - * * *)
. * - * * *

The * - *
effect * effect (V*)
of * - *
IHF (PTE*) - (A1*)
was * - *
apparent * - *
only * - *
when * - *
the * - *
remote * - *
operators * - *
were * - *
present * - *
. * - *

The * - * *
tsx-p2 * - * *
promoter * - * *
is * - * *
one * - * *
of * - * *
at (DNA* - (A0* (A0*
least * - * *
seven * - * *
Escherichia * - * *
coli * - * *
promoters *) - *) *)
that * - * *
are * - * *
activated * activate (V*) *
by * - * *
the (PTE* - (A1* *
cyclic * - * *
AMP * - * *
( * - * *
cAMP * - * *
) * - * *
-cAMP * - * *
receptor * - * *
protein * - * *
( * - * *
CRP * - * *
) * - * *
complex *) - *) *
and * - * *
negatively * - * (A5*)
regulated * regulate * (V*)
by * - * *
the (PTE* - * (A1*
CytR * - * *
repressor *) - * *)
. * - * *

Since * - * *
methylation (PRC*) - (A1*) *
also * - * *
abrogates * abrogate (V*) *
OxyR * - (A0* *
binding * - *) *
, * - * *
this * - * *
indicates * - * *
that * - * *
methylation (PRC*) - * *
plays * - * *
a * - * *
dual * - * *
role * - * *
in * - * *
facilitating * - * *
agn43 (DNA*) - * (A0*)
transcription * transcription * (V*)
. * - * *

These * - * *
findings * - * *
are * - * *
best * - * *
explained * - * *
if * - * *
the (PTE* - (A1* *
Klebsiella * - * *
rcsA * - * *
gene * - * *
product *) - *) *
acts * act (V*) *
as * - * *
a (PTE* - (A8* *
positive * - * *
regulator *) - *) *
of * - * *
colanic * - * *
acid * - * *
biosynthesis * - * *
in * - (A2* *
E (ORG* - * *
. * - * *
coli *) - *) *
and * - * *
that * - * *
activity * - * (A0*
of * - * *
this * - * *
protein * - * *)
is * - * *
in * - * *
turn * - * *
subject * - * *
to * - * *
regulation * regulation * (V*)
by * - * *
Lon (PTE* - * (A1*
protease *) - * *)
. * - * *

An (PRC* - * *
increase *) - * *
to * - * *
17 * - * *
bp * - * *
resulted * - * *
in * - * *
a * - (A9* *
10- * - *) *
to * - * *
20-fold * - * *
increase * increase (V*) *
in * - * *
activity (PRC*) - (A0*) *
, * - * *
while * - * *
smaller * - * *
effects * - * *
were * - * *
seen * - * *
when * - * *
the * - * (A0*
spacer * - * *)
was * - * *
increased * increase * (V*)
to * - * *
16 * - * *
bp * - * *
or * - * *
18 * - * *
bp * - * *
. * - * *

To * - * *
verify * - * *
that * - * *
the * - * *
MetR * - * *
binding * - * *
sites * - * *
play * - * *
a * - * *
functional * - * *
role * - * *
in * - * *
glyA (DNA*) - (A0*) *
expression * express (V*) *
, * - * *
site-directed (EXP* - * (A10*
mutagenesis *) - * *)
was * - * *
used * - * *
to * - * *
alter * alter * (V*)
the (DNA* - * (A0*
two * - * *
binding * - * *
sites *) - * *)
in * - * (A2*
a (ORG* - * *
lambda * - * *
glyA-lacZ * - * *
gene * - * *
fusion * - * *
phage *) - * *)
. * - * *

Database * - *
searches * - *
indicate * - *
that * - *
the (DNA* - (A1*
human * - *
genome *) - *)
encodes * encode (V*)
an (DNA* - (A0*
open * - *
reading * - *
frame *) - *)
for * - *
a * - *
protein * - *
, * - *
BNIP3alpha * - *
, * - *
that * - *
shares * - *
substantial * - *
homology * - *
with * - *
BNIP3 * - *
. * - *

These * - *
results * - *
suggest * - *
that * - *
ydeP * - *
, * - *
ydeO * - *
, * - *
and * - *
yhiE * - *
are * - *
novel * - *
genes * - *
related * - *
to * - *
acid * - *
resistance * - *
and * - *
that * - *
EvgA (PTE*) - (A1*)
regulates * regulate (V*)
several (DNA* - (A0*
acid * - *
resistance * - *
genes *) - *)
. * - *

In * - * (A2* (A2*
strains * - * *) *)
containing * - * * *
a * - * * *
galS (DNA*) - (A0*) * *
mutation * mutation (V*) * *
, * - * * *
overexpression * overexpression * (V*) *
of * - * * *
gal (DNA* - * (A0* *
message *) - * *) *
occurred * - * * *
only * - * * *
in * - * * *
the * - * * *
presence * - * * *
of * - * * *
inducer * - * * *
, * - * * *
while * - * * *
mgl (DNA* - * * (A0*
message *) - * * *)
was * - * * *
constitutively * - * * (A5*)
derepressed * derepress * * (V*)
. (None*) - * * *

A * - *
member * - *
of * - *
the * - *
Polycomb * - *
group * - *
( * - *
Pc-G * - *
) * - *
of * - *
proteins * - *
, * - *
Drosophila (PTE* - (A1*
E * - *
( * - *
z * - *
) *) - *)
acts * act (V*)
as * - *
a (PTE* - (A8*
negative * - *
regulator *) - *)
of * - *
the * - *
segment * - *
identity * - *
genes * - *
of * - *
the * - *
Antennapedia * - *
and * - *
Bithorax * - *
complexes * - *
. * - *

Aberrant * - *
retinal * - *
expression * express (V*)
of * - *
vascular * - *
endothelial * - *
growth * - *
factor * - *
( * - *
VEGF (PTE*) - (A0*)
) * - *
leading * - *
to * - *
neovascularization * - *
is * - *
a * - *
central * - *
feature * - *
of * - *
age-related * - *
macular * - *
degeneration * - *
and * - *
diabetic * - *
retinopathy * - *
, * - *
two * - *
leading * - *
causes * - *
of * - *
vision * - *
loss * - *
. * - *

In * - * * *
previous * - * * *
work * - * * *
, * - * * *
we * - * * *
found * - * * *
that * - * * *
NarL (PTE* - (A1* (A1* *
or * - * * *
NarP *) - *) *) *
activates * activate (V*) * *
the (DNA* - (A0* * *
nir * - * * *
promoter *) - *) * *
by * - * * *
binding * bind * (V*) *
to * - * * *
a * - * (A7* *
site * - * * *
centred * - * * *
at * - * * *
position * - * * *
-69 * - * * *
. * - * * *
5 * - * *) *
and * - * * *
counteracting * - * * *
the * - * * *
repressive * - * * *
effects * effect * * (V*)
of * - * * *
IHF (PTE* - * * (A0*
and * - * * *
Fis *) - * * *)
. * - * * *

In * - *
this * - *
work * - *
, * - *
we * - *
show * - *
that * - *
MelR (PTE*) - (A1*)
additionally * - *
binds * bind (V*)
to * - *
two (DNA* - (A7*
other * - *
related * - *
18 * - *
bp * - *
sequences *) - *)
: * - *
Site * - *
1' * - *
, * - *
centred * - *
at * - *
position * - *
-120 * - *
. * - *
5 * - *
, * - *
located * - *
immediately * - *
upstream * - *
of * - *
Site * - *
1 * - *
, * - *
and * - *
Site * - *
R * - *
, * - *
at * - *
position * - *
-238 * - *
. * - *
5 * - *
, * - *
which * - *
overlaps * - *
the * - *
transcription * - *
start * - *
site * - *
of * - *
the * - *
divergent * - *
melR * - *
promoter * - *
. * - *

Modulation * - *
of * - *
CRP-dependent * - (A5*)
transcription * transcription (V*)
at * - *
the (DNA* - *
Escherichia * - *
coli * - *
acsP2 * - *
promoter *) - *
by * - *
nucleoprotein (PTE* - *
complexes *) - *
: * - *
anti-activation (PRC*) - *
by * - *
the (PTE* - *
nucleoid * - *
proteins * - *
FIS * - *
and * - *
IHF *) - *
. * - *

Five (DNA* - (A0*
major * - *
transcripts *) - *)
were * - *
observed * observe (V*)
for * - *
dcuB (DNA*) - (A4*)
and * - *
fumB (DNA*) - *
: * - *
monocistronic * - *
transcripts * - *
for * - *
both * - *
fumB * - *
and * - *
dcuB * - *
; * - *
a * - *
dcuB-fumB * - *
cotranscript * - *
; * - *
and * - *
two * - *
transcripts * - *
, * - *
possibly * - *
corresponding * - *
to * - *
dcuB-fumB * - *
and * - *
fumB * - *
mRNA * - *
degradation * - *
products * - *
. * - *

The (PTE* - *
LysR-type * - *
transcriptional * - *
regulator * - *
CysB *) - *
controls * - *
the * - *
repression * - *
of * - *
hslJ (DNA*) - (A0*)
transcription * transcription (V*)
in * - *
Escherichia (ORG* - *
coli *) - *
. * - *

Furthermore * - *
, * - *
transcripts (DNA*) - (A0*)
from * - *
three (DNA* - (A6*
tandem * - *
promoters *) - *)
in * - *
ompC * - *
were * - *
identified * identify (V*)
in * - (A3*
vitro * - *)
. * - *

Furthermore * - *
, * - *
repression (PRC*) - *
correlated * - *
with * - *
mSin3A (PTE*) - (A1*)
binding * bind (V*)
, * - *
suggesting * - *
that * - *
the * - *
new * - *
SAPs * - *
are * - *
components * - *
of * - *
functional * - *
mSin3A * - *
corepressor * - *
complexes * - *
. * - *

A * - *
mutation * mutation (V*)
of * - *
the (DNA* - (A0*
PU * - *
. * - *
1 * - *
site *) - *)
which * - *
abolished * - *
PU * - *
. * - *
1 * - *
binding * - *
caused * - *
a (PRC* - *
significant * - *
decrease * - *
in * - *
promoter * - *
activity *) - *
. * - *

It * - *
is * - *
known * - *
that * - *
14-3-3 (PTE* - (A1*
family * - *
proteins *) - *)
interact * - *
with * - *
GR * - *
and * - *
regulate * regulate (V*)
its * - (A0*
transcriptional * - *
activity * - *)
. * - *

The * - *
nucleotide * - *
sequence * - *
of * - *
sfs1 (DNA*) - (A1*)
encoded * encode (V*)
a (PTE* - (A0*
protein *) - *)
of * - *
234 * - *
amino * - *
acids * - *
( * - *
molecular * - *
mass * - *
, * - *
26 * - *
, * - *
227 * - *
Da * - *
) * - *
which * - *
also * - *
has * - *
a * - *
putative * - *
DNA * - *
binding * - *
domain * - *
. * - *

Complementation * complement (V*)
of * - *
such (None* - (A0*
a * - *
mutant *) - *)
with * - *
the (DNA* - (A1*
cloned * - *
fragments *) - *)
reversed * - *
both (DNA* - *
phenotypes *) - *
at * - *
the * - *
same * - *
time * - *
. * - *

Expression * express (V*)
of * - *
the (DNA* - (A0*
microcin * - *
C51 * - *
operon *) - *)
in * - (A2*
Escherichia (ORG* - *
coli * - *
cells *) - *)
is * - *
regulated * - *
as * - *
a * - *
function * - *
of * - *
the * - *
phase * - *
of * - *
growth * - *
; * - *
it * - *
is * - *
stimulated * - *
during * - *
the * - *
decelerating * - *
phase * - *
of * - *
growth * - *
. * - *

Cloning * - *
and * - *
characterization * - *
of * - *
a (DNA* - (A0*
human * - *
ribosomal * - *
protein * - *
gene *) - *)
with * - *
enhanced * - (A5*)
expression * express (V*)
in * - (A2*
fetal (ORG* - *
and * - *
neoplastic * - *
cells *) - *)
. * - *

A (PTE* - (A0*
repressor * - *
protein *) - *)
for * - *
the * - *
regulon * - *
is * - *
encoded * encode (V*)
by * - *
the (DNA* - (A1*
gene * - *
nagC *) - *)
, * - *
one * - *
of * - *
the * - *
genes * - *
of * - *
the * - *
nagBACD * - *
operon * - *
. * - *

We * - *
demonstrated * - *
the * - *
binding * bind (V*)
of * - *
RNA (PTE* - (A1*
polymerase * - *
holoenzymes *) - *)
, * - *
NR (PTE*) - *
( * - *
I * - *
) * - *
, * - *
and * - *
ArgR (PTE*) - *
to * - *
the (DNA* - (A7*
promoter * - *
region *) - *)
in * - (A5*
vitro * - *)
. * - *

Electrophoretic * - *
mobility * - *
shift * - *
assays * - *
showed * - *
that * - *
the (PTE* - (A1*
full-length * - *
BCL6 * - *
protein *) - *)
extracted * - *
from * - *
transfected * - *
COS * - *
cells * - *
and * - *
a (PTE* - *
bacterially * - *
expressed * - *
truncated * - *
protein *) - *
containing * - *
the * - *
BCL6 * - *
zinc * - *
fingers * - *
can * - *
bind * bind (V*)
specifically * - (A5*)
to * - *
DNA (DNA*) - (A7*)
from * - *
the * - *
U3 * - *
promoter/enhancer * - *
region * - *
of * - *
HIV-1 * - *
. * - *

Apoptosis * - *
is * - *
regulated * - *
by * - *
interaction * interact (V*)
of * - *
viral (PTE* - (A0*
and * - *
cellular * - *
BCL-2 * - *
family * - *
antiapoptotic * - *
proteins *) - *)
with * - *
various (PTE* - (A0*
pro-apoptotic * - *
proteins *) - *)
, * - *
several * - *
of * - *
which * - *
are * - *
also * - *
members * - *
of * - *
the * - *
BCL-2 * - *
family * - *
. * - *

The * - *
results * - *
suggest * - *
a * - *
control * - *
circuit * - *
whereby * - *
GadW (PTE*) - (A1*)
interacts * interact (V*)
with * - *
both * - *
the (DNA* - (A1*
gadA * - *
and * - *
gadX * - *
promoters *) - *)
. * - *

This * - * *
high * - * *
level * - * *
of * - * *
gcvA (DNA*) - (A0*) *
expression * express (V*) *
subsequently * - * *
causes * - * *
the * - * *
loss * - * *
of * - * *
purine-mediated * - * (A5*)
repression * repress * (V*)
of * - * *
a (DNA* - * (A0*
gcvT * - * *
: * - * *
: * - * *
lacZ * - * *
fusion *) - * *)
. * - * *

In * - *
this * - *
work * - *
two * - *
additional * - *
heat-stable * - *
proteins * - *
, * - *
integration * - *
host * - *
factor * - *
( * - *
IHF (PTE*) - (A1*)
) * - *
and * - *
the (PTE* - *
histone-like * - *
protein * - *
HU *) - *
were * - *
found * - *
to * - *
interact * interact (V*)
with * - *
the (DNA* - (A1*
ndh * - *
promoter *) - *)
. * - *

Each (PTE* - (A1*
new * - *
SAP *) - *)
repressed * repress (V*)
transcription (PRC*) - (A0*)
when * - *
tethered * - *
to * - *
DNA * - *
. * - *

Furthermore * - * *
, * - * *
SMNdeltaN27 (PRC*) - (A1*) *
inhibits * inhibit (V*) *
pre-mRNA * - (A0* *
splicing * - *) *
in * - (A3* *
vitro * - *) *
, * - * *
while * - * *
wild-type (PTE* - * (A1*
SMN *) - * *)
stimulates * stimulate * (V*)
splicing * - * (A0*)
. * - * *

Binding * - (A0*
sites * - *)
for * - *
the * - *
cAMP-cAMP * - *
receptor * - *
protein * - *
( * - *
CRP * - *
) * - *
complex * - *
and * - *
the * - *
glp * - *
repressor * - *
were * - *
identified * identify (V*)
by * - *
DNase (EXP* - (A10*
I * - *
footprinting *) - *)
. * - *

Our * - *
results * - *
show * - *
that * - *
the (DNA* - *
Fnr-2 * - *
site *) - *
is * - *
critical * - *
for * - *
Fnr-mediated * - (A5*
anaerobic * - *)
repression * repress (V*)
of * - *
the * - *
two * - *
main * - *
cydAB * - *
promoters * - *
, * - *
P1 (DNA*) - (A0*)
and * - *
P2 (DNA*) - *
. * - *

In * - * * *
studies * - * * *
of * - * * *
P * - * * *
( * - * * *
mcc * - * * *
) * - * * *
-lac (DNA*) - (A0*) * *
expression * express (V*) * *
in * - (A2* * *
double (None* - * * *
mutant * - * * *
cells *) - *) * *
, * - * * *
we * - * * *
showed * - * * *
that * - * * *
proteins * - * * *
CRP (PTE*) - * (A1*) *
, * - * * *
Lrp (PTE*) - * * *
and * - * * *
H-NS (PTE*) - * * *
acted * act * (V*) *
in * - * * *
rpoS-dependent * - * (A8* *
and * - * * *
rpoS-independent * - * * *
ways * - * *) *
in * - * (A12* *
transcription * transcription * *) (V*)
of * - * * *
the (DNA* - * * (A0*
microcin * - * * *
C51 * - * * *
operon *) - * * *)
. * - * * *

The * - * * *
overall * - * * *
results * - * * *
are * - * * *
consistent * - * * *
with * - * * *
the * - * * *
hypothesis * - * * *
that * - * * *
nitrate * - * (A1*) (A1*)
represses * - * * *
frdA (DNA* - (A0* * *
operon *) - *) * *
transcription * transcription (V*) * *
not * - * * *
only * - * * *
directly * - * * *
, * - * * *
by * - * * *
repressing * repress * (V*) *
frdA (DNA* - * (A0* *
promoter * - * * *
activity *) - * *) *
, * - * * *
but * - * * *
also * - * * *
indirectly * - * * *
, * - * * *
by * - * * *
repressing * repress * * (V*)
dcuS (DNA* - * * (A0*
promoter * - * * *
activity *) - * * *)
. * - * * *

These * - * *
suppressors * - * *
, * - * *
SKD1 * - * *
and * - * *
SKD2 * - * *
( * - * *
suppressor * - * *
of * - * *
K+ * - * *
transport * - * *
growth * - * *
defect * - * *
) * - * *
, * - * *
were * - * *
cDNAs (DNA*) - (A1*) *
encoding * encode (V*) *
members (PTE* - (A0* *
of * - * *
a * - * *
family * - * *
of * - * *
ATPases *) - *) *
involved * involve * (V*)
in * - * *
membrane * - * (A4*
fusion * - * *)
( * - * *
N-ethylmaleimide-sensitive * - * *
fusion * - * *
protein * - * *
, * - * *
NSF * - * *
) * - * *
, * - * *
cell * - * *
division * - * *
cycle * - * *
regulation * - * *
( * - * *
CDC48p * - * *
) * - * *
, * - * *
peroxisome * - * *
assembly * - * *
( * - * *
Pas1p * - * *
) * - * *
, * - * *
and * - * *
transcriptional * - * *
regulation * - * *
( * - * *
TBP-1 * - * *
) * - * *
. (PTE*) - * (A0*)

Two (DNA* - (A0*
binding * - *
sites *) - *)
have * - *
been * - *
detected * detect (V*)
, * - *
overlapping * - (A2*
the (DNA* - *
promoters *) - *)
of * - *
the * - *
nagE * - *
and * - *
nagB * - *
genes * - *
. * - *

A * - (A1* *
factor * - *) *
that * - * *
positively * - (A5*) *
regulates * regulate (V*) *
cell * - (A0* *
division * - *) *
by * - * *
activating * - * *
transcription * transcription * (V*)
of * - * *
the (DNA* - * (A0*
major * - * *
cluster * - * *
of * - * *
essential * - * *
cell * - * *
division * - * *
genes *) - * *)
of * - * *
Escherichia * - * *
coli * - * *
. * - * *

In * - *
vivo * - *
footprinting * - *
analysis * - *
revealed * - *
that * - *
XylR (PTE*) - (A1*)
binds * bind (V*)
to * - *
at * - *
least * - *
two * - *
DNA * - *
regions * - *
, * - *
IA (DNA*) - (A7*)
and * - *
IF (DNA*) - *
, * - *
each * - *
with * - *
a * - *
direct * - *
repeat * - *
. * - *

Inducible * - (A5*) (A0*
expression * express (V*) *
of * - *) *)
human * - * *
immunodeficiency * - * *
virus * - * *
( * - * *
HIV (ORG*) - * *
) * - * *
is * - * *
regulated * regulate * (V*)
by * - * *
a * - * *
cellular * - * *
transcription * - * *
factor * - * *
, * - * *
nuclear * - * *
factor * - * *
kappa * - * *
B * - * *
( * - * *
NF-kappa (PTE* - * (A1*
B *) - * *)
) * - * *
. * - * *

We * - * *
describe * - * *
here * - * *
a * - (A1* *
factor * - *) *
that * - * *
activates * activate (V*) *
cell * - (A0* *
division * - *) *
by * - * *
specifically * - * *
increasing * - * *
transcription * transcription * (V*)
from * - * *
one (DNA* - * (A6*
of * - * *
the * - * *
two * - * *
promoters *) - * *)
that * - * *
lie * - * *
immediately * - * *
upstream * - * *
of * - * *
the * - * *
ftsQAZ * - * *
gene * - * *
cluster * - * *
. * - * *

In * - *
vitro * - *
transcription * - *
assays * - *
showed * - *
that * - *
phospho-ArcA * - *
( * - *
ArcA-P (PTE*) - *
) * - *
represses * - *
ptsG (DNA*) - (A0*
P1 * - *)
transcription * transcription (V*)
. * - *

In * - *
this * - *
work * - *
, * - *
ArgR (DNA* - (A1*
mutants *) - *)
that * - *
are * - *
defective * - *
in * - *
trimer-trimer * - *
interactions * - *
and * - *
bind * bind (V*)
DNA (DNA*) - (A7*)
as * - *
trimers * - *
in * - *
an * - *
L-arginine-independent * - *
manner * - *
are * - *
isolated * - *
and * - *
characterized * - *
. * - *

These * - * * * *
mutations * - * * * *
also * - * * * *
suppress * - * * * *
induction * induce (V*) * * *
by * - * * * *
nitrite (EXP*) - (A1*) * * *
: * - * * * *
single * - * (A5*) * *
mutations (PRC*) mutations * (V*) * *
at * - * (A2* * *
symmetry-related * - * * * *
positions * - * *) * *
have * - * * * *
similar * - * * * *
effects * - * * * *
, * - * * * *
whilst * - * * * *
double * - * * (A5*) *
mutations * mutations * * (V*) *
have * - * * * *
more * - * * * *
severe * - * * * *
effects * - * * * *
, * - * * * *
probably * - * * * *
because * - * * * *
two (PTE* - * * * (A1*
NarL * - * * * *
subunits *) - * * * *)
bind * bind * * * (V*)
to * - * * * *
the (DNA* - * * * (A7*
inverted * - * * * *
repeat *) - * * * *)
. * - * * * *

CueR (PTE*) - *
( * - *
YbbI * - *
) * - *
of * - *
Escherichia * - *
coli * - *
is * - *
a * - *
MerR * - *
family * - *
regulator * - *
controlling * - *
expression * express (V*)
of * - *
the (PTE* - (A0*
copper * - *
exporter * - *
CopA *) - *)
. * - *

In * - (A5*
vitro * - *)
transcription * transcription (V*)
from * - *
ompB (DNA* - (A6*
promoter * - *
fragments *) - *)
was * - *
specifically * - *
blocked * - *
by * - *
IHF (PTE*) - *
. * - *

Additionally * - * *
, * - * *
although * - * *
CRP (PTE*) - (A1*) (A1*)
is * - * *
unable * - * *
to * - * *
bind * bind (V*) *
to * - * *
the (DNA* - (A7* *
melAB * - * *
promoter *) - *) *
in * - * *
the * - * *
absence * - * *
of * - * *
MelR (PTE*) - (A3*) *
, * - * *
in * - * *
the * - * *
presence * - * *
of * - * *
MelR (PTE*) - * (A3*)
, * - * *
it * - * *
binds * bind * (V*)
to * - * *
a (DNA* - * (A7*
site *) - * *)
located * - * *
between * - * *
MelR * - * *
binding * - * *
Site * - * *
1 * - * *
and * - * *
Site * - * *
2 * - * *
. * - * *

Additional * - * * *
experiments * - * * *
with * - * * *
mutations * mutations (V*) * *
at * - (A2* * *
the * - * * *
-10 * - * * *
sequence * - * * *
of * - * * *
the (DNA* - * * (A1*
gcd * - * * *
promoter *) - *) * *)
suggest * - * * *
that * - * * *
the * - * * *
binding * bind * (V*) *
of * - * * *
RNA (PTE* - * (A1* (A1*
polymerase *) - * *) *)
to * - * * *
the (DNA* - * (A7* *
hpt * - * * *
promoter *) - * *) *
interferes * - * * *
with * - * * *
the * - * * *
interaction * interact * * (V*)
of * - * * *
RNA * - * * *
polymerase * - * * *
with * - * * *
the * - * * *
gcd * - * * *
promoter * - * * *
, * - * * *
and * - * * *
vice * - * * *
versa * - * * *
. * - * * *

E-RC1 (PTE*) - *
displays * - *
functional * - *
selectivity * - *
toward * - *
transcription * - *
factors * - *
, * - *
since * - *
it * - *
cannot * - *
activate * - *
expression * express (V*)
of * - *
chromatin-assembled * - (A0*
HIV-1 * - *
templates * - *)
with * - *
the * - *
E * - *
box-binding * - *
protein * - *
TFE-3 * - *
. * - *

In * - *
an * - *
accompanying * - *
paper * - *
( * - *
J * - *
. * - *
E * - *
. * - *
Kirby * - *
, * - *
J * - *
. * - *
E * - *
. * - *
Trempy * - *
, * - *
and * - *
S * - *
. * - *
Gottesman * - *
, * - *
J * - *
. * - *
Bacteriol * - *
. * - *
176 * - *
: * - *
2068-2081 * - *
, * - *
1994 * - *
) * - *
, * - *
we * - *
show * - *
that * - *
neither * - *
AlpA * - *
nor * - *
SlpA * - *
is * - *
a * - *
component * - *
of * - *
the * - *
protease * - *
itself * - *
but * - *
that * - *
they * - *
are * - *
part * - *
of * - *
a * - (A1*
regulatory * - *
cascade * - *)
which * - *
leads * - *
to * - *
expression * express (V*)
of * - *
the (PTE* - (A0*
Alp * - *
protease *) - *)
. * - *

We * - *
have * - *
identified * - *
five (PTE* - (A0*
hydrophobic * - *
amino * - *
acid * - *
residues *) - *)
on * - *
the * - *
ALK4 * - *
extracellular * - *
domain * - *
( * - *
Leu40 * - *
, * - *
Ile70 * - *
, * - *
Val73 * - *
, * - *
Leu75 * - *
, * - *
and * - *
Pro77 * - *
) * - *
that * - *
, * - *
when * - *
mutated * mutate (V*)
to * - *
alanine (PTE*) - (A7*)
, * - *
have * - *
substantial * - *
effects * - *
on * - *
ALK4-trunc * - *
dominant * - *
negative * - *
activity * - *
. * - *

In * - * *
conclusion * - * *
, * - * *
transcription * transcription (V*) *
of * - * *
the (DNA* - (A0* *
cydAB * - * *
operon *) - *) *
is * - * *
driven * - * *
by * - * *
a (PTE* - * *
complex * - * *
regulatory * - * *
element *) - * *
containing * - * *
at * - * *
least * - * *
five * - * *
promoters * - * *
that * - * *
act * - * *
in * - * *
unison * - * *
to * - * *
provide * - * *
adequate * - * *
oxygen (EXP*) - * *
control * - * *
of * - * *
gene * - * (A0*)
expression * express * (V*)
. * - * *

The (DNA* - (A1*
ftsH * - *
gene *) - *)
, * - *
previously * - *
shown * - *
to * - *
code * code (V*)
for * - *
an (PTE* - (A0*
essential * - *
inner * - *
membrane * - *
protein *) - *)
with * - *
putative * - *
ATPase * - *
activity * - *
, * - *
is * - *
identical * - *
to * - *
hflB * - *
, * - *
a * - *
gene * - *
involved * - *
in * - *
the * - *
stability * - *
of * - *
the * - *
phage * - *
cII * - *
activator * - *
protein * - *
. * - *

The * - *
Gal * - *
isorepressor * - *
is * - *
a * - *
protein * - *
of * - *
346 * - *
amino * - *
acid * - *
residues * - *
whose * - *
amino * - *
acid * - *
sequence * - *
and * - *
cellular * - *
function * - *
, * - *
as * - *
described * - *
here * - *
, * - *
are * - *
very * - *
similar * - *
to * - *
that * - *
of * - *
Gal (PTE* - (A0*
repressor *) - *)
, * - *
encoded * encode (V*)
by * - *
the (DNA* - (A1*
galR * - *
gene *) - *)
. * - *

That * - *
is * - *
, * - *
the (DNA* - (A1*
low-affinity * - *
sites *) - *)
constitute * - *
a * - *
'governor' * - *
, * - *
limiting * limit (V*)
the (PRC* - (A0*
maximum * - *
promoter * - *
activity *) - *)
. * - *

